
<html lang="en"     class="pb-page"  data-request-id="cda27cc8-d3e4-46d4-8604-f14ece0a4485"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;issue:issue:10.1021/jmcmar.2021.64.issue-9;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c02018"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Novel and Potent N-Methyl-d-aspartate Receptor Positive Allosteric Modulators with Antidepressant-like Activity in Rodent Models" /></meta><meta name="dc.Creator" content="Zhongtang  Li" /></meta><meta name="dc.Creator" content="Guanxing  Cai" /></meta><meta name="dc.Creator" content="Fan  Fang" /></meta><meta name="dc.Creator" content="Wenchao  Li" /></meta><meta name="dc.Creator" content="Minghua  Fan" /></meta><meta name="dc.Creator" content="Jingjing  Lian" /></meta><meta name="dc.Creator" content="Yinli  Qiu" /></meta><meta name="dc.Creator" content="Xiangqing  Xu" /></meta><meta name="dc.Creator" content="Xuehui  Lv" /></meta><meta name="dc.Creator" content="Yiyan  Li" /></meta><meta name="dc.Creator" content="Ruqiu  Zheng" /></meta><meta name="dc.Creator" content="Yuxi  Wang" /></meta><meta name="dc.Creator" content="Zhongjun  Li" /></meta><meta name="dc.Creator" content="Guisen  Zhang" /></meta><meta name="dc.Creator" content="Zhenming  Liu" /></meta><meta name="dc.Creator" content="Zhuo  Huang" /></meta><meta name="dc.Creator" content="Liangren  Zhang" /></meta><meta name="dc.Description" content="N-Methyl-d-aspartate receptors (NMDARs) are glutamate-gated Na+ and Ca2+-permeable ion channels involved in excitatory synaptic transmission and synaptic plasticity. NMDAR hypofunction has long bee..." /></meta><meta name="Description" content="N-Methyl-d-aspartate receptors (NMDARs) are glutamate-gated Na+ and Ca2+-permeable ion channels involved in excitatory synaptic transmission and synaptic plasticity. NMDAR hypofunction has long bee..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 3, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c02018" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02018" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c02018" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02018" /></link>
        
    
    

<title>Discovery of Novel and Potent N-Methyl-d-aspartate Receptor Positive Allosteric Modulators with Antidepressant-like Activity in Rodent Models | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c02018" /></meta><meta property="og:title" content="Discovery of Novel and Potent N-Methyl-d-aspartate Receptor Positive Allosteric Modulators with Antidepressant-like Activity in Rodent Models" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0021.jpeg" /></meta><meta property="og:description" content="N-Methyl-d-aspartate receptors (NMDARs) are glutamate-gated Na+ and Ca2+-permeable ion channels involved in excitatory synaptic transmission and synaptic plasticity. NMDAR hypofunction has long been implicated in the pathophysiology including major depressive disorders (MDDs). Herein, we report a series of furan-2-carboxamide analogues as novel NMDAR-positive allosteric modulators (PAMs). Through structure-based virtual screen and electrophysiological tests, FS2921 was identified as a novel NMDAR PAM with potential antidepressant effects. Further structure–activity relationship studies led to the discovery of novel analogues with increased potentiation. Compound 32h caused a significant increase in NMDAR excitability in vitro and impressive activity in the forced swimming test. Moreover, compound 32h showed no significant inhibition of hERG or cell viability and possessed a favorable PK/PD profile. Our study presented a series of novel NMDAR PAMs and provided potential opportunities for discovering of new antidepressants." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c02018"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02018">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c02018&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c02018&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c02018&amp;href=/doi/10.1021/acs.jmedchem.0c02018" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 5551-5576</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01965" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c02041" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Novel and Potent <i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate Receptor Positive Allosteric Modulators with Antidepressant-like Activity in Rodent Models</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Zhongtang Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhongtang Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhongtang++Li">Zhongtang Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guanxing Cai</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guanxing Cai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guanxing++Cai">Guanxing Cai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fan Fang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fan Fang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fan++Fang">Fan Fang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wenchao Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wenchao Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wenchao++Li">Wenchao Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Minghua Fan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Minghua Fan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Minghua++Fan">Minghua Fan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jingjing Lian</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jingjing Lian</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jingjing++Lian">Jingjing Lian</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yinli Qiu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yinli Qiu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Jiangsu Nhwa Pharmaceutical Co., Ltd. 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yinli++Qiu">Yinli Qiu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiangqing Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiangqing Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Jiangsu Nhwa Pharmaceutical Co., Ltd. 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiangqing++Xu">Xiangqing Xu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xuehui Lv</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xuehui Lv</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xuehui++Lv">Xuehui Lv</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yiyan Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yiyan Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yiyan++Li">Yiyan Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ruqiu Zheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ruqiu Zheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ruqiu++Zheng">Ruqiu Zheng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yuxi Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yuxi Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yuxi++Wang">Yuxi Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhongjun Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhongjun Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhongjun++Li">Zhongjun Li</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1642-7773" title="Orcid link">http://orcid.org/0000-0003-1642-7773</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Guisen Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Guisen Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Jiangsu Key Laboratory of Marine Biological Resources and Environment, Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening, School of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Guisen++Zhang">Guisen Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhenming Liu</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhenming Liu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#0d77606164784d6f67607823686978236e63"><span class="__cf_email__" data-cfemail="512b3c3d382411333b3c247f3435247f323f">[email protected]</span></a>. Tel: +86-10-8280-5281.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhenming++Liu">Zhenming Liu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8993-4015" title="Orcid link">http://orcid.org/0000-0002-8993-4015</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhuo Huang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhuo Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#167e637778716c567e657538667d6338737263387578"><span class="__cf_email__" data-cfemail="3d55485c535a477d554e5e134d564813585948135e53">[email protected]</span></a>. Tel: +86-10-8280-5925.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhuo++Huang">Zhuo Huang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9198-4778" title="Orcid link">http://orcid.org/0000-0001-9198-4778</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Liangren Zhang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Liangren Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing 100191, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#7d11141c131a0f18133d1f17100853181908531e13"><span class="__cf_email__" data-cfemail="5a36333b343d283f341a3830372f743f3e2f743934">[email protected]</span></a>. Tel: +86-10-8280-2567.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Liangren++Zhang">Liangren Zhang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7362-9497" title="Orcid link">http://orcid.org/0000-0002-7362-9497</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02018&amp;href=/doi/10.1021%2Facs.jmedchem.0c02018" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 5551–5576</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 3, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 November 2020</li><li><span class="item_label"><b>Published</b> online</span>3 May 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 May 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c02018" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02018</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5551%26pageCount%3D26%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DZhongtang%2BLi%252C%2BGuanxing%2BCai%252C%2BFan%2BFang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D9%26contentID%3Dacs.jmedchem.0c02018%26title%3DDiscovery%2Bof%2BNovel%2Band%2BPotent%2BN-Methyl-d-aspartate%2BReceptor%2BPositive%2BAllosteric%2BModulators%2Bwith%2BAntidepressant-like%2BActivity%2Bin%2BRodent%2BModels%26numPages%3D26%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5576%26publicationDate%3DMay%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c02018"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">702</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c02018" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Novel and Potent N-Methyl-d-aspartate Receptor Positive Allosteric Modulators with Antidepressant-like Activity in Rodent Models&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Zhongtang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Guanxing&quot;,&quot;last_name&quot;:&quot;Cai&quot;},{&quot;first_name&quot;:&quot;Fan&quot;,&quot;last_name&quot;:&quot;Fang&quot;},{&quot;first_name&quot;:&quot;Wenchao&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Minghua&quot;,&quot;last_name&quot;:&quot;Fan&quot;},{&quot;first_name&quot;:&quot;Jingjing&quot;,&quot;last_name&quot;:&quot;Lian&quot;},{&quot;first_name&quot;:&quot;Yinli&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Xiangqing&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Xuehui&quot;,&quot;last_name&quot;:&quot;Lv&quot;},{&quot;first_name&quot;:&quot;Yiyan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Ruqiu&quot;,&quot;last_name&quot;:&quot;Zheng&quot;},{&quot;first_name&quot;:&quot;Yuxi&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zhongjun&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Guisen&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Zhenming&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Zhuo&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Liangren&quot;,&quot;last_name&quot;:&quot;Zhang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;5551-5576&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c02018&quot;},&quot;abstract&quot;:&quot;N-Methyl-d-aspartate receptors (NMDARs) are glutamate-gated Na+ and Ca2+-permeable ion channels involved in excitatory synaptic transmission and synaptic plasticity. NMDAR hypofunction has long been implicated in the pathophysiology including major depressive disorders (MDDs). Herein, we report a series of furan-2-carboxamide analogues as novel NMDAR-positive allosteric modulators (PAMs). Through structure-based virtual screen and electrophysiological tests, FS2921 was identified as a novel NMDAR PAM with potential antidepressant effects. Further structure–activity relationship studies led to the discovery of novel analogues with increased potentiation. Compound 32h caused a significant increase in NMDAR excitability in vitro and impressive activity in the forced swimming test. Moreover, compound 32h showed no significant inhibition of hERG or cell viability and possessed a favorable PK/PD profile. Our study presented a series of novel NMDAR PAMs and provided potential opportunities for discovering of new ant&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02018&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02018" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02018&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02018" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02018&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02018" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02018&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02018&amp;href=/doi/10.1021/acs.jmedchem.0c02018" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c02018" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c02018" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c02018%26sid%3Dliteratum%253Aachs%26pmid%3D33934604%26genre%3Darticle%26aulast%3DLi%26date%3D2021%26atitle%3DDiscovery%2Bof%2BNovel%2Band%2BPotent%2BN-Methyl-d-aspartate%2BReceptor%2BPositive%2BAllosteric%2BModulators%2Bwith%2BAntidepressant-like%2BActivity%2Bin%2BRodent%2BModels%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D9%26spage%3D5551%26epage%3D5576%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291713" title="Polyacrylamide">Polyacrylamide</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=291445" title="Chemical structure">Chemical structure</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/jmcmar.2021.64.issue-9/20210513/jmcmar.2021.64.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText"><i>N</i>-Methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptors (NMDARs) are glutamate-gated Na<sup>+</sup> and Ca<sup>2+</sup>-permeable ion channels involved in excitatory synaptic transmission and synaptic plasticity. NMDAR hypofunction has long been implicated in the pathophysiology including major depressive disorders (MDDs). Herein, we report a series of furan-2-carboxamide analogues as novel NMDAR-positive allosteric modulators (PAMs). Through structure-based virtual screen and electrophysiological tests, FS2921 was identified as a novel NMDAR PAM with potential antidepressant effects. Further structure–activity relationship studies led to the discovery of novel analogues with increased potentiation. Compound <b>32h</b> caused a significant increase in NMDAR excitability <i>in vitro</i> and impressive activity in the forced swimming test. Moreover, compound <b>32h</b> showed no significant inhibition of hERG or cell viability and possessed a favorable PK/PD profile. Our study presented a series of novel NMDAR PAMs and provided potential opportunities for discovering of new antidepressants.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73321" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73321" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">MDDs involve depressed mood, loss of interest and enjoyment, and decreased energy, causing increased global disability and suicide rates.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> However, the pathogenesis of MDDs remains complicated and unclear. Thus far, the monoamine-deficiency hypothesis is the main pathophysiological explanation of MDDs. However, considering a number of refractory patients, a novel therapeutic mechanism should be proposed.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">The recent approval of esketamine by the Food and Drug Administration (FDA) for treating treatment-resistant depression represents an important milestone in MDD drug discovery; indeed, this is the first mechanistically distinct drug approved in the past three decades. Although it is an <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor (NMDAR) blocker, esketamine (<b>1</b>) can alleviate depressive symptoms in deeply depressive and treatment-resistant patients via complex mechanisms, mainly including synaptic or GluN2B-selective extrasynaptic NMDAR inhibition, inhibition of NMDARs localized on GABAergic interneurons, and inhibition of NMDAR-dependent burst firing of lateral habenula neurons.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3,4)</a> However, there are several apparent limitations of esketamine, including its potential for abuse, cardiovascular and urinary tract side effects, and its dissociative effects necessitating the hospitalization of patients during the treatment. Therefore, the identification of safer NMDAR modulators is an essential goal in discovering novel antidepressants.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">NMDARs are distinct dual-ligand-gated ion channels activated by the brain’s primary excitatory neurotransmitter, <span class="smallcaps smallerCapital">l</span>-glutamate, and another co-agonist, <span class="smallcaps smallerCapital">d</span>-serine or glycine. As a heterotetrameric complex, the NMDAR is assembled by two obligatory GluN1 subunits with either two GluN2 subunits (including GluN2A–GluN2D) or a combination of one GluN2 subunit and one GluN3 subunit (including GluN3A–GluN3B).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> NMDARs are nonselective to Na<sup>+</sup>, K<sup>+</sup>, or Ca<sup>2+</sup>; they are stimulated by the simultaneous binding of <span class="smallcaps smallerCapital">l</span>-glutamate to the GluN2 subunit and glycine (or <span class="smallcaps smallerCapital">d</span>-serine) to the GluN1 or GluN3 subunit.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Like other ionotropic glutamate receptors, NMDARs have a modular structure composed of multiple domains: the extracellular amino terminal domain (ATD), which participates in subunit assembly and allosteric regulation; the ligand binding domains (LBDs), which are involved in endogenous ligand binding; and the transmembrane domains (TMD), which form the heterotetrameric ion pore.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Considering that NMDARs are involved in numerous neurological disorders, they have great potential as therapeutic targets.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> However, their blockage may lead to psychotomimetic effects and impaired cognition. Furthermore, hyperactivation of NMDARs may lead to adverse effects, such as epilepsy, neuronal cell death, and hyperalgesia.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> There is growing evidence suggesting that stimulation of hypoactive NMDARs leads to moderate benefits in animal and human antidepressant studies.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> To develop novel pharmacotherapies targeting NMDARs that mimic esketamine’s antidepressant actions and avoid its undesirable effects, several modulators have been discovered. Rapastinel (Glyx-13, <b>2</b>), a partial agonist of the NMDAR glycine site, produced a rapid-acting and long-lasting reduction in depressive symptoms in the phase II trial but failed in the phase III trial.<a onclick="showRef(event, 'ref14 ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16 ref17 ref18 ref19">(14−19)</a> Apimostinel (NRX-1074, <b>3</b>) is another orally bioavailable NMDAR partial agonist in clinical trials with higher potency than rapastinel in terms of NMDAR activity.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Unlike agonists at the glycine site, NMDAR PAMs are supposed to reverse the hypofunction of NMDARs while avoiding the toxicity associated with the overactivation of NMDARs. Additionally, allosteric modulators offer the benefits of higher selectivity and better modulatory control. Recently, there has been increased interest in studying NMDAR PAMs for their potential therapeutic benefits in treating MDDs, schizophrenia, and cognitive deficits.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21−23)</a> Several endogenous neurosteroids have been reported to play critical roles in regulating the nervous system by allosteric modulation of NMDARs.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27">(24−27)</a> Numerous synthetic compounds were also identified as NMDAR PAMs in studies of NMDAR-related physiological activities and therapeutic potential.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31">(28−31)</a> However, none of them have been approved for clinical use. Recently, a series of novel GluN2A-selective PAMs characterized by a thiazolopyrimidinone scaffold have been developed. Structure–activity relationship (SAR) and X-ray crystallography studies have suggested that GNE-6901 (<b>4</b>) binds to an allosteric site between the GluN1-GluN2A LBD dimers.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Additional medicinal chemistry work was then performed to optimize the potency and drug-like properties of GNE-6901. For example, the 3-trifluoromethylpyrazole moiety has been found to have enhanced metabolic stability, and a cyclopropyl nitrile substituent (GNE-0723, <b>5</b>) was introduced to the 3-position to balance several drug-like properties. GNE-0723 achieved the best GluN2A-selectivity over the other NMDAR subtypes and AMPA receptors.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> GNE-5729 (<b>6</b>) is a derivative of GNE-0723 with a pyridopyrimidinone core characterized by an improved pharmacokinetic profile.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p last">Although significant efforts have been made to discover novel PAMs of NMDARs during the past 10 years, few compounds with high activity <i>in vivo</i> have been obtained. Furthermore, there have been few studies on the antidepressant activity of NMDAR PAMs. In this study, we reported the identification of a novel series of NMDAR PAMs with impressive antidepressant potency <i>in vivo</i>. From the initial hit compounds containing the furan-2-carboxamide scaffold, over 60 structural analogues were synthesized and evaluated for a comprehensive SAR investigation, which led to the identification of compound <b>32h</b> as a potent and BBB-penetrable NMDAR PAM suitable for <i>in vivo</i> characterization. Furthermore, compound <b>32h</b> exhibited potential antidepressant activities <i>in vivo</i> with moderate safety profiles in psychotic side effects, hERG channel inhibition, and long-term administration. <i>In vivo</i> PK/PD profiles and the exquisite target selectivity of compound <b>32h</b> were also satisfactory. Taken together, compound <b>32h</b> was supported to be an excellent lead compound for further optimizations of the novel NMDAR PAMs with distinct antidepressant-like effects <i>in vivo</i>.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88450" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88450" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthetic routes of all compounds are summarized in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>–<named-content content-type="anchor" rid="sch2" type="simple"></named-content><named-content content-type="anchor" rid="sch3" type="simple"></named-content><named-content content-type="anchor" rid="sch4" type="simple"></named-content><a class="ref internalNav" href="#sch5" aria-label="5">5</a>. All furan-2-carboxamide analogues (<b>9a-c</b>, <b>16a/b</b>, <b>17a-n</b>, <b>20a-k</b>, <b>22a-d</b>, and <b>24a-e</b>) were generally obtained by an amide coupling reaction in the presence of HATU and <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) in CH<sub>2</sub>Cl<sub>2</sub>. Compounds <b>9a-c</b> were all synthesized with commercially available materials in high yields. For furan-2-carboxamide derivatives <b>16a/b</b> and <b>17a-n</b> (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), commercially available compound <b>10</b> was used as a starting material to prepare compound <b>11</b> by methylation. The hydroxyl of compound <b>11</b> was substituted with chlorine to yield compound <b>12</b> and then substituted with iodine to yield compound <b>13</b>. Compound <b>14</b> was prepared using 3,5-dimethyl<i>-</i>1<i>H</i>-pyrazole by an SN2 nucleophilic substitution reaction. Then, compound <b>15</b> was synthesized by hydrolyzing compound <b>1</b>4 to prepare final products <b>16a/b</b> and <b>17a-n</b>. Target compounds <b>20a-k</b> were obtained from the key intermediate <b>13</b> through the same synthetic route (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Similarly, compounds <b>22a-d</b> with the methoxycarbonyl group at the 2-position of the phenyl group were generated by the general amide coupling reaction. Hydrolyzation without purification and the amide coupling reaction produced the final compounds <b>24a-e</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).</div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>9a-c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h.</p></p></figure><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>16a/b</b> and <b>17a-n</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) H<sub>2</sub>SO<sub>4</sub>, MeOH; (ii) SOCl<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 1 h; (iii) NaI, acetone, reflux, 0.5 h; (iv) 3,5-dimethyl<i>-</i>1<i>H</i>-pyrazole or 3,5-ditrifluoromethyl<i>-</i>1<i>H</i>-pyrazole, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 60 °C, 7 h; (v) NaOH, MeOH, 40 °C, 3 h; (vi) 3-aminopyridine for <b>16a</b> and 2-naphthylamine for <b>16b</b> and substituted aniline for <b>17a-n</b> or DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h.</p></p></figure><figure id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>20a-j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 3-methyl-5-trifluoromethyl<i>-</i>1<i>H</i>-pyrazole or 3,5-ditrifluoromethyl<i>-</i>1<i>H</i>-pyrazole, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 60 °C, 7 h; (ii) NaOH, MeOH, 40 °C, 3 h; (iii) substituted aniline, DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h.</p></p></figure><figure id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>24a-e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h; (ii) NaOH, MeOH, 40 °C, 3 h; (iii) 4-amino-1-butanol for <b>24a</b>, 3-aminopropanol for <b>24b</b>, benzylamine for <b>24c</b>, aniline for <b>24d</b> and butylamine for <b>24e</b>; DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h.</p></p></figure><figure id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis Compounds <b>32a-o</b> and <b>33a-f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) MeI, NaHCO<sub>3</sub>, DMF; (ii) NaBH<sub>3</sub>CN, EtOH; (iii) SOCl<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 1 h; (iv) NaI, acetone, reflux, 0.5 h; (v) 3,5-dimethyl<i>-</i>1<i>H</i>-pyrazole, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 60 °C, 7 h; (vi) NaOH, MeOH, 40 °C, 3 h; (vii) naphthalen-2-amine for <b>33a</b>, isoquinolin-6-amine for <b>33b</b>, quinolin-7-amine for <b>33c</b>, 1<i>H</i>-indol-6-amine for <b>33d</b>, 1<i>H</i>-benzo[<i>d</i>]imidazol-6-amine for <b>33e</b>, 5-amino-1,3-dihydro-2<i>H</i>-benzo[<i>d</i>]imidazol-2-one for <b>33f</b> and substituted aniline, DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h.</p></p></figure><div class="NLM_p last">As shown in <a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>, a series of thiophene-2-carboxamide analogues were also designed and synthesized using a similar route, starting with commercially available 5-formylthiophene-2-carboxylic acid (compound <b>25</b>). Compound <b>25</b> treated with methyl iodide and NaHCO<sub>3</sub> generated compound <b>26</b>. Reduction of compound <b>26</b> produced compound <b>27</b>. Several reactions mentioned above were used to yield an important intermediate <b>31</b> from compound <b>27</b> efficiently. Finally, compound <b>31</b> and different substituted anilines or different aromatic amines were coupled with the general method to generate compounds <b>32a-o</b> and compounds <b>33a-f</b>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63038" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63038" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure-Based Virtual Screening and Identification of Two Potential NMDAR PAMs</h3><div class="NLM_p">Several studies identified an allosteric binding site for GNE series compounds between the GluN2A and GluN1LBDs.<a onclick="showRef(event, 'ref32 ref33 ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref32 ref33 ref34 ref35">(32−35)</a> Our workflow of virtual screening is summarized in the protocol in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A. One co-crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KDT">5KDT</a>, <a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Table S1</a>) of GNE0723 was chosen for the virtual screening to identify novel NMDAR ligands. More than 300,000 compounds from the SPECS chemical library and the Chinese National Compound Library of Peking University (PKU-CNCL) were docked onto the crystal structure using the Glide molecular docking module. Sorted by docking score, all compounds within the top one percent were obtained. Because the residue Val266 of GluN2A at the dimer interface is a key residue for the selectivity of GluN2A-containing NMDARs, compounds interacting with Val266 were isolated using the PoseFilter module in the Maestro platform. Based on compound docking results and physicochemical properties, eight compounds were purchased for further biological activity tests (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Table S2</a>). All of the active compounds passed the pan assay interference compound (PAINS) test by PAINS-remover.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a></div><figure id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potential antidepressants targeting NMDARs (A) and positive allosteric modulators of NMDARs (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The NMDAR currents induced by NMDA in mouse brain slices were detected by patch-clamp experiments. As depicted in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C, slight currents induced by 10 μM NMDA were observed. Then, the selected compounds were added in the presence of 10 μM NMDA. Significantly enhanced currents were observed with FS2915 and FS2921 (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B), representing the most prominent NMDAR sensitization potency with more than 10<sup>3</sup> pA current. Compared with the vehicle, FS2915 enhanced currents by more than 30 folds (△<i>I</i>/<i>I</i><sub>NMDA</sub> > 30), while FS2921 exhibited a △<i>I</i>/<i>I</i><sub>NMDA</sub> value of 19.3. We also calculated the CNS drug-like properties of the selected compounds, with favorable values defined as <i>A</i> log <i>P</i> < 3, polar surface area (PSA) < 90 Å<sup>2</sup>, and blood–brain barrier (BBB) permeability with the ADMET_BBB_Level < 3. FS2915 showed a higher activity and more favorable <i>A</i> log <i>P</i>, but it was predicted to have poor BBB permeability probably because of the higher PSA. FS2921 seemed to possess moderate activity and drug-like properties with the exception of a high <i>A</i> log <i>P</i>. Based on the chemical structure characteristics, furan-2-carboxamide was identified as a common scaffold shared by FS2915 and FS2921, which provided a potential starting scaffold for more chemical modifications to improve biological activities and physicochemical properties (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Summary of the workflow of virtual screening; (B) chemical structures of two identified NMDAR PAMs; (C) whole-cell recordings of currents evoked by 10 μM NMDA and 10 μM FS2915 or FS2921 on slices of the mouse brain. Scale: <i>X</i> axis = 250 s and <i>Y</i> axis = 500 pA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Enhancement Effects on NMDARs and Representative Molecular Properties of the Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center" char="±">current (pA)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">△<i>I</i>/<i>I</i><sub>NMDA</sub> (mean ± SEM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">MW<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center"><i>A</i> log <i>P</i><a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">ADMET_BBB_level<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center">Log BB<a class="ref internalNav" href="#t1fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center">PSA<a class="ref internalNav" href="#t1fn7" aria-label="g">g</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">Vehicle</td><td class="colsep0 rowsep0" align="char" char="±">54.6 ± 4.6</td><td class="colsep0 rowsep0" align="center">ND<a class="ref internalNav" href="#t1fn8" aria-label="h">h</a></td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">FS2915</td><td class="colsep0 rowsep0" align="char" char="±">1317.0 ± 297.6</td><td class="colsep0 rowsep0" align="center">32.8 ± 13.7</td><td class="colsep0 rowsep0" align="center">336.8</td><td class="colsep0 rowsep0" align="center">2.78</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="center">–1.11</td><td class="colsep0 rowsep0" align="center">101.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">FS2921</td><td class="colsep0 rowsep0" align="char" char="±">1183.0 ± 302.9</td><td class="colsep0 rowsep0" align="center">19.3 ± 5.2</td><td class="colsep0 rowsep0" align="center">388.3</td><td class="colsep0 rowsep0" align="center">4.79</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="center">–0.18</td><td class="colsep0 rowsep0" align="center">59.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">NMDAR currents were determined at the saturated concentrations of  glutamate. Data are presented as geometric mean values of at least three independent runs.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Values are the increased folds of test compound (30 μM) coupled with NMDA (100 μM) over NMDA (100 μM) alone. Data are presented as geometric mean values of at least three independent runs.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Molecular weight.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">Predicted octanol/water partition coefficient using the Maestro 11.5 <i>Qikprop</i> module.</p></div><div class="footnote" id="t1fn5"><sup><sup>e</sup></sup><p class="last">0: very high; 1: high; 2: medium; 3: low; 4: undefined.</p></div><div class="footnote" id="t1fn6"><sup><sup>f</sup></sup><p class="last">Log of the brain/blood partition coefficient (Log BB) using the Maestro 11.5 <i>Qikprop</i> module.</p></div><div class="footnote" id="t1fn7"><sup><sup>g</sup></sup><p class="last">Topographical polar surface area using the Maestro 11.5 <i>Qikprop</i> module.</p></div><div class="footnote" id="t1fn8"><sup><sup>h</sup></sup><p class="last">Not determined.</p></div></div></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Allosteric Modulation of NMDARs by FS2921</h3><div class="NLM_p">To better understand the allosteric modulation of native neuronal NMDARs, we performed the whole-cell patch-clamp experiments on neurons with FS2921. <i>In vitro</i> cultured neurons were visibly surrounding by glial cells, and glial cells provided endogenous glycine/<span class="smallcaps smallerCapital">d</span>-serine to support neurons. It was expected that the concentration of glycine/<span class="smallcaps smallerCapital">d</span>-serine around the cells would increase with the culture time.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> After culturing for about 7 days, all the young neurons were screened to provide neurons with normal reaction by adding NMDA (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Due to the low level of endogenous glycine/<span class="smallcaps smallerCapital">d</span>-serine, selected neurons gave the weak currents (below 200 pA) induced by 20 μM NMDA alone.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> When 10 μM FS2921 was added without exogenous glycine/<span class="smallcaps smallerCapital">d</span>-serine, the response to 20 μM NMDA was observed to remain unchanged. Therefore, we suspected that FS2921 could not potentiate the NMDAR response induced by 20 μM NMDA because of the low concentration of <span class="smallcaps smallerCapital">d</span>-serine produced by glial cells cultured for 7 to 8 days. However, when the primary neurons were treated with exogenous 20 μM NMDA and 30 μM glycine, increased NMDA currents were observed when compared with those in neurons treated with NMDA alone.</div><div class="NLM_p">When 10 μM FS2921 was continuously present with exogenous 20 μM NMDA and 30 μM glycine, NMDAR currents were significantly enhanced to more than 600 pA. The results suggested that FS2921 could significantly potentiate the NMDAR response in the presence of the co-agonist glycine. Furthermore, a similar electrophysiological experiment was performed on the GluN1/GluN2A overexpressing HEK-293 cells to prove that FS2921 has no activity as a glutamate agonist or a glycine agonist. The GluN1/GluN2A-overexpressing cell line could avoid the endogenous glutamate or glycine, so that glycine or glutamate alone did not show response, while glycine coupled with glutamate caused apparent currents. FS2921 did not show any response to glycine or NMDA alone, indicating that FS2921 did not act as a glutamate or glycine agonist (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Figure S1</a> in the Supporting Information).</div><div class="NLM_p">Considering that NMDAR requires to be co-activated by two agonists, two different dose–effect relationship studies were performed to determine the allosteric modulation to NMDA and glycine, separately. Whole-cell recording from neurons cultured <i>in vitro</i> showed that NMDA induced the currents in the presence of 30 μM glycine in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B); likewise, glycine induced the currents in the presence of 100 μM NMDA (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). FS2921 slightly increased NMDA potency from 23.9 ± 1.3 to 13.6 ± 1.1 μM, but it had no influence on the maximum currents induced by saturated NMDA. When the recording was performed in the constant presence of 30 μM FS2921 accompanied by 100 μM NMDA, FS2921 did not alter glycine potency with EC<sub>50</sub> = 11.8 ± 1.3 μM but significantly increased the maximum currents. FS2921 was thought to bind to the allosteric site on the GluN1-GluN2A subunit interface and stabilize the conformation of LBDs to increase the open probability of the channel, even in the presence of saturating NMDA and glycine. It was speculated that FS2921 might affect glycine responses and NMDA affinities due to its interactions with the GluN1 and GluN2Asubunits whose LBDs contained ligand-binding pocket of glycine and NMDA, respectively. However, the causes of the differences in allosteric modulation between the two endogenous agonists are still unclear.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Allosteric modulation of NMDARs by FS2921. (A) Representative whole-cell recording from neurons cultured <i>in vitro</i> and the statistical results, showing that FS2921 application enhances the response to NMDA + glycine application. (B) Agonist concentration–response curves of NMDA in the presence of 30 μM glycine, indicating that FS2921 acts as a PAM with a shift of the NMDA EC<sub>50</sub> but no altered steady-state currents. (C) Agonist concentration–response curves of glycine in the presence of 100 μM NMDA, indicating that FS2921 acts as a PAM with significant enhancement of steady-state currents but no shift of the glycine EC<sub>50</sub>. Values are expressed as mean ± SEM from three independent experiments. The <i>p</i> value compared to the control group (**<i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Binding Modes and Isoform Selectivity Analysis of FS2921</h3><div class="NLM_p">As depicted in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, we used induced docking to re-dock FS2921 to the allosteric binding site. Superimposition of the binding modes of GNE-0723 and FS2921 showed many similarities. For example, the imidazole groups on the two compounds superimposed perfectly, and both compounds formed the same π–π interaction with His273. The core structure of FS2921 was located at the same position as the thiazolo[3,2-<i>a</i>]pyrimidin-5-one structure of GNE-0723, and both exhibited the same π–π interaction with Tyr144. The isopropyl group of Val266 was located at the dimer interface of GluN1/GluN2A LBD and had a collision with the 4-bromophenyl group of FS2921. Based on the SAR study of the GNE series compounds, the selectivity to GluN2A against other GluN2 subunits could be attributed to van der Waals interactions between the hydrophobic pocket composed of Val266 and adjacent residues. According to our results, this pocket is occupied by the bulky phenyl of FS2921, suggesting that FS2921 could be a potential GluN2A-selective PAM.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superimposition of the binding modes of FS2921 (yellow) and GNE-0723 (pink) in GluN1/GluN2A LBD (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KDT">5KDT</a>, gray) with (A) and without (B) protein ribbons. The yellow dotted lines represent hydrogen bonds; the blue dotted lines represent π–π interactions; the purple dotted lines represent halogen bonds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To verify our hypothesis, whole-cell voltage-clamp experiments on HEK-293 cells expressing GluN1/GluN2A, GluN1/GluN2B, GluN1/GluN2C, or GluN1/GluN2D were performed to study the isoform selectivity of FS2921. The results indicated that FS2921 accompanied by both 10 μM NMDA and 30 μM glycine selectively enhanced GluN2A currents but did not affect GluN2B currents. Moreover, we found that FS2921 exhibited slight inhibition of GluN1/GluN2C currents (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Figure S2</a>). Our findings demonstrated that FS2921 was a functionally selective GluN1/GluN2A PAM versus GluN1/GluN2B and GluN1/GluN2D. By contrast, FS2921 exhibited a weak NAM effect on GluN1/GluN2C.</div><div class="NLM_p last">To investigate the influence of native AMPA receptors and γ-aminobutyric acid (GABA) receptors on the effect of FS2921, the primary hippocampal neurons cultured for 7–9 days were used. In contrast to the response of AMPA receptors induced by 10 μM AMPA, FS2921 did not have any influence on the currents. Similarly, the responses induced by 10 μM GABA did not differ significantly from those in the presence of FS2921 (30 μM) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Figure S3</a> in the Supporting Information).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Enhancement of Currents of FS2921 on Neuronal NMDARs</h3><div class="NLM_p">When the neurons were cultured for 12–15 days, the concentration of glycine around neurons increased with the expression of serine racemase and growth of glial cells.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> In the condition of high glycine levels, the responses to NMDA of these neurons were raised significantly by FS2921. However, FS2921 could not induce any response without the addition of NMDA. When 100 μM NMDA and no exogenous glycine were applied, we changed the dose of FS2921 and found that the NMDAR-mediated currents increased in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>A,B). The EC<sub>50</sub> value of FS2921 was 8.8 ± 0.9 μM. △<i>I</i>/<i>I</i><sub>NMDA max</sub> was calculated to be 3.8, which indicated increased currents induced by the test compound compared to NMDA (100 μM) alone. Both parameters were tested to evaluate the activity of other derivatives.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Whole-cell recording from neurons cultured <i>in vitro</i> and the statistical results, showing that FS2921 application significantly enhanced the response compared to NMDA application alone; Scale: <i>X</i> axis = 10 s and <i>Y</i> axis = 100 pA. (B) Concentration–response curves of FS2921 showing the response to NMDA (100 μM). EC<sub>50</sub> values were determined in the presence of saturating glutamate. The values are the mean of at least five experiments. (C) FS2921 reduced immobility duration in the forced swim test (FST) on C57BL/6N mice. (D) FS2921 administration and chronic social defeat stress (CSDS) were both performed daily as indicated by the arrows. FS2921 reversed the reduced social interaction caused by CSDS. Values are expressed as mean ± SD from three independent experiments (<i>n</i> = 10–11). The <i>p</i> value compared to the control group (*<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Antidepressant Effects of FS2921</h3><div class="NLM_p">To identify the antidepressant effect of FS2921 <i>in vivo</i>, we investigated mice behavior using the FST and chronic social defeat stress (CSDS). The FST is widely used to study depressive-like behaviors in rodents; in this test, a rodent’s immobility time in water reflects a measure of behavioral despair. In our tests, one intracerebroventricular treatment with FS2921 moderately decreased the immobility time in the FST compared with the control group (<i>p</i> < 0.05) (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>C). The fluoxetine group exhibited a significant decrease in the immobility time (<i>p</i> < 0.01) at the same dose as FS2921.</div><div class="NLM_p last">To mimic complicated symptoms of major depression in patients, CSDS is often applied in animals to induce depressive-like behaviors, including decreases in food intake, inhibition of body weight gain, and social-avoidance behavior. CSDS was performed in accordance with the previously described protocols (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>D).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> In brief, C57BL/6N mice were pretreated with FS2921 every day before applying CSDS. With intracerebroventricular administration of FS2921 and CSDS repeated for up to 10 days, social interaction tests were performed on day 11. The results showed that FS2921 moderately reversed the reduction in social interactions induced by CSDS and exhibited an equal antidepressant effect compared with that of fluoxetine.</div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> SAR Analysis</h3><div class="NLM_p">Based on the structural similarities between FS2915 and FS2921, the furan-2-carboxamide scaffold was determined to be a dominant skeleton for designing analogues. The current-enhancing potency of each compound was measured by a whole-cell patch-clamp assay carried out on neurons cultured <i>in vitro</i>. The results are expressed as △<i>I</i>/<i>I</i><sub>NMDA</sub> values presented in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>–<named-content content-type="anchor" rid="tbl3" type="simple"></named-content><named-content content-type="anchor" rid="tbl4" type="simple"></named-content><named-content content-type="anchor" rid="tbl5" type="simple"></named-content><a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Chemical Structures and In Vitro Activity of <i>N</i>-Phenylfuran-2-carboxamide Analogues with Substituents in the Furyl and Phenyl</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0014.gif" alt="" id="gr13" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0015.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Values are the increased folds of the test compound (30 μM) coupled with NMDA (100 μM) over NMDA (100 μM) alone.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Log of the brain/blood partition coefficient (Log BB) using the Maestro 11.5 <i>Qikprop</i> module; 0: very high; 1: high; 2: medium; 3: low; 4: undefined.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Polar surface area using the Maestro 11.5 <i>Qikprop</i> module.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Chemical Structures and In Vitro Activity of 5-((3,5-Dimethyl<i>-</i>1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-phenylfuran-2-carboxamide with Substituents on the Phenyl</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0016.gif" alt="" id="gr15" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="(" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center" char="±">△<i>I</i>/<i>I</i><sub>NMDA</sub> (mean ± SEM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="(">Log BB (BBB_level)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">PSA<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">FS2921</td><td class="colsep0 rowsep0" align="left">CH<sup>3</sup></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char="±">3.2 ± 0.7</td><td class="colsep0 rowsep0" align="char" char="(">–0.13 (2)</td><td class="colsep0 rowsep0" align="char" char=".">59.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17a</b></td><td class="colsep0 rowsep0" align="left">CH<sup>3</sup></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="(">–0.20 (2)</td><td class="colsep0 rowsep0" align="char" char=".">59.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17b</b></td><td class="colsep0 rowsep0" align="left">CH<sup>3</sup></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">3.2 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="(">–0.14 (2)</td><td class="colsep0 rowsep0" align="char" char=".">59.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17c</b></td><td class="colsep0 rowsep0" align="left">CH<sup>3</sup></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="(">–0.31 (2)</td><td class="colsep0 rowsep0" align="char" char=".">59.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="(">–0.4 (2)</td><td class="colsep0 rowsep0" align="char" char=".">61.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="(">–0.19 (2)</td><td class="colsep0 rowsep0" align="char" char=".">61.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17f</b></td><td class="colsep0 rowsep0" align="left">CH<sup>2</sup>CH<sup>3</sup></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char="±">2.6 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="(">–0.2 (2)</td><td class="colsep0 rowsep0" align="char" char=".">59.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17g</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char="±">1.7 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="(">–0.0 (2)</td><td class="colsep0 rowsep0" align="char" char=".">60.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17h</b></td><td class="colsep0 rowsep0" align="left">NHCH<sup>3</sup></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="(">–0.5 (3)</td><td class="colsep0 rowsep0" align="char" char=".">73.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17i</b></td><td class="colsep0 rowsep0" align="left">CH<sup>2</sup>CH<sup>2</sup>OH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.4 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="(">–0.9 (3)</td><td class="colsep0 rowsep0" align="char" char=".">81.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17j</b></td><td class="colsep0 rowsep0" align="left">Phenyl-</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="(">–0.4 (2)</td><td class="colsep0 rowsep0" align="char" char=".">58.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17k</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Phenyl-</td><td class="colsep0 rowsep0" align="char" char="±">6.7 ± 3.2</td><td class="colsep0 rowsep0" align="char" char="(">–0.4 (2)</td><td class="colsep0 rowsep0" align="char" char=".">61.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17l</b></td><td class="colsep0 rowsep0" align="left">CH<sup>2</sup>OH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">1.1 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="(">–0.4 (2)</td><td class="colsep0 rowsep0" align="char" char=".">83.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17m</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">4.7 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="(">–0.0 (2)</td><td class="colsep0 rowsep0" align="char" char=".">60.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>17n</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">0.9 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="(">–0.1 (2)</td><td class="colsep0 rowsep0" align="char" char=".">60.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>22a</b></td><td class="colsep0 rowsep0" align="left">COOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="(">–0.8 (3)</td><td class="colsep0 rowsep0" align="char" char=".">94.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>22b</b></td><td class="colsep0 rowsep0" align="left">COOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">0.1 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="(">–0.8 (3)</td><td class="colsep0 rowsep0" align="char" char=".">93.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>22c</b></td><td class="colsep0 rowsep0" align="left">COOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="char" char="±">2.7 ± 0.6</td><td class="colsep0 rowsep0" align="char" char="(">–0.6 (3)</td><td class="colsep0 rowsep0" align="char" char=".">91.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Values are the increased folds of the test compound (30 μM) coupled with NMDA (100 μM) over NMDA (100 μM) alone.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Log of the brain/blood partition coefficient (Log BB) using the Maestro 11.5 <i>Qikprop</i> module; 0: very high; 1: high; 2: medium; 3: low; 4: undefined.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">Polar surface area using the Maestro 11.5 <i>Qikprop</i> module.</p></div></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Chemical Structures and In Vitro Activity of 5-((5-Trifluoromethyl<i>-</i>1<i>H</i>-pyrazol-1-yl) methyl))-<i>N</i>-phenylfuran-2-carboxamides with Substituents on the Phenyl</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0017.gif" alt="" id="gr16" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="(" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center" char="±">△<i>I</i>/<i>I</i><sub>NMDA</sub> (mean ± SEM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="(">Log BB (BBB_level)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">PSA<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">7.7 ± 3.</td><td class="colsep0 rowsep0" align="char" char="(">0.2 (1)</td><td class="colsep0 rowsep0" align="char" char=".">59.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20b</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="(">0.2 (1)</td><td class="colsep0 rowsep0" align="char" char=".">59.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20c</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">2.4 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="(">0.4 (1)</td><td class="colsep0 rowsep0" align="char" char=".">58.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20d</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.7 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="(">0.4 (1)</td><td class="colsep0 rowsep0" align="char" char=".">59.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20e</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">10.7 ± 3.5</td><td class="colsep0 rowsep0" align="char" char="(">0.4 (1)</td><td class="colsep0 rowsep0" align="char" char=".">59.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20f</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">0.4 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="(">0.6 (0)</td><td class="colsep0 rowsep0" align="char" char=".">60.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20g</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">2.9 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="(">0.6 (0)</td><td class="colsep0 rowsep0" align="char" char=".">61.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20h</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">13.8 ± 4.9</td><td class="colsep0 rowsep0" align="char" char="(">0.6 (0)</td><td class="colsep0 rowsep0" align="char" char=".">60.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20i</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">2.5 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="(">0.1 (1)</td><td class="colsep0 rowsep0" align="char" char=".">76.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20j</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">5.5 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="(">0.4 (1)</td><td class="colsep0 rowsep0" align="char" char=".">61.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>22d</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">COOCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 2.5</td><td class="colsep0 rowsep0" align="char" char="(">–0.1(3)</td><td class="colsep0 rowsep0" align="char" char=".">94.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Values are the increased folds of the test compounds (30 μM) coupled with NMDA (100 μM) over NMDA (100 μM) alone.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Log of the brain/blood partition coefficient (Log BB) using the Maestro 11.5 <i>Qikprop</i> module; 0: very high; 1: high; 2: medium; 3: low; 4: undefined.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Polar surface area using the Maestro 11.5 <i>Qikprop</i> module.</p></div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Chemical Structures and In Vitro Activity of 5-((3,5-Dimethyl<i>-</i>1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-phenylthiophene-2-carboxamide with Substituents on the Phenyl</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0018.gif" alt="" id="gr17" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="(" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>4</sub></th><th class="colsep0 rowsep0" align="center" char="±">△<i>I</i>/<i>I</i><sub>NMDA</sub> (mean ± SEM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="(">Log BB (BBB_level)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">PSA<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.5 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="(">0.1 (1)</td><td class="colsep0 rowsep0" align="char" char=".">50.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32b</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">–0.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="(">0.1 (1)</td><td class="colsep0 rowsep0" align="char" char=".">50.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32c</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">10.1 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="(">–0.1 (2)</td><td class="colsep0 rowsep0" align="char" char=".">50.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32d</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">2.8 ± 1.8</td><td class="colsep0 rowsep0" align="char" char="(">–0.3 (2)</td><td class="colsep0 rowsep0" align="char" char=".">50.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32e</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">1.8 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="(">–0.6 (3)</td><td class="colsep0 rowsep0" align="char" char=".">63.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">2.4 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="(">–0.1 (2)</td><td class="colsep0 rowsep0" align="char" char=".">51.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">3.5 ± 1.1</td><td class="colsep0 rowsep0" align="char" char="(">0.1 (1)</td><td class="colsep0 rowsep0" align="char" char=".">51.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32h</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">12.5 ± 5.7</td><td class="colsep0 rowsep0" align="char" char="(">0.1 (1)</td><td class="colsep0 rowsep0" align="char" char=".">51.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">6.0 ± 2.4</td><td class="colsep0 rowsep0" align="char" char="(">0.1 (1)</td><td class="colsep0 rowsep0" align="char" char=".">51.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32j</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>2</sub>CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">2.7 ± 2.2</td><td class="colsep0 rowsep0" align="char" char="(">–0.6 (3)</td><td class="colsep0 rowsep0" align="char" char=".">66.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32k</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="(">0.1 (1)</td><td class="colsep0 rowsep0" align="char" char=".">51.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32l</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="char" char="±">5.0 ± 2.7</td><td class="colsep0 rowsep0" align="char" char="(">0.0 (1)</td><td class="colsep0 rowsep0" align="char" char=".">51.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32m</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="char" char="±">0.4 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="(">–0.4 (2)</td><td class="colsep0 rowsep0" align="char" char=".">68.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32n</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">2.8 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="(">–0.4 (2)</td><td class="colsep0 rowsep0" align="char" char=".">52.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32o</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">pyridin-3-yl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="char" char="±">14.3 ± 4.8</td><td class="colsep0 rowsep0" align="char" char="(">–0.4 (3)</td><td class="colsep0 rowsep0" align="char" char=".">65.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Values are the increased folds of the test compound (30 μM) coupled with NMDA (100 μM) over NMDA (100 μM) alone.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Log of the brain/blood partition coefficient (Log BB) using the Maestro 11.5 <i>Qikprop</i> module; 0: very high; 1: high; 2: medium; 3: low; 4: undefined.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Polar surface area using the Maestro 11.5 <i>Qikprop</i> module.</p></div></div></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Chemical Structures and In Vitro Activity of 5-((3,5-Dimethyl<i>-</i>1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(aromatic Ring)-thiophene-2-carboxamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0019.gif" alt="" id="gr18" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0020.gif" alt="" id="gr19" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Values are the increased folds of the test compound (30 μM) coupled with NMDA (100 μM) over NMDA (100 μM) alone.</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">Log of the brain/blood partition coefficient (Log BB) using the Maestro 11.5 <i>Qikprop</i> module; 0: very high; 1: high; 2: medium; 3: low; 4: undefined.</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Polar surface area using the Maestro 11.5 <i>Qikprop</i> module.</p></div></div><div></div></div><div class="NLM_p">FS2915 and FS2921 were used as starting hits for the first round of structural investigation (shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The removal of (3,5-dimethyl<i>-</i>1<i>H</i>-pyrazol-1-yl)methyl or 3,5-dimethyl<i>-</i>1<i>H</i>-pyrazol-1-yl in FS2921 (<b>9a</b> and <b>9b</b>) resulted in a loss of potentiating activity. The chlorine on the furan moiety (<b>9c</b>) induced decreased potentiating activity. By merging the scaffold of FS2915 and that of FS2921 to obtain compound <b>24a</b> with a Cl atom at the <i>para</i>-position of the benzanilide moiety, the potentiating activity was also found to decrease. When the 4-hydroxybutyl group was changed to a truncated 3-hydroxypropyl (<b>24b</b>) or a benzyl group (<b>24c</b>), the potentiating activity increased slightly compared to that of compound <b>24a</b>. Nevertheless, when the 4-hydroxybutyl group was further changed to a phenyl (<b>24d</b>) or <i>n</i>-butyl group (<b>24e</b>), the potentiating activity decreased significantly compared to that of compound <b>24a</b>. The first round of structural investigation determined that both the 3,5-dimethyl<i>-</i>1<i>H</i>-pyrazol-1-yl group and the 4-hydroxybutyl)carbamoyl group are important to the common scaffold and that the potentiating activity persists when both of them are present. However, due to the bulky groups at the R<sub>2</sub> position, the PSA values of compounds <b>24a-e</b> were all above 90, resulting in low Log BB permeability. Taken together, the 3,5-dimethyl<i>-</i>1<i>H</i>-pyrazol-1-yl group at the R<sub>1</sub> position contributed to the satisfactory activity and the favorable Log BB, which was considered suitable for further SAR exploration.</div><div class="NLM_p">In the next round of structural investigation based on FS2921, we explored the effects of diverse substitutions at the 2-position and 4-position of the phenyl. The potentiating activity results for these analogues are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>. Chlorine or fluorine substitution at the 4-position slightly decreased the potentiating activity when compounds <b>17a</b> and <b>17b</b> were compared with FS292 and compounds <b>22a</b> and <b>22b</b> with <b>22c</b>. Removal of the <i>ortho</i>-methyl group induced a significant potentiating activity decrease when compounds <b>17d</b> and <b>17e</b> were compared with FS2921. As can be seen from compounds <b>17c</b>/<b>17d</b>/<b>17h</b>/<b>17i</b>/<b>17j</b>, removing the substitution at the 4-position of the phenyl also reduced compound potentiating activity. When an ethyl group (<b>17f</b>), chlorine (<b>17g</b>), or methoxycarbonyl group (<b>22c</b>) was introduced to replace the <i>ortho</i>-methyl group of FS2921, the activity decreased moderately. Similar results were observed in compounds <b>17l</b>/<b>17n/22b</b> when compared with compound <b>17b</b>. When a phenyl group was added to the <i>ortho</i>-position, compound <b>17j</b> showed a loss in activity. However, compound <b>17k</b> was found to be more effective, suggesting that a bulky group at the 4-position was tolerated. Increased potentiating activity was also observed in the compound with a 2,4-dichlorophenyl moiety (<b>17m</b>).</div><div class="NLM_p">The SAR results indicated that the methyl or chlorine groups were preferable substitutions at the 2-position on the phenyl. Combined with the predicted Log BB, the introduction at the 2-position of some polar groups such as hydroxyl/amino/ester led to a decrease in activity and a decrease in brain permeability. The introduction of substituents at the 4-position of the phenyl is critical to activity. This position can also accommodate larger substitutions.</div><div class="NLM_p">Next, we changed the methyl group of the pyrazol moiety to a trifluoromethyl group to gain BBB permeability. Bearing the 3-methyl-5-(trifluoromethyl)<i>-</i>1<i>H</i>-pyrazol moiety, the potentiation of compound <b>20a</b> increased by 2-fold compared to that of compound <b>17b</b>. However, compound <b>20b</b> with a <i>para</i>-bromine group showed a slight decrease in enhancement potentiating activity. Nevertheless, when the two methyl groups on the pyrazol ring were both changed to trifluoromethyl groups, some opposite results were observed. Compared to compounds <b>17a</b>/<b>b</b>, compounds <b>20c</b>/<b>d</b> seemed to be unaffected by trifluoromethyl groups, but the predicted Log BB improved. Compound <b>20e</b> was found to exhibit a high potentiating activity with an enhanced △<i>I</i>/<i>I</i><sub>NMDA</sub> value of 10.7 ± 3.5. Moreover, compound <b>20h</b> (△<i>I</i>/<i>I</i><sub>NMDA</sub> = 13.8 ± 4.9) showed potentiating activity that was more than 4 fold that of FS2921 and possessed micromolar potency (EC<sub>50</sub> = 12.5 μM) (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Compounds <b>20d</b> and <b>20f</b> were observed to slightly enhance currents. When one <i>meta</i>-chlorine of compound <b>20h</b> was moved to the <i>para</i>-position (<b>20g</b>), the potentiation was retained but greatly reduced. As can be seen from compounds <b>20h</b>/<b>20i</b>/<b>20j</b>, the <i>meta</i>-methoxyl group was just as potent as the <i>meta</i>-fluorine group but was significantly weaker than the <i>meta</i>-chlorine group. By comparing compound <b>20c</b> with <b>20j</b> and <b>20g</b> with <b>20f</b>, <i>meta</i>-substituents seemed to be more positive than <i>ortho</i>-substituents.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. EC<sub>50</sub> and <i>E</i><sub>max</sub> on the Primary Neuron of Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="char" char="." /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (μM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="±"><i>E</i><sub>max</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>FS2921</b></td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="char" char="±">3.8 ± 0.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20h</b></td><td class="colsep0 rowsep0" align="char" char=".">12.5</td><td class="colsep0 rowsep0" align="char" char="±">13.8 ± 4.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32c</b></td><td class="colsep0 rowsep0" align="char" char=".">7.8</td><td class="colsep0 rowsep0" align="char" char="±">10.2 ± 4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32h</b></td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char="±">14.3 ± 4.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32o</b></td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char="±">12.8 ± 2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>33d</b></td><td class="colsep0 rowsep0" align="char" char=".">9.0</td><td class="colsep0 rowsep0" align="char" char="±">10.5 ± 2.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">NMDAR EC<sub>50</sub> values were determined in the presence of saturating glutamate. The values are the mean of at least five experiments. The EC<sub>50</sub> of each compound is expressed relative to the maximal response that it induces.</p></div></div></div><div class="NLM_p">After transforming the furan moiety of FS2921 to a thiophene moiety, we explored a new scaffold of thiophene-2-carboxamide that possessed increased stability and lower toxicity. Compound <b>32a</b> exhibited a slight decrease in activity compared with FS2921. Unexpectedly, as can be seen with compound <b>32b</b>, the potentiating activity of currents was eliminated. Compound <b>32c</b> displayed a significant improvement in potentiation (△<i>I</i>/<i>I</i><sub>NMDA</sub> = 10.1 ± 0.8), of which EC<sub>50</sub> was determined to be 7.75 μM (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). When a phenyl or pyridine group was introduced to the <i>para</i>-position (compounds <b>32d</b>/<b>32e</b>/<b>32n</b>/<b>32o</b>), the potencies of all analogues were retained. Moreover, compound <b>32o</b> exhibited a significant increase with potentiating activity and potency (△<i>I</i>/<i>I</i> = 14.3 ± 4.8 and EC<sub>50</sub> = 3.6 μM) (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). Next, as shown in compounds <b>32f-j</b>, the collocation of <i>para</i>-substitutions and <i>meta</i>-substitutions was investigated, where the fluorine, chlorine, methyl, or ethoxyl group all showed potential. Among them, compound <b>32h</b> provided superior potentiating activity with a △<i>I</i>/<i>I</i><sub>NMDA</sub> value of 12.5 ± 5.7 and an improved EC<sub>50</sub> value of 2.4 μM (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>). When one of the two chlorine substitutions of compound <b>32h</b> was replaced by fluorine, the potentiation of currents was reduced significantly, as can be seen in compounds <b>32g</b>/<b>32i</b>. When substitutions were introduced to both <i>meta</i>-positions, it was observed that <i>meta</i>-fluorine groups were more potent than <i>meta</i>-methoxyl groups and <i>meta</i>-chlorine groups by comparing compounds <b>32k-m</b>.</div><div class="NLM_p">We proceeded with our exploration of the SAR by replacing the substituted phenyl with different aromatic rings. When a pyridin-3-yl moiety (<b>16a</b>) replaced the benzene moiety of FS2921, the activity was retained. The same result was observed with the naphthalen-2-yl moiety (<b>16b</b>). However, for the thiophene-2-carboxamide scaffold, a naphthalene-2-yl moiety induced a slight decrease in potentiating activity by comparing compound <b>33a</b> with <b>16b</b>. When a quinolone moiety replaced the naphthalene moiety, the potentiation of currents was reduced significantly as shown in compounds <b>33b</b> and <b>33c</b>. Benzo-heterocycles were also introduced to replace the substituted phenyl, such as indole (<b>33d</b>), benzimidazole (<b>33e</b>), or benzimidazolone (<b>33f</b>). The activity for compound <b>33d</b> increased significantly with △<i>I</i>/<i>I</i><sub>NMDA</sub> = 8.9 ± 2.9, but compounds <b>33e</b> and <b>33f</b> exhibited a large decrease in potentiating activity. The EC<sub>50</sub> of compound <b>33d</b> was determined to be 9.0 μM (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>).</div><div class="NLM_p last">It was exciting to observe that most of these analogues exhibited NMDA potentiating behaviors like FS2921. Some of these compounds showed a more significant potentiation to NMDAR currents than FS2921 and were selected for EC<sub>50</sub> determination. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>, among these compounds, compound <b>32h</b> had the best EC<sub>50</sub> value of 2.44 μM, and the other compounds (<b>20h</b>/<b>32c</b>/<b>32o</b>/<b>33d</b>) were observed to exhibit micromolar activity as well. Therefore, these five compounds were selected for further evaluation of <i>in vivo</i> activities and safety profiles.</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Effects of the Selected Derivatives of FS2921 in the FST</h3><div class="NLM_p">To demonstrate the potential antidepressant effects of NMDAR PAMs, we further investigated several novel analogues of FS2921 in the FST (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). Because intracerebroventricular administration is complicated and requires evaluating the blood–brain barrier effect, we used intraperitoneal (i.p.) administrations in the following behavioral experiments. Based on the <i>in vitro</i> data, compounds <b>20h/32c</b>/<b>32h</b>/<b>32o</b>/<b>33d</b> were chosen for the tests in ICR mice, with fluoxetine as the positive drug at the same dose of 30 mg/kg. The results showed that compounds <b>20h</b> and <b>32c</b> significantly decreased the immobility time compared with the vehicle group. Similarly, the compounds <b>32h</b> and <b>32o</b> moderately reduced the immobility duration compared with the vehicle group, while compound <b>33d</b> did not show significant effects.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of the selected compounds in the ICR mice FST by single i.p. treatment. Values are expressed as mean ± SEM from 10–12 independent experiments. The <i>p</i> value was obtained by comparing it with the control group (*<i>p</i> < 0.05, **<i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To differentiate the <i>in vivo</i> efficacy of the selected derivatives, we further investigated compounds <b>20h</b>/<b>32c</b>/<b>32h</b>/<b>32o</b> at lower concentrations in the FST. Each compound was tested at two doses (3 and 10 mg/kg), and each experiment was performed three times with intraperitoneal administration. Duloxetine, which is considered a more effective antidepressant drug than fluoxetine in clinical practice, was used as the positive control. Administration of duloxetine caused a robust decrease in the immobility time, demonstrating its extraordinary antidepressant effect. Compounds <b>20h</b> and <b>32h</b> significantly shortened the immobility time at two doses (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). However, compounds <b>32c</b> and <b>32o</b> did not change the immobility time compared with the vehicle group (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Figure S4</a>).</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of the compounds <b>20h</b> and <b>32h</b> in the ICR mice FST with treatment repeated three times. Values are expressed as mean ± SEM from eight independent experiments. The <i>p</i> value is obtained by comparing it with the control group (*<i>p</i> < 0.05, **<i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Influence of the Selected FS2921 Analogues on Locomotion of ICR Mice</h3><div class="NLM_p">Spontaneous locomotor activity tests are used to investigate the influence of antidepressants on the spontaneous locomotor activity in animals. It is considered that hypoactivity or hyperactivity induced by candidate compounds should be determined to avoid potential psychotic side effects. Compounds <b>20h</b>/<b>32c</b>/<b>32h</b>/<b>32o</b>/<b>33d</b> were investigated at a dose of 10 mg/kg by intraperitoneal injection. The results showed that none of the analogues caused hyperlocomotion or hypolocomotion of the treated mice (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Figure S5</a>).</div><div class="NLM_p last">Monoamine neurotransmitter antagonists can attenuate hyperlocomotion induced by dopamine receptor direct agonists such as apomorphine. To determine whether these compounds affected the function of monoamine neurotransmitters, we investigated the compounds <b>20h</b>/<b>32c</b>/<b>32h</b>/<b>32o</b>/<b>33d</b> in APO (apomorphine)-induced climbing tests. The results showed that none of these analogues affected APO-induced climbing; by contrast, risperidone (an inhibitor of D<sub>2</sub> receptors and 5-HT<sub>2</sub>A receptors) significantly inhibited the APO-induced climbing behavior (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Figure S6</a>).</div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Effects of the Compounds <b>20h</b> and <b>32h</b> on Additional Targets</h3><div class="NLM_p">We detected the influence of the compounds <b>20h</b> and <b>32h</b> on native AMPA receptors and γ-aminobutyric acid (GABA) receptors were detected (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Figure S3</a>). The primary hippocampal neurons cultured for 7–9 days were used. Similar to FS2921, these two derivatives did not have any influence on the currents of AMPA receptors induced by 10 μM AMPA. Likewise, the responses induced by 10 μM GABA did not significantly differ from those in the presence of the test compounds (30 μM).</div><div class="NLM_p last">Several common antidepressant drug targets were also explored to determine if the potential antidepressant effects of compound <b>32h</b> was related to other targets. Binding affinities of compound <b>32h</b> tested by a radioligand binding assay showed that the <i>K</i><sub>i</sub>/IC<sub>50</sub> values were all greater than 10 μM for the main GPCRs (D<sub>2</sub>, D<sub>3</sub>, α<sub>1</sub>, 5-HT<sub>1A</sub>, 5-HT<sub>1B</sub>, 5-HT<sub>2A</sub>, 5-HT<sub>2C</sub>, and 5-HT<sub>6</sub>) or transporters (DAT, NET, and SERT) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Table S3</a> in the Supporting Information). The additional antitarget results indicated that compound <b>32h</b> had no influence on these targets and that the antidepressant effects seen <i>in vivo</i> could not come from other CNS-relevant receptors.</div></div><div id="sec3_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Pharmacokinetic Profiles and Brain Penetration Properties of Compounds <b>20h</b>/<b>32c</b>/<b>32o</b>/<b>32h</b> in Mice</h3><div class="NLM_p">Pharmacokinetics profiles of the selected compounds were extensively studied in ICR mice by i.v. administration at 3 mg/kg and p.o. administration at 10 mg/kg. The plasma concentration–time curves are shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Figure S7</a> in the Supporting Information. Compound <b>32h</b> showed a rapid distribution (<i>t</i><sub>max</sub> = 0.5 ± 0.0 h) compared with compound <b>20h</b> (<i>t</i><sub>max</sub> = 2.0 ± 0.0 h) at a dose of 10 mg/kg (p.o.). However, the half-life of compound <b>32h</b> via p.o. (<i>t</i><sub>1/2</sub> = 2.9 ± 0.2 h.) administration was shorter than that of compound <b>20h</b> (<i>t</i><sub>1/2</sub> = 5.7 ± 0.7 h) ; nevertheless, compound <b>32h</b> still showed an effective blood plasma concentration (<i>C</i><sub>max</sub> = 760 ± 86 ng/mL) comparable to that of compound <b>20h</b> (<i>C</i><sub>max</sub> = 989 ± 22 ng/mL). Finally, the oral bioavailabilities of compounds <b>20h</b> and <b>32h</b> were 72.3 and 62.3%, respectively. Further tests for their brain penetration properties were performed at 0.5 and 2.0 h, and the brain/plasma ratios were calculated. The results showed that the brain/plasma ratio of compound <b>20h</b> was lower than 0.2 at both time points after one single administration (10 mg/kg p.o. or 3 mg/kg i.v.). The BBB permeability of compound <b>32h</b> was found to be prominent in that a single oral administration resulted in a brain/plasma ratio higher than 0.3, and the brain concentration of compound <b>32h</b> rapidly reached its highest level of 280.7 ± 28.5 ng/mL in half an hour. Notably, considering the brain concentration at 2.0 h (<i>C</i><sub>brain/2.0h</sub> = 148.2 ± 13.6 ng/mL) after a single oral administration as <i>C</i><sub>max</sub> of the brain concentration, compound <b>20h</b> seemed to provide a moderate brain exposure (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. PK and Brain Penetration Properties of Compounds <b>20h</b> and <b>32h</b> in ICR Mice<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center"><b>20h</b></th><th class="rowsep1 colsep0" colspan="2" align="center"><b>32h</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">3 mg/kg (i.v.)</th><th class="colsep0 rowsep0" align="center">10 mg/kg (p.o.)</th><th class="colsep0 rowsep0" align="center">3 mg/kg (i.v.)</th><th class="colsep0 rowsep0" align="center">10 mg/kg (p.o.)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (ng/mL)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">989.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">760.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0-t</sub> (h·ng/mL)</td><td class="colsep0 rowsep0" align="left">1751.0</td><td class="colsep0 rowsep0" align="left">4217.0</td><td class="colsep0 rowsep0" align="left">1448.0</td><td class="colsep0 rowsep0" align="left">3051.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (L/h)</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">MRT (h)</td><td class="colsep0 rowsep0" align="left">3.4</td><td class="colsep0 rowsep0" align="left">4.7</td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">4.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>dss</sub> (L/kg)</td><td class="colsep0 rowsep0" align="left">12.7</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">8.3</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>F</i> (%)</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">72.2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">63.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain concentration at 0.5 h (ng/mL)</td><td class="colsep0 rowsep0" align="left">73.6 ± 19.3</td><td class="colsep0 rowsep0" align="left">93.4 ± 10.4</td><td class="colsep0 rowsep0" align="left">160.2 ± 13.4</td><td class="colsep0 rowsep0" align="left">280.7 ± 28.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma concentration at 0.5 h (ng/mL)</td><td class="colsep0 rowsep0" align="left">506.5 ± 75.4</td><td class="colsep0 rowsep0" align="left">580.2 ± 24.4</td><td class="colsep0 rowsep0" align="left">388.7 ± 50.4</td><td class="colsep0 rowsep0" align="left">760.2 ± 79.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain/plasma ratio at 0.5 h</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">0.41</td><td class="colsep0 rowsep0" align="left">0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain concentration at 2.0 h (ng/mL)</td><td class="colsep0 rowsep0" align="left">49.0 ± 10.9</td><td class="colsep0 rowsep0" align="left">148.2 ± 13.6</td><td class="colsep0 rowsep0" align="left">85.5 ± 29.7</td><td class="colsep0 rowsep0" align="left">173.8 ± 12.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">plasma concentration at 2.0 h (ng/mL)</td><td class="colsep0 rowsep0" align="left">304.2 ± 49.2</td><td class="colsep0 rowsep0" align="left">988.8 ± 20.0</td><td class="colsep0 rowsep0" align="left">239.3 ± 52.8</td><td class="colsep0 rowsep0" align="left">451.0 ± 38.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">brain/plasma ratio at 2.0 h</td><td class="colsep0 rowsep0" align="left">0.16</td><td class="colsep0 rowsep0" align="left">0.15</td><td class="colsep0 rowsep0" align="left">0.34</td><td class="colsep0 rowsep0" align="left">0.38</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Values are expressed as mean ± SD from male ICR mice (<i>n</i> = 6/treatment group).</p></div></div></div><div class="NLM_p last">Given the favorable potential antidepressant effects of compounds <b>20h</b> and <b>32h</b> by intraperitoneal injection, <i>in vivo</i> PK profiles of compounds <b>32c</b> and <b>32o</b> should be explored to clarify why these two compounds did not show significant efficacy in the FST. For compound <b>32c</b>, despite the high <i>C</i><sub>brain</sub>/<i>C</i><sub>plasma</sub> ratio, the concentrations in plasma and brain were rather low. The high CL (13.6 L/h/kg) led to a short <i>t</i><sub>1/2</sub> and an AUC<sub>0-t</sub> of 105.94 h·ng/mL. It was difficult for compound <b>32c</b> to maintain an effective drug concentration. In our experiments, compound <b>32o</b> showed poor water solubility, which made this compound difficult to inject intravenously. After the intravenous injection, compound <b>32o</b> might precipitate in plasma; thus, low concentrations were detected after the i.v. administration compared with p.o. administration. Taking into account the poor water solubility, intraperitoneal injection of compound <b>32o</b> in the FST might face the same problem as i.v. administration, which could explain its inefficiency <i>in vivo</i>. However, after p.o. administration, rather high concentrations were detected, revealing that compound <b>32o</b> had a high permeability value. Additionally, compound <b>32o</b> exhibited a short <i>t</i><sub>1/2</sub> and definitely a low <i>C</i><sub>brain</sub>/<i>C</i><sub>plasma</sub> ratio (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Table S4</a> in the Supporting Information).</div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Pharmacokinetic Profiles and Brain Distribution Study of Compound <b>32h</b> in Rats</h3><div class="NLM_p last">A pharmacokinetics study of compound <b>32h</b> was also performed in Sprague–Dawley rats for further evaluation. The concentrations in plasma and cerebrospinal fluid were determined at 10 time points after i.v. administration at 3 mg/kg and p.o. administration at 10 mg/kg (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Figure S8</a> in the Supporting Information). Compound <b>32h</b> displayed suitable <i>in vivo</i> PK profiles with a low clearance and a reasonable half-life; however, it exhibited different oral bioavailabilities across species. In contrast to the concentration in plasma, the level in cerebrospinal fluid (CSF) was too low to be detected. The results of brain penetration showed that the <i>C</i><sub>brain</sub>/<i>C</i><sub>plasma</sub> ratio at 20/80 min reached 1.5 in rats after i.v. administration at 3 mg/kg. Generally, compounds with a brain/plasma ratio greater than 0.3–0.5 are considered to have sufficiently good CNS diffusion, and compounds with a value greater than 1 freely cross the BBB. Accordingly, compound <b>32h</b> has a satisfactory CNS distribution.</div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Cytotoxicity and hERG Channel Inhibition of the Selected Compounds</h3><div class="NLM_p">For further druggability studies of the selected compounds, a CCK8 assay was applied to detect cytotoxicity. The results are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a> for three representative mammalian cell lines at 60 and 120 μM of each compound. Unexpectedly, compound <b>20h</b> exhibited significant cytotoxicity with IC<sub>50</sub> values of 23.2 ± 1.4, 29.7 ± 1.2, and 84.8 ± 29.6 μM for VERO, L929, and HEK293, respectively. The compounds <b>32h</b>, <b>32o</b>, and <b>33d</b> showed no significant cytotoxicity. Moreover, compound <b>32c</b> exhibited slight cytotoxicity at high concentrations (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>).</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Pharmacokinetics Study of Compound <b>32h</b> in Rats<a class="ref internalNav" href="#t9fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="8" align="center">PK profiles of compound <b>32h</b> in plasma</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2</sub> (min)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>max</sub> (min)</th><th class="colsep0 rowsep0" align="center">CL (L/h/kg)</th><th class="colsep0 rowsep0" align="center"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0-t</sub> (h·ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">3, i.v.</td><td class="colsep0 rowsep0" align="center">2347.8 ± 476.17</td><td class="colsep0 rowsep0" align="center">102.2 ± 7.8</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">1.67 ± 0.22</td><td class="colsep0 rowsep0" align="center">1.27 ± 0.22</td><td class="colsep0 rowsep0" align="center">1816.88 ± 252.26</td><td class="colsep0 rowsep0" align="center"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center">10, p.o.</td><td class="colsep0 rowsep0" align="center">190.2 ± 122.2</td><td class="colsep0 rowsep0" align="center">67.8 ± 35.8</td><td class="colsep0 rowsep0" align="center">33.3 ± 11.6</td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center"> </td><td class="colsep0 rowsep0" align="center">502.7 ± 201.3</td><td class="colsep0 rowsep0" align="center">8.32</td></tr></tbody></table><table class="table "><colgroup><col /></col><col /></col><col /></col><col /></col><col /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="5" align="center">brain penetration analysis of compound <b>32h</b></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">time (min)</th><th class="colsep0 rowsep0" align="center">brain conc (ng/g)</th><th class="colsep0 rowsep0" align="center">plasma conc (ng/mL)</th><th class="colsep0 rowsep0" align="center">brain/plasma ratio</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">3, i.v.</td><td class="colsep0 rowsep0">20</td><td class="colsep0 rowsep0">2190.2 ± 274.6</td><td class="colsep0 rowsep0">1489.2 ± 208.7</td><td class="colsep0 rowsep0">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0">3, i.v.</td><td class="colsep0 rowsep0">80</td><td class="colsep0 rowsep0">353.6 ± 99.0</td><td class="colsep0 rowsep0">238.8 ± 26.0</td><td class="colsep0 rowsep0">1.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t9fn1"><div class="footnote" id="t9fn1"><sup><sup>a</sup></sup><p class="last">Values are expressed as mean ± standard deviation (SD) from male Sprague–Dawley rats (<i>n</i> = 3/treatment group).</p></div></div></div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Cytotoxicity and hERG Channel Inhibition of the Selected Compounds<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="8" align="center" char="±">inhibition (%)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">VERO</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">L929</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">HEK293</th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">hERG</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compounds</th><th class="colsep0 rowsep0" align="center" char="±">120 μM</th><th class="colsep0 rowsep0" align="center" char="±">60 μM</th><th class="colsep0 rowsep0" align="center" char="±">120 μM</th><th class="colsep0 rowsep0" align="center" char="±">60 μM</th><th class="colsep0 rowsep0" align="center" char="±">120 μM</th><th class="colsep0 rowsep0" align="center" char="±">60 μM</th><th class="colsep0 rowsep0" align="center" char="±">100 μM</th><th class="colsep0 rowsep0" align="center" char="±">30 μM</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>20h</b></td><td class="colsep0 rowsep0" align="char" char="±">95.8 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">96.2 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">90.6 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">84.3 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">73.6 ± 7.6</td><td class="colsep0 rowsep0" align="char" char="±">42.0 ± 4.4</td><td class="colsep0 rowsep0" align="char" char="±">68.4 ± 7.3</td><td class="colsep0 rowsep0" align="char" char="±">49.1 ± 5.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32c</b></td><td class="colsep0 rowsep0" align="char" char="±">8.7 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">–1.5 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">23.9 ± 1.0</td><td class="colsep0 rowsep0" align="char" char="±">11.5 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">34.4 ± 3.6</td><td class="colsep0 rowsep0" align="char" char="±">16.3 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">47.6 ± 6.3</td><td class="colsep0 rowsep0" align="char" char="±">33.4 ± 8.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32h</b></td><td class="colsep0 rowsep0" align="char" char="±">22.6 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">21.9 ± 1.5</td><td class="colsep0 rowsep0" align="char" char="±">–4.6 ± 1.4</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">–14.0 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="±">–5.2 ± 0.9</td><td class="colsep0 rowsep0" align="char" char="±">45.0 ± 9.1</td><td class="colsep0 rowsep0" align="char" char="±">35.4 ± 6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>32o</b></td><td class="colsep0 rowsep0" align="char" char="±">–7.5 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">–3.8 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">28.6 ± 1.7</td><td class="colsep0 rowsep0" align="char" char="±">27.5 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">18.0 ± 1.9</td><td class="colsep0 rowsep0" align="char" char="±">6.5 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">53.4 ± 13.8</td><td class="colsep0 rowsep0" align="char" char="±">44.2 ± 5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><b>33d</b></td><td class="colsep0 rowsep0" align="char" char="±">–0.4 ± 2.0</td><td class="colsep0 rowsep0" align="char" char="±">–3.2 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="±">25.5 ± 1.3</td><td class="colsep0 rowsep0" align="char" char="±">2.8 ± 1.6</td><td class="colsep0 rowsep0" align="char" char="±">2.5 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">–7.4 ± 1.2</td><td class="colsep0 rowsep0" align="char" char="±">46.7 ± 11.4</td><td class="colsep0 rowsep0" align="char" char="±">33.6 ± 11.6</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup><sup>a</sup></sup><p class="last">Values are expressed as mean ± SEM from three independent experiments</p></div></div></div><div class="NLM_p last">The inhibition of the hERG channel of the selected compounds was further tested by patch-clamp assays to predict cardiovascular toxicity. Unwanted inhibition of the hERG channel can induce serious cardiac arrhythmias, such as long QT syndrome characterized by prolonged QT intervals and torsades de pointes. The results of compounds <b>32c</b>/<b>32h</b>/<b>33d</b> exhibited negligible affinities toward the hERG channel with inhibitions of 46.7 ± 11.4, 47.6 ± 6.3, and 45.0 ± 9.1%, respectively, at a 100 μM dose (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>). Compound <b>20h</b> at a dose of 30 μM showed a higher hERG inhibition compared with other compounds (50%, 49.1 ± 5.3%). Compound <b>32o</b> showed moderate inhibition of 44.2 ± 5.1% at 30 μM and 53.4 ± 13.8% at 100 μM. Taken together, considering the low EC<sub>50</sub> in primary neurons, compound <b>32h</b> (EC<sub>50</sub> = 2.44 μM) displayed a good safety profile with low cytotoxicity and cardiotoxicity.</div></div><div id="sec3_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Acute Toxicity and Effect on Mouse Body Weight</h3><div class="NLM_p last">The acute toxicities of compounds <b>20h</b> and <b>32h</b> were investigated in terms of LD<sub>50</sub> values. Both compounds showed quite low acute toxicities, even at the highest tested dose (1500 mg/kg, dissolved in PEG400), and were not lethal in any of the mice 24 h after administration by i.p. injection. Then, successive p.o. administrations of compounds <b>20h</b> and <b>32h</b> were performed for 28 days, and body weight was recorded every day. Only a slight reduction in body weight was observed for each compound compared with the vehicle (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">Figure S9</a> in the Supporting Information). Nevertheless, weight gain trends and daily behavior of the drug administration groups were unaffected. Taken together, these results suggested that both compounds displayed a remarkable safety profile.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i33">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_50102" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_50102" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">We aimed to develop novel NMDAR PAMs with improved <i>in vivo</i> activity and drug properties for further development as clinical antidepressants. Starting with virtual screens, the scaffold of furan-2-carboxamide was identified to possess PAM effects on NMDA responses of brain slides and cultured neurons. Further studies determined FS2921 as a functionally selective GluN1/GluN2A PAM versus GluN1/GluN2B and GluN1/GluN2D. FS2921 exhibited a weak NAM effect for GluN1/GluN2C but did not show any influence on native AMPA receptors and GABA receptors. Subsequently, a series of novel derivatives were designed and synthesized based on the discovered core scaffolds. Several selected candidates, including the compound <b>32h</b>, exhibited favorable <i>in vitro</i> activity with △<i>I</i>/<i>I</i><sub>NDMA</sub> = 12.5 ± 5.7 and EC<sub>50</sub> = 2.4 μM. It was also found that the compound <b>32h</b> was as efficacious as duloxetine in FST. Furthermore, the PK/PD studies of the compound <b>32h</b> in mice and rats displayed superior profiles, including moderate drug exposure and excellent brain penetration properties. In addition, the compound <b>32h</b> exhibited excellent safety profiles in cytotoxicity, hERG inhibition, and long-term drug administration. The excellent potency, exquisite target selectivity, and <i>in vivo</i> PK/PD profile of the compound <b>32h</b> supported it as an excellent lead compound for further optimizations to discover a promising pharmacotherapeutic for the treatment of depression.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i34">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40755" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40755" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Structure-Based Virtual Screening and Docking</h3><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A, the GluN2A and GluN1 ligand-binding domains’ (LBDs) crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KDT">5KDT</a>) was selected for the study <i>in silico</i>. Approximately 300,000 compounds from the SPECS chemical library and PKU-CNCL database were prepared to generate conformations by the LigPrep module of the Schrodinger suite (Schrodinger, NY, USA). Then, energy-minimized conformations were docked into the GNE0723 binding site of the crystal structure prepared by the Protein Preparation Wizard module. Then, three predicted binding poses were generated for each compound. According to the score obtained by the extra precision (XP) scoring function of the Glide module, the top 1000 compounds were retained, among which 361 compounds were selected for the binding pose filter with a π–π interaction with Tyr144. The remaining compounds were structurally clustered into 26 clusters based on the Tanimoto coefficients computed using the ECFP_6 fingerprint. Lastly, eight candidate compounds were purchased for further evaluation by patch-clamp experiments on mice brain slices.</div><div class="NLM_p last">For induced-docking studies, the prepared crystal structure (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KDT">5KDT</a>) was used in the Induced Docking module with XP. For ligand preparation, conformations of <b>GNE-0723</b> and FS2921 were generated and energy-minimized by the LigPrep module. Images depicting the proposed binding modes were generated using Maestro 11.5 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> General Chemistry</h3><div class="NLM_p last">All commercially available reagents and solvents were used without further purification. Reactions were monitored by thin-layer chromatography (TLC) on precoated glass silica gel plates (GF254, 0.25 mm, Yantai Xinde Chemical Co., Ltd.) using a CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH system or an EtOAc/Petroleum ether system. Column chromatographic purification was carried out using silica gel. Melting points were determined using an X-4 micro melting point apparatus. <sup>1</sup>H NMR and <sup>13</sup>C NMR spectra were recorded on a Bruker Avance III 400 spectrometer using chloroform-<i>d</i> or DMSO-<i>d</i><sub>6</sub> as the solvent. <i>J</i> values were reported in hertz (Hz). Chemical shifts were given in δ values (ppm), using tetramethylsilane (TMS) as the internal standard. Signal multiplicities are characterized as the following abbreviation: s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and br (broad signal). All final test compounds’ purity is determined by high-performance liquid chromatography (HPLC), and all final test compounds display purity higher than 95%. HPLC methods used the following: Waters LC-20 AD spectrometer; Waters Xbridge BEH Amide column (4.6 × 250 mm, 5 μm i.d.); mobile phase, H<sub>2</sub>O aq/acetonitrile (30/70; Thermo Fisher Scientific Inc., USA) at a flow rate of 1 mL/min. The column temperature was 25 °C. The detection wavelength was 254 nm.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> General Procedure A: Synthesis of Pyrazol-Compounds <b>14</b>, <b>22a/b</b>, and <b>30</b></h3><div class="NLM_p last">Properly substituted parazoles (1 mmol) was solved in dry CH<sub>3</sub>CN and followed with K<sub>2</sub>CO<sub>3</sub> (2 mmol). To the mixture was added the solution of intermediates <b>13</b> or <b>29</b> (1.5 mmol) in CH<sub>3</sub>CN. The resulting suspension was stirred under 60 °C for 8 h, and then evaporated under reduced pressure. The residue was treated with water/CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was evaporated to remove the solvent for further purification. The final product was obtained through silica gel column chromatography by elution with EtOAc/Petroleum ether.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> General Procedure B: Hydrolysis of Methyl Esters to Obtain Carboxylic Acids <b>15</b>, <b>19a/b</b>, <b>23a-d</b>, and <b>31</b></h3><div class="NLM_p last">To a solution of methyl esters (1 mmol) in <i>methanol</i>, NaOH (1.5 mmol) was added. The mixture was stirred at room temperature overnight. Then the solvent was removed under reduced pressure and redissolved in water/EtOAc. The aqueous layer was added 1 M HCl to pH 4, and then washed with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layer was evaporated to remove the solvent for the next step without further purification.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> General Procedure C: Coupling of Carboxamides <b>9a-c</b>, <b>16a/b</b>, <b>17a-n</b>, <b>20a-k</b>, <b>22a-d</b>, <b>32a-o</b>, and <b>33a-f</b></h3><div class="NLM_p">A mixture of Furan-2-carboxylic acid or thiophene-2-carboxylic acid (1 mmol), DIPEA (2 mmol), and HATU (1.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) were stirred at 0 °C for 20 min. Properly substituted aniline (2 mmol) was added to the solvent, and the reaction was stirred at room temperature overnight. The resulting mixture was washed with water and dried over Na<sub>2</sub>SO<sub>4</sub>. Then, the solvent was removed under reduced pressure for further purification. The residue was purified through silica gel column chromatography by elution with a CH<sub>2</sub>Cl<sub>2</sub>/MeOH/50% aq NH<sub>4</sub>OH system to give the target products.</div><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> <i>N</i>-(4-Bromo-2-methylphenyl)furan-2-carboxamide (<b>9a</b>)</h4><div class="NLM_p last">Compound <b>9a</b> was prepared with general procedure C using starting materials <b>7a</b> and <b>8</b>. The final product was obtained as a white solid in 93% yield. M.p.: 105–107 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.82 (s, 1H), 7.94 (d, 1H), 7.50 (d, <i>J</i> = 2.0 Hz, 1H), 7.45–7.37 (m, 1H), 7.34–7.29 (m, 2H), 6.70 (dd, <i>J</i> = 3.4, 1.7 Hz, 1H), 2.23 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.73, 147.86, 146.12, 136.77, 135.50, 133.23, 129.30, 128.78, 118.79, 115.16, 112.58, 18.06. HRMS (ESI): calcd for C<sub>12</sub>H<sub>11</sub>Br NO<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 279.9973, found 279.9975; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> <i>N</i>-(4-Bromo-2-methylphenyl)-5-methylfuran-2-carboxamide (<b>9b</b>)</h4><div class="NLM_p last">Compound <b>9b</b> was prepared with general procedure C using starting materials <b>7b</b> and <b>8</b>. The final product was obtained as a white solid in 96% yield. M.p.: 138–140 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.67 (s, 1H), 7.49 (d, <i>J</i> = 2.0 Hz, 1H), 7.39 (dd, <i>J</i> = 8.5, 2.2 Hz, 1H), 7.30 (d, <i>J</i> = 8.5 Hz, 1H), 7.20 (d, <i>J</i> = 3.3 Hz, 1H), 6.32 (d, <i>J</i> = 3.2 Hz, 1H), 2.38 (s, 3H), 2.22 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.74, 155.51, 146.33, 136.75, 135.66, 133.19, 129.26, 128.72, 118.64, 116.33, 108.94, 18.09, 14.03. HRMS (ESI): calcd for C<sub>13</sub>H<sub>13</sub>BrNO<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 294.0130, found 294.0125; purity: ≥99% by HPLC analysis.</div></div><div id="sec5_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> <i>N</i>-(4-Bromo-2-methylphenyl)-5-chlorofuran-2-carboxamide (<b>9c</b>)</h4><div class="NLM_p last">Compound <b>9c</b> was prepared with general procedure C using starting materials <b>7c</b> and <b>8</b>. The final compound was obtained as a white solid in 89% yield. M.p.: 122–124 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.92 (s, 1H), 7.51 (d, <i>J</i> = 1.7 Hz, 1H), 7.44–7.34 (m, 2H), 7.27 (d, <i>J</i> = 8.5 Hz, 1H), 6.75 (d, <i>J</i> = 3.6 Hz, 1H), 2.21 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 155.69, 147.42, 138.28, 137.02, 135.22, 133.29, 129.35, 128.96, 119.07, 117.45, 109.95, 18.07. HRMS (ESI): calcd for C<sub>12</sub>H<sub>10</sub>ClBrNO<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 313.9683, found 313.9690; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Methyl 5-(Hydroxymethyl)furan-2-carboxylate (<b>11</b>)</h4><div class="NLM_p last">To a solution of starting material <b>10</b> in dry methanol (10 mL) was added concentrated sulfuric acid (2 mL) at 0 °C. After slow addition, the mixture was stirred for 10 h at room temperature. Then, to the mixture was added 2 N NaHCO<sub>3</sub> until the pH becomes 7. After that, the mixture was extracted with dichloromethane three times, and the organic phase was combined and dried over Na<sub>2</sub>SO<sub>4</sub>. Then, the solvent was removed under reduced pressure for further purification. The residue was purified through silica gel column chromatography by elution with EtOAc/petroleum ether (1:2). The final compound was obtained as a pale yellow oil in 94% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.13 (d, <i>J</i> = 3.4 Hz, 1H), 6.42 (dd, <i>J</i> = 3.4, 0.7 Hz, 1H), 4.70–4.65 (m, 2H), 3.89 (s, 3H), 2.69 (s, 1H). <sup>13</sup>C NMR (101 MHz, chloroform-<i>d</i>) δ 159.23, 158.47, 143.97, 118.91, 109.42, 57.49, 51.96. MS (ESI): calcd for C<sub>7</sub>H<sub>9</sub>O<sub>4</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 157, found 157.</div></div><div id="sec5_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> Methyl 5-(Chloromethyl)furan-2-carboxylate (<b>12</b>)</h4><div class="NLM_p last">A solution of compound <b>11</b> (1 mmol) in a mixture of CH<sub>2</sub>Cl<sub>2</sub> (9.5 mL) and DMF (0.5 mL) was treated with SOCl<sub>2</sub> (1.5 mmol). The mixture was stirred for 1 h at room temperature. Then, the reaction was treated with saturated NaHCO<sub>3</sub> solution. The residue was purified through silica gel column chromatography by elution with EtOAc/petroleum ether (1:4). The final compound was obtained as a colorless oil in 86% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.13 (d, <i>J</i> = 3.5 Hz, 1H), 6.49 (d, <i>J</i> = 3.5 Hz, 1H), 4.60 (s, 2H), 3.90 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 158.78, 154.13, 144.80, 118.80, 111.39, 52.04, 36.65. MS (ESI): calcd for C<sub>7</sub>H<sub>8</sub>ClO<sub>3</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 175, found 175.</div></div><div id="sec5_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> Methyl 5-(Iodomethyl)furan-2-carboxylate (<b>13</b>)</h4><div class="NLM_p last">To a solution of compound <b>12</b> (1 mmol) in acetone (10 mL) was added NaI (1.5 mmol). The mixture was refluxed for 10 h and cooled to r.t. Then, the reaction was treated with EtOAc/water. The organic layer was evaporated to remove the solvent for the next step without further purification.</div></div><div id="sec5_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> Methyl 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxylate (<b>14</b>)</h4><div class="NLM_p last">Compound <b>14</b> was prepared with general procedure A using 3,5-dimethyl<i>-</i>1<i>H</i>-pyrazole and intermediate <b>13</b>. The final compound was obtained as a colorless oil in 66% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.07 (d, <i>J</i> = 2.8 Hz, 1H), 6.17 (d, <i>J</i> = 2.8 Hz, 1H), 5.82 (s, 1H), 5.20 (s, 2H), 3.85 (s, 3H), 2.26 (s, 3H), 2.19 (s, 3H). MS (ESI): calcd for C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>3</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 235, found 235.</div></div><div id="sec5_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxylic Acid (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was prepared with general procedure B using starting material intermediate <b>26</b>. The final compound was obtained as a white solid for the next step without further purification.</div></div><div id="sec5_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(pyridin-3-yl)furan-2-carboxamide (<b>16a</b>)</h4><div class="NLM_p last">Compound <b>16a</b> was prepared with general procedure C using pyridin-3-amine and intermediate <b>15</b>. The final compound was obtained as a white solid in 65% yield. M.p.: 144–146 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.36 (s, 1H), 8.90 (s, 1H), 8.31 (d, <i>J</i> = 4.3 Hz, 1H), 8.14 (d, <i>J</i> = 8.3 Hz, 1H), 7.38 (dd, <i>J</i> = 9.7, 3.4 Hz, 2H), 6.47 (d, <i>J</i> = 2.5 Hz, 1H), 5.85 (s, 1H), 5.29 (s, 2H), 2.28 (s, 3H), 2.08 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.82, 154.41, 146.95, 146.88, 145.09, 142.41, 139.58, 135.67, 127.84, 123.99, 116.42, 110.77, 105.71, 45.52, 13.73, 11.08. HRMS (ESI): calcd for C<sub>16</sub>H<sub>17</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 297.1352, found 297.1354; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(naphthalen-2-yl)furan-2-carboxamide (<b>16b</b>)</h4><div class="NLM_p last">Compound <b>16b</b> was prepared with general procedure C using naphthalen-2-amine and intermediate <b>15</b>. The final compound was obtained as a white solid in 45% yield. M.p.: 138–140 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32 (s, 1H), 8.37 (s, 1H), 7.96–7.74 (m, 4H), 7.56–7.33 (m, 3H), 6.49 (d, J = 3.4 Hz, 1H), 5.86 (s, 1H), 5.31 (s, 2H), 2.31 (s, 3H), 2.09 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.73, 154.21, 147.36, 146.86, 139.60, 136.61, 133.74, 130.46, 128.68, 127.92, 127.82, 126.89, 125.31, 121.31, 117.10, 115.93, 110.69, 105.71, 45.56, 13.76, 11.11. HRMS (ESI): calcd for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 346.1556, found 346.1549; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(4-fluoro-2-methylphenyl)furan-2-carboxamide (<b>17a</b>)</h4><div class="NLM_p last">Compound <b>17a</b> was prepared with general procedure C using 4-fluoro-2-methylaniline and intermediate <b>15</b>. The final compound was obtained as a white solid in 47% yield. M.p.: 120–122 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.73 (s, 1H), 7.37–7.29 (m, 1H), 7.26 (d, <i>J</i> = 3.0 Hz, 1H), 7.14 (dd, <i>J</i> = 9.6, 2.4 Hz, 1H), 7.04 (td, <i>J</i> = 8.6, 2.7 Hz, 1H), 6.47 (d, <i>J</i> = 3.3 Hz, 1H), 5.85 (s, 1H), 5.27 (s, 2H), 2.30 (s, 3H), 2.21 (s, 3H), 2.08 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.47 (d, <i>J</i> = 242.0 Hz), 156.81, 153.88, 147.39, 146.83, 139.59, 137.03 (d, <i>J</i> = 8.3 Hz), 132.21 (d, <i>J</i> = 2.8 Hz), 128.86 (d, <i>J</i> = 8.8 Hz), 117.09 (d, <i>J</i> = 22.2 Hz), 115.60, 113.10 (d, <i>J</i> = 22.0 Hz), 110.66, 105.65, 45.46, 18.32, 13.74, 11.11. HRMS (ESI): calcd for C<sub>18</sub>H<sub>19</sub>FN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 328.1461, found 328.1463; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> <i>N</i>-(4-Chloro-2-methylphenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>17b</b>)</h4><div class="NLM_p last">Compound <b>17b</b> was prepared with general procedure C using 4-chloro-2-methylaniline and intermediate <b>15</b>. The final compound was obtained as a white solid in 49% yield. M.p.:133–135 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.94 (d, <i>J</i> = 9.2 Hz, 1H), 7.88 (s, 1H), 7.28 (s, 0H), 7.19 (s, 2H), 7.14 (d, <i>J</i> = 2.9 Hz, 1H), 6.33 (d, <i>J</i> = 2.7 Hz, 1H), 5.87 (s, 1H), 5.23 (s, 2H), 2.30 (s, 3H), 2.28 (s, 3H), 2.23 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 155.72, 152.46, 148.32, 147.38, 139.12, 133.77, 130.34, 130.24, 130.03, 126.82, 123.56, 116.22, 110.54, 105.97, 45.80, 17.43, 13.49, 11.07. HRMS (ESI): calcd for C<sub>18</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>Cl [M + H]<sup>+</sup><i>m</i>/<i>z</i> 344.1166, found 344.1159; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(<i>o</i>-tolyl)furan-2-carboxamide (<b>17c</b>)</h4><div class="NLM_p last">Compound <b>17c</b> was prepared with general procedure C using <i>o</i>-toluidine and intermediate <b>15</b>. The final compound was obtained as a white solid in 55% yield. M.p.: 98–100 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.03–7.90 (m, 2H), 7.32–7.20 (m, 2H), 7.16–7.04 (m, 2H), 6.32 (s, 1H), 5.87 (s, 1H), 5.22 (s, 2H), 2.30 (s, 6H), 2.23 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 155.80, 152.31, 148.28, 147.64, 139.16, 135.15, 130.49, 128.55, 126.87, 125.12, 122.41, 115.94, 110.48, 105.94, 45.81, 17.57, 13.51, 11.08. HRMS (ESI): calcd for C<sub>18</sub>H<sub>20</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 310.1556, found 310.1555; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-phenylfuran-2-carboxamide (<b>17d</b>)</h4><div class="NLM_p last">Compound <b>17d</b> was prepared with general procedure C using aniline and intermediate <b>15</b>. The final compound was obtained as a white solid in 75% yield. M.p.: 124–126 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.10 (s, 1H), 7.72 (d, <i>J</i> = 8.6 Hz, 2H), 7.41–7.28 (m, 3H), 7.10 (t, <i>J</i> = 7.4 Hz, 1H), 6.46 (d, <i>J</i> = 3.5 Hz, 1H), 5.85 (s, 1H), 5.28 (s, 2H), 2.29 (s, 3H), 2.09 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.53, 154.08, 147.37, 146.83, 139.57, 138.93, 129.10, 124.21, 120.84, 115.77, 110.62, 105.69, 45.54, 13.75, 11.10. HRMS (ESI): calcd for C<sub>17</sub>H<sub>18</sub>N<sub>3</sub>O<sub>2</sub> [M + H] + <i>m</i>/<i>z</i> 296.1399, found 296.1401; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-(4-Bromophenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>17e</b>)</h4><div class="NLM_p last">Compound <b>17e</b> was prepared with general procedure C using 4-bromoaniline and intermediate<b>15</b>. The final compound was obtained as a white solid in 62% yield. M.p.: 168–170 °C.<sup>1</sup>HNMR (400 MHz, CDCl<sub>3</sub>) δ 8.33 (s, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 2H), 7.42 (d, <i>J</i> = 8.5 Hz, 2H), 7.12 (d, <i>J</i> = 3.2 Hz, 1H), 6.28 (d, <i>J</i> = 2.9 Hz, 1H), 5.85 (s, 1H), 5.18 (s, 2H), 2.26 (s, 3H), 2.21 (s, 3H). <sup>13</sup>C NMR(101 MHz, CDCl<sub>3</sub>) δ 155.83, 152.38, 148.37, 147.37, 139.20, 136.51, 131.98 (2C),121.62 (2C), 117.11, 116.36, 110.79, 106.08, 77.26, 45.75, 13.47, 11.11. HRMS (ESI): calcd for C<sub>17</sub>H<sub>17</sub>BrN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 374.0504, found 374.0505; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-(4-Bromo-2-ethylphenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>17f</b>)</h4><div class="NLM_p last">Compound <b>17f</b> was prepared with general procedure C using 4-bromo-2-aniline and intermediate <b>15</b>. The final compound was obtained as a white solid in 68% yield. M.p.: 155–157 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.90 (d, <i>J</i> = 8.7 Hz, 2H), 7.33 (d, <i>J</i> = 7.0 Hz, 2H), 7.14 (d, <i>J</i> = 3.4 Hz, 1H), 6.34 (d, <i>J</i> = 3.4 Hz, 1H), 5.85 (s, 1H), 5.22 (s, 2H), 2.61 (q, <i>J</i> = 7.6 Hz, 2H), 2.29 (s, 3H), 2.21 (s, 3H), 1.25 (t, <i>J</i> = 7.6 Hz, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 155.80, 152.45, 148.33, 147.43, 139.10, 136.35, 133.62, 131.38, 129.75, 124.27, 118.32, 116.28, 110.63, 105.94, 45.80, 24.07, 13.57, 13.51, 11.09. HRMS (ESI): calcd for C<sub>19</sub>H<sub>21</sub>BrN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 402.0817, found 402.0818; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(4-Bromo-2-chlorophenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>17g</b>)</h4><div class="NLM_p last">Compound <b>17g</b> was prepared with general procedure C using 4-bromo-2-chloro-aniline and intermediate <b>15</b>. The final compound was obtained as a white solid in 58% yield. M.p.: 186–188 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.51 (s, 1H), 8.40 (d, <i>J</i> = 8.9 Hz, 1H), 7.53 (s, 1H), 7.39 (d, <i>J</i> = 8.9 Hz, 1H), 7.16 (d, <i>J</i> = 3.1 Hz, 1H), 6.36 (d, <i>J</i> = 2.9 Hz, 1H), 5.86 (s, 1H), 5.23 (s, 2H), 2.33 (s, 3H), 2.21 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 155.42, 153.08, 148.42, 146.90, 139.19, 133.45, 131.48, 130.91, 123.39, 122.14, 116.88, 116.34, 110.77, 105.96, 45.69, 13.51, 11.11. HRMS (ESI): calcd for C<sub>17</sub>H<sub>16</sub>ClN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 408.0114, found 408.0112; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(2-(methylamino)phenyl)furan-2-carboxamide (<b>17h</b>)</h4><div class="NLM_p last">Compound <b>17h</b> was prepared with general procedure C using N<sup>1</sup>-methylbenzene-1,2-diamine and intermediate <b>15</b>. The final compound was obtained as a white solid in 38% yield. M.p.: 135 ∼ 137 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.41 (s, 1H), 7.26 (s, 1H), 7.18–7.04 (m, 2H), 6.68–6.55 (m, 2H), 6.47 (d, <i>J</i> = 2.9 Hz, 1H), 5.85 (s, 1H), 5.26 (s, 2H), 5.13 (d, <i>J</i> = 4.5 Hz, 1H), 2.71 (d, <i>J</i> = 4.8 Hz, 3H), 2.30 (s, 3H), 2.09 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 157.20, 153.53, 147.74, 146.76, 145.32, 139.55, 127.75, 127.52, 122.81, 115.83, 115.33, 110.75, 110.58, 105.64, 45.48, 30.28, 13.75, 11.13. HRMS (ESI): calcd for C<sub>18</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 325.1665, found 325.1671; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(2-(2-hydroxyethyl)phenyl)furan-2-carboxamide (<b>17i</b>)</h4><div class="NLM_p last">Compound <b>17i</b> was prepared with general procedure C using 2-(2-aminophenyl)ethan-1-ol and intermediate <b>15</b>. The final compound was obtained as a white solid in 38% yield. M.p.: 93–95 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.23 (s, 1H), 7.60 (d, <i>J</i> = 7.9 Hz, 1H), 7.33–7.21 (m, 2H), 7.18 (d, 1H), 7.17–7.12 (m, 1H), 6.56–6.45 (m, 1H), 5.85 (s, 1H), 5.53–5.33 (m, 1H), 5.27 (s, 2H), 3.70 (t, <i>J</i> = 5.7 Hz, 2H), 2.78 (t, <i>J</i> = 5.6 Hz, 2H), 2.31 (s, 3H), 2.09 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.43, 153.82, 147.62, 146.91, 139.66, 136.46, 134.56, 130.86, 126.96, 125.84, 125.32, 115.41, 110.79, 105.64, 62.68, 45.38, 35.44, 13.75, 11.08. HRMS (ESI): calcd for C<sub>19</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 340.1661, found 340.1664; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-([1,1′-Biphenyl]-2-yl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>17j</b>)</h4><div class="NLM_p last">Compound <b>17j</b> was prepared with general procedure C using [1,1′-biphenyl]-4-amine and intermediate <b>15</b>. The final compound was obtained as a white solid in 38% yield. M.p.: 97 ∼ 99 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.46 (s, 1H), 7.63 (d, <i>J</i> = 7.8 Hz, 1H), 7.49–7.27 (m, 8H), 7.10 (d, <i>J</i> = 2.9 Hz, 1H), 6.43 (d, <i>J</i> = 3.2 Hz, 1H), 5.84 (s, 1H), 5.19 (s, 2H), 2.21 (s, 3H), 2.08 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.90, 153.77, 147.38, 146.82, 139.52, 139.08, 137.47, 134.40, 130.77, 129.12 (2C), 128.92 (2C), 128.35, 127.85, 127.38, 126.88, 115.62, 110.78, 105.64, 45.36, 13.74, 11.07. HRMS (ESI): calcd for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 372.1712, found 372.1717; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-([1,1′-Biphenyl]-4-yl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>17k</b>)</h4><div class="NLM_p last">Compound <b>17k</b> was prepared with general procedure C using [1,1′-biphenyl]-2-amine and intermediate <b>15</b>. The final compound was obtained as a white solid in 38% yield. M.p.: 178–180 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.23 (s, 1H), 7.85 (d, <i>J</i> = 8.6 Hz, 2H), 7.67 (d, <i>J</i> = 8.7 Hz, 4H), 7.45 (t, <i>J</i> = 7.6 Hz, 2H), 7.40–7.29 (m, 2H), 6.47 (d, <i>J</i> = 3.3 Hz, 1H), 5.86 (s, 1H), 5.30 (s, 2H), 2.30 (s, 3H), 2.09 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.55, 154.15, 147.38, 146.87, 140.13, 139.57, 138.48, 135.86, 129.35 (2C), 127.54, 127.31 (2C), 126.75 (2C), 121.12 (2C), 115.90, 110.66, 105.72, 45.56, 13.75, 11.10. HRMS (ESI): calcd for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 372.1712, found 372.1714; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-(4-Chloro-2-(hydroxymethyl)phenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>17l</b>)</h4><div class="NLM_p last">Compound <b>17l</b> was prepared with general procedure C using (2-amino-5-chlorophenyl)methanol and intermediate <b>15</b>. The final compound was obtained as a white solid in 44% yield. M.p.: 131–133 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.04 (s, 1H), 7.75 (d, <i>J</i> = 8.6 Hz, 1H), 7.46 (d, <i>J</i> = 2.3 Hz, 1H), 7.35 (dd, <i>J</i> = 8.6, 2.4 Hz, 1H), 7.23 (d, <i>J</i> = 3.4 Hz, 1H), 6.51 (d, <i>J</i> = 3.4 Hz, 1H), 5.84 (s, 1H), 5.75 (t, <i>J</i> = 5.5 Hz, 1H), 5.27 (s, 2H), 4.57 (d, <i>J</i> = 5.4 Hz, 2H), 2.31 (s, 3H), 2.08 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.22, 154.14, 147.18, 146.91, 139.66, 137.03, 134.72, 129.36, 127.58, 127.48, 125.69, 116.16, 111.06, 105.63, 60.94, 45.36, 13.75, 11.10. HRMS (ESI): calcd for C<sub>18</sub>H<sub>19</sub>N<sub>3</sub>O<sub>3</sub>Cl [M + H]<sup>+</sup><i>m</i>/<i>z</i> 360.1115, found 360.1119; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> <i>N</i>-(2,4-Dichlorophenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>17m</b>)</h4><div class="NLM_p last">Compound <b>17m</b> was prepared with general procedure C using 2,4-dichloroaniline and intermediate <b>15</b>. The final compound was obtained as a white solid in 63% yield. M.p.: 175–177 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.53 (s, 1H), 8.47 (d, <i>J</i> = 8.9 Hz, 1H), 7.42 (s, 1H), 7.19 (d, <i>J</i> = 3.3 Hz, 1H), 6.38 (d, <i>J</i> = 3.2 Hz, 1H), 5.87 (s, 1H), 5.25 (s, 2H), 2.35 (s, 3H), 2.23 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 155.48, 153.06, 148.45, 146.93, 139.20, 133.00, 129.18, 128.77, 128.02, 123.24, 121.88, 116.87, 110.75, 105.96, 45.72, 13.50, 11.10. HRMS (ESI): calcd for C<sub>17</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 364.0620, found 364.0623; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> <i>N</i>-(4-Chloro-2-fluorophenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>17n</b>)</h4><div class="NLM_p last">Compound <b>17n</b> was prepared with general procedure C using 2-fluoro-4-chloroaniline and intermediate <b>15</b>. The final compound was obtained as a white solid in 66% yield. M.p.: 131–133 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.86 (s, 1H), 7.79–7.40 (m, 2H), 7.29 (d, <i>J</i> = 10.7 Hz, 2H), 6.50 (s, 1H), 5.85 (s, 1H), 5.28 (s, 2H), 2.30 (s, 3H), 2.08 (s, 3H).<sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.14 (d, <i>J</i> = 246.4 Hz), 156.69, 154.22, 146.91, 146.86 , 139.60, 131.31 (d, <i>J</i> = 3.5 Hz), 130.72 (d, <i>J</i> = 11.1 Hz), 129.87 (d, <i>J</i> = 9.1 Hz), 117.20 (d, <i>J</i> = 25.9 Hz), 116.28, 115.14 (d, <i>J</i> = 22.1 Hz), 110.83, 105.66, 45.43, 13.75, 11.11. HRMS (ESI): calcd for C<sub>17</sub>H<sub>16</sub>ClFN<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 348.0915, found 348.0913; purity: ≥95% by HPLC analysis.</div></div><div id="sec5_5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> Methyl 5-((3-Methyl-5-(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxylate (<b>18a</b>) or Methyl 5-((3,5-Bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxylate (<b>18b</b>)</h4><div class="NLM_p last">Compound <b>18a/18b</b> was prepared with general procedure A using 3-methyl-5-(trifluoromethyl)<i>-</i>1<i>H</i>-pyrazole or 3,5-bis(trifluoromethyl)<i>-</i>1<i>H</i>-pyrazole and intermediate <b>25</b>. The final compound was obtained as a colorless oil without further purification for the next step.</div></div><div id="sec5_5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 5-((3-Methyl-5-(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxylic Acid (<b>19a</b>) or 5-((3,5-Bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxylic Acid (<b>19b</b>)</h4><div class="NLM_p last">Compound <b>19a</b> or <b>19b</b> was prepared with general procedure B using intermediate <b>18a</b> or <b>18b</b>. The final compound was obtained as a white solid without further purification for the next step.</div></div><div id="sec5_5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-(4-Chloro-2-methylphenyl)-5-((5-methyl-3-(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>20a</b>)</h4><div class="NLM_p last">Compound <b>20a</b> was prepared with general procedure C using 4-chloro-2-methylaniline and intermediate <b>19a</b>. The final compound was obtained as a white solid in 60% yield. M.p.: 127 ∼ 129 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.76 (s, 1H), 7.42–7.34 (m, 2H), 7.34–7.24 (m, 2H), 6.63 (d, <i>J</i> = 3.4 Hz, 1H), 6.57 (s, 1H), 5.52 (s, 2H), 2.43 (s, 3H), 2.21 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.54, 152.33, 147.73, 142.03, 140.34 (q, <i>J</i> = 37.2 Hz), 136.30, 134.92, 130.47, 130.36, 128.34, 126.39, 122.00 (q, <i>J</i> = 268.2 Hz), 115.80, 111.68, 104.55 (d, <i>J</i> = 2.5 Hz), 46.51, 18.05, 11.19. HRMS (ESI): calcd for C<sub>18</sub>H<sub>16</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 398.0883, found 398.0873; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-(4-Bromo-2-methylphenyl)-5-((5-methyl-3-(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>20b</b>)</h4><div class="NLM_p last">Compound <b>20b</b> was prepared with general procedure C using 4-bromo-2-methylaniline and intermediate <b>19a</b>. The final compound was obtained as a white solid in 57% yield. M.p.: 98–100 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.75 (s, 1H), 7.57–7.46 (m, 1H), 7.45–7.36 (m, 1H), 7.37–7.25 (m, 2H), 6.63 (d, <i>J</i> = 3.4 Hz, 1H), 6.56 (s, 1H), 5.52 (s, 2H), 2.43 (s, 3H), 2.21 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.48, 152.34, 147.72, 142.03, 140.35 (q, <i>J</i> = 37.2 Hz), 136.62, 135.38, 133.26, 129.34, 128.61, 122.00 (q, <i>J</i> = 268.1 Hz), 118.82, 115.82, 111.68, 104.55, 46.51, 17.9, 11.19. HRMS (ESI): calcd for C<sub>18</sub>H<sub>16</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 442.0378, found 442.0383; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 5-((3,5-Bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(4-fluoro-2-methylphenyl)furan-2-carboxamide (<b>20c</b>)</h4><div class="NLM_p last">Compound <b>20c</b> was prepared with general procedure C using 4-fluoro-2-methylaniline and intermediate <b>19b</b>. The final compound was obtained as a white solid in 55% yield. M.p.: 162–164 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.12 (s, 1H), 7.94–7.90 (m, 2H), 7.83 (s, 1H), 7.21 (d, <i>J</i> = 4.0 Hz, 1H), 6.97–6.92 (m, 1H), 6.63 (d, <i>J</i> = 4.0 Hz, 1H), 5.55 (s, 2H), 2.32 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 161.15, 158.72, 155.50, 148.61, 148.48, 130.88, 130.85, 124.42, 124.34, 117.24, 117.02, 115.96, 113.50, 113.28, 113.00, 106.86, 77.33, 77.02, 76.70, 48.36, 48.34, 17.47. HRMS (ESI): calcd for: C<sub>19</sub>H<sub>12</sub>F<sub>7</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 436.0896, found 436.0894; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 5-((3,5-Bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(4-chloro-2-methylphenyl)furan-2-carboxamide (<b>20d</b>)</h4><div class="NLM_p last">Compound <b>20d</b> was prepared with general procedure C using 4-chloro-2-methylaniline and intermediate <b>19b</b>. The final compound was obtained as a white solid in 48% yield. M.p.: 145–147 °C.<sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.03 (d, <i>J</i> = 6.0 Hz, 2H), 7.90 (s, 1H), 7.23 (m, 3H), 6.97 (s, 1H), 6.64 (d, <i>J</i> = 4.0 Hz, 2H), 5.55 (s, 2H), 2.31 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 155.32, 148.67, 148.42, 133.68, 133.24, 130.31, 130.08, 129.95, 126.91, 123.20, 124.68, 121.45, 120.47, 118.81, 116.13, 113.09, 106.88, 48.33, 17.14. HRMS (ESI): calcd for: C<sub>18</sub>H<sub>12</sub>ClF<sub>6</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 452.0600, found 452.0600; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 5-((3,5-Bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(4-bromo-2-methylphenyl)furan-2-carboxamide (<b>20e</b>)</h4><div class="NLM_p last">Compound <b>20e</b> was prepared with general procedure C using 4-bromo-2-methylaniline and intermediate <b>19b</b>. The final compound was obtained as a white solid in 68% yield. M.p.: 130–132 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.72 (s, 1H), 7.65 (s, 1H), 7.50 (s, 1H), 7.40 (d, 1H), 7.37–7.32 (m, 2H), 6.72 (d, <i>J</i> = 2.6 Hz, 1H), 5.75 (s, 2H), 2.21 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.38, 150.46, 148.07, 141.26 (q, <i>J</i> = 40.2 Hz), 136.39, 135.32, 133.26, 133.20 (q, <i>J</i> = 40.2 Hz), 129.34, 128.40, 120.86 (q, <i>J</i> = 269.0 Hz), 119.38 (q, <i>J</i> = 269.8 Hz), 118.76, 115.79, 112.69, 108.22, 48.88, 17.86. HRMS (ESI): calcd for C<sub>18</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>F<sub>6</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 496.0095, found 496.0103; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 5-((3,5-Bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(2,4-dichlorophenyl)furan-2-carboxamide (<b>20f</b>)</h4><div class="NLM_p last">Compound <b>20f</b> was prepared with general procedure C using 2,4-dichloroaniline and intermediate <b>19b</b>. The final compound was obtained as an off-white solid in 63% yield. M.p.: 123–125 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.58 (s, 1H), 8.50 (d, <i>J</i> = 12.0 Hz, 1H), 7.45 (d, <i>J</i> = 4.0 Hz, 1H), 7.3 (dd, <i>J</i> = 2.0, 9.0 Hz 1H), 7.25 (d, <i>J</i> = 4.0 Hz, 1H), 6.97 (s, 1H), 6.65 (d, <i>J</i> = 4.0 Hz, 1H), 5.57 (s, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 155.19, 149.21, 147.93, 132.86, 130.65, 129.43, 128.88, 127.99, 123.43, 121.91, 121.60, 119.11, 116.68, 116.64, 113.06, 106.82, 48.33. HRMS (ESI): calcd for: C<sub>17</sub>H<sub>9</sub>Cl<sub>2</sub>F<sub>6</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 472.0054, found 472.0056; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 5-((3,5-Bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(3,4-dichlorophenyl)furan-2-carboxamide (<b>20g</b>)</h4><div class="NLM_p last">Compound <b>20g</b> was prepared with general procedure C using 3,4-dichloroaniline and intermediate <b>19b</b>. The final compound was obtained as a white solid in 55% yield. M.p.: 143–145 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (s, 1H), 8.07 (d, <i>J</i> = 4.0 Hz, 1H), 7.69 (d, <i>J</i> = 8.0 Hz, 2H), 7.62 (d, <i>J</i> = 8.0 Hz, 1H), 7.61, 7.60, 7.42 (d, <i>J</i> = 4.0 Hz, 1H), 6.72 (d, <i>J</i> = 4.0 Hz, 1H), 5.76 (s, 1H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 156.45, 151.07, 147.59, 139.04, 133.00, 131.37, 131.11, 125.80, 121.92, 120.96, 120.71, 120.27, 116.48, 112.76, 108.39, 107.13, 48.93. HRMS (ESI): calcd for: C<sub>17</sub>H<sub>9</sub>Cl<sub>2</sub>F<sub>6</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 472.0054, found 472.0057; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 5-((3,5-Bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(3,5-dichlorophenyl)furan-2-carboxamide (<b>20h</b>)</h4><div class="NLM_p last">Compound <b>20h</b> was prepared with general procedure C using 3,5-dichloroaniline and intermediate <b>19b</b>. The final compound was obtained as a white solid in 51% yield. M.p.: 148–150 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1H), 7.62 (d, <i>J</i> = 2.0 Hz, 2H), 7.24 (d, <i>J</i> = 4.0 Hz, 1H), 7.16 (t, <i>J</i> = 4.0 Hz, 1H), 6.99 (s, 1H), 6.62 (d, <i>J</i> = 4.0 Hz, 1H), 5.55 (s, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 155.34, 149.04, 147.71, 138.94, 135.39 (2C), 133.64, 133.24, 124.68, 121.45, 120.47, 118.16 (2C), 116.86, 113.21, 107.06, 48.31. HRMS (ESI): calcd for: C<sub>17</sub>H<sub>9</sub>C<sub>l2</sub>F<sub>6</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 472.0054, found 472.0053; HPLC purity >97% by HPLC analysis..</div></div><div id="sec5_5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 5-((3,5-Bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(3,5-dimethoxyphenyl)furan-2-carboxamide (<b>20i</b>)</h4><div class="NLM_p last">Compound <b>20i</b> was prepared with general procedure C using 3,5-dimethoxy aniline and intermediate <b>19b</b>. The final compound was obtained as a white solid in 41% yield. M.p.: 123–125 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.00 (s, 1H), 7.20 (d, <i>J</i> = 4.0 Hz, 1H), 6.98 (s, 1H), 6.89 (d, <i>J</i> = 4.0 Hz, 2H), 6.60 (d, <i>J</i> = 4.0 Hz, 1H), 6.30 (t, <i>J</i> = 4.0 Hz, 1H), 5.55 (s, 2H), 3.83 (s, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 161.13 (2C), 155.42, 148.62, 148.34, 138.84, 124.68, 121.45, 116.02 (2C), 112.99, 107.16, 98.15 (2C), 97.25, 77.22, 55.41 (2C), 48.42. HRMS (ESI): calcd for: C<sub>19</sub>H<sub>16</sub>F<sub>6</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 464.1045, found 464.1045; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 5-((3,5-Bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(4-fluoro-3-methylphenyl)furan-2-carboxamide (<b>20j</b>)</h4><div class="NLM_p last">Compound <b>20j</b> was prepared with general procedure C using 4-fluoro-3-methyl aniline and intermediate <b>19b</b>. The final compound was obtained as a white solid in 49% yield. M.p.: 132–134 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.97 (s, 1H), 7.50 (dd, <i>J</i> = 4.0, 8.0 Hz 1H), 7.39 (m, 1H), 7.20 (d, <i>J</i> = 4.0 Hz, 1H), 7.01 (m, 2H), 6.60 (d, <i>J</i> = 4.0 Hz, 1H), 5.55 (s, 2H), 2.31 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 159.48, 155.39, 148.57, 148.37, 132.72, 125.70, 125.52, 123.23, 123.18, 120.49, 119.10, 119.02, 115.97, 115.47, 115.24, 113.01, 48.40, 14.70. HRMS (ESI): calcd for: C<sub>18</sub>H<sub>13</sub>F<sub>7</sub>N<sub>3</sub>O<sub>2</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 436.0885, found 436.0893; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> Methyl 2-(5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamido)-5-fluorobenzoate (<b>22a</b>)</h4><div class="NLM_p last">Compound <b>22a</b> was prepared with general procedure C using methyl 2-amino-5-fluorobenzoate and intermediate <b>15</b>. The final compound was obtained as an off-white solid in 49% yield. M.p.: 168–170 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.81 (bs, 1H), 8.87–8.84 (m, 1H), 7.76 (d, <i>J</i> = 8.0 Hz, 1H), 7.33–7.28 (m, 1H), 7.19 (s, 1H), 6.41 (s, 1H), 5.86 (s, 1H), 5.25 (s, 2H), 3.99 (s, 3H), 2.43 (s, 3H), 2.24 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.59, 156.34, 153.19, 148.34, 147.64, 139.68, 137.52, 122.38, 121.85, 121.63, 117.09, 116.85, 116.43, 110.86, 105.75, 52.61, 45.66, 13.48, 11.04. HRMS (ESI): calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 372.1360, found 372.1356; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> Methyl 5-Chloro-2-(5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamido)benzoate (<b>22b</b>)</h4><div class="NLM_p last">Compound <b>22b</b> was prepared with general procedure C using methyl 2-amino-5-chlorobenzoate and intermediate <b>15</b>. The final compound was obtained as an off-white solid in 43% yield. M.p.: 180–182 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.86 (s, 1H), 8.81 (d, <i>J</i> = 9.1 Hz, 1H), 8.02 (s, 1H), 7.51 (d, <i>J</i> = 9.1 Hz, 1H), 7.17 (d, <i>J</i> = 3.1 Hz, 1H), 6.37 (d, <i>J</i> = 2.6 Hz, 1H), 5.84 (s, 1H), 5.25 (s, 2H), 3.97 (s, 3H), 2.41 (s, 3H), 2.21 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.53, 156.36, 153.36, 148.33, 139.73, 139.60, 134.50, 130.49, 127.80, 121.87, 116.63, 116.46, 110.86, 105.72, 77.23, 52.63, 45.69, 13.54, 11.05. HRMS (ESI): calcd for C<sub>19</sub>H<sub>19</sub>ClN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 388.1064, found 388.1068; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> Methyl 5-Bromo-2-(5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamido)benzoate (<b>22c</b>)</h4><div class="NLM_p last">Compound <b>22c</b> was prepared with general procedure C using methyl 2-amino-5-bromobenzoate and intermediate <b>15</b>. The final compound was obtained as an off-white solid in 37% yield. M.p.: 174–176 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.92 (s, 1H), 7.78 (s, 2H), 7.29 (d, <i>J</i> = 3.3 Hz, 1H), 6.49 (d, <i>J</i> = 3.4 Hz, 1H), 5.85 (s, 1H), 5.28 (s, 2H), 3.71 (s, 3H), 2.30 (s, 3H), 2.24 (s, 3H), 2.08 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 165.67, 156.66, 154.08, 147.25, 146.84, 139.73, 139.61, 136.84, 134.65, 130.43, 130.39, 119.06, 115.98, 110.77, 105.66, 52.79, 45.46, 18.24, 13.75, 11.12. HRMS (ESI): calcd for C<sub>19</sub>H<sub>19</sub>BrN<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 432.0715, found 432.0716; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> Methyl-2-(5-((3,5-bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamido)-5-fluorobenzoate (<b>22d</b>)</h4><div class="NLM_p last">Compound <b>22d</b> was prepared with general procedure C using methyl 2-amino-5-bromobenzoate and intermediate <b>19b</b>. The final compound was obtained as a white solid in 40% yield. M.p.: 116–118 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 11.82 (s, 1H), 8.84 (dd, <i>J</i> = 5.0, 19.0 Hz 1H), 7.76 (dd, <i>J</i> = 4.0, 8.0 Hz 1H), 7.33–7.28 (m, 1H), 7.22 (d, <i>J</i> = 4.0 Hz, 1H), 6.97 (s, 1H), 6.57 (d, <i>J</i> = 4.0 Hz, 1H), 5.60 (s, 2H), 3.99 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 167.37, 158.79, 156.36, 156.00, 149.33, 148.57, 137.27, 122.40, 121.70, 121.48, 117.15, 116.91, 116.88, 116.81, 116.14, 112.53, 106.69, 52.58, 48.57. HRMS (ESI): calcd for C<sub>19</sub>H<sub>13</sub>F<sub>7</sub>N<sub>3</sub>O<sub>4</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 480.0783, found 480.0789; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> 5-Fluoro-2-(5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamido)benzoic Acid (<b>23a</b>)</h4><div class="NLM_p last">Compound <b>23a</b> was prepared with general procedure B using intermediate <b>22a</b>. The final compound was obtained as a white solid without further purification for the next step.</div></div><div id="sec5_5_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 5-Chloro-2-(5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamido)benzoic Acid (<b>23b</b>)</h4><div class="NLM_p last">Compound <b>23b</b> was prepared with general procedure B using intermediate <b>22b</b>. The final compound was obtained as a white solid without further purification for the next step.</div></div><div id="sec5_5_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> 5-Bromo-2-(5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamido)benzoic Acid (<b>23c</b>)</h4><div class="NLM_p last">Compound <b>23c</b> was prepared with general procedure B using intermediate <b>22c</b>. The final compound was obtained as a white solid without further purification for the next step.</div></div><div id="sec5_5_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 5-Fluoro-2-(5-((3,5-bis(trifluoromethyl)-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamido)benzoic Acid (<b>23d</b>)</h4><div class="NLM_p last">Compound <b>23d</b> was prepared with general procedure B using intermediate <b>22d</b>. The final compound was obtained as a white solid without further purification for the next step.</div></div><div id="sec5_5_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> <i>N</i>-(4-Chloro-2-((4-hydroxybutyl)carbamoyl)phenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>24a</b>)</h4><div class="NLM_p last">Compound <b>24a</b> was prepared with general procedure C using 4-aminobutan-1-ol and intermediate <b>23b</b>. The final compound was obtained as a white solid in 86% yield. M.p.: 175–177 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.44 (s, 1H), 8.94 (s, 1H), 8.60 (d, <i>J</i> = 8.8 Hz, 1H), 7.89 (s, 1H), 7.59 (d, <i>J</i> = 8.2 Hz, 1H), 7.18 (s, 1H), 6.61 (s, 1H), 5.81 (s, 1H), 5.26 (s, 2H), 4.18–4.00 (m, 1H), 3.18 (d, <i>J</i> = 4.7 Hz, 2H), 2.44 (s, 3H), 2.05 (s, 3H), 1.55 (q, 2H), 1.37 (q, 2H), 0.92 (t, J = 6.9 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.32, 155.81, 154.36, 147.45, 139.92, 138.19, 132.19, 128.18, 127.12, 122.28, 122.14, 116.67, 111.66, 105.41, 49.05, 45.12, 39.52, 31.23, 20.15, 14.11, 13.71, 11.05. HRMS (ESI): calcd for C<sub>22</sub>H<sub>26</sub>ClN<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 445.1643, found 445.1641; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> <i>N</i>-(4-Chloro-2-((3-hydroxypropyl)carbamoyl)phenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>24b</b>)</h4><div class="NLM_p last">Compound <b>24b</b> was prepared with general procedure C using 3-aminopropan-1-ol and intermediate <b>23b</b>. The final compound was obtained as a white solid in 88% yield. M.p.: 190–192 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (s, 1H), 10.64 (s, 1H), 8.51 (d, <i>J</i> = 8.9 Hz, 1H), 8.00 (s, 1H), 7.75 (d, <i>J</i> = 8.0 Hz, 2H), 7.67 (d, <i>J</i> = 9.0 Hz, 1H), 7.43 (t, <i>J</i> = 7.6 Hz, 2H), 7.27–7.12 (m, 2H), 6.63 (d, <i>J</i> = 2.5 Hz, 1H), 5.78 (s, 1H), 5.25 (s, 2H), 2.38 (s, 3H), 2.03 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 166.28, 155.79, 154.40, 147.26, 146.96, 139.87, 138.68, 137.52, 132.43, 129.09, 129.02, 127.45, 124.98, 123.97, 122.96, 121.54, 116.99, 111.82, 105.40, 45.04, 13.74, 11.15. HRMS (ESI): calcd for C<sub>21</sub>H<sub>24</sub>ClN<sub>4</sub>O<sub>4</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 431.1486, found 431.1483; purity: ≥95% by HPLC analysis.</div></div><div id="sec5_5_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> <i>N</i>-(2-(Benzylcarbamoyl)-4-chlorophenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>24c</b>)</h4><div class="NLM_p last">Compound <b>24b</b> was prepared with general procedure C using phenylmethanamine and intermediate <b>23b</b>. The final compound was obtained as a white solid in 79% yield. M.p.: 210–212 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.42 (s, 1H), 9.53 (t, <i>J</i> = 5.2 Hz, 1H), 8.62 (d, <i>J</i> = 9.0 Hz, 1H), 7.99 (s, 1H), 7.62 (d, <i>J</i> = 9.0 Hz, 1H), 7.37 (s, 4H), 7.28 (s, 1H), 7.19 (d, <i>J</i> = 2.5 Hz, 1H), 6.72–6.52 (m, 1H), 5.77 (s, 1H), 5.25 (s, 2H), 4.54 (d, <i>J</i> = 5.4 Hz, 2H), 2.38 (s, 3H), 2.05 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.46, 155.85, 154.41, 147.40, 146.95, 139.92, 139.15, 138.36, 132.48, 128.85 (2C), 128.30, 127.81 (2C), 127.44, 127.21, 122.39, 121.77, 116.78, 111.69, 105.44, 45.11, 43.19, 13.74, 11.06. HRMS (ESI): calcd for C<sub>25</sub>H<sub>24</sub>ClN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 463.1512, found 463.1512; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>N</i>-(4-Chloro-2-(phenylcarbamoyl)phenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>24d</b>)</h4><div class="NLM_p last">Compound <b>24b</b> was prepared with general procedure C using aniline and intermediate <b>23b</b>. The final compound was obtained as an off-white solid in 75% yield. M.p.: 228–230 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.42 (s, 1H), 9.08–8.84 (m, 1H), 8.59 (d, <i>J</i> = 9.0 Hz, 1H), 7.89 (s, 1H), 7.60 (d, <i>J</i> = 9.0 Hz, 1H), 7.18 (d, <i>J</i> = 2.9 Hz, 1H), 6.60 (d, <i>J</i> = 2.8 Hz, 1H), 5.83 (s, 1H), 5.27 (s, 2H), 4.53 (t, <i>J</i> = 4.9 Hz, 1H), 3.51 (q, <i>J</i> = 5.7 Hz, 2H), 3.41–3.35 (m, 2H), 2.44 (s, 3H), 2.06 (s, 3H), 1.73 (p, <i>J</i> = 6.4 Hz, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.40, 155.82, 154.41, 147.41, 146.98, 139.98, 138.14, 132.22, 128.24, 127.12, 122.27, 122.17, 116.70, 111.64, 105.47, 59.05, 45.13, 37.32, 32.39, 13.74, 11.09. HRMS (ESI): calcd for C<sub>24</sub>H<sub>22</sub>ClN<sub>4</sub>O<sub>3</sub> [M + H]<sup>+</sup><i>m</i>/<i>z</i> 449.1380, found 449.1380; purity: ≥95% by HPLC analysis.</div></div><div id="sec5_5_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>N</i>-(4-Chloro-2-((<i>n</i>-butyl)carbamoyl)phenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)furan-2-carboxamide (<b>24e</b>)</h4><div class="NLM_p last">Compound <b>24b</b> was prepared with general procedure C using butan-1-amine and intermediate <b>23b</b>. The final compound was obtained as a white solid in 90% yield. M.p.:142–144 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.45 (s, 1H), 8.97 (s, 1H), 8.60 (d, <i>J</i> = 9.0 Hz, 1H), 7.90 (s, 1H), 7.61 (d, <i>J</i> = 9.0 Hz, 1H), 7.19 (s, 1H), 6.61 (s, 1H), 5.83 (s, 1H), 5.27 (s, 2H), 4.46 (t, <i>J</i> = 4.6 Hz, 1H), 3.45 (q, <i>J</i> = 5.6 Hz, 2H), 2.45 (s, 3H), 2.06 (s, 3H), 1.67–1.55 (m, 2H), 1.55–1.43 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.31, 155.82, 154.40, 147.40, 146.97, 139.97, 138.18, 132.25, 128.20, 127.11, 122.26, 122.10, 116.74, 111.70, 105.44, 60.89, 45.10, 30.48, 30.48, 25.87, 13.75, 11.08. HRMS (ESI): calcd for C<sub>22</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub>Cl [M + H]<sup>+</sup><i>m</i>/<i>z</i> 429.1693, found 429.1698; purity: ≥95% by HPLC analysis.</div></div><div id="sec5_5_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> Methyl 5-Formylthiophene-2-carboxylate (<b>26</b>)</h4><div class="NLM_p last">To a mixture of starting material 5-formylthiophene-2-carboxylic acid (<b>25</b>, 2 mmol) and MeI (2.5 mmol) in DMF 20 mL, NaHCO<sub>3</sub> (5 mmol) was added. Then, the reaction was stirred for 20 h at r.t. The mixture was filtered to remove solids, and the residue was concentrated in vacuo. The residue was diluted with EtOAc (10 mL) and washed with water (3 × 8 mL). The organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and purified through silica gel column chromatography by elution with EtOAc/Petroleum ether (1:5). The final compound was obtained as a pale yellow oil in 98% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.99 (s, 1H), 7.86 (d, <i>J</i> = 4.0 Hz, 1H), 7.75 (d, <i>J</i> = 3.9 Hz, 1H), 3.96 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 183.31, 161.95, 147.78, 140.96, 135.03, 133.36, 52.79. MS (ESI): calcd for C<sub>7</sub>H<sub>7</sub>O<sub>3</sub>S [M + H]<sup>+</sup><i>m</i>/<i>z</i> 171, found 171.</div></div><div id="sec5_5_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> Methyl 5-(Hydroxymethyl)thiophene-2-carboxylate (<b>27</b>)</h4><div class="NLM_p last">To a solution of intermediate <b>26</b> (1 mmol) in EtOH (10 mL) was added NaBH<sub>3</sub>CN (0.5 mmol) at 0 °C. The mixture was stirred for 2 h from 0 °C to r.t. The reaction was diluted with 20 mL of water and washed with EtOAc (3 × 10 mL). Combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and purified through silica gel column chromatography by elution with EtOAc/Petroleum ether (1:2). The final compound was obtained as a colorless oil in 98% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.69 (d, <i>J</i> = 3.8 Hz, 1H), 7.00 (dt, <i>J</i> = 3.8, 0.9 Hz, 1H), 4.86 (d, <i>J</i> = 5.6 Hz, 2H), 3.89 (s, 3H), 2.30 (t, <i>J</i> = 6.0 Hz, 1H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 162.73, 151.83, 133.56, 132.75, 125.32, 60.22, 52.18. MS (ESI): calcd for C<sub>7</sub>H<sub>9</sub>O<sub>3</sub>S [M + H]<sup>+</sup><i>m</i>/<i>z</i> 173, found 173.</div></div><div id="sec5_5_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> Methyl 5-(Chloromethyl)thiophene-2-carboxylate (<b>28</b>)</h4><div class="NLM_p last">Compound <b>28</b> was prepared using the same procedure as for compound <b>12</b> to afford the product as a pale yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.67 (d, <i>J</i> = 3.8 Hz, 1H), 7.09 (dt, <i>J</i> = 3.8, 0.8 Hz, 1H), 4.78 (d, <i>J</i> = 0.8 Hz, 2H), 3.90 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 162.30, 147.14, 134.14, 133.30, 127.88, 52.28, 39.82. MS (ESI): calcd for C<sub>7</sub>H<sub>8</sub>ClO<sub>2</sub>S [M + H]<sup>+</sup><i>m</i>/<i>z</i> 191, found 191.</div></div><div id="sec5_5_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> Methyl 5-(Iodomethyl)thiophene-2-carboxylate (<b>29</b>)</h4><div class="NLM_p last">Compound <b>28</b> was prepared using the same procedure as for compound <b>13</b> to afford a crude product as a brown oil. The final product was directly used in the next step without further purification.</div></div><div id="sec5_5_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> Methyl 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxylate (<b>30</b>)</h4><div class="NLM_p last">Compound <b>30</b> was prepared with general procedure A using intermediate <b>29</b>. The final compound was obtained as an off-white solid in 69% yield. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.62 (dd, <i>J</i> = 3.8, 1.0 Hz, 1H), 6.85 (dd, <i>J</i> = 3.8, 0.9 Hz, 1H), 5.84 (s, 1H), 5.33 (d, <i>J</i> = 1.0 Hz, 2H), 3.84 (d, <i>J</i> = 1.1 Hz, 3H), 2.23 (d, <i>J</i> = 1.0 Hz, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 162.40, 148.33, 147.42, 138.95, 133.48, 132.99, 125.87, 106.01, 52.12, 47.78, 13.51, 11.04. MS (ESI): calcd for C<sub>12</sub>H<sub>15</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup><i>m</i>/<i>z</i> 251, found 251.</div></div><div id="sec5_5_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxylic Acid (<b>37</b>)</h4><div class="NLM_p last">Compound <b>31</b> was prepared with general procedure B using intermediate <b>30</b>. The final compound was obtained as an off-white solid in 73% yield. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.05 (s, 1H), 7.58 (d, <i>J</i> = 3.7 Hz, 1H), 7.02 (dd, <i>J</i> = 3.8, 1.0 Hz, 1H), 5.84 (s, 1H), 5.39 (d, <i>J</i> = 0.9 Hz, 2H), 2.21 (d, <i>J</i> = 0.8 Hz, 3H), 2.10 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 163.17, 148.14, 147.11, 139.20, 134.40, 133.46, 127.06, 105.78, 47.33, 13.79, 11.03. HRMS (ESI): calcd for C<sub>11</sub>H<sub>13</sub>N<sub>2</sub>O<sub>2</sub>S [M + H]<sup>+</sup><i>m</i>/<i>z</i> 237, found 237.</div></div><div id="sec5_5_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> <i>N</i>-(4-Bromo-2-methylphenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxamide (<b>32a</b>)</h4><div class="NLM_p last">Compound <b>32a</b> was prepared with general procedure C using 4-bromo-2-methylaniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 66% yield. M.p.: 97–99 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.90 (s, 1H), 7.81 (d, <i>J</i> = 3.1 Hz, 1H), 7.50 (s, 1H), 7.40 (d, <i>J</i> = 8.4 Hz, 1H), 7.25 (d, <i>J</i> = 8.4 Hz, 1H), 7.07 (d, <i>J</i> = 2.7 Hz, 1H), 5.85 (s, 1H), 5.40 (s, 2H), 2.23 (s, 3H), 2.21 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.17, 147.03, 146.52, 139.22, 139.12, 137.03, 135.76, 133.27, 129.47, 129.33, 129.03, 126.94, 118.94, 105.76, 47.36, 18.05, 13.81, 11.07. HRMS (ESI): calcd for C<sub>18</sub>H<sub>19</sub>BrN<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 404.0432, found 404.0435; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> <i>N</i>-(4-Chloro-2-methylphenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxamid (<b>32b</b>)</h4><div class="NLM_p last">Compound <b>32b</b> was prepared with general procedure C using 4-chloro-2-methylaniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 56% yield. M.p.: 110–112 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.90 (s, 1H), 7.81 (d, <i>J</i> = 3.6 Hz, 1H), 7.36 (s, 1H), 7.34–7.24 (m, 2H), 7.07 (d, <i>J</i> = 3.5 Hz, 1H), 5.85 (s, 1H), 5.40 (s, 2H), 2.24 (s, 3H), 2.21 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.23, 147.04, 146.52, 139.23, 139.11, 136.68, 135.31, 130.57, 130.37, 129.45, 128.72, 126.93, 126.39, 105.76, 47.36, 18.12, 13.81, 11.07. HRMS (ESI): calcd for C<sub>18</sub>H<sub>19</sub>ClN<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 360.0937, found 360.0933; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(4-fluoro-2-methylphenyl)thiophene-2-carboxamide (<b>32c</b>)</h4><div class="NLM_p last">Compound <b>32c</b> was prepared with general procedure C using 4-fluoro-2-methylaniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 61% yield. M.p.: 124–126 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.88 (s, 1H), 7.80 (d, <i>J</i> = 3.3 Hz, 1H), 7.34–7.23 (m, 1H), 7.19–7.10 (m, 1H), 7.11–6.98 (m, 2H), 5.85 (s, 1H), 5.40 (s, 2H), 2.24 (s, 3H), 2.21 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.53 (d), 160.35, 147.03, 146.35, 139.37, 139.10, 137.28 (d, <i>J</i> = 8.4 Hz), 132.54 (d, <i>J</i> = 2.7 Hz), 129.26, 129.11 (d, <i>J</i> = 8.9 Hz), 126.91, 117.09 (d, <i>J</i> = 22.1 Hz), 113.11 (d, <i>J</i> = 22.1 Hz), 105.75, 47.36, 18.32, 13.80, 11.06. HRMS (ESI): calcd for C<sub>18</sub>H<sub>19</sub>FN<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 344.1233, found 344.1230; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(3-methyl-[1,1′-biphenyl]-4-yl)thiophene-2-carboxamide (<b>32d</b>)</h4><div class="NLM_p last">Compound <b>32d</b> was prepared with general procedure C using 3-methyl-[1,1′-biphenyl]-4-amine and intermediate <b>31</b>. The final compound was obtained as a white solid in 59% yield. M.p.: 70–72 °C.<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.92 (s, 3H), 7.84 (d, <i>J</i> = 4.0 Hz, 1H), 7.67 (d, <i>J</i> = 8.0 Hz, 1H), 7.58 (s, 1H), 7.52–7.45 (m, 2H), 7.39–7.36 (m, 2H), 7.09 (d, <i>J</i> = 4.0 Hz, 1H), 5.86 (s, 1H), 5.40 (s, 2H), 2.29 (s, 3H), 2.25 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.25, 147.04, 146.38, 140.17, 139.56, 139.13, 138.35, 135.75, 134.65, 129.37, 129.31, 129.10, 127.79, 127.50, 127.03, 126.95, 124.77, 105.77, 47.37, 18.50, 13.82, 11.09. HRMS (ESI): calcd for C<sub>24</sub>H<sub>24</sub>N<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 402.1640, found 402.1633; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(2-methyl-4-(pyridin-3-yl)phenyl)thiophene-2-carboxamide (<b>32e</b>)</h4><div class="NLM_p last">Compound <b>32e</b> was prepared with general procedure C using 2-methyl-4-(pyridin-3-yl)aniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 58% yield. M.p.: 74–76 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.94 (s, 1H), 8.92 (d, <i>J</i> = 2.0 Hz, 1H), 8.57 (dd, <i>J</i> = 2.0, 4.0 Hz, 1H), 8.10 (d, <i>J</i> = 8.0 Hz, 1H), 7.84 (d, <i>J</i> = 4.0 Hz, 1H), 7.66 (s, 1H), 7.58 (d, <i>J</i> = 12.0 Hz, 1H), 7.50–7.47 (m 1H), 7.42 (d, <i>J</i> = 12.0 Hz, 1H), 7.10 (d, <i>J</i> = 4.0 Hz, 1H), 5.86 (s, 1H), 5.41 (s, 2H), 2.30 (s, 3H), 2.24 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.25, 148.83, 148.02, 147.05, 146.47, 139.47, 139.14, 136.44, 135.57, 135.14, 134.87, 134.41, 129.40, 129.31, 127.60, 126.96, 124.97, 124.31, 105.77, 47.37, 18.47, 13.82, 11.09. HRMS (ESI): calcd for C<sub>23</sub>H<sub>23</sub>N<sub>4</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 403.1593, found 403.1586; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(4-fluoro-3-methylphenyl)thiophene-2-carboxamide (<b>32f</b>)</h4><div class="NLM_p last">Compound <b>32f</b> was prepared with general procedure C using 4-fluoro-3-methyl aniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 57% yield. M.p.: 154–156 °C.<sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.74 (s, 1H), 7.45 (m, 2H), 7.44, 7.32 (m, 1H), 6.98 (d, <i>J</i> = 4.0 Hz, 1H), 6.88 (d, <i>J</i> = 4.0 Hz, 1H), 5.88 (s, 1H), 5.35 (s, 2H), 2.28 (s, 6H), 2.26 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 159.72, 148.43, 145.54, 139.08, 138.60, 133.22, 128.63, 126.01, 125.56, 125.37, 123.64, 119.43, 115.36, 106.08, 47.68, 14.69, 14.65, 13.52, 11.09. HRMS (ESI): calcd for C<sub>18</sub>H<sub>19</sub>FN<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 344.1233, found 344.1226; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> <i>N</i>-(3-Chloro-4-fluorophenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxamide (<b>32g</b>)</h4><div class="NLM_p last">Compound <b>32g</b> was prepared with general procedure C using 3-chloro-4-fluoroaniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 74% yield. M.p.: 163–165 °C.<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.34 (s, 1H), 7.98 (dd, <i>J</i> = 4.0, 8.0 Hz 1H), 7.84 (d, <i>J</i> = 4.0 Hz, 1H), 7.65 (m, 1H), 7.41 (t, <i>J</i> = 8.0 Hz, 1H), 7.08 (d, <i>J</i> = 4.0 Hz, 1H), 5.85 (s, 1H), 5.41(s, 2H), 2.23 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.26, 152.66, 147.07 (d, <i>J</i> = 28 Hz), 139.16 (d, <i>J</i> = 36 Hz), 136.42, 129.82, 126.99, 122.18, 121.00 (d, J = 28 Hz), 119.62, 119.43, 117.45, 117.23, 105.79, 47.37, 13.81, 11.06. HRMS (ESI): calcd for C<sub>17</sub>H<sub>16</sub>ClFN<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 363.0687. found 363.0680; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> <i>N</i>-(3,4-Dichlorophenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxamide (<b>32h</b>)</h4><div class="NLM_p last">Compound <b>32h</b> was prepared with general procedure C using 3,4-dichloroaniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 70% yield. M.p.: 162–164 °C.<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.41 (s, 1H), 8.06 (d, <i>J</i> = 3.2 Hz, 1H), 7.86 (d, <i>J</i> = 4.0 Hz, 1H), 7.70 (dd, <i>J</i> = 4.0, 8.0 Hz 1H), 7.62 (d, <i>J</i> = 8.0 Hz, 1H), 7.07 (d, <i>J</i> = 4.0 Hz, 1H), 5.86 (s, 1H), 5.41 (s, 2H), 2.23 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.38, 147.39, 139.33, 139.17, 138.94, 131.36, 131.09, 130.04, 127.03, 125.64, 121.82, 120.62, 113.46, 105.79, 47.36, 13.81, 11.07. HRMS (ESI): calcd for C<sub>17</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 380.0391, found 380.0385; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> <i>N</i>-(3-Fluoro-4-chlorophenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxamide (<b>32i</b>)</h4><div class="NLM_p last">Compound <b>32i</b> was prepared with general procedure C using 3-fluoro-4-chloroaniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 54% yield. M.p.: 246 ∼ 248 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.42 (bs, 1H), 7.86 (d, <i>J</i> = 4.0 Hz, 1H) 7.82 (d, <i>J</i> = 2.0 Hz, 1H), 7.32–7.15 (m, 1H), 7.09 (d, <i>J</i> = 4.0 Hz, 1H), 5.86 (s, 1H), 5.41 (s, 2H), 2.23 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.51, 147.63, 147.10, 141.57, 139.18, 138.70, 134.46, 130.23, 127.07, 123.31, 118.65, 105.80, 47.36, 13.81, 11.06. HRMS (ESI): calcd for C<sub>17</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 380.0391, found 380.0385; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> <i>N</i>-(3,4-Diethyoxylphenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxamide (<b>32j</b>)</h4><div class="NLM_p last">Compound <b>32j</b> was prepared with general procedure C using 3,4-diethyoxylaniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 44% yield. M.p.: 223–225 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.47 (s, 1H), 7.86 (d, <i>J</i> = 4.0 Hz, 1H), 7.50–7.44 (m, 2H), 7.09 (d, <i>J</i> = 4.0 Hz, 1H), 6.99–6.93 (m, 1H), 5.86 (s, 1H), 5.41 (s, 2H), 2.23 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.52, 147.57, 147.10, 141.75, 139.18, 138.78, 130.17, 127.03, 105.80, 103.50, 103.21, 101.07, 47.36, 13.81, 11.06. HRMS (ESI): calcd for C<sub>17</sub>H<sub>16</sub>F<sub>2</sub>N<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 348.0982, found 347.0977; purity: ≥99% by HPLC analysis.</div></div><div id="sec5_5_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> <i>N</i>-(3,5-Dichlorophenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxamide (<b>32k</b>)</h4><div class="NLM_p last">Compound <b>32k</b> was prepared with general procedure C using 3,5-dichloroaniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 39% yield. M.p.: 239–241 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.44 (s, 1H), 7.87–7.84 (m, 2H), 7.58–7.51 (m, 2H), 7.09 (d, <i>J</i> = 4.0 Hz, 1H), 5.85 (s, 1H), 5.41 (s, 2H), 2.23 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.41, 147.38, 147.09, 139.17, 138.95, 130.94, 130.03, 127.00, 117.48, 113.94, 108.83, 108.58, 105.80, 101.81, 47.37, 13.81, 11.06. HRMS (ESI): calcd for C<sub>17</sub>H<sub>16</sub>ClFN<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 364.0687, found 364.0686; purity: ≥97% by HPLC analysis.</div></div><div id="sec5_5_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> <i>N</i>-(3,5-Difluorophenyl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxamide (<b>32l</b>)</h4><div class="NLM_p last">Compound <b>32l</b> was prepared with general procedure C using 3,5-difluoroaniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 67% yield. M.p.: 194–196 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.76 (s, 1H), 7.45 (d, <i>J</i> = 4.0 Hz, 1H), 6.88 (d, <i>J</i> = 4.0 Hz, 1H), 6.86 (d, <i>J</i> = 2.0 Hz, 2H), 6.28 (t, <i>J</i> = 2.0 Hz, 1H), 5.88 (s, 1H), 5.36 (s, 2H), 3.80 (s, 6H), 2.28 (s, 3H), 2.26 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 161.05 (2C), 159.80, 148.43, 145.69, 139.52, 139.12, 138.90, 128.53, 126.01, 106.08, 98.29 (2C), 97.14, 55.38 (2C), 47.67, 13.52, 11.08. HRMS (ESI): calcd for C<sub>19</sub>H<sub>22</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup><i>m</i>/<i>z</i> 372.1382, found 372.1375; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> <i>N</i>-(3,5-Dimethoxyphenyl)-5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxamide (<b>32m</b>)</h4><div class="NLM_p last">Compound <b>32m</b> was prepared with general procedure C using 3,5-dimethoxyaniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 77% yield. M.p.: 146–148 °C.<sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.77 (bs, 2H), 7.43 (dd, J = 2.0, 12.0 Hz, 1H), 6.93 (dd, <i>J</i> = 4.0, 8.0 Hz, 1H), 6.87–6.83 (m, 2H), 5.88 (s, 1H), 5.35 (s, 2H), 4.15–4.06 (m, 4H), 2.28 (s, 3H), 2.26 (s, 3H), 1.47–1.43 (m, 6H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 159.69, 148.92, 148.38, 145.58, 145.29, 139.11, 139.03, 131.44, 128.35, 125.99, 113.90, 112.33, 106.86, 106.05, 64.95, 64.45, 47.68, 14.86, 14.71, 13.51, 11.08. HRMS (ESI): calcd for C<sub>21</sub>H<sub>26</sub>N<sub>3</sub>O<sub>3</sub>S [M + H]<sup>+</sup><i>m</i>/<i>z</i> 400.1695, found 400.1691; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108"> <i>N</i>-([1,1′-Biphenyl]-4-yl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxamide (<b>32n</b>)</h4><div class="NLM_p last">Compound <b>32n</b> was prepared with general procedure C using [1,1′-biphenyl]-4-amine and intermediate <b>31</b>. The final compound was obtained as a white solid in 56% yield. M.p.: 188 ∼ 190 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (bs, 1H), 7.70–7.67 (m, 2H), 7.60–7.57 (m, 4H), 7.49 (d, <i>J</i> = 4.0 Hz, 1H), 7.45 (t, <i>J</i> = 8.0 Hz, 2H), 7.35 (t, <i>J</i> = 8.0 Hz, 1H), 6.85 (d, <i>J</i> = 4.0 Hz, 1H), 5.89 (s, 1H), 5.35 (s, 2H), 2.29 (s, 3H), 2.27 (s, 3H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) δ 159.75, 148.45, 145.63, 140.43, 139.11, 138.80, 137.38, 137.01, 128.79, 128.68, 127.66, 127.16, 126.84, 126.04, 120.50, 106.10, 77.35, 77.03, 76.71, 47.71, 13.54, 11.11. HRMS (ESI): calcd for C<sub>23</sub>H<sub>22</sub>N<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 388.1484, found 388.1479; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109"> 5-((3,5-Dimethyl<i>-</i>1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(4-(pyridin-3-yl)phenyl)thiophene-2-carboxamide (<b>32o</b>)</h4><div class="NLM_p last">Compound <b>32o</b> was prepared with general procedure C using 4-(pyridin-3-yl)aniline and intermediate <b>31</b>. The final compound was obtained as a white solid in 57% yield. M.p.: 191–193 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.32 (s, 1H), 8.91 (d, <i>J</i> = 4.0 Hz, 1H), 8.55 (dd, <i>J</i> = 2.0, 4.0 Hz, 1H), 8.08 (m, 1H), 7.90 (d, <i>J</i> = 4.0 Hz, 1H), 7.80 (dd, <i>J</i> = 8.0, 48.0 Hz, 1H), 7.47 (dd, <i>J</i> = 2.0, 4.0 Hz, 1H), 7.09 (d, <i>J</i> = 4.0 Hz, 1H), 5.86 (s, 1H), 5.76 (s, 1H), 5.41 (s, 2H), 2.24 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.24, 148.59, 147.81, 147.07, 146.87, 139.69, 139.31, 139.16, 135.51, 134.08, 132.62, 129.59, 127.59, 126.95, 124.30, 121.16, 105.79, 55.38, 47.40, 13.82, 11.08. HRMS (ESI): calcd for C<sub>22</sub>H<sub>21</sub>N<sub>4</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 389.1436, found 389.1427; purity: ≥99% by HPLC analysis.</div></div><div id="sec5_5_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(naphthalen-2-yl)thiophene-2-carboxamide (<b>33a</b>)</h4><div class="NLM_p last">Compound <b>33a</b> was prepared with general procedure C using naphthalen-2-amine and intermediate <b>31</b>. The final compound was obtained as an off-white solid in 73% yield. M.p.: 197–199 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.56 (s, 1H), 9.21 (s, 1H), 8.43 (m, 2H) 8.12 (d, <i>J</i> = 8.0 Hz, 1H), 7.97 (d, <i>J</i> = 4.0 Hz, 1H), 7.94 (dd, <i>J</i> = 2.0, 10.0 Hz, 1H), 7.7 (d, <i>J</i> = 6.0 Hz, 1H), 7.11 (d, <i>J</i> = 4.0 Hz, 1H), 5.86 (s, 1H), 5.43 (s, 2H), 2.25 (s, 3H), 2.12 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.68, 151.96, 147.35, 147.09, 143.52, 140.85, 139.31, 139.18, 136.55, 130.09, 128.93, 127.06, 125.64, 122.39, 120.67, 114.66, 105.80, 47. 13.82, 11.08. HRMS (ESI): calcd for C<sub>21</sub>H<sub>20</sub>N<sub>3</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 362.1327, found 362.1320; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(isoquinolin-6-yl)thiophene-2-carboxamide (<b>33b</b>)</h4><div class="NLM_p last">Compound <b>33b</b> was prepared with general procedure C using isoquinolin-6-amine and intermediate <b>31</b>. The final compound was obtained as an off-white solid in 73% yield. M.p.: 195–198 °C.<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.40 (bs, 1H), 10.19 (s, 1H), 8.18 (s, 1H), 8.07 (s, 1H), 7.88 (d, J = 4.0 Hz, 1H), 7.56 (d, J = 8.0 Hz, 1H), 7.43 (d, J = 8.0 Hz, 1H), 7.07 (d, J = 4.0 Hz, 1H), 5.86 (s, 1H), 5.40 (s, 2H), 2.24 (s, 3H), 2.12 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.01, 147.02, 146.30, 142.71, 140.22, 139.13, 133.75, 129.05, 126.87, 116.41, 105.77, 49.07, 47.41, 13.82, 11.08. HRMS (ESI): calcd for C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 363.1280, found 363.1275; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(quinolin-7-yl)thiophene-2-carboxamide (<b>33c</b>)</h4><div class="NLM_p last">Compound <b>33c</b> was prepared with general procedure C using quinolin-7-amine and intermediate <b>37</b>. The final compound was obtained as a white solid in 79% yield. M.p.: 285–287 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.06 (bs, 1H), 10.09 (s, 1H), 7.96 (s, 1H), 7.87 (d, <i>J</i> = 4.0 Hz, 1H), 7.48 (d, <i>J</i> = 8.0 Hz, 1H), 7.29 (t, <i>J</i> = 2.0 Hz, 1H) 7.21 (dd, <i>J</i> = 2.0, 80 Hz, 1H), 7.06 (d, <i>J</i> = 4.0 Hz, 1H), 6.38–6.37 (m, 1H), 5.86 (s, 1H), 5.40 (s, 2H), 2.24 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 159.85, 147.00, 146.10, 140.49, 139.12, 136.24, 133.07, 128.83, 126.86, 125.71, 124.79, 120.15, 113.83, 105.77, 103.95, 101.41, 47.41, 13.83, 11.09. HRMS (ESI): calcd for C<sub>20</sub>H<sub>19</sub>N<sub>4</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 363.1280, found 363.1271; purity: ≥99% by HPLC analysis.</div></div><div id="sec5_5_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(1<i>H</i>-indol-6-yl)thiophene-2-carboxamide (<b>33d</b>)</h4><div class="NLM_p last">Compound <b>33d</b> was prepared with general procedure C using 1<i>H</i>-indol-6-amine and intermediate <b>31</b>. The final compound was obtained as a white solid in 79% yield. M.p.: 191 ∼ 194 °C.<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (s, 1H), 8.34 (s, 1H), 7.93–7.77 (m, 5H), 7.51–7.41 (m, 2H), 7.09 (d, J = 4.0 Hz, 1H), 5.87 (s, 1H), 5.42 (s, 2H), 2.25 (s, 3H), 2.12 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.36, 147.05, 146.79, 139.80, 139.16, 136.77, 133.75, 130.45, 129.53, 128.71, 127.93, 127.85, 127.01, 126.91, 125.33, 121.28, 117.09, 105.79, 47.39, 13.83, 11.09. HRMS (ESI): calcd for C<sub>19</sub>H<sub>19</sub>N<sub>4</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 351.1280, found 351.1273; purity: ≥96% by HPLC analysis.</div></div><div id="sec5_5_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114"> <i>N</i>-(1<i>H</i>-Benzo[<i>d</i>]imidazol-5-yl)-5-((3,5-dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)thiophene-2-carboxamide (<b>33e</b>)</h4><div class="NLM_p last">Compound <b>33e</b> was prepared with general procedure C using 1<i>H</i>-benzo[<i>d</i>]imidazol-6-amine and intermediate <b>31</b>. The final compound was obtained as a white solid in 83% yield. M.p.: 304–306 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.62 (s, 1H), 10.55 (s, 1H), 10.09 (s, 1H), 7.85 (d, <i>J</i> = 4.0 Hz, 1H), 7.48 (s, 1H), 7.20 (dd, <i>J</i> = 2.0, 8.0 Hz, 1H), 7.04 (d, <i>J</i> = 4.0 Hz, 1H), 6.86 (d, <i>J</i> = 12.0 Hz, 1H), 5.85 (s, 1H), 5.39 (s, 2H) 2.23 (s, 3H), 2.11 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.16, 147.05, 146.76, 140.11, 139.80, 139.15, 138.64, 135.82, 129.48, 129.38, 127.33, 126.94, 126.76, 121.08, 105.79, 47.40, 13.83, 11.08. HRMS (ESI): calcd for C<sub>18</sub>H<sub>18</sub>N<sub>5</sub>OS [M + H]<sup>+</sup><i>m</i>/<i>z</i> 351.1280, found 351.1273; purity: ≥98% by HPLC analysis.</div></div><div id="sec5_5_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115"> 5-((3,5-Dimethyl-1<i>H</i>-pyrazol-1-yl)methyl)-<i>N</i>-(2-oxo-2,3-dihydro-1<i>H</i>-benzo[<i>d</i>]imidazol-5-yl)thiophene-2-carboxamide (<b>33f</b>)</h4><div class="NLM_p last">Compound <b>33f</b> was prepared with general procedure C using 5-amino-1,3-dihydro-2H-benzo[<i>d</i>]imidazol-2-one and intermediate <b>31</b>. The final compound was obtained as a white solid in 84% yield. M.p.: 199–201 °C.<sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.51 (s, 1H), 8.86 (dd, <i>J</i> = 2.0, 4.0 Hz, 1H), 8.48 (s, 1H), 8.29 (d, <i>J</i> = 8.0 Hz, 1H), 7.97–7.90 (m, 3H), 7.47 (dd, <i>J</i> = 2.0, 4.0 Hz, 1H), 7.11 (d, <i>J</i> = 4.0 Hz, 1H), 5.87 (s, 1H), 5.43 (s, 2H), 2.25 (s, 3H), 2.12 (s, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.54, 151.43, 148.77, 147.15, 147.09, 140.04, 139.51, 139.18, 136.01, 129.88, 128.83, 127.01, 125.11, 121.47, 120.75, 117.75, 105.80, 47.40, 13.83, 11.09. HRMS (ESI): calcd for C<sub>18</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub>S [M + H]<sup>+</sup><i>m</i>/<i>z</i> 368.1181, found 368.1175; purity: ≥97% by HPLC analysis.</div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> Animals</h3><div class="NLM_p last">Male adult C57BL/6 mice (6–8 weeks old) and ICR mice (6–8 weeks old) were obtained from Beijing Vital River Lab Animal Technology Co., Ltd. All animals were housed in cages under artificial lighting from 7:00 AM to 7:00 PM, with free access to food and water. Animals were assigned to different experimental groups randomly, each kept in a separate cage. All experimental procedures were approved by the Peking University Institutional Animal Care and Use Committee.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> Cell Culture and Transfection</h3><div class="NLM_p last">HEK-293 cells were incubated in Dulbecco’s modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum (FBS) at 37 °C under 5% CO<sub>2</sub>. For electrophysiological recording, cells were plated onto coverslips in 35 mm dishes 2 days before. Then, cells were transiently transfected with cDNA of GluN1/GluN2A, GluN1/GluN2B, GluN1/GluN2C, and GluN1/GluN2D using Lipofectamine 2000 (Invitrogen) 16–24 h following the manufacturer’s instructions. 200 mM AP-5 was added in the medium when replacing DMEM to inhibit cell death. After 18–24 h of transfection, coverslips were prepared in an external solution for recording.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> Culture of Cortical Neurons</h3><div class="NLM_p">The primary cortical culture was obtained from embryos of embryonic day 18 (E18) ICR mice embryos of either sex after decapitation. Hippocampal regions were gently removed and digested with 0.25% trypsin for 30 min at 37 °C followed by trituration with a pipette in plating medium (DMEM with 10% FBS). Dissociated neurons were plated onto poly-<span class="smallcaps smallerCapital">d</span>-lysine coated coverslips in 35 mm dishes at a density of 1 × 10<sup>6</sup> cells per dish. After 4 h, the medium was displaced by neurobasal medium supplemented with 2% B27 and 0.5 mmol/L GlutaMAX-I. Neurons were obtained at 37 °C under 5% CO<sub>2</sub>, and half the medium was replaced every 3 days. After being cultured for 7–9 days, cortical neurons were harvested and used for electrophysiological experiments in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>. After being cultured for 12–15 days, cortical neurons were harvested and used for electrophysiological experiments in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and evaluations of all derivatives.</div><div class="NLM_p last">The cultured hippocampal neurons used for the tests on AMPARs and GABARs were obtained from embryos of embryonic day 18 (E18) ICR mice embryos of either sex after decapitation. The neurons were cultured for 7–9 days as the protocol mentioned above before tests.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i119" class="anchor-spacer"></div><h3 class="article-section__title" id="_i119"> Slice Preparations</h3><div class="NLM_p last">C57BL/6 mice were anesthetized and decapitated, and brains were dissected and placed into ice-cold slice solution of the following: 110 mM choline chloride, 2.5 mM KCl, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 25 mM NaHCO<sub>3</sub>, 0.5 mM CaCl<sub>2</sub>, 7 mM MgCl<sub>2</sub>, 25 mM glucose, 0.6 mM ascorbic acid, 3.1 mM pyruvic acid (bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub>, pH 7.4). For epilepsy tissues of patients, brain tissues were put into ice-cold slice solution immediately after surgery. Acute horizontal slices were cut by a vibratome at 350 μm thickness and then transferred to artificial cerebrospinal fluid (ACSF): 125 mM NaCl, 2.5 mM KCl, 2.0 mM CaCl<sub>2</sub>, 2.0 mM MgCl<sub>2</sub>, 25 mM NaHCO<sub>3</sub>, 1.25 mM NaH<sub>2</sub>PO<sub>4</sub>, 10 mM glucose (bubbled with 95% O<sub>2</sub> and 5% CO<sub>2</sub>, pH 7.4). Slices were incubated at 37 °C for 30 min and stored at room temperature before recording. Magnesium was abolished when recording. TTX (500 nM) and strychnine (1 mM) were applied to the recording solution to obtain NMDA-mediated current.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i120" class="anchor-spacer"></div><h3 class="article-section__title" id="_i120"> Electrophysiological Recording</h3><div class="NLM_p">For whole-cell voltage-clamp recording in primary neuron and transfected cells, cells were held at −70 mV and recorded at room temperature using a HEKA EPC10 amplifier with PatchMaster software (HEKA Elektronik). Patch pipettes were pulled from borosilicate glass to a resistance of 4–6 MΩ when filled with an internal pipette solution composed of the following: 122 mM CsCl, 1 mM CaCl<sub>2</sub>, 5 mM MgCl<sub>2</sub>, 10 mM EGTA, 10 mM HEPES, 4 mM Na<sub>2</sub>ATP, 0.3 mM Tris-GTP, 14 mM Tris-phosphocreatine, adjusted to pH 7.3 with CsOH. Cells were perfused with the external solution containing: 140 mM NaCl, 2.5 mM KCl, 2 mM CaCl<sub>2</sub>, 10 mM HEPES, and 10 mM glucose, pH 7.4. NMDA and other compounds were applied via gravity-fed tubes for NMDA current recording until the current reached a steady current value (5–10 s). Data were acquired with PatchMaster software (HEKA) and filtered at 1 kHz with an LIH 8 + 8 computer interface.</div><div class="NLM_p">For <i>in vitro</i> slice recording, the internal solution was the same as for primary cultured neurons. All recordings were performed with a MultiClamp 700B amplifier (Molecular Devices), and data were obtained with clamp 10.6 software, filtered at 2 kHz and sampling rate at 33 kHz with a Digidata 1440A digitizer (Molecular Devices). Slices were incubated in flow ACSF at 32–33 °C. For NMDA current recording, NMDA and other compounds were dissolved in ACSF until a peak current amplitude was obtained (15–30 min). Data were acquired with PatchMaster software (HEKA) and filtered at 1 kHz with an LIH 8 + 8 computer interface.</div><div class="NLM_p last">Potentiating activity for the compound was calculated as △<i>I</i>/<i>I</i><sub>NMDA</sub> from the following equation:<span class="NLM_disp-formula" id="ueq1"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_m001.gif" alt="" id="_i121" /></img></span></div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i122" class="anchor-spacer"></div><h3 class="article-section__title" id="_i122"> In Vivo Efficacy Studies</h3><div id="sec5_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123"> Drugs</h4><div class="NLM_p last">FS2921 and fluoxetine were dissolved in artificial cerebrospinal fluid in a concentration of 10 μM/L. Selected compounds, fluoxetine and duloxetine, were dissolved in phosphate-buffered saline (PBS) containing 4% DMSO and Tween 80 (2%) at indicated doses.</div></div><div id="sec5_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124"> Studies with C57BL/6N Mice by Intracerebroventricular Injections</h4><div class="NLM_p last">The cannulas were attached to skulls of C57BL/6N mice (from bregma: AP, +0.8; ML, −1.5; DV, −2.5) under a stereotaxic surgery and secured by dental cement and screws. For injections, the cannulas were connected to the microinjector through an injection needle and long hose. Drugs were injected into the lateral ventricle for 4 μL over the course of 10 min (at a rate of 0.4 μL/min). Mice were not anesthetized for the daily injections and could move around during the intracerebroventricular injections. After injection for 30 min, each mouse was placed in a clear cylindrical tank (40 cm tall ×20 cm diameter), filled with water (30 cm tall) at 24 ± 2 °C. Mice were judged as immobile when they float motionlessly. Mice were forced to swim freely for 6 min, and the last four minutes was considered when analyzing. Water was changed after every test.</div></div><div id="sec5_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125"> Studies with ICR Mice by i.p. Administrations</h4><div class="NLM_p last">ICR mice were randomly separated into seven groups (<i>n</i> = 10) and administered with selected compounds and fluoxetine by intraperitoneal injection only once at a dose of 30 mg/kg. The control group has injected the vehicle. After injection for 20 min, each mouse was placed in a clear cylindrical tank (40 cm tall ×20 cm diameter), filled with water (30 cm tall) at 24 ± 2 °C. Mice were judged as immobile when they float motionlessly. Mice were forced to swim freely for 6 min, and the last four minutes was considered when analyzing. Water was changed after every test. Then, ICR mice (<i>n</i> = 10 in each group) were i.p. administrated with the vehicle, duloxetine (15 mg/kg), compound <b>20e</b> (3 and 10 mg/kg), and compound <b>32h</b> (3 and 10 mg/kg). As described above, each mouse underwent the FST after injection for 30 min.</div></div><div id="sec5_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126"> Chronic Social Defeat Stress and Social Interaction Testing</h4><div class="NLM_p last">FS2921 or fluoxetine were dissolved in artificial cerebrospinal fluid in a concentration of 10 μM/L and injected into the lateral ventricle (from bregma: AP, +0.8; ML, −1.5; DV, −2.5) of C57BL/6N mice for 4 μL over the course of 10 min (at a rate of 0.4 μL/min) for 11 days. Every day after injection of FS2921, fluoxetine, or the vehicle for 30 min, mice were subjected to social defeat stress. Chronic social defeat stress was performed according to previously described protocols.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> C57BL/6 mice were physically defeated by a novel CD-1 aggressor for 5 min/day and then kept in one side of the cages divided by a transparent, perforated baffle plate, sensory contacting with CD-1 mice on the other side for 24 h for 10 days. CD-1 aggressors were changed daily. On day 11, after injection of the drugs for 30 min, mice were assayed on the social interaction test. The depression level of mice was obtained based on the social interaction ratio.</div></div><div id="sec5_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127"> Hyperactivity Test</h4><div class="NLM_p last">Mice (10 mice in each group) were dosed with the vehicle and selected compounds (10 mg/kg) by intraperitoneal injection. Animals were placed in Plexiglas cages for evaluating locomotor activity. After the environmental adaptation for 60 min, the total locomotor distance of each animal was recorded for 90 min.</div></div><div id="sec5_11_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128"> Apomorphine-Induced Climbing</h4><div class="NLM_p last">Mice (10 mice in each group) were dosed with the vehicle and selected compounds (10 mg/kg) by intraperitoneal injection. Animals were then challenged at 30 min post-injection with 1.0 mg/kg apomorphine in 0.9% NaCl + 0.1% ascorbic acid, placed in cylindrical wire cages (12 cm in diameter, 14 cm in height), and observed for climbing behavior at 10, 20, and 30 min post-dose. The climbing behavior was scored as follows: 3 or 4 paws on the cage floor = 0 scores; 2 and 3 paws on the cage = 1 score; 4 paws on the cage = 2 scores.</div></div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i129" class="anchor-spacer"></div><h3 class="article-section__title" id="_i129"> Cytotoxicity Test</h3><div class="NLM_p last">Cytotoxicity of selected compounds was determined using the cell counting kit-8 (CCK8) assay kit (Beyotime, Shanghai, China). Briefly, fibroblasts L929, HEK293, and VERO were cultured in 96-well plates at a density of 1000 cells per well at 37 °C overnight. Then, different amounts of selected compounds were added into cells and incubated for 48 h. According to the manufacture’s instruction, 10 μL of CCK8 detection reagent was added into 100 μL of medium per well. After 1 h, the absorbance was read at 450 nm for CCK8 using a Spark multimode microplate reader. Cell inhibition was calculated as relative absorbance compared to a DMSO-only control.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i130" class="anchor-spacer"></div><h3 class="article-section__title" id="_i130"> Receptor Binding Studies</h3><div id="sec5_13_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131"> Materials</h4><div class="NLM_p last">The following specific radioligands and tissue sources were used: (a) the serotonin 5-HT<sub>1A</sub> receptor, [<sup>3</sup>H] 8-OH-DPAT, from h5-HT<sub>1A</sub>-CHO cells, (b) the serotonin 5-HT<sub>1B</sub> receptor, [<sup>3</sup>H] GR125743, from h5-HT<sub>1A</sub>-CHO cells, (c) the serotonin 5-HT<sub>2A</sub> receptor, [<sup>3</sup>H] ketanserin in the presence of 4-dione hydrochloride hydrate (35 nM), from h5-HT<sub>2A</sub>-CHO cells, (d) the serotonin 5-HT<sub>2C</sub> receptor, [<sup>3</sup>H] mesulergine, in the presence of spiperone (40 nM), from rat cerebral cortex, (e) the serotonin 5-HT<sub>6</sub> receptor, [<sup>3</sup>H] lysergic acid diethylamide, from h5-HT<sub>6</sub>-CHO cells, (f) the dopamine D2 receptor, [<sup>3</sup>H] <i>N</i>-methylspiperone, from hD<sub>2</sub>-CHO cells, (g) the dopaminergic D3 receptor, [<sup>3</sup>H] <i>N</i>-methylspiperone, from hD<sub>3</sub>-CHO cells, (h) the adrenergic α1 receptor, [<sup>3</sup>H] prazosin, from rat cerebral cortex, (i) the serotonin transporter (SERT), [<sup>3</sup>H] paroxetine, from hSERT-CHO cells, (j) the dopamine transporter (DAT), [<sup>3</sup>H] WIN35,428, from rat striatum, and (k) the noradrenaline transporter (NET), [<sup>3</sup>H] nisoxetine, from hNET-CHO cells.</div></div><div id="sec5_13_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132"> General Procedures for the Binding Assays</h4><div class="NLM_p last">The radioligand competitive binding assay for each receptor was performed as depicted before.<a onclick="showRef(event, 'cit41a cit41b'); return false;" href="javascript:void(0);" class="ref cit41a cit41b">(41a−)</a><a onclick="showRef(event, 'cit41c'); return false;" href="javascript:void(0);" class="ref cit41c">(41c)</a> Compound <b>32h</b> was dissolved in 50% (v/v) DMSO, and the compound concentration was 2 × 10<sup>–3</sup> M; dilution to the initial concentration of the new compound, 2 × 10<sup>–4</sup> M, contained 5% DMSO. For one receptor binding assays, total binding (TB) was determined in the presence of the radioligand. Nonspecific binding (NB) was determined in the presence of the radioligand and competitive ligand for the related receptor, whereas compound binding (CB) was determined in the presence of the radioligand and compound <b>32h</b>. Each specific binding (SB) was calculated as the total binding (TB) minus the nonspecific binding (NB) at a particular concentration of radioligand. Each percentage of inhibition (%) was calculated as follows: percentage of inhibition (%) = [(TB – CB)/(TB – NB)] × 100. Blank binding experiments contained 0.25% (v/v) DMSO were performed; DMSO had no effect. All compounds were tested at least three times over a 6-fold concentration range (10<sup>–5</sup> M to 10<sup>–10</sup> M). IC<sub>50</sub> values were determined by nonlinear regression analysis with fitting to the Hill equation curve. <i>K</i><sub>i</sub> values were calculated using the Cheng and Prussoff equation, <i>K</i><sub>i</sub> = IC<sub>50</sub>/(1 + <i>C</i>/<i>K</i><sub>d</sub>), where <i>C</i> represents the concentration of the hot ligand used and <i>K</i><sub>d</sub> is the receptor dissociation constant of each labeled ligand. The <i>K</i><sub>i</sub> value was derived from at least three independent experiments.</div></div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i133" class="anchor-spacer"></div><h3 class="article-section__title" id="_i133"> In Vivo Metabolism Studies</h3><div id="sec5_14_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i134" class="anchor-spacer"></div><h4 class="article-section__title" id="_i134"> Pharmacokinetics Study in Mice</h4><div class="NLM_p last">The HPLC conditions were as follows: column, Diamonsil C18 (150 mm × 4.6 mm, 5 μm, 120 A); mobile phase, 0.1% FA in water/acetonitrile (Merck Company, Germany) (v/v, 0–8.0 min, 40:60); flow rate, 0.2 mL/min; column temperature, 40 °C. UV detection, 254 nm. ICR mice (<i>n</i> = 6/group) were dosed with compounds <b>20h/32c/32h/32o</b> via the tail vein for i.v. administration (3 mg/kg) or i.p. administration (10 mg/kg). After the last administration, 80 μL of orbital blood was extracted at 0.25, 0.5, 1, 2, 3, 4, 5, 6, 8, and 24 h. After separated by centrifugation (rpm =18,000, 10 min), the plasma sample (30 μL) was prepared for high-pressure liquid chromatography/tandem mass spectrometry (LC–MS/MS) analysis by protein precipitation with acetonitrile (100 μL). The plasma samples were analyzed for drug and internal standard via an API 4000 Q trap mass spectrometer (Applied Biosystems, Foster City, CA, USA) coupled with a 1200 series HPLC system (Agilent, Santa Clara, CA, USA). Isocratic elution was used with 80% acetonitrile and 20% water with 0.1% formic acid to separate analytes. The total run time was 3 min, and the flow rate was 0.3 mL/min.</div></div><div id="sec5_14_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i135" class="anchor-spacer"></div><h4 class="article-section__title" id="_i135"> Blood–Brain Barrier (BBB) Penetration Study in Mice</h4><div class="NLM_p last">At 0.5 and 2 h after the last administration, after euthanizing the mice using CO<sub>2</sub> gas, the blood was collected from the heart immediately and the plasma was separated by centrifugation at 18000 rpm for 10 min at 4 °C. The remaining blood was washed out from the circulation by performing cardiac perfusion with physiological saline containing 10 U/mL heparin. The brain was then removed from the skull and added to three volumes of PBS buffer per weight, homogenized, and stored at −20 °C. The compound concentrations in plasma and brain samples were determined via the LC–MS/MS protocol.</div></div><div id="sec5_14_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i136" class="anchor-spacer"></div><h4 class="article-section__title" id="_i136"> Pharmacokinetics Study of Compound <b>32h</b> in Rats</h4><div class="NLM_p last">The same process was performed for the pharmacokinetics study of compound <b>32h</b> in rats. The Sprague–Dawley rats (<i>n</i> = 3/group) were dosed with compounds <b>32h</b> via the tail vein for i.v. administration (3 mg/kg) or i.p. administration (10 mg/kg). After the last administration, 80 μL of orbital blood and 50 μL of CSF were extracted at 10, 20, 40, 80, 160, 320, 640 and 1280 min. The samples were tested with the protocol above.</div></div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i137" class="anchor-spacer"></div><h3 class="article-section__title" id="_i137"> hERG Affinity</h3><div class="NLM_p last">Chinese hamster ovary (CHO) cells were stably transfected with hERG cDNA, passaged in Ham’s F-12 nutrient mixture supplemented with 10% fetal bovine serum, penicillin (100 U/mL), streptomycin (100 μg/mL), and Geneticin (200 μg/mL). For whole-cell patch-clamp recordings, CHO cells steadily expressing the hERG channel were seeded on 8 mm × 8 mm glass coverslips in 35 mm<sup>2</sup> diameter dishes at a density that enabled the germs to be isolated for recording and cultured at 37 °C under 5% CO<sub>2</sub>. Currents were recorded at room temperature using an EPC 10 amplifier with Patchmaster software (HEKA). The total resistance of patch electrodes was measured to be 3–5 MΩ. The extracellular solution contained 140 mM, 4 mM KCl, 1.8 mM CaCl<sub>2</sub>, 1 mM MgCl<sub>2</sub>, 10 mM glucose, and 10 mM HEPES with pH adjusted to 7.4 with NaOH. The internal pipette solution contained 130 mM KCl, 1 mM MgCl<sub>2</sub>, 5 mM ethylene glycol-bis(β-aminoethyl ether)-<i>N</i>,<i>N</i>,<i>N</i>,<i>N</i>′-tetraacetic acid salt (EGTA), 5 mM MgATP, and 10 mM HEPES with the pH adjusted to 7.2 with KOH. Cells were clamped from the holding potential at −80 to −60 mV for 500 ms, and the potential was raised to +30 mV for 2 s, then repolarized to −60 mV for 2 s, and returned back to the initial value at last. The voltage protocol was run once every 10 s. Data were acquired and analyzed using the PatchMaster software (HEKA).</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i138" class="anchor-spacer"></div><h3 class="article-section__title" id="_i138"> Statistical Analysis</h3><div class="NLM_p last">All values are presented as mean ± SEM or mean ± SD. For the calculation of EC<sub>50</sub>, the variable slope model was used with the following equation: <i>Y</i> = <i>Y</i><sub>min</sub> + (<i>Y</i><sub>max</sub> – <i>Y</i><sub>min</sub>)/(1 + 10 <sup>((log EC50–<i>X</i>)×HillSlope)</sup>). Differences between groups were analyzed by two-tailed Student’s <i>t</i> test. One-way ANOVA followed by post hoc Bonferroni’s or Donnet’s multiple comparisons was used to compare more than two groups. Two-way ANOVA followed by post hoc Bonferroni’s multiple comparisons test was used for comparison of a series of data collection among groups.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i139"><a href="/doi/suppl/10.1021/acs.jmedchem.0c02018" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70685" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70685" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c02018?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02018</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Figure S1. Effects of FS2921 on NMDA or glycine alone; Figure S2. Whole cell voltage clamp recordings on HEK-293 cells expressing GluN1/GluN2A, GluN1/GluN2B, GluN1/GluN2C or GluN1/GluN2D of FS2921; Figure S3. Effect of FS2921 at native AMPA and GABA receptors; Figure S4. Effects of compounds <b>32c</b>/<b>32o</b> in the FST; Figure S5. Effects of selected compounds administered for hyperactivity in mice; Figure S6. Effects of selected compounds on apomorphine (APO)-induced climbing in mice; Figure S7. Plasma concentration–time profiles for compound <b>20h</b> and compound <b>32h</b>; Figure S8. Concentration–time profiles of compound <b>32h</b> in plasma and cerebrospinal fluid; Figure S9. Effects of compounds <b>20h</b> and <b>32h</b> administered p.o. at 30 mg/kg of the weight of the mice; Table S1. Selected crystal complexes of NMDAR LBD; Table S2. G score and inhibition rate at 10 μM of hit compounds; Table S3. Binding affinities of compound <b>32h</b> for inhibiting radioligand binding to anti-depressant drug targets; Table S4. PK and brain penetration properties of compounds <b>32c</b>/<b>32o</b> in ICR mice (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">PDB ID of the co-crystal structure of GNE0723 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_003.pdb" class="ext-link">PDB</a>)</p></li><li><p class="inline">SMILES representation of compounds with key data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_004.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf">jm0c02018_si_001.pdf (2.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_003.pdb">jm0c02018_si_003.pdb (713.99 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_004.csv">jm0c02018_si_004.csv (5.32 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c02018" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54140" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54140" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhenming Liu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8993-4015" title="Orcid link">http://orcid.org/0000-0002-8993-4015</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#09736465607c496b63647c276c6d7c276a67"><span class="__cf_email__" data-cfemail="1f657273766a5f7d75726a317a7b6a317c71">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhuo Huang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9198-4778" title="Orcid link">http://orcid.org/0000-0001-9198-4778</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#7f170a1e1118053f170c1c510f140a511a1b0a511c11"><span class="__cf_email__" data-cfemail="aec6dbcfc0c9d4eec6ddcd80dec5db80cbcadb80cdc0">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liangren Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-7362-9497" title="Orcid link">http://orcid.org/0000-0002-7362-9497</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#711d18101f1603141f31131b1c045f1415045f121f"><span class="__cf_email__" data-cfemail="e18d88808f8693848fa1838b8c94cf848594cf828f">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhongtang Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guanxing Cai</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fan Fang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenchao Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Minghua Fan</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jingjing Lian</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yinli Qiu</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd. 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiangqing Xu</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Nhwa Pharmaceutical Co., Ltd. 69 Democratic South Road, Xuzhou, Jiangsu 221116, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xuehui Lv</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yiyan Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruqiu Zheng</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yuxi Wang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhongjun Li</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical
Sciences, Peking University, Beijing 100191, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1642-7773" title="Orcid link">http://orcid.org/0000-0003-1642-7773</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guisen Zhang</span> - <span class="hlFld-Affiliation affiliation">Jiangsu
Key Laboratory of Marine Biological Resources and Environment, Jiangsu
Key Laboratory of Marine Pharmaceutical Compound Screening, School
of Pharmacy, Jiangsu Ocean University, Lianyungang 222005, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Z.L., G.C., and F.F. equally contributed to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i141">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by the National Major Scientific and Technological Special Project for Significant New Drugs Development (2018ZX09711002-013-004, 2018ZX09735-001) and the National Natural Science Foundation of China (NSFC) (81872730).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">NMDAR</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor</p></td></tr><tr><td class="NLM_term">MDD</td><td class="NLM_def"><p class="first last">major depressive disorders</p></td></tr><tr><td class="NLM_term">PAM</td><td class="NLM_def"><p class="first last">positive allosteric modulator</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular regulated kinase</p></td></tr><tr><td class="NLM_term">PFC</td><td class="NLM_def"><p class="first last">prefrontal cortex</p></td></tr><tr><td class="NLM_term">LTP</td><td class="NLM_def"><p class="first last">long-term potentiation</p></td></tr><tr><td class="NLM_term">LTD</td><td class="NLM_def"><p class="first last">long-term depression</p></td></tr><tr><td class="NLM_term">AMPA</td><td class="NLM_def"><p class="first last">α-amino-3-hydroxy-5-methyl-4-isoxazole-propionicacid</p></td></tr><tr><td class="NLM_term">AMPAR</td><td class="NLM_def"><p class="first last">α-amino-3-hydroxy-5-methyl-4-isoxazole-propionicacid receptor</p></td></tr><tr><td class="NLM_term">mTOR</td><td class="NLM_def"><p class="first last">mammalian target of rapamycin</p></td></tr><tr><td class="NLM_term">ATD</td><td class="NLM_def"><p class="first last">amino terminal domain</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand binding domains</p></td></tr><tr><td class="NLM_term">TMD</td><td class="NLM_def"><p class="first last">transmembrane domains</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term">Log BB</td><td class="NLM_def"><p class="first last">log of the brain/blood partition coefficient</p></td></tr><tr><td class="NLM_term">IC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal inhibitory concentration</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal effective concentration</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">protein data bank</p></td></tr><tr><td class="NLM_term">Log <i>P</i></td><td class="NLM_def"><p class="first last">octanol/water partition coefficient</p></td></tr><tr><td class="NLM_term">PKUCNCL</td><td class="NLM_def"><p class="first last">Chinese National Compound Library of Peking University</p></td></tr><tr><td class="NLM_term">PAINS</td><td class="NLM_def"><p class="first last">pan assay interference compounds</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">FST</td><td class="NLM_def"><p class="first last">forced swimming test</p></td></tr><tr><td class="NLM_term">CSDS</td><td class="NLM_def"><p class="first last">chronic social defeat stress</p></td></tr><tr><td class="NLM_term">ICR</td><td class="NLM_def"><p class="first last">Institute of Cancer Research</p></td></tr><tr><td class="NLM_term">APO</td><td class="NLM_def"><p class="first last">apomorphine</p></td></tr><tr><td class="NLM_term">D<sub>2</sub></td><td class="NLM_def"><p class="first last">dopamine 2</p></td></tr><tr><td class="NLM_term">D3</td><td class="NLM_def"><p class="first last">dopamine 3</p></td></tr><tr><td class="NLM_term">5-HT<sub>1A</sub></td><td class="NLM_def"><p class="first last">5-hydroxytryptamine 1A</p></td></tr><tr><td class="NLM_term">5-HT<sub>1B</sub></td><td class="NLM_def"><p class="first last">5-hydroxytryptamine 1B</p></td></tr><tr><td class="NLM_term">5-HT<sub>2A</sub></td><td class="NLM_def"><p class="first last">5-hydroxytryptamine 2A</p></td></tr><tr><td class="NLM_term">5-HT<sub>2B</sub></td><td class="NLM_def"><p class="first last">5-hydroxytryptamine 2B</p></td></tr><tr><td class="NLM_term">5-HT<sub>2C</sub></td><td class="NLM_def"><p class="first last">5-hydroxytryptamine 2C</p></td></tr><tr><td class="NLM_term">5-HT<sub>6</sub></td><td class="NLM_def"><p class="first last">5-hydroxytryptamine 6</p></td></tr><tr><td class="NLM_term">SER</td><td class="NLM_def"><p class="first last">serotonin transporter</p></td></tr><tr><td class="NLM_term">NET</td><td class="NLM_def"><p class="first last">noradrenaline transporter</p></td></tr><tr><td class="NLM_term">DAT</td><td class="NLM_def"><p class="first last">dopamine transporter</p></td></tr><tr><td class="NLM_term">i.v.</td><td class="NLM_def"><p class="first last">intravenous injection</p></td></tr><tr><td class="NLM_term">i.p.</td><td class="NLM_def"><p class="first last">intraperitoneal injection</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentrations</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>max</sub></td><td class="NLM_def"><p class="first last">distribution half-life</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">eliminate half-life</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">MRT</td><td class="NLM_def"><p class="first last">mean residence time</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>d</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">MRT</td><td class="NLM_def"><p class="first last">mean retention time</p></td></tr><tr><td class="NLM_term">LC–MS/MS</td><td class="NLM_def"><p class="first last">liquid chromatography/tandem mass spectrometry</p></td></tr><tr><td class="NLM_term">CHO</td><td class="NLM_def"><p class="first last">Chinese hamster ovary</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go related gene.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i143">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07368" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07368" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 41 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">World Health Organization</span> <i>Depression and other common mental disorders:
global health estimates</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=World+Health+Organization&title=Depression+and+other+common+mental+disorders%3A%0Aglobal+health+estimates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DDepression%2520and%2520other%2520common%2520mental%2520disorders%253A%250Aglobal%2520health%2520estimates%26pub%3DWorld%2520Health%2520Organization%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boku, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hishimoto, A.</span></span> <span> </span><span class="NLM_article-title">Neural basis of major depressive disorder: Beyond monoamine hypothesis</span>. <i>Psychiatry Clin. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1111/pcn.12604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1111%2Fpcn.12604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=28926161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2018&pages=3-12&author=S.+Bokuauthor=S.+Nakagawaauthor=H.+Todaauthor=A.+Hishimoto&title=Neural+basis+of+major+depressive+disorder%3A+Beyond+monoamine+hypothesis&doi=10.1111%2Fpcn.12604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neural basis of major depressive disorder: Beyond monoamine hypothesis</span></div><div class="casAuthors">Boku, Shuken; Nakagawa, Shin; Toda, Hiroyuki; Hishimoto, Akitoyo</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry and Clinical Neurosciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-12</span>CODEN:
                <span class="NLM_cas:coden">PCNEFP</span>;
        ISSN:<span class="NLM_cas:issn">1323-1316</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The monoamine hypothesis has been accepted as the most common hypothesis of major depressive disorder (MDD) for a long period because of its simplicity and understandability.  Actually, most currently used antidepressants have been considered to act based on the monoamine hypothesis.  However, an important problem of the monoamine hypothesis has been pointed out as follows: it fails to explain the latency of response to antidepressants.  In addn., many patients with MDD have remained refractory to currently used antidepressants.  Therefore, monoamine-alternate hypotheses are required to explain the latency of response to antidepressants.  Such hypotheses have been expected to contribute to identifying hopeful new therapeutic targets for MDD.  Past studies have revealed that the vol. of the hippocampus is decreased in patients with MDD, which is likely caused by the failure of the hypothalamic-pituitary-adrenal axis and following elevation of glucocorticoids.  Two hypotheses have been proposed to explain the vol. of the hippocampus: (i) the neuroplasticity hypothesis; and (ii) the neurogenesis hypothesis.  The neuroplasticity hypothesis explains how the hippocampal vol. is decreased by the morphol. changes of hippocampal neurons, such as the shortening length of dendrites and the decreased no. and d. of spines.  The neurogenesis hypothesis explains how the hippocampal vol. is decreased by the decrease of neurogenesis in the hippocampal dentate gyrus.  These hypotheses are able to explain the latency of response to antidepressants.  In this review, we first overview how the neuroplasticity and neurogenesis hypotheses have been developed.  We then describe the details of these hypotheses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ-o-pmwi-M7Vg90H21EOLACvtfcHk0liLFLJzq9OzZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVehsg%253D%253D&md5=36b5009c7c8c80dd123cfd1a862fc85b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fpcn.12604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpcn.12604%26sid%3Dliteratum%253Aachs%26aulast%3DBoku%26aufirst%3DS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DToda%26aufirst%3DH.%26aulast%3DHishimoto%26aufirst%3DA.%26atitle%3DNeural%2520basis%2520of%2520major%2520depressive%2520disorder%253A%2520Beyond%2520monoamine%2520hypothesis%26jtitle%3DPsychiatry%2520Clin.%2520Neurosci.%26date%3D2018%26volume%3D72%26spage%3D3%26epage%3D12%26doi%3D10.1111%2Fpcn.12604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span> <span> </span><span class="NLM_article-title">Ketamine’s antidepressant action: beyond NMDA receptor inhibition</span>. <i>Expert. Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1389</span>– <span class="NLM_lpage">1392</span>, <span class="refDoi"> DOI: 10.1080/14728222.2016.1238899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1080%2F14728222.2016.1238899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=27646666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1aktLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=1389-1392&author=K.+Hashimoto&title=Ketamine%E2%80%99s+antidepressant+action%3A+beyond+NMDA+receptor+inhibition&doi=10.1080%2F14728222.2016.1238899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ketamine's antidepressant action: beyond NMDA receptor inhibition</span></div><div class="casAuthors">Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1389-1392</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is one of the most attractive antidepressants since this drug causes rapid-onset and sustained antidepressant effects in treatment resistant patients with depression.  There are unanswered questions about how ketamine induces its rapid and sustained antidepressant actions.  This key article suggests that (2R,6R)-HNK (hydroxynorketamine), a major metabolite of (R)-ketamine, shows antidepressant effects in rodent models of depression, indicating that the metab. of (R)-ketamine to (2R,6R)-HNK is pivotal in its antidepressant action.  Here these findings are put into context and their significance is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUC0l8Vic2CbVg90H21EOLACvtfcHk0lggFMbsiRKzLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1aktLbM&md5=0ebafd17a6a405308fe4dd3115677fd4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F14728222.2016.1238899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728222.2016.1238899%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DKetamine%25E2%2580%2599s%2520antidepressant%2520action%253A%2520beyond%2520NMDA%2520receptor%2520inhibition%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Targets%26date%3D2016%26volume%3D20%26spage%3D1389%26epage%3D1392%26doi%3D10.1080%2F14728222.2016.1238899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molero, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos-Quiroga, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo-Śnchez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-Rojas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meana, J. J.</span></span> <span> </span><span class="NLM_article-title">Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1007/s40263-018-0519-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1007%2Fs40263-018-0519-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=29736744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVWgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=411-420&author=P.+Moleroauthor=J.+A.+Ramos-Quirogaauthor=R.+Martin-Santosauthor=E.+Calvo-%C5%9Anchezauthor=L.+Guti%C3%A9rrez-Rojasauthor=J.+J.+Meana&title=Antidepressant+Efficacy+and+Tolerability+of+Ketamine+and+Esketamine%3A+A+Critical+Review&doi=10.1007%2Fs40263-018-0519-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review</span></div><div class="casAuthors">Molero, P.; Ramos-Quiroga, J. A.; Martin-Santos, R.; Calvo-Sanchez, E.; Gutierrez-Rojas, L.; Meana, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Ketamine and its enantiomer S-ketamine (esketamine) are promising candidates to produce a rapid-onset antidepressant effect in treatment-resistant depression.  Ketamine causes continued blockade of the glutamate N-methyl-D-aspartate (NMDA) receptor, though this might not primarily mediate the antidepressant effect.  Alternative hypotheses include selectivity for the NMDA receptor subtype contg. the NMDA receptor subunit 2B (NR2B), inhibition of the phosphorylation of the eukaryotic elongation factor 2 (eEF2) kinase, increased expression of brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrKB), and activation of the mammalian target of rapamycin (mTOR) signaling pathway, alongside other independent actions attributed to the ketamine metab. to R-hydroxynorketamine (R-HNK).  The enantiomer S-ketamine (esketamine) displays approx. fourfold greater affinity for the glutamate NMDA receptor in vitro than R-ketamine.  Proof-of-concept single-dose and repeat-dose studies with i.v. ketamine show a significant antidepressant and probably antisuicidal effect in the short term, with response rates over 60% as early as 4.5 h after a single dose, with a sustained effect after 24 h, and over 40% after 7 days.  This response can be further sustained over several weeks with repeated doses (two to three doses per wk).  Tolerability seems acceptable in the short term, with transient elevation of blood pressure and mild and transient dissociative and psychotomimetic effects.  Intranasal esketamine has shown a comparable antidepressant effect, which has resulted in the US FDA granting the drug a "breakthrough therapy" designation, and theor. it may offer an improved tolerability profile.  However, major concerns remain regarding an effective protocol to maintain the clin. antidepressant effect of ketamine seen with acute administration and the safety of ketamine and esketamine in the long term, specifically related to potential neurocognitive and urol. toxicity, together with the potential induction of substance use disorders.  Ketamine and esketamine are not currently approved treatments for depression, but the clin. use of ketamine is increasing in a variety of practice settings internationally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9YS8yRNy4o7Vg90H21EOLACvtfcHk0lggFMbsiRKzLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVWgt74%253D&md5=24142c2b26f02e7f181ba9a0a7bdb3f0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs40263-018-0519-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-018-0519-3%26sid%3Dliteratum%253Aachs%26aulast%3DMolero%26aufirst%3DP.%26aulast%3DRamos-Quiroga%26aufirst%3DJ.%2BA.%26aulast%3DMartin-Santos%26aufirst%3DR.%26aulast%3DCalvo-%25C5%259Anchez%26aufirst%3DE.%26aulast%3DGuti%25C3%25A9rrez-Rojas%26aufirst%3DL.%26aulast%3DMeana%26aufirst%3DJ.%2BJ.%26atitle%3DAntidepressant%2520Efficacy%2520and%2520Tolerability%2520of%2520Ketamine%2520and%2520Esketamine%253A%2520A%2520Critical%2520Review%26jtitle%3DCNS%2520Drugs%26date%3D2018%26volume%3D32%26spage%3D411%26epage%3D420%26doi%3D10.1007%2Fs40263-018-0519-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karper, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heninger, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, M. B.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charney, D. S.</span></span> <span> </span><span class="NLM_article-title">Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses</span>. <i>Arch. Gen. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1001/archpsyc.1994.03950030035004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1001%2Farchpsyc.1994.03950030035004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=8122957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaK2cXkslemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1994&pages=199-214&author=J.+H.+Krystalauthor=L.+P.+Karperauthor=J.+P.+Seibylauthor=G.+K.+Freemanauthor=R.+Delaneyauthor=J.+D.+Bremnerauthor=G.+R.+Heningerauthor=M.+B.+Bowersauthor=D.+S.+Charney&title=Subanesthetic+effects+of+the+noncompetitive+NMDA+antagonist%2C+ketamine%2C+in+humans.+Psychotomimetic%2C+perceptual%2C+cognitive%2C+and+neuroendocrine+responses&doi=10.1001%2Farchpsyc.1994.03950030035004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses</span></div><div class="casAuthors">Krystal, John H.; Karper, Laurence P.; Seibyl, John P.; Freeman, Glenna K.; Delaney, Richard; Bremner, J. Douglas; Heninger, George R.; Bowers, Malcolm B., Jr.; Charney, Dennis S.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">199-214</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">When given at subanesthetic doses to healthy subjects, the N-methyl-D-aspartate (NMDA) agonist ketamine: (1) produced behaviors similar to the pos. and neg. symptoms of schizophrenia; (2) elicited alterations in perception; (3) impaired performance on tests of vigilance, verbal fluency, and the Wisconsin Card Sorting Test; (4) evoked symptoms similar to those of dissociative states; and (5) preferentially disrupted delayed word recall, sparing immediate recall and postdistraction recall.  Ketamine had no effect on the Mini-Mental State Examn.  Ketamine also had no effect on plasma 3-methoxy-4-hydroxyphenethylene glycol levels, although it blunted a test day decline in plasma homovanillic acid levels at the higher dose tested.  It also dose-dependently increased plasma cortisol and prolactin levels.  Ketamine produced small dose-dependent increases in blood pressure.  These data indicate that NMDA antagonists produce a broad range of symptoms, behaviors, and cognitive deficits that resemble aspects of endogenous psychoses, particularly schizophrenia and dissociative states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDWxsI3lz_fbVg90H21EOLACvtfcHk0liYDFsHzZ7LnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslemtrY%253D&md5=6554b88d3fd5f747a925fe5ffaf49cd6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1994.03950030035004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1994.03950030035004%26sid%3Dliteratum%253Aachs%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26aulast%3DKarper%26aufirst%3DL.%2BP.%26aulast%3DSeibyl%26aufirst%3DJ.%2BP.%26aulast%3DFreeman%26aufirst%3DG.%2BK.%26aulast%3DDelaney%26aufirst%3DR.%26aulast%3DBremner%26aufirst%3DJ.%2BD.%26aulast%3DHeninger%26aufirst%3DG.%2BR.%26aulast%3DBowers%26aufirst%3DM.%2BB.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26atitle%3DSubanesthetic%2520effects%2520of%2520the%2520noncompetitive%2520NMDA%2520antagonist%252C%2520ketamine%252C%2520in%2520humans.%2520Psychotomimetic%252C%2520perceptual%252C%2520cognitive%252C%2520and%2520neuroendocrine%2520responses%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1994%26volume%3D51%26spage%3D199%26epage%3D214%26doi%3D10.1001%2Farchpsyc.1994.03950030035004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulbrich, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacoff, E. Y.</span></span> <span> </span><span class="NLM_article-title">Rules of engagement for NMDA receptor subunits</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">14163</span>– <span class="NLM_lpage">14168</span>, <span class="refDoi"> DOI: 10.1073/pnas.0802075105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1073%2Fpnas.0802075105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=18779583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFGqtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=14163-14168&author=M.+H.+Ulbrichauthor=E.+Y.+Isacoff&title=Rules+of+engagement+for+NMDA+receptor+subunits&doi=10.1073%2Fpnas.0802075105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Rules of engagement for NMDA receptor subunits</span></div><div class="casAuthors">Ulbrich, Maximilian H.; Isacoff, Ehud Y.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">14163-14168</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Canonical NMDA receptors assemble from two glycine-binding NR1 subunits with two glutamate-binding NR2 subunits to, form glutamate-gated excitatory receptors that mediate synaptic transmission and plasticity.  The role of glycine-binding NR3 subunits is less clear.  Whereas in Xenopus laevis oocytes, two NR3 subunits coassemble with two NR1 subunits to form a glycine-gated receptor, such a receptor has yet to be found in mammalian cells.  Meanwhile, NR1, NR2, and NR3 appear to coassemble into triheteromeric receptors in neurons, but it is not clear whether this occurs in oocytes.  To test the rules that govern subunit assembly in NMDA receptors, we developed a single-mol. fluorescence colocalization method.  The method focuses selectively on the plasma membrane and simultaneously dets. the subunit compn. of hundreds of individual protein complexes within an optical patch on a live cell.  We find that NR1, NR2, and NR3 follow an exclusion rule that yields sep. populations of NR1/NR2 and NR1/NR3 receptors on the surface of oocytes.  In contrast, coexpression of NR1, NR3A, and NR3B yields triheteromeric receptors with a fixed stoichiometry of two NR1 subunits with one NR3A and one NR3B.  At least part of this regulation of subunit stoichiometry appears to be caused by internal retention.  Thus, depending on the mixt. of subunits, functional receptors on the cell surface may follow either an exclusion rule or a stoichiometric combination rule, providing an important constraint on functional diversity.  Cell-to-cell differences in the rules may help sculpt distinct physiol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLoiHDKdxm17Vg90H21EOLACvtfcHk0liYDFsHzZ7LnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFGqtL7E&md5=506fb5c2c91089fd273b465ef181bf20</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0802075105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0802075105%26sid%3Dliteratum%253Aachs%26aulast%3DUlbrich%26aufirst%3DM.%2BH.%26aulast%3DIsacoff%26aufirst%3DE.%2BY.%26atitle%3DRules%2520of%2520engagement%2520for%2520NMDA%2520receptor%2520subunits%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D14163%26epage%3D14168%26doi%3D10.1073%2Fpnas.0802075105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollmuth, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBain, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingledine, R.</span></span> <span> </span><span class="NLM_article-title">Glutamate receptor ion channels: structure, regulation, and function</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1124/pr.109.002451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+receptor+ion+channels%3A+structure%2C+regulation%2C+and+function&doi=10.1124%2Fpr.109.002451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0ljB_xP0UoSiYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520receptor%2520ion%2520channels%253A%2520structure%252C%2520regulation%252C%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496%26doi%3D10.1124%2Fpr.109.002451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karakas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, H.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a heterotetrameric NMDA receptor ion channel</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1126/science.1251915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1126%2Fscience.1251915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=24876489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFSmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2014&pages=992-997&author=E.+Karakasauthor=H.+Furukawa&title=Crystal+structure+of+a+heterotetrameric+NMDA+receptor+ion+channel&doi=10.1126%2Fscience.1251915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a heterotetrameric NMDA receptor ion channel</span></div><div class="casAuthors">Karakas, Erkan; Furukawa, Hiro</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">6187</span>),
    <span class="NLM_cas:pages">992-997</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">N-Methyl-L-aspartate (NMDA) receptors belong to the family of ionotropic glutamate receptors, which mediate most excitatory synaptic transmission in mammalian brains.  Calcium permeation triggered by activation of NMDA receptors is the pivotal event for initiation of neuronal plasticity.  Here, we show the crystal structure of the intact heterotetrameric GluN1-GluN2B NMDA receptor ion channel at 4 angstroms.  The NMDA receptors are arranged as a dimer of GluN1-GluN2B heterodimers with the twofold symmetry axis running through the entire mol. composed of an amino-terminal domain (ATD), a ligand-binding domain (LBD), and a transmembrane domain (TMD).  The ATD and LBD are much more highly packed in the NMDA receptors than non-NMDA receptors, which may explain why ATD regulates ion channel activity in NMDA receptors but not in non-NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaR6ovzl-ld7Vg90H21EOLACvtfcHk0ljB_xP0UoSiYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFSmu7k%253D&md5=1024cf903b20d0a7b1bc6a78f7fd283a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1251915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1251915%26sid%3Dliteratum%253Aachs%26aulast%3DKarakas%26aufirst%3DE.%26aulast%3DFurukawa%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520a%2520heterotetrameric%2520NMDA%2520receptor%2520ion%2520channel%26jtitle%3DScience%26date%3D2014%26volume%3D344%26spage%3D992%26epage%3D997%26doi%3D10.1126%2Fscience.1251915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1038/nrn3504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1038%2Fnrn3504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=23686171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVSit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=383-400&author=P.+Paolettiauthor=C.+Belloneauthor=Q.+Zhou&title=NMDA+receptor+subunit+diversity%3A+impact+on+receptor+properties%2C+synaptic+plasticity+and+disease&doi=10.1038%2Fnrn3504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease</span></div><div class="casAuthors">Paoletti, Pierre; Bellone, Camilla; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">383-400</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  NMDA receptors (NMDARs) are glutamate-gated ion channels and are crucial for neuronal communication.  NMDARs form tetrameric complexes that consist of several homologous subunits.  The subunit compn. of NMDARs is plastic, resulting in a large no. of receptor subtypes.  As each receptor subtype has distinct biophys., pharmacol. and signaling properties, there is great interest in detg. whether individual subtypes carry out specific functions in the CNS in both normal and pathol. conditions.  Here, we review the effects of subunit compn. on NMDAR properties, synaptic plasticity and cellular mechanisms implicated in neuropsychiatric disorders.  Understanding the rules and roles of NMDAR diversity could provide new therapeutic strategies against dysfunctions of glutamatergic transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqubMsb4ZP2U7Vg90H21EOLACvtfcHk0liK1cajL8Qfyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVSit7Y%253D&md5=f69790da360242d491bf1a5eb146613d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrn3504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3504%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DBellone%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DNMDA%2520receptor%2520subunit%2520diversity%253A%2520impact%2520on%2520receptor%2520properties%252C%2520synaptic%2520plasticity%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D383%26epage%3D400%26doi%3D10.1038%2Fnrn3504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danysz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, C. G.</span></span> <span> </span><span class="NLM_article-title">Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=9860805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaK1MXltFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=597-664&author=W.+Danyszauthor=C.+G.+Parsons&title=Glycine+and+N-methyl-D-aspartate+receptors%3A+physiological+significance+and+possible+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications</span></div><div class="casAuthors">Danysz, Wojciech; Parsons, Chris G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">597-664</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with many refs. on the physiol. significance of the glycine site as an attractive target for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWhTWVIfqWebVg90H21EOLACvtfcHk0liK1cajL8Qfyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFyhsQ%253D%253D&md5=6df1d6a32e8e6bf358b1a8073bc15317</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDanysz%26aufirst%3DW.%26aulast%3DParsons%26aufirst%3DC.%2BG.%26atitle%3DGlycine%2520and%2520N-methyl-D-aspartate%2520receptors%253A%2520physiological%2520significance%2520and%2520possible%2520therapeutic%2520applications%26jtitle%3DPharmacol.%2520Rev.%26date%3D1998%26volume%3D50%26spage%3D597%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swan, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meldrum, B. S.</span></span> <span> </span><span class="NLM_article-title">Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">850</span>– <span class="NLM_lpage">852</span>, <span class="refDoi"> DOI: 10.1126/science.6093256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1126%2Fscience.6093256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=6093256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaL2MXjsl0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1984&pages=850-852&author=R.+P.+Simonauthor=J.+H.+Swanauthor=T.+Griffithsauthor=B.+S.+Meldrum&title=Blockade+of+N-methyl-D-aspartate+receptors+may+protect+against+ischemic+damage+in+the+brain&doi=10.1126%2Fscience.6093256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain</span></div><div class="casAuthors">Simon, R. P.; Swan, J. H.; Griffiths, T.; Meldrum, B. S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4676</span>),
    <span class="NLM_cas:pages">850-2</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">In rats ischemia of the forebrain induced by a 30-min occlusion of the carotid artery followed by 120 min of arterial reperfusion produced ischemic lesions of selectively vulnerable pyramidal cells in both hippocampi.  Focal microinfusion into the dorsal hippocampus of 2-amino-7-phosphonoheptanoic acid  [85797-13-3], an antagonist of excitation at the N-methyl-D-aspartate-preferring receptor, before ischemia was induced protected against the development of ischemic damage.  Apparently, excitatory neurotransmission plays an important role in selective neuronal loss due to cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZAGwtHGrEWrVg90H21EOLACvtfcHk0liJZJZYOnhNTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXjsl0%253D&md5=057560bcd8ee07a6a4bc35862e4b4424</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.6093256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6093256%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DR.%2BP.%26aulast%3DSwan%26aufirst%3DJ.%2BH.%26aulast%3DGriffiths%26aufirst%3DT.%26aulast%3DMeldrum%26aufirst%3DB.%2BS.%26atitle%3DBlockade%2520of%2520N-methyl-D-aspartate%2520receptors%2520may%2520protect%2520against%2520ischemic%2520damage%2520in%2520the%2520brain%26jtitle%3DScience%26date%3D1984%26volume%3D226%26spage%3D850%26epage%3D852%26doi%3D10.1126%2Fscience.6093256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Croucher, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meldrum, B. S.</span></span> <span> </span><span class="NLM_article-title">Anticonvulsant action of excitatory amino acid antagonists</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">899</span>– <span class="NLM_lpage">901</span>, <span class="refDoi"> DOI: 10.1126/science.7079744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1126%2Fscience.7079744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=7079744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaL38XktFKqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=1982&pages=899-901&author=M.+J.+Croucherauthor=J.+F.+Collinsauthor=B.+S.+Meldrum&title=Anticonvulsant+action+of+excitatory+amino+acid+antagonists&doi=10.1126%2Fscience.7079744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Anticonvulsant action of excitatory amino acid antagonists</span></div><div class="casAuthors">Croucher, M J.; Collins, J. F.; Meldrum, B. S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">4548</span>),
    <span class="NLM_cas:pages">899-901</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Compds. that antagonize neuronal excitation induced by dicarboxylic amino acids were tested in 2 animal models of epilepsy, namely sound-induced seizures in DBA/2 mice and threshold pentylenetetrazol seizures in Swiss mice.  Sound-induced seizures could be prevented by intracerebroventricular injection of compds. that block excitation due to N-methyl-D-aspartic acid  [6384-92-5].  The most potent compd., (-)-2-amino-7-phosphonoheptanoic acid  [81338-23-0], was anticonvulsant in both test systems when given either i.p. or intracerebroventricularly.  Specific antagonists of excitation that is caused by amino acids provide a new class of anticonvulsant agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcJYQLKxgFVrVg90H21EOLACvtfcHk0liJZJZYOnhNTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktFKqu74%253D&md5=19a991a8488325c2b63885b20adc8e7e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.7079744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7079744%26sid%3Dliteratum%253Aachs%26aulast%3DCroucher%26aufirst%3DM.%2BJ.%26aulast%3DCollins%26aufirst%3DJ.%2BF.%26aulast%3DMeldrum%26aufirst%3DB.%2BS.%26atitle%3DAnticonvulsant%2520action%2520of%2520excitatory%2520amino%2520acid%2520antagonists%26jtitle%3DScience%26date%3D1982%26volume%3D216%26spage%3D899%26epage%3D901%26doi%3D10.1126%2Fscience.7079744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodge, D.</span></span> <span> </span><span class="NLM_article-title">Evidence for involvement of N-methylaspartate receptors in ’windup’ of class 2 neurones in the dorsal horn of the rat</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>424</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(87)91487-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2F0006-8993%2887%2991487-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=2823998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaL2sXmt12ru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=1987&pages=402-406&author=S.+N.+Daviesauthor=D.+Lodge&title=Evidence+for+involvement+of+N-methylaspartate+receptors+in+%E2%80%99windup%E2%80%99+of+class+2+neurones+in+the+dorsal+horn+of+the+rat&doi=10.1016%2F0006-8993%2887%2991487-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurons in the dorsal horn of the rat</span></div><div class="casAuthors">Davies, Stephen N.; Lodge, David</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">424</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">402-6</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The effects of ketamine and kynurenate on the initial response and frequency dependent potentiation of response (wind-up) of class 2 neurons were examd. in the rat dorsal horn induced by repeated elec. stimulation of their receptive fields.  Iontophoretic kynurenate reduced both the initial response and the wind-up.  Iontophoretic or i.v. ketamine had no consistent effect on the initial response but consistently reduced wind-up.  N-Methylaspartate receptors therefore appear to contribute to the wind-up, but not the initial response, of class 2 neurons in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjiS775AxsxLVg90H21EOLACvtfcHk0liJZJZYOnhNTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmt12ru78%253D&md5=d69854b247a30a47275601027b7a9d96</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2887%2991487-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252887%252991487-9%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DS.%2BN.%26aulast%3DLodge%26aufirst%3DD.%26atitle%3DEvidence%2520for%2520involvement%2520of%2520N-methylaspartate%2520receptors%2520in%2520%25E2%2580%2599windup%25E2%2580%2599%2520of%2520class%25202%2520neurones%2520in%2520the%2520dorsal%2520horn%2520of%2520the%2520rat%26jtitle%3DBrain%2520Res.%26date%3D1987%26volume%3D424%26spage%3D402%26epage%3D406%26doi%3D10.1016%2F0006-8993%2887%2991487-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preskorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macaluso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zammit, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, R. M.</span></span> <span> </span><span class="NLM_article-title">GLYX-13 Clinical Study Group. Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent</span>. <i>J. Psychiatr. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1097/01.pra.0000462606.17725.93</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1097%2F01.pra.0000462606.17725.93" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=25782764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A280%3ADC%252BC2MnlsFajtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=140-149&author=S.+Preskornauthor=M.+Macalusoauthor=D.+V.+Mehraauthor=G.+Zammitauthor=J.+R.+Moskalauthor=R.+M.+Burch&title=GLYX-13+Clinical+Study+Group.+Randomized+proof+of+concept+trial+of+GLYX-13%2C+an+N-methyl-D-aspartate+receptor+glycine+site+partial+agonist%2C+in+major+depressive+disorder+nonresponsive+to+a+previous+antidepressant+agent&doi=10.1097%2F01.pra.0000462606.17725.93"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent</span></div><div class="casAuthors">Preskorn Sheldon; Macaluso Matthew; Mehra D O Vishaal; Zammit Gary; Moskal Joseph R; Burch Ronald M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric practice</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Approximately 45% of patients with major depressive disorder (MDD) do not remit when treated with biogenic amine antidepressants.  Consequently, there is a significant need for antidepressant agents with different mechanisms of action.  Early proof of concept (POC) studies with such novel agents play a significant role in helping drug developers identify agents and mechanisms of action that merit more intensive research.  Studies have demonstrated that high affinity N-methyl-Daspartate (NMDA) receptor blockers (eg, ketamine) can produce rapid antidepressant effects in patients who have not responded to currently available agents, but treatment with these agents is accompanied by psychotomimetic effects that make their use problematic.  This column describes a POC study involving GLYX-13, an N-methyl-D-aspartate receptor glycine site functional partial agonist.  METHOD:  In this double-blind, randomized, placebo-controlled study, a single intravenous (IV) dose of GLYX-13 (1, 5, 10, or 30 mg/kg) or placebo was administered to 116 subjects with MDD who had not benefitted from a trial of at least one biogenic amine antidepressant during the current episode.  The primary outcome measure was score on the Hamilton Depression Rating Scale-17 (Ham-D17), which was used to rate overall depressive symptoms at baseline and at 24 hours and days 3, 7, 14, and, in some arms, days 21 and 28 after administration.  RESULTS:  GLYX-13, 5 or 10 mg/kg IV, reduced depressive symptoms as assessed by the Ham-D17 at days 1 through 7.  Onset of action as assessed using the Bech-6 occurred within 2 hours.  GLYX-13 did not elicit psychotomimetic or other significant side effects.  CONCLUSION:  In this early POC study, GLYX-13 reduced depressive symptoms within 2 hours and this effect was maintained for 7 days on average in subjects with MDD who had not responded to another antidepressant agent during the current depressive episode.  The findings of this study support the hypothesis that modulation of the NMDA receptor is a valid target for the development of antidepressant drugs and the need for additional studies to further evaluate the effects of GLYX-13.  POC studies such as the one described here play a pivotal role in allowing drug researchers to decide whether to move forward with larger and more expensive studies, and they enable them to focus available resources on those molecules that appear to have the most therapeutic promise.  Based on the POC study described here, a multiple dose study has been completed which showed sustained therapeutic benefit with repeated dosing of GLYX-13 for more than 6 weeks.  Phase 3 studies are now being planned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRv64RH14l-ZEwlCcfExbvbfW6udTcc2ebIzXZv40_i_rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnlsFajtA%253D%253D&md5=9e82a9c5facdfbf48c4bf31c24a059bc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2F01.pra.0000462606.17725.93&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.pra.0000462606.17725.93%26sid%3Dliteratum%253Aachs%26aulast%3DPreskorn%26aufirst%3DS.%26aulast%3DMacaluso%26aufirst%3DM.%26aulast%3DMehra%26aufirst%3DD.%2BV.%26aulast%3DZammit%26aufirst%3DG.%26aulast%3DMoskal%26aufirst%3DJ.%2BR.%26aulast%3DBurch%26aufirst%3DR.%2BM.%26atitle%3DGLYX-13%2520Clinical%2520Study%2520Group.%2520Randomized%2520proof%2520of%2520concept%2520trial%2520of%2520GLYX-13%252C%2520an%2520N-methyl-D-aspartate%2520receptor%2520glycine%2520site%2520partial%2520agonist%252C%2520in%2520major%2520depressive%2520disorder%2520nonresponsive%2520to%2520a%2520previous%2520antidepressant%2520agent%26jtitle%3DJ.%2520Psychiatr.%2520Pract.%26date%3D2015%26volume%3D21%26spage%3D140%26epage%3D149%26doi%3D10.1097%2F01.pra.0000462606.17725.93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moskal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colley, P. A.</span></span> <span> </span><span class="NLM_article-title">The use of antibody engineering to create novel drugs that target N-methyl-D-aspartate receptors</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.2174/1389450013348399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.2174%2F1389450013348399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=11554557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVGlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=331-345&author=J.+R.+Moskalauthor=H.+Yamamotoauthor=P.+A.+Colley&title=The+use+of+antibody+engineering+to+create+novel+drugs+that+target+N-methyl-D-aspartate+receptors&doi=10.2174%2F1389450013348399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The use of antibody engineering to create novel drugs that target N-methyl-D-aspartate receptors</span></div><div class="casAuthors">Moskal, Joseph R.; Yamamoto, Hirotaka; Colley, Patricia A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-345</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  According to a recent World Health Organization survey, there are over four hundred million people worldwide suffering from mental and neurol. disorders; schizophrenia affects some forty-five million people, and unipolar major depression ranked fifth in major causes of disability and death.  Clearly it is of the utmost importance to develop new, effective, and safe neuro-pharmaceuticals with this increasing "global burden of disease".  To this end, we have developed a strategy of generating monoclonal antibodies that act as modulators of the cell-surface central nervous system receptor-ion channel complexes.  In this review we will focus on the generation and characterization of a monoclonal antibody that acts as a partial agonist to the N-methyl-D-aspartate receptor.  The creation of peptide mimetics, derived from this monoclonal antibody, that may be useful as cognitive enhancers and protect neurons hypoxic and ischemic insults caused by stroke, will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcm86hOZbC8rVg90H21EOLACvtfcHk0lgc85bMh92j9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVGlu74%253D&md5=49ff6126fb6a6f520f88b6a92bf34653</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1389450013348399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450013348399%26sid%3Dliteratum%253Aachs%26aulast%3DMoskal%26aufirst%3DJ.%2BR.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DColley%26aufirst%3DP.%2BA.%26atitle%3DThe%2520use%2520of%2520antibody%2520engineering%2520to%2520create%2520novel%2520drugs%2520that%2520target%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2001%26volume%3D2%26spage%3D331%26epage%3D345%26doi%3D10.2174%2F1389450013348399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, P. K.</span></span> <span> </span><span class="NLM_article-title">A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuropharm.2008.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=18796308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlShurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1238-1250&author=X.+L.+Zhangauthor=J.+A.+Sullivanauthor=J.+R.+Moskalauthor=P.+K.+Stanton&title=A+NMDA+receptor+glycine+site+partial+agonist%2C+GLYX-13%2C+simultaneously+enhances+LTP+and+reduces+LTD+at+Schaffer+collateral-CA1+synapses+in+hippocampus&doi=10.1016%2Fj.neuropharm.2008.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus</span></div><div class="casAuthors">Zhang, Xiao-lei; Sullivan, John A.; Moskal, Joseph R.; Stanton, Patric K.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1238-1250</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate glutamate receptors (NMDARs) are a key route for Ca2+ influx into neurons important to both activity-dependent synaptic plasticity and, when uncontrolled, triggering events that cause neuronal degeneration and death.  Among regulatory binding sites on the NMDAR complex is a glycine binding site, distinct from the glutamate binding site, which must be co-activated for NMDAR channel opening.  We developed a novel glycine site partial agonist, GLYX-13, which is both nootropic and neuroprotective in vivo.  Here, we assessed the effects of GLYX-13 on long-term synaptic plasticity and NMDAR transmission at Schaffer collateral-CA1 synapses in hippocampal slices in vitro.  GLYX-13 simultaneously enhanced the magnitude of long-term potentiation (LTP) of synaptic transmission, while reducing long-term depression (LTD).  GLYX-13 reduced NMDA receptor-mediated synaptic currents in CA1 pyramidal neurons evoked by low frequency Schaffer collateral stimulation, but enhanced NMDAR currents during high frequency bursts of activity, and these actions were occluded by a satg. concn. of the glycine site agonist D-serine.  Direct two-photon imaging of Schaffer collateral burst-evoked increases in [Ca2+] in individual dendritic spines revealed that GLYX-13 selectively enhanced burst-induced NMDAR-dependent spine Ca2+ influx.  Examg. the rate of MK-801 block of synaptic vs. extrasynaptic NMDAR-gated channels revealed that GLYX-13 selectively enhanced activation of burst-driven extrasynaptic NMDARs, with an action that was blocked by the NR2B-selective NMDAR antagonist ifenprodil.  Our data suggest that GLYX-13 may have unique therapeutic potential as a learning and memory enhancer because of its ability to simultaneously enhance LTP and suppress LTD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRu93yHBUZTbVg90H21EOLACvtfcHk0ljeg8_1rT6t3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlShurvE&md5=31eaf74a8f163be613619c93cf0fb2cc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DSullivan%26aufirst%3DJ.%2BA.%26aulast%3DMoskal%26aufirst%3DJ.%2BR.%26aulast%3DStanton%26aufirst%3DP.%2BK.%26atitle%3DA%2520NMDA%2520receptor%2520glycine%2520site%2520partial%2520agonist%252C%2520GLYX-13%252C%2520simultaneously%2520enhances%2520LTP%2520and%2520reduces%2520LTD%2520at%2520Schaffer%2520collateral-CA1%2520synapses%2520in%2520hippocampus%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1238%26epage%3D1250%26doi%3D10.1016%2Fj.neuropharm.2008.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moskal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disterhoft, J. F.</span></span> <span> </span><span class="NLM_article-title">GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1087</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuropharm.2005.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=16051282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFehsLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=1077-1087&author=J.+R.+Moskalauthor=A.+G.+Kuoauthor=C.+Weissauthor=P.+L.+Woodauthor=H.+A.+O%E2%80%99Connorauthor=S.+Kelsoauthor=R.+B.+Harrisauthor=J.+F.+Disterhoft&title=GLYX-13%3A+a+monoclonal+antibody-derived+peptide+that+acts+as+an+N-methyl-D-aspartate+receptor+modulator&doi=10.1016%2Fj.neuropharm.2005.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">GLYX-13: A monoclonal antibody-derived peptide that acts as an N-methyl-aspartate receptor modulator</span></div><div class="casAuthors">Moskal, Joseph R.; Kuo, Amy G.; Weiss, Craig; Wood, Paul L.; O'Connor Hanson, Amy; Kelso, Stephen; Harris, Robert B.; Disterhoft, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1077-1087</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We previously created a monoclonal antibody (MAb), B6B21, that acts as a partial agonist at the glycine site of the N-methyl-D-aspartate (NMDA) receptor [Moskal, J.R., Schaffner, A.E., 1986. Monoclonal antibodies to the dentate gyrus: immunocytochem. characterization and flow cytometric anal. of hippocampal neurons bearing a unique cell-surface antigen. J. Neurosci. 6, 2045-2053.].  The hypervariable region of the light chain of B6B21 was cloned and sequenced.  Peptides were then synthesized based on this sequence information and screened using rat hippocampal membrane prepns. to measure [3H]MK-801 binding in the presence of 7-chlorokynurenic acid, a glycine site-specific competitive inhibitor of NMDA receptor [Moskal, J.R., Yamamoto, H., Colley, P.A., 2001. The use of antibody engineering to create novel drugs that target N-methyl-D-aspartate receptors. Curr. Drug Targets 2, 331-345.].  Peptides that were able to increase [3H]MK-801 binding in a dose-dependent manner under these conditions were named Glyxins.  Here we report that GLYX-13, a tetrapeptide (TPPT-amide), was found to readily cross the blood-brain barrier and modulate the NMDA receptor in a glycine-like fashion when examd. pharmacol. and electrophysiol.  When GLYX-13 was administered to rats at 0.5-1.0 mg/kg i.v., a significant enhancement in learning was obsd. using a hippocampus-dependent trace eyeblink conditioning paradigm.  These data indicate that the Glyxins are a new class of NMDA receptor modulators that may have therapeutic potential.  Based on the broad agonist range in vitro and the potent cognitive-enhancing properties in a valid in vivo model of learning, GLYX-13 is a new drug candidate with potential for the treatment of cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6lXatf4j137Vg90H21EOLACvtfcHk0ljeg8_1rT6t3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFehsLzN&md5=ffea1f50f3b57a761fb1ce63e5706664</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DMoskal%26aufirst%3DJ.%2BR.%26aulast%3DKuo%26aufirst%3DA.%2BG.%26aulast%3DWeiss%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DP.%2BL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DH.%2BA.%26aulast%3DKelso%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DR.%2BB.%26aulast%3DDisterhoft%26aufirst%3DJ.%2BF.%26atitle%3DGLYX-13%253A%2520a%2520monoclonal%2520antibody-derived%2520peptide%2520that%2520acts%2520as%2520an%2520N-methyl-D-aspartate%2520receptor%2520modulator%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D1077%26epage%3D1087%26doi%3D10.1016%2Fj.neuropharm.2005.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moskal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgdorf, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroes, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disterhoft, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leander, J. D.</span></span> <span> </span><span class="NLM_article-title">GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1517/13543784.2014.852536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1517%2F13543784.2014.852536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=24251380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFarsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=243-254&author=J.+R.+Moskalauthor=R.+Burchauthor=J.+S.+Burgdorfauthor=R.+A.+Kroesauthor=P.+K.+Stantonauthor=J.+F.+Disterhoftauthor=J.+D.+Leander&title=GLYX-13%2C+an+NMDA+receptor+glycine+site+functional+partial+agonist+enhances+cognition+and+produces+antidepressant+effects+without+the+psychotomimetic+side+effects+of+NMDA+receptor+antagonists&doi=10.1517%2F13543784.2014.852536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists</span></div><div class="casAuthors">Moskal, Joseph R.; Burch, Ronald; Burgdorf, Jeffrey S.; Kroes, Roger A.; Stanton, Patric K.; Disterhoft, John F.; Leander, J. David</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-254</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The N-methyl-D-aspartate receptor-ionophore complex plays a key role in learning and memory and has efficacy in animals and humans with affective disorders.  GLYX-13 is an N-methyl-d-aspartate receptor (NMDAR) glycine-site functional partial agonist and cognitive enhancer that also shows rapid antidepressant activity without psychotomimetic side effects.  Areas covered: The authors review the mechanism of action of GLYX-13 that was investigated in preclin. studies and evaluated in clin. studies.  Specifically, the authors review its pharmacol., pharmacokinetics, and drug safety that were demonstrated in clin. studies.  Expert opinion: NMDAR full antagonists can produce rapid antidepressant effects in treatment-resistant subjects; however, they are often accompanied by psychotomimetic effects that make chronic use outside of a clin. trial inpatient setting problematic.  GLYX-13 appears to exert its antidepressant effects in the frontal cortex via NMDAR-triggered synaptic plasticity.  Understanding the mechanistic underpinning of GLYX-13's antidepressant action should provide both novel insights into the role of the glutamatergic system in depression and identify new targets for therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1qLFmRChVArVg90H21EOLACvtfcHk0liDEonyzNVyTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFarsA%253D%253D&md5=438f7150450c25f13107b9ed359c5a75</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1517%2F13543784.2014.852536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2014.852536%26sid%3Dliteratum%253Aachs%26aulast%3DMoskal%26aufirst%3DJ.%2BR.%26aulast%3DBurch%26aufirst%3DR.%26aulast%3DBurgdorf%26aufirst%3DJ.%2BS.%26aulast%3DKroes%26aufirst%3DR.%2BA.%26aulast%3DStanton%26aufirst%3DP.%2BK.%26aulast%3DDisterhoft%26aufirst%3DJ.%2BF.%26aulast%3DLeander%26aufirst%3DJ.%2BD.%26atitle%3DGLYX-13%252C%2520an%2520NMDA%2520receptor%2520glycine%2520site%2520functional%2520partial%2520agonist%2520enhances%2520cognition%2520and%2520produces%2520antidepressant%2520effects%2520without%2520the%2520psychotomimetic%2520side%2520effects%2520of%2520NMDA%2520receptor%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2014%26volume%3D23%26spage%3D243%26epage%3D254%26doi%3D10.1517%2F13543784.2014.852536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span>Clinicaltrials.gov: NCT03560518; NCT02943577;
NCT02943564; NCT02932943;
NCT03614156; NCT03002077; NCT02951988.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinicaltrials.gov%3A+NCT03560518%3B+NCT02943577%3B%0ANCT02943564%3B+NCT02932943%3B%0ANCT03614156%3B+NCT03002077%3B+NCT02951988."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Allergan</span>.  <i>Data on Allergan’s Rapastinel and NRX-1074 (AGN-241660)
presented at the Society for Neuroscience (SfN) Annual Meeting</i>; <span class="NLM_publisher-name">Allergan</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Allergan&title=Data+on+Allergan%E2%80%99s+Rapastinel+and+NRX-1074+%28AGN-241660%29%0Apresented+at+the+Society+for+Neuroscience+%28SfN%29+Annual+Meeting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DData%2520on%2520Allergan%25E2%2580%2599s%2520Rapastinel%2520and%2520NRX-1074%2520%2528AGN-241660%2529%250Apresented%2520at%2520the%2520Society%2520for%2520Neuroscience%2520%2528SfN%2529%2520Annual%2520Meeting%26pub%3DAllergan%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnell, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapkota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span> <span> </span><span class="NLM_article-title">Positive and negative allosteric modulators of N-methyl-d-aspartate (NMDA) Receptors: structure activity relationships and mechanisms of action</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01640</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01640" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFCntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3-23&author=E.+S.+Burnellauthor=M.+Irvineauthor=G.+Fangauthor=K.+Sapkotaauthor=D.+E.+Janeauthor=D.+T.+Monaghan&title=Positive+and+negative+allosteric+modulators+of+N-methyl-d-aspartate+%28NMDA%29+Receptors%3A+structure+activity+relationships+and+mechanisms+of+action&doi=10.1021%2Facs.jmedchem.7b01640"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Positive and Negative Allosteric Modulators of N-Methyl-D-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action</span></div><div class="casAuthors">Burnell, Erica S.; Irvine, Mark; Fang, Guangyu; Sapkota, Kiran; Jane, David E.; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-23</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Excitatory activity in the CNS is predominately mediated by L-glutamate through several families of L-glutamate neurotransmitter receptors.  Of these, the N-methyl-D-aspartate receptor (NMDAR) family has many crit. roles in CNS function and in various neuropathol. and psychiatric conditions.  Until recently, the types of compds. available to regulate NMDAR function have been quite limited in terms of mechanism of action, subtype selectivity, and biol. effect.  However, several new classes of NMDAR agents have now been identified that are pos. or neg. allosteric modulators (PAMs and NAMs, resp.) with various patterns of NMDAR subtype selectivity.  These new agents act at several newly recognized binding sites on the NMDAR complex and offer significantly greater pharmacol. control over NMDAR activity than previously available agents.  The purpose of this review is to summarize the structure-activity relationships for these new NMDAR modulator drug classes and to describe the current understanding of their mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDN2OGZJwr-LVg90H21EOLACvtfcHk0ljge4qi60S7xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFCntbk%253D&md5=2b9bc7f16ea2b763895334409c6beae0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01640%26sid%3Dliteratum%253Aachs%26aulast%3DBurnell%26aufirst%3DE.%2BS.%26aulast%3DIrvine%26aufirst%3DM.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DSapkota%26aufirst%3DK.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DPositive%2520and%2520negative%2520allosteric%2520modulators%2520of%2520N-methyl-d-aspartate%2520%2528NMDA%2529%2520Receptors%253A%2520structure%2520activity%2520relationships%2520and%2520mechanisms%2520of%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3%26epage%3D23%26doi%3D10.1021%2Facs.jmedchem.7b01640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span> <span> </span><span class="NLM_article-title">Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuint.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=22269804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVOrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=581-592&author=D.+T.+Monaghanauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=G.+Fangauthor=D.+E.+Jane&title=Pharmacological+modulation+of+NMDA+receptor+activity+and+the+advent+of+negative+and+positive+allosteric+modulators&doi=10.1016%2Fj.neuint.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators</span></div><div class="casAuthors">Monaghan, Daniel T.; Irvine, Mark W.; Costa, Blaise Mathias; Fang, Guangyu; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">581-592</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The NMDA receptor (NMDAR) family of l-glutamate receptors are well known to have diverse roles in CNS function as well as in various neuropathol. and psychiatric conditions.  Until recently, the types of agents available to pharmacol. regulate NMDAR function have been quite limited in terms of mechanism of action and subtype selectivity.  This has changed significantly in the past two years.  The purpose of this review is to summarize the many drug classes now available for modulating NMDAR activity.  Previously, this included competitive antagonists at the l-glutamate and glycine binding sites, high and low affinity channel blockers, and GluN2B-selective N-terminal domain binding site antagonists.  More recently, we and others have identified new classes of NMDAR agents that are either pos. or neg. allosteric modulators (PAMs and NAMs, resp.).  These compds. include the pan potentiator UBP646, the GluN2A-selective potentiator/GluN2C and GluN2D inhibitor UBP512, the GluN2D-selective potentiator UBP551, the GluN2C/GluN2D-selective potentiator CIQ as well as the new NMDAR-NAMs such as the pan-inhibitor UBP618, the GluN2C/GluN2D-selective inhibitor QZN46 and the GluN2A inhibitors UBP608 and TCN201.  These new agents do not bind within the l-glutamate or glycine binding sites, the ion channel pore or the N-terminal regulatory domain.  Collectively, these new allosteric modulators appear to be acting at multiple novel sites on the NMDAR complex.  Importantly, these agents display improved subtype-selectivity and as NMDAR PAMs and NAMs, they represent a new generation of potential NMDAR therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbjX9esQoLw7Vg90H21EOLACvtfcHk0ljge4qi60S7xg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVOrsLk%253D&md5=451c3bb058975f210b9936e67079392f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DPharmacological%2520modulation%2520of%2520NMDA%2520receptor%2520activity%2520and%2520the%2520advent%2520of%2520negative%2520and%2520positive%2520allosteric%2520modulators%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26spage%3D581%26epage%3D592%26doi%3D10.1016%2Fj.neuint.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collingridge, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volianskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidball, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolotto, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molńr, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span> <span> </span><span class="NLM_article-title">The NMDA receptor as a target for cognitive enhancement</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuropharm.2012.06.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=22796429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=13-26&author=G.+L.+Collingridgeauthor=A.+Volianskisauthor=N.+Bannisterauthor=G.+Franceauthor=L.+Hannaauthor=M.+Mercierauthor=P.+Tidballauthor=G.+Fangauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=D.+T.+Monaghanauthor=Z.+A.+Bortolottoauthor=E.+Mol%C5%84rauthor=D.+Lodgeauthor=D.+E.+Jane&title=The+NMDA+receptor+as+a+target+for+cognitive+enhancement&doi=10.1016%2Fj.neuropharm.2012.06.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The NMDA receptor as a target for cognitive enhancement</span></div><div class="casAuthors">Collingridge, Graham L.; Volianskis, Arturas; Bannister, Neil; France, Grace; Hanna, Lydia; Mercier, Marion; Tidball, Patrick; Fang, Guangyu; Irvine, Mark W.; Costa, Blaise M.; Monaghan, Daniel T.; Bortolotto, Zuner A.; Molnar, Elek; Lodge, David; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NMDA receptors (NMDARs) play an important role in neural plasticity including long-term potentiation and long-term depression, which are likely to explain their importance for learning and memory.  Cognitive decline is a major problem facing an aging human population, so much so that its reversal has become an important goal for scientific research and pharmaceutical development.  Enhancement of NMDAR function is a core strategy toward this goal.  In this review we indicate some of the major ways of potentiating NMDAR function by both direct and indirect modulation.  There is good evidence that both pos. and neg. modulation can enhance function suggesting that a subtle approach correcting imbalances in particular clin. situations will be required.  Excessive activation and the resultant deleterious effects will need to be carefully avoided.  Finally we describe some novel pos. allosteric modulators of NMDARs, with some subunit selectivity, and show initial evidence of their ability to affect NMDAR mediated events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwosQmB8cQb7Vg90H21EOLACvtfcHk0lgr7j3X0itMhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P&md5=4d63552250a5bb940a8d0a7a2d51fd75</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.051%26sid%3Dliteratum%253Aachs%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DVolianskis%26aufirst%3DA.%26aulast%3DBannister%26aufirst%3DN.%26aulast%3DFrance%26aufirst%3DG.%26aulast%3DHanna%26aufirst%3DL.%26aulast%3DMercier%26aufirst%3DM.%26aulast%3DTidball%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DBortolotto%26aufirst%3DZ.%2BA.%26aulast%3DMol%25C5%2584r%26aufirst%3DE.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DThe%2520NMDA%2520receptor%2520as%2520a%2520target%2520for%2520cognitive%2520enhancement%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D13%26epage%3D26%26doi%3D10.1016%2Fj.neuropharm.2012.06.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malayev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farb, D. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">901</span>– <span class="NLM_lpage">909</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0704543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1038%2Fsj.bjp.0704543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=11861317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1CntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2002&pages=901-909&author=A.+Malayevauthor=T.+T.+Gibbsauthor=D.+H.+Farb&title=Inhibition+of+the+NMDA+response+by+pregnenolone+sulphate+reveals+subtype+selective+modulation+of+NMDA+receptors+by+sulphated+steroids&doi=10.1038%2Fsj.bjp.0704543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids</span></div><div class="casAuthors">Malayev, Andrew; Gibbs, Terrell T.; Farb, David H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">901-909</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The neurosteroid pregnenolone sulfate (PS) potentiates N-methyl-D-aspartate (NMDA) receptor mediated responses in various neuronal prepns.  The NR1 subunit can combine with NR2A, NR2B, NR2C, or NR2D subunits to form functional receptors.  Differential NR2 subunit expression in brain and during development raises the question of how the NR2 subunit influences NMDA receptor modulation by neuroactive steroids.  The authors examd. the effects of PS on the four diheteromeric NMDA receptor subtypes generated by co-expressing the NR1100 subunit with each of the four NR2 subunits in Xenopus oocytes.  Whereas PS potentiated NMDA-, glutamate-, and glycine-induced currents of NR1/NR2A and NR1/NR2B receptors, it was inhibitory at NR1/NR2C and NR1/NR2D receptors.  In contrast, pregnanolone sulfate (3α5βS), a neg. modulator of the NMDA receptor that acts at a distinct site from PS, inhibited all four subtypes, but was approx. 4-fold more potent at NR1/NR2C and NR1/NR2D than at NR1/NR2A and NR1/NR2B receptors.  These findings demonstrate that residues on the NR2 subunit are key determinants of modulation by PS and 3α5βS.  The modulatory effects of PS, but not 3α5βS, on dose-response curves for NMDA, glutamate, and glycine are consistent with a two-state model in which PS either stabilizes or destabilizes the active state of the receptor, depending upon which NR2 subunit is present.  The selectivity of sulfated steroid modulators for NMDA receptors of specific subunit compn. is consistent with a neuromodulatory role for endogenous sulfated steroids.  The results indicate that it may be possible to develop therapeutic agents that target steroid modulatory sites of specific NMDA receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfxjDMjy0jsrVg90H21EOLACvtfcHk0lgr7j3X0itMhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1CntLk%253D&md5=dae9a8ea2c48ecc4fa74140772b00ccb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704543%26sid%3Dliteratum%253Aachs%26aulast%3DMalayev%26aufirst%3DA.%26aulast%3DGibbs%26aufirst%3DT.%2BT.%26aulast%3DFarb%26aufirst%3DD.%2BH.%26atitle%3DInhibition%2520of%2520the%2520NMDA%2520response%2520by%2520pregnenolone%2520sulphate%2520reveals%2520subtype%2520selective%2520modulation%2520of%2520NMDA%2520receptors%2520by%2520sulphated%2520steroids%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D135%26spage%3D901%26epage%3D909%26doi%3D10.1038%2Fsj.bjp.0704543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlcek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chodounska, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyklicky, L.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2005.08.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuroscience.2005.08.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=16257494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2006&pages=93-102&author=M.+Horakauthor=K.+Vlcekauthor=H.+Chodounskaauthor=L.+Vyklicky&title=Subtype-dependence+of+N-methyl-D-aspartate+receptor+modulation+by+pregnenolone+sulfate&doi=10.1016%2Fj.neuroscience.2005.08.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate</span></div><div class="casAuthors">Horak, M.; Vlcek, K.; Chodounska, H.; Vyklicky, L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate receptors play a crit. role in synaptogenesis, synaptic plasticity, and excitotoxicity.  They are heteromeric complexes of NR1 combined with NR2A-D and/or NR3A-B subunits.  The subunit compn. dets. the biophys. and pharmacol. properties of the N-methyl-D-aspartate receptor channel complex.  In this study, the authors report that responses mediated by recombinant rat N-methyl-D-aspartate receptors expressed in human embryonic kidney HEK293 cells are differentially affected by naturally occurring neurosteroid pregnenolone sulfate.  The authors show that responses induced by 1 mM glutamate in NR1-1a/NR2A and NR1-1a/NR2B receptors are potentiated five- to eight-fold more by pregnenolone sulfate than responses of NR1-1a/NR2C and NR1-1a/NR2D receptors with no differences in the concn. of pregnenolone sulfate that produced 50% potentiation.  In addn. to potentiation, pregnenolone sulfate also has an inhibitory effect at recombinant N-methyl-D-aspartate receptors, with values of the concn. of pregnenolone sulfate that produces 50% inhibition of NR1/NR2D=NR1/NR2C<NR1/NR2B<NR1/NR2A.  In addn., the authors show that the structure of the extracellular loop between the third and fourth transmembrane domains of the NR2 subunit is crit. for both the potentiating and inhibitory effects of pregnenolone sulfate.  The modulatory effects of pregnenolone sulfate are consistent with a model in which this neurosteroid acts at two distinct binding sites on the N-methyl-D-aspartate receptor.  These data provide insight into the mechanisms by which pregnenolone sulfate and related sulfated neurosteroids modulate activity of N-methyl-D-aspartate receptor channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9RQ7MIHbT5LVg90H21EOLACvtfcHk0liHbOwbLNhRgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFKitg%253D%253D&md5=479309e4152abd84f6f79d4e566ce7df</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2005.08.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2005.08.058%26sid%3Dliteratum%253Aachs%26aulast%3DHorak%26aufirst%3DM.%26aulast%3DVlcek%26aufirst%3DK.%26aulast%3DChodounska%26aufirst%3DH.%26aulast%3DVyklicky%26aufirst%3DL.%26atitle%3DSubtype-dependence%2520of%2520N-methyl-D-aspartate%2520receptor%2520modulation%2520by%2520pregnenolone%2520sulfate%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D137%26spage%3D93%26epage%3D102%26doi%3D10.1016%2Fj.neuroscience.2005.08.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfort, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linsenbardt, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennerick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorumski, C. F.</span></span> <span> </span><span class="NLM_article-title">The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">17290</span>– <span class="NLM_lpage">17300</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2619-13.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1523%2FJNEUROSCI.2619-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=24174662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjtrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=17290-17300&author=S.+M.+Paulauthor=J.+J.+Dohertyauthor=A.+J.+Robichaudauthor=G.+M.+Belfortauthor=B.+Y.+Chowauthor=R.+S.+Hammondauthor=D.+C.+Crawfordauthor=A.+J.+Linsenbardtauthor=H.+J.+Shuauthor=Y.+Izumiauthor=S.+J.+Mennerickauthor=C.+F.+Zorumski&title=The+major+brain+cholesterol+metabolite+24%28S%29-hydroxycholesterol+is+a+potent+allosteric+modulator+of+N-methyl-D-aspartate+receptors&doi=10.1523%2FJNEUROSCI.2619-13.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors</span></div><div class="casAuthors">Paul, Steven M.; Doherty, James J.; Robichaud, Albert J.; Belfort, Gabriel M.; Chow, Brian Y.; Hammond, Rebecca S.; Crawford, Devon C.; Linsenbardt, Andrew J.; Shu, Hong-Jin; Izumi, Yukitoshi; Mennerick, Steven J.; Zorumski, Charles F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">17290-17300</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels that are crit. to the regulation of excitatory synaptic function in the CNS.  NMDARs govern experience-dependent synaptic plasticity and have been implicated in the pathophysiol. of various neuropsychiatric disorders including the cognitive deficits of schizophrenia and certain forms of autism.  Certain neurosteroids modulate NMDARs exptl. but their low potency, poor selectivity, and very low brain concns. make them poor candidates as endogenous ligands or therapeutic agents.  Here we show that the major brain-derived cholesterol metabolite 24(S)-hydroxycholesterol (24(S)-HC) is a very potent, direct, and selective pos. allosteric modulator of NMDARs with a mechanism that does not overlap that of other allosteric modulators.  At submicromolar concns. 24(S)-HC potentiates NMDAR-mediated EPSCs in rat hippocampal neurons but fails to affect AMPAR or GABAA receptors (GABAARs)-mediated responses.  Cholesterol itself and other naturally occurring oxysterols present in brain do not modulate NMDARs at concns. ≤10 μM.  In hippocampal slices, 24(S)-HC enhances the ability of subthreshold stimuli to induce long-term potentiation (LTP).  24(S)-HC also reverses hippocampal LTP deficits induced by the NMDAR channel blocker ketamine.  Finally, we show that synthetic drug-like derivs. of 24(S)-HC, which potently enhance NMDAR-mediated EPSCs and LTP, restore behavioral and cognitive deficits in rodents treated with NMDAR channel blockers.  Thus, 24(S)-HC may function as an endogenous modulator of NMDARs acting at a novel oxysterol modulatory site that also represents a target for therapeutic drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNdn3JBVmtLVg90H21EOLACvtfcHk0liHbOwbLNhRgQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjtrbI&md5=35ab8bb8030a4ac752f224f8cd942fb4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2619-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2619-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DBelfort%26aufirst%3DG.%2BM.%26aulast%3DChow%26aufirst%3DB.%2BY.%26aulast%3DHammond%26aufirst%3DR.%2BS.%26aulast%3DCrawford%26aufirst%3DD.%2BC.%26aulast%3DLinsenbardt%26aufirst%3DA.%2BJ.%26aulast%3DShu%26aufirst%3DH.%2BJ.%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DMennerick%26aufirst%3DS.%2BJ.%26aulast%3DZorumski%26aufirst%3DC.%2BF.%26atitle%3DThe%2520major%2520brain%2520cholesterol%2520metabolite%252024%2528S%2529-hydroxycholesterol%2520is%2520a%2520potent%2520allosteric%2520modulator%2520of%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D17290%26epage%3D17300%26doi%3D10.1523%2FJNEUROSCI.2619-13.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mony, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, P.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">3134</span>– <span class="NLM_lpage">3146</span>, <span class="refDoi"> DOI: 10.1038/emboj.2011.203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1038%2Femboj.2011.203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=21685875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslSmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=3134-3146&author=L.+Monyauthor=S.+Zhuauthor=S.+Carvalhoauthor=P.+Paoletti&title=Molecular+basis+of+positive+allosteric+modulation+of+GluN2B+NMDA+receptors+by+polyamines&doi=10.1038%2Femboj.2011.203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines</span></div><div class="casAuthors">Mony, Laetitia; Zhu, Shujia; Carvalho, Stephanie; Paoletti, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3134-3146</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">NMDA receptors (NMDARs) form glutamate-gated ion channels that have central roles in neuronal communication and plasticity throughout the brain.  Dysfunctions of NMDARs are involved in several central nervous system disorders, including stroke, chronic pain and schizophrenia.  One hallmark of NMDARs is that their activity can be allosterically regulated by a variety of extracellular small ligands.  While much has been learned recently regarding allosteric inhibition of NMDARs, the structural determinants underlying pos. allosteric modulation of these receptors remain poorly defined.  Polyamines, naturally occurring polycations that selectively enhance NMDARs contg. the GluN2B subunit, bind at a dimer interface between GluN1 and GluN2B subunit N-terminal domains (NTDs).  Polyamines act by shielding neg. charges present on GluN1 and GluN2B NTD lower lobes, allowing their close apposition, an effect that in turn prevents NTD clamshell closure.  The authors' work reveals the mechanistic basis for pos. allosteric modulation of NMDARs.  It provides the first example of an intersubunit binding site in this class of receptors, a discovery that holds promise for future drug interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJznH0dGqqFrVg90H21EOLACvtfcHk0lhI-ScHaQbc8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslSmtbg%253D&md5=fdefbcfe99f7538c90ea3d6d1a0c7c9b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Femboj.2011.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2011.203%26sid%3Dliteratum%253Aachs%26aulast%3DMony%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DCarvalho%26aufirst%3DS.%26aulast%3DPaoletti%26aufirst%3DP.%26atitle%3DMolecular%2520basis%2520of%2520positive%2520allosteric%2520modulation%2520of%2520GluN2B%2520NMDA%2520receptors%2520by%2520polyamines%26jtitle%3DEMBO%2520J.%26date%3D2011%26volume%3D30%26spage%3D3134%26epage%3D3146%26doi%3D10.1038%2Femboj.2011.203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo-Martin, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skifter, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span> <span> </span><span class="NLM_article-title">A novel family of negative and positive allosteric modulators of NMDA receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>335</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.174144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1124%2Fjpet.110.174144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=20858708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=614-621&author=B.+M.+Costaauthor=M.+W.+Irvineauthor=G.+Fangauthor=R.+J.+Eavesauthor=M.+B.+Mayo-Martinauthor=D.+A.+Skifterauthor=D.+E.+Janeauthor=D.+T.+Monaghan&title=A+novel+family+of+negative+and+positive+allosteric+modulators+of+NMDA+receptors&doi=10.1124%2Fjpet.110.174144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A novel family of negative and positive allosteric modulators of NMDA receptors</span></div><div class="casAuthors">Costa, Blaise Mathias; Irvine, Mark W.; Fang, Guangyu; Eaves, Richard J.; Mayo-Martin, Marie Belen; Skifter, Donald A.; Jane, David E.; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-621</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate (NMDA) receptor family regulates various central nervous system functions, such as synaptic plasticity.  However, hypo- or hyperactivation of NMDA receptors is critically involved in many neurol. and psychiatric conditions, such as pain, stroke, epilepsy, neurodegeneration, schizophrenia, and depression.  Consequently, subtype-selective pos. and neg. modulators of NMDA receptor function have many potential therapeutic applications not addressed by currently available compds.  We have identified allosteric modulators with several novel patterns of NMDA receptor subtype selectivity that have a novel mechanism of action.  In a series of carboxylated naphthalene and phenanthrene derivs., compds. were identified that selectively potentiate responses at GluN1/GluN2A [e.g., 9-iodophenanthrene-3-carboxylic acid (UBP512)]; GluN1/GluN2A and GluN1/GluN2B [9-cyclopropylphenanthrene-3-carboxylic acid (UBP710)]; GluN1/GluN2D [3,5-dihydroxynaphthalene-2-carboxylic acid (UBP551)]; or GluN1/GluN2C and GluN1/GluN2D receptors [6-, 7-, 8-, and 9-nitro isomers of naphth[1,2-c][1,2,5]oxadiazole-5-sulfonic acid (NSC339614)] and have no effect or inhibit responses at the other NMDA receptors.  Selective inhibition was also obsd.; UBP512 inhibits only GluN1/GluN2C and GluN1/GluN2D receptors, whereas 6-bromo-2-oxo-2H-chromene-3-carboxylic acid (UBP608) inhibits GluN1/GluN2A receptors with a 23-fold selectivity compared with GluN1/GluN2D receptors.  The actions of these compds. were not competitive with the agonists L-glutamate or glycine and were not voltage-dependent.  Whereas the N-terminal regulatory domain was not necessary for activity of either potentiators or inhibitors, segment 2 of the agonist ligand-binding domain was important for potentiating activity, whereas subtype-specific inhibitory activity was dependent upon segment 1.  In terms of chem. structure, activity profile, and mechanism of action, these modulators represent a new class of pharmacol. agents for the study of NMDA receptor subtype function and provide novel lead compds. for a variety of neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ9F9N6PVoh7Vg90H21EOLACvtfcHk0lhI-ScHaQbc8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI&md5=cefc65523d06856f6dd704274ecb6f22</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.174144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.174144%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DEaves%26aufirst%3DR.%2BJ.%26aulast%3DMayo-Martin%26aufirst%3DM.%2BB.%26aulast%3DSkifter%26aufirst%3DD.%2BA.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DA%2520novel%2520family%2520of%2520negative%2520and%2520positive%2520allosteric%2520modulators%2520of%2520NMDA%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D614%26epage%3D621%26doi%3D10.1124%2Fjpet.110.174144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sapkota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnell, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volianskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culley, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dravid, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collingridge, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span> <span> </span><span class="NLM_article-title">Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuropharm.2017.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=28709671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2htr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=64-79&author=K.+Sapkotaauthor=M.+W.+Irvineauthor=G.+Fangauthor=E.+S.+Burnellauthor=N.+Bannisterauthor=A.+Volianskisauthor=G.+R.+Culleyauthor=S.+M.+Dravidauthor=G.+L.+Collingridgeauthor=D.+E.+Janeauthor=D.+T.+Monaghan&title=Mechanism+and+properties+of+positive+allosteric+modulation+of+N-methyl-d-aspartate+receptors+by+6-alkyl+2-naphthoic+acid+derivatives&doi=10.1016%2Fj.neuropharm.2017.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism and properties of positive allosteric modulation of n-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives</span></div><div class="casAuthors">Sapkota, Kiran; Irvine, Mark W.; Fang, Guangyu; Burnell, Erica S.; Bannister, Neil; Volianskis, Arturas; Culley, Georgia R.; Dravid, Shashank M.; Collingridge, Graham L.; Jane, David E.; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-79</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The theory that N-methyl-D-aspartate receptor (NMDAR) hypofunction is responsible for the symptoms of schizophrenia is well supported by many pharmacol. and genetic studies.  Accordingly, pos. allosteric modulators (PAMs) that augment NMDAR signaling may be useful for treating schizophrenia.  Previously we have identified several NMDAR PAMs contg. a carboxylic acid attached to naphthalene, phenanthrene, or coumarin ring systems.  In this study, we describe several functional and mechanistic properties of UBP684, a 2-naphthoic acid deriv., which robustly potentiates agonist responses at each of the four GluN1a/GluN2 receptors and at neuronal NMDARs.  UBP684 increases the maximal L-glutamate/glycine response while having minor subunit-specific effects on agonist potency.  PAM binding is independent of agonist binding, and PAM activity is independent of membrane voltage, redox state, and the GluN1 exon 5 N-terminal insert.  UBP684 activity is, however, markedly pH-dependent, with greater potentiation occurring at lower pHs and inhibitory activity at pH 8.4.  UBP684 increases channel open probability (Po) and slows receptor deactivation time upon removal of L-glutamate, but not glycine.  The structurally related PAM, UBP753, reproduced most of these findings, but did not prolong agonist removal deactivation time.  Studies using cysteine mutants to lock the GluN1 and GluN2 ligand-binding domains (LBDs) in the agonist-bound states indicate that PAM potentiation requires GluN2 LBD conformational flexibility.  Together, these findings suggest that UBP684 and UBP753 stabilize the GluN2 LBD in an active conformation and thereby increase Po.  Thus, UBP684 and UBP753 may serve as lead compds. for developing agents to enhance NMDAR activity in disorders assocd. with NMDAR hypofunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqtmyAYdoW9rVg90H21EOLACvtfcHk0lhZdLLWoLye8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2htr%252FL&md5=c5ec93c00e1d39fb12593b89f7236572</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DSapkota%26aufirst%3DK.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DBurnell%26aufirst%3DE.%2BS.%26aulast%3DBannister%26aufirst%3DN.%26aulast%3DVolianskis%26aufirst%3DA.%26aulast%3DCulley%26aufirst%3DG.%2BR.%26aulast%3DDravid%26aufirst%3DS.%2BM.%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DMechanism%2520and%2520properties%2520of%2520positive%2520allosteric%2520modulation%2520of%2520N-methyl-d-aspartate%2520receptors%2520by%25206-alkyl%25202-naphthoic%2520acid%2520derivatives%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D125%26spage%3D64%26epage%3D79%26doi%3D10.1016%2Fj.neuropharm.2017.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullasseril, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtkaya, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santangelo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellano, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">90</span>, <span class="refDoi"> DOI: 10.1038/ncomms1085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1038%2Fncomms1085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=20981015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=90&author=P.+Mullasserilauthor=K.+B.+Hansenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=H.+Yuanauthor=N.+L.+Kurtkayaauthor=R.+Santangeloauthor=A.+G.+Orrauthor=P.+Leauthor=K.+M.+Vellanoauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=A+subunit-selective+potentiator+of+NR2C-+and+NR2D-containing+NMDA+receptors&doi=10.1038%2Fncomms1085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span></div><div class="casAuthors">Mullasseril Praseeda; Hansen Kasper B; Vance Katie M; Ogden Kevin K; Yuan Hongjie; Kurtkaya Natalie L; Santangelo Rose; Orr Anna G; Le Phuong; Vellano Kimberly M; Liotta Dennis C; Traynelis Stephen F</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NMDA receptors are tetrameric complexes of NR1 and NR2A-D subunits that mediate excitatory synaptic transmission and have a role in neurological disorders.  In this article, we identify a novel subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit, which could allow selective modification of circuit function in regions expressing NR2C/D subunits.  The substituted tetrahydroisoquinoline CIQ (3-chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone) enhances receptor responses two-fold with an EC(50) of 3 μM by increasing channel opening frequency without altering mean open time or EC(50) values for glutamate or glycine.  The actions of CIQ depend on a single residue in the M1 region (NR2D Thr592) and on the linker between the N-terminal domain and agonist binding domain.  CIQ potentiates native NR2D-containing NMDA receptor currents from subthalamic neurons.  Our identification of a subunit-selective NMDA receptor modulator reveals a new class of pharmacological tools with which to probe the role of NR2C- and NR2D-containing NMDA receptors in brain function and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtyzdcP07UmufW6udTcc2ea70juoSg-yKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D&md5=8cde7c73dc6bf72ea3050c21db4f5ad4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fncomms1085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1085%26sid%3Dliteratum%253Aachs%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DKurtkaya%26aufirst%3DN.%2BL.%26aulast%3DSantangelo%26aufirst%3DR.%26aulast%3DOrr%26aufirst%3DA.%2BG.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DVellano%26aufirst%3DK.%2BM.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DA%2520subunit-selective%2520potentiator%2520of%2520NR2C-%2520and%2520NR2D-containing%2520NMDA%2520receptors%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D90%26doi%3D10.1038%2Fncomms1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanger, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1124/mol.114.094516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1124%2Fmol.114.094516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=25205677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSlur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=548-560&author=A.+Khatriauthor=P.+B.+Burgerauthor=S.+A.+Swangerauthor=K.+B.+Hansenauthor=S.+Zimmermanauthor=E.+Karakasauthor=D.+C.+Liottaauthor=H.+Furukawaauthor=J.+P.+Snyderauthor=S.+F.+Traynelis&title=Structural+determinants+and+mechanism+of+action+of+a+GluN2C-selective+NMDA+receptor+positive+allosteric+modulator&doi=10.1124%2Fmol.114.094516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator</span></div><div class="casAuthors">Khatri, Alpa; Burger, Pieter B.; Swanger, Sharon A.; Hansen, Kasper B.; Zimmerman, Sommer; Karakas, Erkan; Liotta, Dennis C.; Furukawa, Hiro; Snyder, James P.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">548-560, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NMDA receptors are tetrameric complexes of GluN1, GluN2A-D, and GluN3A-B subunits and are involved in normal brain function and neurol. disorders.  We identified a novel class of stereoselective pyrrolidinone (PYD) pos. allosteric modulators for GluN2C-contg. NMDA receptors, exemplified by Me 4-(3-acetyl-4-hydroxy-1-[2-(2-methyl-1H-indol-3-yl)ethyl]-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)benzoate.  Here we explore the site and mechanism of action of a prototypical analog, PYD-106, which at 30 μM does not alter responses of NMDA receptors contg. GluN2A, GluN2B, and GluN2D and has no effect on AMPA [α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid] and kainate receptors.  Coapplication of 50 μM PYD-106 with a maximally effective concn. of glutamate and glycine increases the response of GluN1/GluN2C NMDA receptors in HEK-293 cells to 221% of that obtained in the absence of PYD (taken as 100%).  Evaluation of the concn. dependence of this enhancement revealed an EC50 value for PYD of 13 μM.  PYD-106 increased opening frequency and open time of single channel currents activated by maximally effective concns. of agonist but only had modest effects on glutamate and glycine EC50.  PYD-106 selectively enhanced the responses of diheteromeric GluN1/GluN2C receptors but not triheteromeric GluN1/GluN2A/GluN2C receptors.  Inclusion of residues encoded by GluN1-exon 5 attenuated the effects of PYD.  Three GluN2C residues (Arg194, Ser470, Lys470), at which mutagenesis virtually eliminated PYD function, line a cavity at the interface of the ligand binding and the amino terminal domains in a homol. model of GluN1/GluN2C built from crystallog. data on GluN1/GluN2B.  We propose that this domain interface constitutes a new allosteric modulatory site on the NMDA receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO8Jlk1LXDrrVg90H21EOLACvtfcHk0lhJa6njZHtn-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSlur3F&md5=ebc48a2c667046b1adab7037868278e1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.094516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.094516%26sid%3Dliteratum%253Aachs%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DBurger%26aufirst%3DP.%2BB.%26aulast%3DSwanger%26aufirst%3DS.%2BA.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DZimmerman%26aufirst%3DS.%26aulast%3DKarakas%26aufirst%3DE.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DFurukawa%26aufirst%3DH.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DStructural%2520determinants%2520and%2520mechanism%2520of%2520action%2520of%2520a%2520GluN2C-selective%2520NMDA%2520receptor%2520positive%2520allosteric%2520modulator%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26spage%3D548%26epage%3D560%26doi%3D10.1124%2Fmol.114.094516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span> <span> </span><span class="NLM_article-title">Positive allosteric modulators of GluN2A-containing NMDARs with distinct modes of action and impacts on circuit function</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">983</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2016.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuron.2016.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=26875626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=983-999&author=D.+H.+Hackosauthor=P.+J.+Lupardusauthor=T.+Grandauthor=Y.+Chenauthor=T.-M.+Wangauthor=P.+Reynenauthor=A.+Gustafsonauthor=H.+J.+Wallweberauthor=M.+Volgrafauthor=B.+D.+Sellersauthor=J.+B.+Schwarzauthor=P.+Paolettiauthor=M.+Shengauthor=Q.+Zhouauthor=J.+E.+Hanson&title=Positive+allosteric+modulators+of+GluN2A-containing+NMDARs+with+distinct+modes+of+action+and+impacts+on+circuit+function&doi=10.1016%2Fj.neuron.2016.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function</span></div><div class="casAuthors">Hackos, David H.; Lupardus, Patrick J.; Grand, Teddy; Chen, Yelin; Wang, Tzu-Ming; Reynen, Paul; Gustafson, Amy; Wallweber, Heidi J. A.; Volgraf, Matthew; Sellers, Benjamin D.; Schwarz, Jacob B.; Paoletti, Pierre; Sheng, Morgan; Zhou, Qiang; Hanson, Jesse E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">983-999</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To enhance physiol. function of NMDA receptors (NMDARs), we identified pos. allosteric modulators (PAMs) of NMDARs with selectivity for GluN2A subunit-contg. receptors.  X-ray crystallog. revealed a binding site at the GluN1-GluN2A dimer interface of the extracellular ligand-binding domains (LBDs).  Despite the similarity between the LBDs of NMDARs and AMPA receptors (AMPARs), GluN2A PAMs with good selectivity against AMPARs were identified.  Potentiation was obsd. with recombinant triheteromeric GluN1/GluN2A/GluN2B NMDARs and with synaptically activated NMDARs in brain slices from wild-type (WT), but not GluN2A knockout (KO), mice.  Individual GluN2A PAMs exhibited variable degrees of glutamate (Glu) dependence, impact on NMDAR Glu EC50, and slowing of channel deactivation.  These distinct PAMs also exhibited differential impacts during synaptic plasticity induction.  The identification of a new NMDAR modulatory site and characterization of GluN2A-selective PAMs provide powerful mol. tools to dissect NMDAR function and demonstrate the feasibility of a therapeutically desirable type of NMDAR enhancement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGros48fNAsozLVg90H21EOLACvtfcHk0lhJa6njZHtn-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSrtbw%253D&md5=38661a9f898df39ba616e77f0bdf34e9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DGrand%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.-M.%26aulast%3DReynen%26aufirst%3DP.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DSheng%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520GluN2A-containing%2520NMDARs%2520with%2520distinct%2520modes%2520of%2520action%2520and%2520impacts%2520on%2520circuit%2520function%26jtitle%3DNeuron%26date%3D2016%26volume%3D89%26spage%3D983%26epage%3D999%26doi%3D10.1016%2Fj.neuron.2016.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villemure, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirksen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietz, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ScearceLevie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of GluN2A-selective NMDA receptor positive allosteric modulators (PAMs): tuning deactivation kinetics via structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2760</span>– <span class="NLM_lpage">2779</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b02010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b02010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1ynt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2760-2779&author=M.+Volgrafauthor=B.+D.+Sellersauthor=Y.+Jiangauthor=G.+Wuauthor=C.+Q.+Lyauthor=E.+Villemureauthor=R.+M.+Pastorauthor=P.+W.+Yuenauthor=A.+Luauthor=X.+Luoauthor=M.+Liuauthor=S.+Zhangauthor=L.+Sunauthor=Y.+Fuauthor=P.+J.+Lupardusauthor=H.+J.+Wallweberauthor=B.+M.+Liedererauthor=G.+Deshmukhauthor=E.+Pliseauthor=S.+Tayauthor=P.+Reynenauthor=J.+Herringtonauthor=A.+Gustafsonauthor=Y.+Liuauthor=A.+Dirksenauthor=M.+G.+Dietzauthor=Y.+Liuauthor=T.+M.+Wangauthor=J.+E.+Hansonauthor=D.+Hackosauthor=K.+ScearceLevieauthor=J.+B.+Schwarz&title=Discovery+of+GluN2A-selective+NMDA+receptor+positive+allosteric+modulators+%28PAMs%29%3A+tuning+deactivation+kinetics+via+structure-based+design&doi=10.1021%2Facs.jmedchem.5b02010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design</span></div><div class="casAuthors">Volgraf, Matthew; Sellers, Benjamin D.; Jiang, Yu; Wu, Guosheng; Ly, Cuong Q.; Villemure, Elisia; Pastor, Richard M.; Yuen, Po-wai; Lu, Aijun; Luo, Xifeng; Liu, Mingcui; Zhang, Shun; Sun, Liang; Fu, Yuhong; Lupardus, Patrick J.; Wallweber, Heidi J. A.; Liederer, Bianca M.; Deshmukh, Gauri; Plise, Emile; Tay, Suzanne; Reynen, Paul; Herrington, James; Gustafson, Amy; Liu, Yichin; Dirksen, Akim; Dietz, Matthias G. A.; Liu, Yanzhou; Wang, Tzu-Ming; Hanson, Jesse E.; Hackos, David; Scearce-Levie, Kimberly; Schwarz, Jacob B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2760-2779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate receptor (NMDAR) is a Na+ and Ca2+ permeable ionotropic glutamate receptor that is activated by the coagonists glycine and glutamate.  NMDARs are crit. to synaptic signaling and plasticity, and their dysfunction has been implicated in a no. of neurol. disorders, including schizophrenia, depression, and Alzheimer's disease.  Herein we describe the discovery of potent GluN2A-selective NMDAR pos. allosteric modulators (PAMs) starting from a high-throughput screening hit.  Using structure-based design, we sought to increase potency at the GluN2A subtype, while improving selectivity against related α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs).  The structure-activity relationship of channel deactivation kinetics was studied using a combination of electrophysiol. and protein crystallog.  Effective incorporation of these strategies resulted in the discovery of GNE-0723 (46), a highly potent and brain penetrant GluN2A-selective NMDAR PAM suitable for in vivo characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdza-qdjBnZbVg90H21EOLACvtfcHk0ljt7aD95cay6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1ynt70%253D&md5=2d9f7199cd3d9d9ac513006612e9bb01</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b02010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b02010%26sid%3Dliteratum%253Aachs%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DVillemure%26aufirst%3DE.%26aulast%3DPastor%26aufirst%3DR.%2BM.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DReynen%26aufirst%3DP.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDirksen%26aufirst%3DA.%26aulast%3DDietz%26aufirst%3DM.%2BG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.%2BM.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26aulast%3DHackos%26aufirst%3DD.%26aulast%3DScearceLevie%26aufirst%3DK.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520GluN2A-selective%2520NMDA%2520receptor%2520positive%2520allosteric%2520modulators%2520%2528PAMs%2529%253A%2520tuning%2520deactivation%2520kinetics%2520via%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2760%26epage%3D2779%26doi%3D10.1021%2Facs.jmedchem.5b02010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemure, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, P.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span> <span> </span><span class="NLM_article-title">GluN2A-Selective pyridopyrimidinone series of NMDAR positive allosteric modulators with an improved <i>in vivo</i> profile</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00388</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00388" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=84-89&author=E.+Villemureauthor=M.+Volgrafauthor=Y.+Jiangauthor=G.+Wuauthor=C.+Q.+Lyauthor=P.-w.+Yuenauthor=A.+Luauthor=X.+Luoauthor=M.+Liuauthor=S.+Zhangauthor=P.+J.+Lupardusauthor=H.+J.+Wallweberauthor=B.+M.+Liedererauthor=G.+Deshmukhauthor=E.+Pliseauthor=S.+Tayauthor=T.-M.+Wangauthor=J.+E.+Hansonauthor=D.+H.+Hackosauthor=K.+Scearce-Levieauthor=J.+B.+Schwarzauthor=B.+D.+Sellers&title=GluN2A-Selective+pyridopyrimidinone+series+of+NMDAR+positive+allosteric+modulators+with+an+improved+in+vivo+profile&doi=10.1021%2Facsmedchemlett.6b00388"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00388%26sid%3Dliteratum%253Aachs%26aulast%3DVillemure%26aufirst%3DE.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DYuen%26aufirst%3DP.-w.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.-M.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26atitle%3DGluN2A-Selective%2520pyridopyrimidinone%2520series%2520of%2520NMDAR%2520positive%2520allosteric%2520modulators%2520with%2520an%2520improved%2520in%2520vivo%2520profile%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D8%26spage%3D84%26epage%3D89%26doi%3D10.1021%2Facsmedchemlett.6b00388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perszyk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzman, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kell, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epplin, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahirovic, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menaldino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e34711</span> <span class="refDoi"> DOI: 10.7554/eLife.34711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.7554%2FeLife.34711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=29792594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlyqtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&author=R.+Perszykauthor=B.+M.+Katzmanauthor=H.+Kusumotoauthor=S.+A.+Kellauthor=M.+P.+Epplinauthor=Y.+A.+Tahirovicauthor=R.+L.+Mooreauthor=D.+Menaldinoauthor=P.+Burgerauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=An+NMDAR+positive+and+negative+allosteric+modulator+series+share+a+binding+site+and+are+interconverted+by+methyl+groups&doi=10.7554%2FeLife.34711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups</span></div><div class="casAuthors">Perszyk, Riley; Katzman, Brooke M.; Kusumoto, Hirofumi; Kell, Steven A.; Epplin, Matthew P.; Tahirovic, Yesim A.; Moore, Rhonda L.; Menaldino, David; Burger, Pieter; Liotta, Dennis C.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e34711/1-e34711/37</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate receptors (NMDARs) are an important receptor in the brain and have been implicated in multiple neurol. disorders.  Many non-selective NMDAR-targeting drugs are poorly tolerated, leading to efforts to target NMDAR subtypes to improve the therapeutic index.  We describe here a series of neg. allosteric NMDAR modulators with submaximal inhibition at satg. concns.  Modest changes to the chem. structure interconvert neg. and pos. modulation.  All modulators share the ability to enhance agonist potency and are use-dependent, requiring the binding of both agonists before modulators act with high potency.  Data suggest that these modulators, including both enantiomers, bind to the same site on the receptor and share structural determinants of action.  Due to the modulator properties, submaximal neg. modulators in this series may spare NMDAR at the synapse, while augmenting the response of NMDAR in extrasynaptic spaces.  These modulators could serve as useful tools to probe the role of extrasynaptic NMDARs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKDjnf2F9Q17Vg90H21EOLACvtfcHk0lhCRoTxXhzg1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlyqtrzM&md5=fc150a9e282d0a5ea34e697e1d43bcfe</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.7554%2FeLife.34711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.34711%26sid%3Dliteratum%253Aachs%26aulast%3DPerszyk%26aufirst%3DR.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DKusumoto%26aufirst%3DH.%26aulast%3DKell%26aufirst%3DS.%2BA.%26aulast%3DEpplin%26aufirst%3DM.%2BP.%26aulast%3DTahirovic%26aufirst%3DY.%2BA.%26aulast%3DMoore%26aufirst%3DR.%2BL.%26aulast%3DMenaldino%26aufirst%3DD.%26aulast%3DBurger%26aufirst%3DP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DAn%2520NMDAR%2520positive%2520and%2520negative%2520allosteric%2520modulator%2520series%2520share%2520a%2520binding%2520site%2520and%2520are%2520interconverted%2520by%2520methyl%2520groups%26jtitle%3DeLife%26date%3D2018%26volume%3D7%26doi%3D10.7554%2FeLife.34711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0liJVMfOYsmW1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, R. O.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molliver, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, S. H.</span></span> <span> </span><span class="NLM_article-title">D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1604</span>– <span class="NLM_lpage">1615</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.17-05-01604.1997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1523%2FJNEUROSCI.17-05-01604.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=9030620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaK2sXhtlOmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=1604-1615&author=M.+J.+Schellauthor=R.+O.+Bradyauthor=M.+E.+Molliverauthor=S.+H.+Snyder&title=D-serine+as+a+neuromodulator%3A+regional+and+developmental+localizations+in+rat+brain+glia+resemble+NMDA+receptors&doi=10.1523%2FJNEUROSCI.17-05-01604.1997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors</span></div><div class="casAuthors">Schell, Michael J.; Brady, Roscoe O., Jr.; Molliver, Mark E.; Snyder, Solomon H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1604-1615</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">D-Serine is localized in mammalian brain to a discrete population of glial cells near NMDA receptors, suggesting that D-serine is an endogenous agonist of the receptor-assocd. glycine site.  To explore this possibility, the authors have compared the immunohistochem. localizations of D-serine, glycine, and NMDA receptors in rat brain.  In the telencephalon, D-serine is concd. in protoplasmic astrocytes, which are abundant in neuropil in close vicinity to NMDA receptor 2A/B subunits.  Ultrastructural examn. of the CA1 region of hippocampus reveals D-serine in the cytosolic matrix of astrocytes that ensheath neurons and blood vessels, whereas, NR2A/B is concd. in dendritic spines.  By contrast, glycine immunore-activity in telencephalon is the lowest in brain.  During postnatal week 2, D-serine levels in cerebellum are comparable to those in adult cerebral cortex but fall to undetectable levels by day 26.  During week 2, the authors observe parallel ontogeny of D-serine in Bergmann glia and NR2A/B in Purkinje cells, suggesting a role for astrocytic D-serine in NMDA receptor-mediated synaptogenesis.  D-Serine in the radial processes of Bergmann glia is also well positioned to regulate NMDA receptor-dependent granule cell migration.  In the inner granule layer, D-serine is found transiently in protoplasmic astrocytes surrounding glomeruli, where it could regulate development of the mossy fiber/granule cell synapse.  D-Serine seems to be the endogenous ligand of glycine sites in the telencephalon and developing cerebellum, whereas glycine predominates in the adult cerebellum, olfactory bulb, and hindbrain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZcgf__hbuOrVg90H21EOLACvtfcHk0liJVMfOYsmW1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtlOmsrY%253D&md5=9c4f92beca536383322b27867f25da66</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.17-05-01604.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.17-05-01604.1997%26sid%3Dliteratum%253Aachs%26aulast%3DSchell%26aufirst%3DM.%2BJ.%26aulast%3DBrady%26aufirst%3DR.%2BO.%26aulast%3DMolliver%26aufirst%3DM.%2BE.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DD-serine%2520as%2520a%2520neuromodulator%253A%2520regional%2520and%2520developmental%2520localizations%2520in%2520rat%2520brain%2520glia%2520resemble%2520NMDA%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D1997%26volume%3D17%26spage%3D1604%26epage%3D1615%26doi%3D10.1523%2FJNEUROSCI.17-05-01604.1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kartvelishvily, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shleper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolosker, H.</span></span> <span> </span><span class="NLM_article-title">Neuron-derived D-serine release provides a novel means to activate N-methyl-D-aspartate receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">14151</span>– <span class="NLM_lpage">14162</span>, <span class="refDoi"> DOI: 10.1074/jbc.M512927200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1074%2Fjbc.M512927200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=16551623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFeisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=14151-14162&author=E.+Kartvelishvilyauthor=M.+Shleperauthor=L.+Balanauthor=E.+Duminauthor=H.+Wolosker&title=Neuron-derived+D-serine+release+provides+a+novel+means+to+activate+N-methyl-D-aspartate+receptors&doi=10.1074%2Fjbc.M512927200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Neuron-derived D-Serine Release Provides a Novel Means to Activate N-Methyl-D-aspartate Receptors</span></div><div class="casAuthors">Kartvelishvily, Elena; Shleper, Maria; Balan, Livia; Dumin, Elena; Wolosker, Herman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">14151-14162</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">D-Serine is a coagonist of N-methyl-D-aspartate (NMDA) receptors that occurs at high levels in the brain.  Biosynthesis of D-serine is carried out by serine racemase, which converts L-to D-serine.  D-Serine has been demonstrated to occur in glial cells, leading to the proposal that astrocytes are the only source of D-serine.  The authors now report significant amts. of serine racemase and D-serine in primary neuronal cultures and neurons in vivo.  Several neuronal culture types expressed serine racemase, and D-serine synthesis was comparable with that in glial cultures.  Immunohistochem. staining of brain sections with new antibodies revealed the presence of serine racemase and D-serine in neurons.  Cortical neurons expressing serine racemase also expressed the NR2a subunit in situ.  Neuron-derived D-serine contributes to NMDA receptor activation in cortical neuronal cultures.  Degrdn. of endogenous D-serine by addn. of the recombinant enzyme D-serine deaminase diminished NMDA-elicited excitotoxicity.  Release of neuronal D-serine was mediated by ionotropic glutamate receptor agonists such as NMDA, α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid, and kainate.  Removal of either external Ca2+ or Na+ blocked D-serine release.  Release of D-serine was mostly through a cytosolic route because it was insensitive to bafilomycin A1, a potent inhibitor of vesicular neurotransmitter uptake.  D-Serine was also not transported into purified synaptic vesicles under conditions optimal for the uptake of known transmitters.  The authors' results suggest that neurons are a major source of D-serine.  Glutamate-induced neuronal D-serine release provides a novel mechanism for activating NMDA receptors by an autocrine or paracrine way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtkYIUvWVLsLVg90H21EOLACvtfcHk0lhpls9C8WeAEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFeisLo%253D&md5=2cabb656cd09b55e9a150749f0adb0a5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M512927200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M512927200%26sid%3Dliteratum%253Aachs%26aulast%3DKartvelishvily%26aufirst%3DE.%26aulast%3DShleper%26aufirst%3DM.%26aulast%3DBalan%26aufirst%3DL.%26aulast%3DDumin%26aufirst%3DE.%26aulast%3DWolosker%26aufirst%3DH.%26atitle%3DNeuron-derived%2520D-serine%2520release%2520provides%2520a%2520novel%2520means%2520to%2520activate%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D14151%26epage%3D14162%26doi%3D10.1074%2Fjbc.M512927200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balu, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. T.</span></span> <span> </span><span class="NLM_article-title">Astrocytes in primary cultures express serine racemase, synthesize d-serine and acquire A1 reactive astrocyte features</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.bcp.2017.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=29305854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslKgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2018&pages=245-251&author=S.+Liauthor=Y.+Unoauthor=U.+Rudolphauthor=J.+Cobbauthor=J.+Liuauthor=T.+Andersonauthor=D.+Levyauthor=D.+T.+Baluauthor=J.+T.+Coyle&title=Astrocytes+in+primary+cultures+express+serine+racemase%2C+synthesize+d-serine+and+acquire+A1+reactive+astrocyte+features&doi=10.1016%2Fj.bcp.2017.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Astrocytes in primary cultures express serine racemase, synthesize D-serine and acquire A1 reactive astrocyte features</span></div><div class="casAuthors">Li, Suyan; Uno, Yota; Rudolph, Uwe; Cobb, Johanna; Liu, Jing; Anderson, Thea; Levy, Deborah; Balu, Darrick T.; Coyle, Joseph T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245-251</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">D-Serine is a co-agonist at forebrain N-methyl-D-aspartate receptors (NMDAR) and is synthesized by serine racemase (SR).  Although D-serine and SR were originally reported to be localized to glia, recent studies have provided compelling evidence that under healthy physiol. conditions both are localized primarily in neurons.  However, in pathol. conditions, reactive astrocytes can also express SR and synthesize D-serine.  Since cultured astrocytes exhibit features of reactive astrocytes, we have characterized D-serine synthesis and the expression of enzymes involved in its disposition in primary glial cultures.  The levels of SR were quite low early in culture and increased markedly in all astrocytes with the duration in vitro.  The concn. of D-serine in the culture medium increased in parallel with SR expression in the astrocytes.  Microglia, identified by robust expression of Iba1, did not express SR.  While the levels of glial fibrillary acidic protein (GFAP), glycine decarboxylase (GLDC) and phosphoglycerate dehydrogenase (PHGDH), the initial enzyme in the pathway converting glycine to L-serine, remained const. in culture, the expression of lipocalin-2, a marker for pan-reactive astrocytes, increased several-fold.  The cultured astrocytes also expressed Complement-C3a, a marker for a subpopulation of reactive astrocytes (A1).  Astrocytes grown from mice with a copy no. variant assocd. with psychosis, which have four copies of the GLDC gene, showed a more rapid prodn. of D-serine and a redn. in glycine in the culture medium.  These results substantiate the conclusion that A1 reactive astrocytes express SR and release D-serine under pathol. conditions, which may contribute to their neurotoxic effects by activating extra-synaptic NMDARs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwIDj_YSoGobVg90H21EOLACvtfcHk0lhpls9C8WeAEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslKgsA%253D%253D&md5=9ae885e6aa789aa1a423793c7921a8f8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DUno%26aufirst%3DY.%26aulast%3DRudolph%26aufirst%3DU.%26aulast%3DCobb%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DT.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DBalu%26aufirst%3DD.%2BT.%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26atitle%3DAstrocytes%2520in%2520primary%2520cultures%2520express%2520serine%2520racemase%252C%2520synthesize%2520d-serine%2520and%2520acquire%2520A1%2520reactive%2520astrocyte%2520features%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D151%26spage%3D245%26epage%3D251%26doi%3D10.1016%2Fj.bcp.2017.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Chromodomain Y-like protein-mediated histone crotonylation regulates stress-induced depressive behaviors</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2018.11.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.biopsych.2018.11.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=30665597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2019&pages=635-649&author=Y.+Liuauthor=M.+Liauthor=M.+Fanauthor=Y.+Songauthor=H.+Yuauthor=X.+Zhiauthor=K.+Xiaoauthor=S.+Laiauthor=J.+Zhangauthor=X.+Jinauthor=Y.+Shangauthor=J.+Liangauthor=Z.+Huang&title=Chromodomain+Y-like+protein-mediated+histone+crotonylation+regulates+stress-induced+depressive+behaviors&doi=10.1016%2Fj.biopsych.2018.11.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Chromodomain Y-like Protein-Mediated Histone Crotonylation Regulates Stress-Induced Depressive Behaviors</span></div><div class="casAuthors">Liu, Yongqing; Li, Minghua; Fan, Minghua; Song, Yan; Yu, Huajing; Zhi, Xiaojie; Xiao, Kuo; Lai, Shirong; Zhang, Jingliang; Jin, Xueqin; Shang, Yongfeng; Liang, Jing; Huang, Zhuo</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">635-649</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Major depressive disorder is a prevalent and life-threatening illness in modern society.  The susceptibility to major depressive disorder is profoundly influenced by environmental factors, such as stressful lifestyle or traumatic events, which could impose maladaptive transcriptional program through epigenetic regulation.  However, the underlying mol. mechanisms remain elusive.  Here, we examd. the role of histone crotonylation, a novel type of histone modification, and chromodomain Y-like protein (CDYL), a crotonyl-CoA hydratase and histone methyllysine reader, in this process.  We used chronic social defeat stress and microdefeat stress to examine the depressive behaviors.  In addn., we combined procedures that diagnose behavioral strategy in male mice with histone extn., viral-mediated CDYL manipulations, RNA sequencing, chromatin immunopptn., Western blot, and mRNA quantification.  The results indicate that stress-susceptible rodents exhibit lower levels of histone crotonylation in the medial prefrontal cortex concurrent with selective upregulation of CDYL.  Overexpression of CDYL in the prelimbic cortex, a subregion of the medial prefrontal cortex, increases microdefeat-induced social avoidance behaviors and anhedonia in mice.  Conversely, knockdown of CDYL in the prelimbic cortex prevents chronic social defeat stress-induced depression-like behaviors.  Mechanistically, we show that CDYL inhibits structural synaptic plasticity mainly by transcriptional repression of neuropeptide VGF nerve growth factor inducible, and this activity is dependent on its dual effect on histone crotonylation and H3K27 trimethylation on the VGF promoter.  Our results demonstrate that CDYL-mediated histone crotonylation plays a crit. role in regulating stress-induced depression, providing a potential therapeutic target for major depressive disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5ON7xmtkLJrVg90H21EOLACvtfcHk0liXNBcASASKXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyrtrc%253D&md5=24fe3342df22401e6178ffde37667c13</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2018.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2018.11.025%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZhi%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DShang%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DChromodomain%2520Y-like%2520protein-mediated%2520histone%2520crotonylation%2520regulates%2520stress-induced%2520depressive%2520behaviors%26jtitle%3DBiol.%2520Psychiatry%26date%3D2019%26volume%3D85%26spage%3D635%26epage%3D649%26doi%3D10.1016%2Fj.biopsych.2018.11.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of fused tricyclic heterocycle piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">10017</span>– <span class="NLM_lpage">10039</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01096</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01096" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyju7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10017-10039&author=X.+Caoauthor=Y.+Zhangauthor=Y.+Chenauthor=Y.+Qiuauthor=M.+Yuauthor=X.+Xuauthor=X.+Liuauthor=B.+F.+Liuauthor=L.+Zhangauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+fused+tricyclic+heterocycle+piperazine+%28piperidine%29+derivatives+as+potential+multireceptor+atypical+antipsychotics&doi=10.1021%2Facs.jmedchem.8b01096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics</span></div><div class="casAuthors">Cao, Xudong; Zhang, Yifang; Chen, Yin; Qiu, Yinli; Yu, Minquan; Xu, Xiangqing; Liu, Xin; Liu, Bi-Feng; Zhang, Liangren; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10017-10039</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, a novel series of multireceptor ligands was developed as polypharmacol. antipsychotic agents using the designed multiple ligand approach between dopamine receptors and serotonin receptors.  Among them, compd. I possessed unique pharmacol. features, exhibiting high affinities for D2, D3, 5-HT1A, 5-HT2A, and 5-HT6 receptors and low efficacy at the off-target receptors (5-HT2C, histamine H1, and adrenergic α1 receptor).  Compd. I showed dose-dependent inhibition of apomorphine- and MK-801-induced motor behavior, and the conditioned avoidance response with low cataleptic effect.  Moreover, compd. I resulted nonsignificantly serum prolactin levels and wt. gain change compared with risperidone.  Addnl., compd. I possessed a favorable pharmacokinetic profile with oral bioavailability of 58.8% in rats.  Furthermore, compd. I displayed procognition properties in a novel object recognition task in rats.  Taken together, compd. I may constitute a novel class of atypical antipsychotic drugs for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowt81tvRDharVg90H21EOLACvtfcHk0liXNBcASASKXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyju7bI&md5=a75cb3491503c106d136f8a8c71ecc1a</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01096%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520fused%2520tricyclic%2520heterocycle%2520piperazine%2520%2528piperidine%2529%2520derivatives%2520as%2520potential%2520multireceptor%2520atypical%2520antipsychotics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D10017%26epage%3D10039%26doi%3D10.1021%2Facs.jmedchem.8b01096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit41b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4671</span>– <span class="NLM_lpage">4690</span>, <span class="refDoi"> DOI: 10.1021/jm400408r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400408r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslWmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4671-4690&author=Y.+Chenauthor=S.+Wangauthor=X.+Xuauthor=X.+Liuauthor=M.+Yuauthor=S.+Zhaoauthor=S.+Liuauthor=Y.+Qiuauthor=T.+Zhangauthor=B.+F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+investigation+of+coumarin+piperazine+%28piperidine%29+derivatives+as+potential+multireceptor+atypical+antipsychotics&doi=10.1021%2Fjm400408r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Investigation of Coumarin Piperazine (Piperidine) Derivatives as Potential Multireceptor Atypical Antipsychotics</span></div><div class="casAuthors">Chen, Yin; Wang, Songlin; Xu, Xiangqing; Liu, Xin; Yu, Minquan; Zhao, Song; Liu, Shicheng; Qiu, Yinli; Zhang, Tan; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4671-4690</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery and synthesis of potential and novel antipsychotic coumarin derivs., assocd. with potent dopamine D2, D3, and serotonin 5-HT1A and 5-HT2A receptor properties, are the focus of the present article.  The most-promising deriv. was 7-(4-(4-(6-fluorobenzo[d]isoxazol-3-yl)-piperidin-1-yl)butoxy)-4-methyl-8-chloro-2H-chromen-2-one (I).  This deriv. possesses unique pharmacol. features, including high affinity for dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors.  Moreover, it possesses low affinity for 5-HT2C and H1 receptors (to reduce the risk of obesity assocd. with chronic treatment) and hERG channels (to reduce the incidence of torsade de pointes).  In animal models, compd. I inhibited apomorphine-induced climbing behavior, MK-801-induced hyperactivity, and the conditioned avoidance response without observable catalepsy at the highest dose tested.  Further, fewer preclin. adverse events were noted with I compared with risperidone in assays that measured prolactin secretion and wt. gain.  Acceptable pharmacokinetic properties were also noted with I.  Taken together, I may constitute a novel class of drugs for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoByJHAgVuYCLVg90H21EOLACvtfcHk0li_EJ1dCaFnKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslWmtbw%253D&md5=5862884cd1ca8f74276d266757689334</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1021%2Fjm400408r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400408r%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520investigation%2520of%2520coumarin%2520piperazine%2520%2528piperidine%2529%2520derivatives%2520as%2520potential%2520multireceptor%2520atypical%2520antipsychotics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4671%26epage%3D4690%26doi%3D10.1021%2Fjm400408r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit41c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new 6-hydroxypyridazinone benzisoxazoles: Potential multi-receptor targeting atypical antipsychotics</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">713</span>– <span class="NLM_lpage">728</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.ejmech.2016.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=27639363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFentrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=713-728&author=X.+Caoauthor=Y.+Chenauthor=Y.+Zhangauthor=Y.+Qiuauthor=M.+Yuauthor=X.+Xuauthor=X.+Liuauthor=B.+F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+new+6-hydroxypyridazinone+benzisoxazoles%3A+Potential+multi-receptor+targeting+atypical+antipsychotics&doi=10.1016%2Fj.ejmech.2016.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41cR"><div class="casContent"><span class="casTitleNuber">41c</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new 6-hydroxypyridazinone benzisoxazoles: Potential multi-receptor-targeting atypical antipsychotics</span></div><div class="casAuthors">Cao, Xudong; Chen, Yin; Zhang, Yifang; Qiu, Yinli; Yu, Minquan; Xu, Xiangqing; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">713-728</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In recent years, multi-targeting directed ligands have attracted great interest as possible new atypical antipsychotics.  Combinations of dopamine and serotonin receptor ligands within single mols. might afford new therapeutic opportunities.  Herein, we describe the synthesis of a novel series of 6-hydroxypyridazinone benzisoxazoles and their binding behaviors to different receptors in terms of atypical antipsychotic behaviors.  The most potent compd. (I) exhibited excellent affinities for certain receptors (D2, Ki = 0.5 ± 0.07 nM; 5-HT1A, Ki = 5.9 ± 0.8 nM; 5-HT2A, Ki = 0.3 ± 0.01 nM; 5-HT6, Ki = 0.5 ± 0.04 nM) and combined with low affinities for the H1, 5-HT2C, and adrenergic α1 receptors.  In contrast to risperidone, compd. I exhibited a high cataleptic threshold; this may be useful in the development of a novel class of drugs treating schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPYNduByBs3rVg90H21EOLACvtfcHk0li_EJ1dCaFnKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFentrbO&md5=304d05e5fc29593b59031b813b57fc03</span></div><a href="/servlet/linkout?suffix=cit41c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%25206-hydroxypyridazinone%2520benzisoxazoles%253A%2520Potential%2520multi-receptor%2520targeting%2520atypical%2520antipsychotics%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D713%26epage%3D728%26doi%3D10.1016%2Fj.ejmech.2016.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41a','cit41b','cit41c']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0021.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>9a-c</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>16a/b</b> and <b>17a-n</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) H<sub>2</sub>SO<sub>4</sub>, MeOH; (ii) SOCl<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 1 h; (iii) NaI, acetone, reflux, 0.5 h; (iv) 3,5-dimethyl<i>-</i>1<i>H</i>-pyrazole or 3,5-ditrifluoromethyl<i>-</i>1<i>H</i>-pyrazole, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 60 °C, 7 h; (v) NaOH, MeOH, 40 °C, 3 h; (vi) 3-aminopyridine for <b>16a</b> and 2-naphthylamine for <b>16b</b> and substituted aniline for <b>17a-n</b> or DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h.</p></p></figure><figure data-id="sch3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Compounds <b>20a-j</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) 3-methyl-5-trifluoromethyl<i>-</i>1<i>H</i>-pyrazole or 3,5-ditrifluoromethyl<i>-</i>1<i>H</i>-pyrazole, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 60 °C, 7 h; (ii) NaOH, MeOH, 40 °C, 3 h; (iii) substituted aniline, DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h.</p></p></figure><figure data-id="sch4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Compounds <b>24a-e</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h; (ii) NaOH, MeOH, 40 °C, 3 h; (iii) 4-amino-1-butanol for <b>24a</b>, 3-aminopropanol for <b>24b</b>, benzylamine for <b>24c</b>, aniline for <b>24d</b> and butylamine for <b>24e</b>; DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h.</p></p></figure><figure data-id="sch5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis Compounds <b>32a-o</b> and <b>33a-f</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (i) MeI, NaHCO<sub>3</sub>, DMF; (ii) NaBH<sub>3</sub>CN, EtOH; (iii) SOCl<sub>2</sub>, DMF, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 1 h; (iv) NaI, acetone, reflux, 0.5 h; (v) 3,5-dimethyl<i>-</i>1<i>H</i>-pyrazole, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, 60 °C, 7 h; (vi) NaOH, MeOH, 40 °C, 3 h; (vii) naphthalen-2-amine for <b>33a</b>, isoquinolin-6-amine for <b>33b</b>, quinolin-7-amine for <b>33c</b>, 1<i>H</i>-indol-6-amine for <b>33d</b>, 1<i>H</i>-benzo[<i>d</i>]imidazol-6-amine for <b>33e</b>, 5-amino-1,3-dihydro-2<i>H</i>-benzo[<i>d</i>]imidazol-2-one for <b>33f</b> and substituted aniline, DIPEA, HATU, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to r.t., 12 h.</p></p></figure><figure data-id="fig1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potential antidepressants targeting NMDARs (A) and positive allosteric modulators of NMDARs (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (A) Summary of the workflow of virtual screening; (B) chemical structures of two identified NMDAR PAMs; (C) whole-cell recordings of currents evoked by 10 μM NMDA and 10 μM FS2915 or FS2921 on slices of the mouse brain. Scale: <i>X</i> axis = 250 s and <i>Y</i> axis = 500 pA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Allosteric modulation of NMDARs by FS2921. (A) Representative whole-cell recording from neurons cultured <i>in vitro</i> and the statistical results, showing that FS2921 application enhances the response to NMDA + glycine application. (B) Agonist concentration–response curves of NMDA in the presence of 30 μM glycine, indicating that FS2921 acts as a PAM with a shift of the NMDA EC<sub>50</sub> but no altered steady-state currents. (C) Agonist concentration–response curves of glycine in the presence of 100 μM NMDA, indicating that FS2921 acts as a PAM with significant enhancement of steady-state currents but no shift of the glycine EC<sub>50</sub>. Values are expressed as mean ± SEM from three independent experiments. The <i>p</i> value compared to the control group (**<i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Superimposition of the binding modes of FS2921 (yellow) and GNE-0723 (pink) in GluN1/GluN2A LBD (PDB ID: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KDT">5KDT</a>, gray) with (A) and without (B) protein ribbons. The yellow dotted lines represent hydrogen bonds; the blue dotted lines represent π–π interactions; the purple dotted lines represent halogen bonds.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Whole-cell recording from neurons cultured <i>in vitro</i> and the statistical results, showing that FS2921 application significantly enhanced the response compared to NMDA application alone; Scale: <i>X</i> axis = 10 s and <i>Y</i> axis = 100 pA. (B) Concentration–response curves of FS2921 showing the response to NMDA (100 μM). EC<sub>50</sub> values were determined in the presence of saturating glutamate. The values are the mean of at least five experiments. (C) FS2921 reduced immobility duration in the forced swim test (FST) on C57BL/6N mice. (D) FS2921 administration and chronic social defeat stress (CSDS) were both performed daily as indicated by the arrows. FS2921 reversed the reduced social interaction caused by CSDS. Values are expressed as mean ± SD from three independent experiments (<i>n</i> = 10–11). The <i>p</i> value compared to the control group (*<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Effects of the selected compounds in the ICR mice FST by single i.p. treatment. Values are expressed as mean ± SEM from 10–12 independent experiments. The <i>p</i> value was obtained by comparing it with the control group (*<i>p</i> < 0.05, **<i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/medium/jm0c02018_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Effects of the compounds <b>20h</b> and <b>32h</b> in the ICR mice FST with treatment repeated three times. Values are expressed as mean ± SEM from eight independent experiments. The <i>p</i> value is obtained by comparing it with the control group (*<i>p</i> < 0.05, **<i>p</i> < 0.01).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-9/acs.jmedchem.0c02018/20210506/images/large/jm0c02018_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02018&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i143">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34458" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34458" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 41 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">World Health Organization</span> <i>Depression and other common mental disorders:
global health estimates</i>; <span class="NLM_publisher-name">World Health Organization</span>, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=World+Health+Organization&title=Depression+and+other+common+mental+disorders%3A%0Aglobal+health+estimates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DDepression%2520and%2520other%2520common%2520mental%2520disorders%253A%250Aglobal%2520health%2520estimates%26pub%3DWorld%2520Health%2520Organization%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boku, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hishimoto, A.</span></span> <span> </span><span class="NLM_article-title">Neural basis of major depressive disorder: Beyond monoamine hypothesis</span>. <i>Psychiatry Clin. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1111/pcn.12604</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1111%2Fpcn.12604" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=28926161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVehsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2018&pages=3-12&author=S.+Bokuauthor=S.+Nakagawaauthor=H.+Todaauthor=A.+Hishimoto&title=Neural+basis+of+major+depressive+disorder%3A+Beyond+monoamine+hypothesis&doi=10.1111%2Fpcn.12604"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neural basis of major depressive disorder: Beyond monoamine hypothesis</span></div><div class="casAuthors">Boku, Shuken; Nakagawa, Shin; Toda, Hiroyuki; Hishimoto, Akitoyo</div><div class="citationInfo"><span class="NLM_cas:title">Psychiatry and Clinical Neurosciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-12</span>CODEN:
                <span class="NLM_cas:coden">PCNEFP</span>;
        ISSN:<span class="NLM_cas:issn">1323-1316</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The monoamine hypothesis has been accepted as the most common hypothesis of major depressive disorder (MDD) for a long period because of its simplicity and understandability.  Actually, most currently used antidepressants have been considered to act based on the monoamine hypothesis.  However, an important problem of the monoamine hypothesis has been pointed out as follows: it fails to explain the latency of response to antidepressants.  In addn., many patients with MDD have remained refractory to currently used antidepressants.  Therefore, monoamine-alternate hypotheses are required to explain the latency of response to antidepressants.  Such hypotheses have been expected to contribute to identifying hopeful new therapeutic targets for MDD.  Past studies have revealed that the vol. of the hippocampus is decreased in patients with MDD, which is likely caused by the failure of the hypothalamic-pituitary-adrenal axis and following elevation of glucocorticoids.  Two hypotheses have been proposed to explain the vol. of the hippocampus: (i) the neuroplasticity hypothesis; and (ii) the neurogenesis hypothesis.  The neuroplasticity hypothesis explains how the hippocampal vol. is decreased by the morphol. changes of hippocampal neurons, such as the shortening length of dendrites and the decreased no. and d. of spines.  The neurogenesis hypothesis explains how the hippocampal vol. is decreased by the decrease of neurogenesis in the hippocampal dentate gyrus.  These hypotheses are able to explain the latency of response to antidepressants.  In this review, we first overview how the neuroplasticity and neurogenesis hypotheses have been developed.  We then describe the details of these hypotheses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZ-o-pmwi-M7Vg90H21EOLACvtfcHk0lgcjl9Z6c7n8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVehsg%253D%253D&md5=36b5009c7c8c80dd123cfd1a862fc85b</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fpcn.12604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpcn.12604%26sid%3Dliteratum%253Aachs%26aulast%3DBoku%26aufirst%3DS.%26aulast%3DNakagawa%26aufirst%3DS.%26aulast%3DToda%26aufirst%3DH.%26aulast%3DHishimoto%26aufirst%3DA.%26atitle%3DNeural%2520basis%2520of%2520major%2520depressive%2520disorder%253A%2520Beyond%2520monoamine%2520hypothesis%26jtitle%3DPsychiatry%2520Clin.%2520Neurosci.%26date%3D2018%26volume%3D72%26spage%3D3%26epage%3D12%26doi%3D10.1111%2Fpcn.12604" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, K.</span></span> <span> </span><span class="NLM_article-title">Ketamine’s antidepressant action: beyond NMDA receptor inhibition</span>. <i>Expert. Opin. Ther. Targets</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1389</span>– <span class="NLM_lpage">1392</span>, <span class="refDoi"> DOI: 10.1080/14728222.2016.1238899</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1080%2F14728222.2016.1238899" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=27646666" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1aktLbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2016&pages=1389-1392&author=K.+Hashimoto&title=Ketamine%E2%80%99s+antidepressant+action%3A+beyond+NMDA+receptor+inhibition&doi=10.1080%2F14728222.2016.1238899"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Ketamine's antidepressant action: beyond NMDA receptor inhibition</span></div><div class="casAuthors">Hashimoto, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1389-1392</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is one of the most attractive antidepressants since this drug causes rapid-onset and sustained antidepressant effects in treatment resistant patients with depression.  There are unanswered questions about how ketamine induces its rapid and sustained antidepressant actions.  This key article suggests that (2R,6R)-HNK (hydroxynorketamine), a major metabolite of (R)-ketamine, shows antidepressant effects in rodent models of depression, indicating that the metab. of (R)-ketamine to (2R,6R)-HNK is pivotal in its antidepressant action.  Here these findings are put into context and their significance is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUC0l8Vic2CbVg90H21EOLACvtfcHk0ljU9lLiwY6YyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1aktLbM&md5=0ebafd17a6a405308fe4dd3115677fd4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1080%2F14728222.2016.1238899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14728222.2016.1238899%26sid%3Dliteratum%253Aachs%26aulast%3DHashimoto%26aufirst%3DK.%26atitle%3DKetamine%25E2%2580%2599s%2520antidepressant%2520action%253A%2520beyond%2520NMDA%2520receptor%2520inhibition%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Targets%26date%3D2016%26volume%3D20%26spage%3D1389%26epage%3D1392%26doi%3D10.1080%2F14728222.2016.1238899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molero, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramos-Quiroga, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Santos, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo-Śnchez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutiérrez-Rojas, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meana, J. J.</span></span> <span> </span><span class="NLM_article-title">Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">411</span>– <span class="NLM_lpage">420</span>, <span class="refDoi"> DOI: 10.1007/s40263-018-0519-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1007%2Fs40263-018-0519-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=29736744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpsVWgt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=411-420&author=P.+Moleroauthor=J.+A.+Ramos-Quirogaauthor=R.+Martin-Santosauthor=E.+Calvo-%C5%9Anchezauthor=L.+Guti%C3%A9rrez-Rojasauthor=J.+J.+Meana&title=Antidepressant+Efficacy+and+Tolerability+of+Ketamine+and+Esketamine%3A+A+Critical+Review&doi=10.1007%2Fs40263-018-0519-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review</span></div><div class="casAuthors">Molero, P.; Ramos-Quiroga, J. A.; Martin-Santos, R.; Calvo-Sanchez, E.; Gutierrez-Rojas, L.; Meana, J. J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">411-420</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Ketamine and its enantiomer S-ketamine (esketamine) are promising candidates to produce a rapid-onset antidepressant effect in treatment-resistant depression.  Ketamine causes continued blockade of the glutamate N-methyl-D-aspartate (NMDA) receptor, though this might not primarily mediate the antidepressant effect.  Alternative hypotheses include selectivity for the NMDA receptor subtype contg. the NMDA receptor subunit 2B (NR2B), inhibition of the phosphorylation of the eukaryotic elongation factor 2 (eEF2) kinase, increased expression of brain-derived neurotrophic factor (BDNF) and tropomyosin receptor kinase B (TrKB), and activation of the mammalian target of rapamycin (mTOR) signaling pathway, alongside other independent actions attributed to the ketamine metab. to R-hydroxynorketamine (R-HNK).  The enantiomer S-ketamine (esketamine) displays approx. fourfold greater affinity for the glutamate NMDA receptor in vitro than R-ketamine.  Proof-of-concept single-dose and repeat-dose studies with i.v. ketamine show a significant antidepressant and probably antisuicidal effect in the short term, with response rates over 60% as early as 4.5 h after a single dose, with a sustained effect after 24 h, and over 40% after 7 days.  This response can be further sustained over several weeks with repeated doses (two to three doses per wk).  Tolerability seems acceptable in the short term, with transient elevation of blood pressure and mild and transient dissociative and psychotomimetic effects.  Intranasal esketamine has shown a comparable antidepressant effect, which has resulted in the US FDA granting the drug a "breakthrough therapy" designation, and theor. it may offer an improved tolerability profile.  However, major concerns remain regarding an effective protocol to maintain the clin. antidepressant effect of ketamine seen with acute administration and the safety of ketamine and esketamine in the long term, specifically related to potential neurocognitive and urol. toxicity, together with the potential induction of substance use disorders.  Ketamine and esketamine are not currently approved treatments for depression, but the clin. use of ketamine is increasing in a variety of practice settings internationally.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9YS8yRNy4o7Vg90H21EOLACvtfcHk0ljU9lLiwY6YyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpsVWgt74%253D&md5=24142c2b26f02e7f181ba9a0a7bdb3f0</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1007%2Fs40263-018-0519-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40263-018-0519-3%26sid%3Dliteratum%253Aachs%26aulast%3DMolero%26aufirst%3DP.%26aulast%3DRamos-Quiroga%26aufirst%3DJ.%2BA.%26aulast%3DMartin-Santos%26aufirst%3DR.%26aulast%3DCalvo-%25C5%259Anchez%26aufirst%3DE.%26aulast%3DGuti%25C3%25A9rrez-Rojas%26aufirst%3DL.%26aulast%3DMeana%26aufirst%3DJ.%2BJ.%26atitle%3DAntidepressant%2520Efficacy%2520and%2520Tolerability%2520of%2520Ketamine%2520and%2520Esketamine%253A%2520A%2520Critical%2520Review%26jtitle%3DCNS%2520Drugs%26date%3D2018%26volume%3D32%26spage%3D411%26epage%3D420%26doi%3D10.1007%2Fs40263-018-0519-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krystal, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karper, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freeman, G. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delaney, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bremner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heninger, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, M. B.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charney, D. S.</span></span> <span> </span><span class="NLM_article-title">Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses</span>. <i>Arch. Gen. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">199</span>– <span class="NLM_lpage">214</span>, <span class="refDoi"> DOI: 10.1001/archpsyc.1994.03950030035004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1001%2Farchpsyc.1994.03950030035004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=8122957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaK2cXkslemtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1994&pages=199-214&author=J.+H.+Krystalauthor=L.+P.+Karperauthor=J.+P.+Seibylauthor=G.+K.+Freemanauthor=R.+Delaneyauthor=J.+D.+Bremnerauthor=G.+R.+Heningerauthor=M.+B.+Bowersauthor=D.+S.+Charney&title=Subanesthetic+effects+of+the+noncompetitive+NMDA+antagonist%2C+ketamine%2C+in+humans.+Psychotomimetic%2C+perceptual%2C+cognitive%2C+and+neuroendocrine+responses&doi=10.1001%2Farchpsyc.1994.03950030035004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses</span></div><div class="casAuthors">Krystal, John H.; Karper, Laurence P.; Seibyl, John P.; Freeman, Glenna K.; Delaney, Richard; Bremner, J. Douglas; Heninger, George R.; Bowers, Malcolm B., Jr.; Charney, Dennis S.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">199-214</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">When given at subanesthetic doses to healthy subjects, the N-methyl-D-aspartate (NMDA) agonist ketamine: (1) produced behaviors similar to the pos. and neg. symptoms of schizophrenia; (2) elicited alterations in perception; (3) impaired performance on tests of vigilance, verbal fluency, and the Wisconsin Card Sorting Test; (4) evoked symptoms similar to those of dissociative states; and (5) preferentially disrupted delayed word recall, sparing immediate recall and postdistraction recall.  Ketamine had no effect on the Mini-Mental State Examn.  Ketamine also had no effect on plasma 3-methoxy-4-hydroxyphenethylene glycol levels, although it blunted a test day decline in plasma homovanillic acid levels at the higher dose tested.  It also dose-dependently increased plasma cortisol and prolactin levels.  Ketamine produced small dose-dependent increases in blood pressure.  These data indicate that NMDA antagonists produce a broad range of symptoms, behaviors, and cognitive deficits that resemble aspects of endogenous psychoses, particularly schizophrenia and dissociative states.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDWxsI3lz_fbVg90H21EOLACvtfcHk0lgqe-uwq7vxjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslemtrY%253D&md5=6554b88d3fd5f747a925fe5ffaf49cd6</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1994.03950030035004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1994.03950030035004%26sid%3Dliteratum%253Aachs%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26aulast%3DKarper%26aufirst%3DL.%2BP.%26aulast%3DSeibyl%26aufirst%3DJ.%2BP.%26aulast%3DFreeman%26aufirst%3DG.%2BK.%26aulast%3DDelaney%26aufirst%3DR.%26aulast%3DBremner%26aufirst%3DJ.%2BD.%26aulast%3DHeninger%26aufirst%3DG.%2BR.%26aulast%3DBowers%26aufirst%3DM.%2BB.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26atitle%3DSubanesthetic%2520effects%2520of%2520the%2520noncompetitive%2520NMDA%2520antagonist%252C%2520ketamine%252C%2520in%2520humans.%2520Psychotomimetic%252C%2520perceptual%252C%2520cognitive%252C%2520and%2520neuroendocrine%2520responses%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1994%26volume%3D51%26spage%3D199%26epage%3D214%26doi%3D10.1001%2Farchpsyc.1994.03950030035004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulbrich, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isacoff, E. Y.</span></span> <span> </span><span class="NLM_article-title">Rules of engagement for NMDA receptor subunits</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">14163</span>– <span class="NLM_lpage">14168</span>, <span class="refDoi"> DOI: 10.1073/pnas.0802075105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1073%2Fpnas.0802075105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=18779583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFGqtL7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=14163-14168&author=M.+H.+Ulbrichauthor=E.+Y.+Isacoff&title=Rules+of+engagement+for+NMDA+receptor+subunits&doi=10.1073%2Fpnas.0802075105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Rules of engagement for NMDA receptor subunits</span></div><div class="casAuthors">Ulbrich, Maximilian H.; Isacoff, Ehud Y.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">14163-14168</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Canonical NMDA receptors assemble from two glycine-binding NR1 subunits with two glutamate-binding NR2 subunits to, form glutamate-gated excitatory receptors that mediate synaptic transmission and plasticity.  The role of glycine-binding NR3 subunits is less clear.  Whereas in Xenopus laevis oocytes, two NR3 subunits coassemble with two NR1 subunits to form a glycine-gated receptor, such a receptor has yet to be found in mammalian cells.  Meanwhile, NR1, NR2, and NR3 appear to coassemble into triheteromeric receptors in neurons, but it is not clear whether this occurs in oocytes.  To test the rules that govern subunit assembly in NMDA receptors, we developed a single-mol. fluorescence colocalization method.  The method focuses selectively on the plasma membrane and simultaneously dets. the subunit compn. of hundreds of individual protein complexes within an optical patch on a live cell.  We find that NR1, NR2, and NR3 follow an exclusion rule that yields sep. populations of NR1/NR2 and NR1/NR3 receptors on the surface of oocytes.  In contrast, coexpression of NR1, NR3A, and NR3B yields triheteromeric receptors with a fixed stoichiometry of two NR1 subunits with one NR3A and one NR3B.  At least part of this regulation of subunit stoichiometry appears to be caused by internal retention.  Thus, depending on the mixt. of subunits, functional receptors on the cell surface may follow either an exclusion rule or a stoichiometric combination rule, providing an important constraint on functional diversity.  Cell-to-cell differences in the rules may help sculpt distinct physiol. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLoiHDKdxm17Vg90H21EOLACvtfcHk0lgqe-uwq7vxjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFGqtL7E&md5=506fb5c2c91089fd273b465ef181bf20</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0802075105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0802075105%26sid%3Dliteratum%253Aachs%26aulast%3DUlbrich%26aufirst%3DM.%2BH.%26aulast%3DIsacoff%26aufirst%3DE.%2BY.%26atitle%3DRules%2520of%2520engagement%2520for%2520NMDA%2520receptor%2520subunits%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D14163%26epage%3D14168%26doi%3D10.1073%2Fpnas.0802075105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollmuth, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McBain, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myers, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingledine, R.</span></span> <span> </span><span class="NLM_article-title">Glutamate receptor ion channels: structure, regulation, and function</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1124/pr.109.002451</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1124%2Fpr.109.002451" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=20716669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2010&pages=405-496&author=S.+F.+Traynelisauthor=L.+P.+Wollmuthauthor=C.+J.+McBainauthor=F.+S.+Mennitiauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=K.+B.+Hansenauthor=H.+Yuanauthor=S.+J.+Myersauthor=R.+Dingledine&title=Glutamate+receptor+ion+channels%3A+structure%2C+regulation%2C+and+function&doi=10.1124%2Fpr.109.002451"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Glutamate receptor ion channels: structure, regulation, and function</span></div><div class="casAuthors">Traynelis, Stephen F.; Wollmuth, Lonnie P.; McBain, Chris J.; Menniti, Frank S.; Vance, Katie M.; Ogden, Kevin K.; Hansen, Kasper B.; Yuan, Hongjie; Myers, Scott J.; Dingledine, Ray</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">405-496</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  The mammalian ionotropic glutamate receptor family encodes 18 gene products that coassemble to form ligand-gated ion channels contg. an agonist recognition site, a transmembrane ion permeation pathway, and gating elements that couple agonist-induced conformational changes to the opening or closing of the permeation pore.  Glutamate receptors mediate fast excitatory synaptic transmission in the central nervous system and are localized on neuronal and non-neuronal cells.  These receptors regulate a broad spectrum of processes in the brain, spinal cord, retina, and peripheral nervous system.  Glutamate receptors are postulated to play important roles in numerous neurol. diseases and have attracted intense scrutiny.  The description of glutamate receptor structure, including its transmembrane elements, reveals a complex assembly of multiple semiautonomous extracellular domains linked to a pore-forming element with striking resemblance to an inverted potassium channel.  In this review we discuss International Union of Basic and Clin. Pharmacol. glutamate receptor nomenclature, structure, assembly, accessory subunits, interacting proteins, gene expression and translation, post-translational modifications, agonist and antagonist pharmacol., allosteric modulation, mechanisms of gating and permeation, roles in normal physiol. function, as well as the potential therapeutic use of pharmacol. agents acting at glutamate receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov0rj4nMr5ObVg90H21EOLACvtfcHk0liJKG1_R_NS-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVSltbbJ&md5=5d0a7945b5ad99113adf9f6312bafe13</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1124%2Fpr.109.002451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fpr.109.002451%26sid%3Dliteratum%253Aachs%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26aulast%3DWollmuth%26aufirst%3DL.%2BP.%26aulast%3DMcBain%26aufirst%3DC.%2BJ.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DMyers%26aufirst%3DS.%2BJ.%26aulast%3DDingledine%26aufirst%3DR.%26atitle%3DGlutamate%2520receptor%2520ion%2520channels%253A%2520structure%252C%2520regulation%252C%2520and%2520function%26jtitle%3DPharmacol.%2520Rev.%26date%3D2010%26volume%3D62%26spage%3D405%26epage%3D496%26doi%3D10.1124%2Fpr.109.002451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karakas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, H.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a heterotetrameric NMDA receptor ion channel</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">992</span>– <span class="NLM_lpage">997</span>, <span class="refDoi"> DOI: 10.1126/science.1251915</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1126%2Fscience.1251915" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=24876489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosFSmu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2014&pages=992-997&author=E.+Karakasauthor=H.+Furukawa&title=Crystal+structure+of+a+heterotetrameric+NMDA+receptor+ion+channel&doi=10.1126%2Fscience.1251915"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a heterotetrameric NMDA receptor ion channel</span></div><div class="casAuthors">Karakas, Erkan; Furukawa, Hiro</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">6187</span>),
    <span class="NLM_cas:pages">992-997</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">N-Methyl-L-aspartate (NMDA) receptors belong to the family of ionotropic glutamate receptors, which mediate most excitatory synaptic transmission in mammalian brains.  Calcium permeation triggered by activation of NMDA receptors is the pivotal event for initiation of neuronal plasticity.  Here, we show the crystal structure of the intact heterotetrameric GluN1-GluN2B NMDA receptor ion channel at 4 angstroms.  The NMDA receptors are arranged as a dimer of GluN1-GluN2B heterodimers with the twofold symmetry axis running through the entire mol. composed of an amino-terminal domain (ATD), a ligand-binding domain (LBD), and a transmembrane domain (TMD).  The ATD and LBD are much more highly packed in the NMDA receptors than non-NMDA receptors, which may explain why ATD regulates ion channel activity in NMDA receptors but not in non-NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaR6ovzl-ld7Vg90H21EOLACvtfcHk0liJKG1_R_NS-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosFSmu7k%253D&md5=1024cf903b20d0a7b1bc6a78f7fd283a</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1126%2Fscience.1251915&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1251915%26sid%3Dliteratum%253Aachs%26aulast%3DKarakas%26aufirst%3DE.%26aulast%3DFurukawa%26aufirst%3DH.%26atitle%3DCrystal%2520structure%2520of%2520a%2520heterotetrameric%2520NMDA%2520receptor%2520ion%2520channel%26jtitle%3DScience%26date%3D2014%26volume%3D344%26spage%3D992%26epage%3D997%26doi%3D10.1126%2Fscience.1251915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellone, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span> <span> </span><span class="NLM_article-title">NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease</span>. <i>Nat. Rev. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">383</span>– <span class="NLM_lpage">400</span>, <span class="refDoi"> DOI: 10.1038/nrn3504</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1038%2Fnrn3504" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=23686171" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnvVSit7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=383-400&author=P.+Paolettiauthor=C.+Belloneauthor=Q.+Zhou&title=NMDA+receptor+subunit+diversity%3A+impact+on+receptor+properties%2C+synaptic+plasticity+and+disease&doi=10.1038%2Fnrn3504"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease</span></div><div class="casAuthors">Paoletti, Pierre; Bellone, Camilla; Zhou, Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">383-400</span>CODEN:
                <span class="NLM_cas:coden">NRNAAN</span>;
        ISSN:<span class="NLM_cas:issn">1471-003X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  NMDA receptors (NMDARs) are glutamate-gated ion channels and are crucial for neuronal communication.  NMDARs form tetrameric complexes that consist of several homologous subunits.  The subunit compn. of NMDARs is plastic, resulting in a large no. of receptor subtypes.  As each receptor subtype has distinct biophys., pharmacol. and signaling properties, there is great interest in detg. whether individual subtypes carry out specific functions in the CNS in both normal and pathol. conditions.  Here, we review the effects of subunit compn. on NMDAR properties, synaptic plasticity and cellular mechanisms implicated in neuropsychiatric disorders.  Understanding the rules and roles of NMDAR diversity could provide new therapeutic strategies against dysfunctions of glutamatergic transmission.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqubMsb4ZP2U7Vg90H21EOLACvtfcHk0liJKG1_R_NS-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnvVSit7Y%253D&md5=f69790da360242d491bf1a5eb146613d</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1038%2Fnrn3504&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrn3504%26sid%3Dliteratum%253Aachs%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DBellone%26aufirst%3DC.%26aulast%3DZhou%26aufirst%3DQ.%26atitle%3DNMDA%2520receptor%2520subunit%2520diversity%253A%2520impact%2520on%2520receptor%2520properties%252C%2520synaptic%2520plasticity%2520and%2520disease%26jtitle%3DNat.%2520Rev.%2520Neurosci.%26date%3D2013%26volume%3D14%26spage%3D383%26epage%3D400%26doi%3D10.1038%2Fnrn3504" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danysz, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parsons, C. G.</span></span> <span> </span><span class="NLM_article-title">Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications</span>. <i>Pharmacol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">597</span>– <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=9860805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaK1MXltFyhsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=597-664&author=W.+Danyszauthor=C.+G.+Parsons&title=Glycine+and+N-methyl-D-aspartate+receptors%3A+physiological+significance+and+possible+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications</span></div><div class="casAuthors">Danysz, Wojciech; Parsons, Chris G.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">597-664</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review with many refs. on the physiol. significance of the glycine site as an attractive target for drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWhTWVIfqWebVg90H21EOLACvtfcHk0lgBeZEbWq3EVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXltFyhsQ%253D%253D&md5=6df1d6a32e8e6bf358b1a8073bc15317</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDanysz%26aufirst%3DW.%26aulast%3DParsons%26aufirst%3DC.%2BG.%26atitle%3DGlycine%2520and%2520N-methyl-D-aspartate%2520receptors%253A%2520physiological%2520significance%2520and%2520possible%2520therapeutic%2520applications%26jtitle%3DPharmacol.%2520Rev.%26date%3D1998%26volume%3D50%26spage%3D597%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swan, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffiths, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meldrum, B. S.</span></span> <span> </span><span class="NLM_article-title">Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>226</i></span>,  <span class="NLM_fpage">850</span>– <span class="NLM_lpage">852</span>, <span class="refDoi"> DOI: 10.1126/science.6093256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1126%2Fscience.6093256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=6093256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaL2MXjsl0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=226&publication_year=1984&pages=850-852&author=R.+P.+Simonauthor=J.+H.+Swanauthor=T.+Griffithsauthor=B.+S.+Meldrum&title=Blockade+of+N-methyl-D-aspartate+receptors+may+protect+against+ischemic+damage+in+the+brain&doi=10.1126%2Fscience.6093256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain</span></div><div class="casAuthors">Simon, R. P.; Swan, J. H.; Griffiths, T.; Meldrum, B. S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">226</span>
        (<span class="NLM_cas:issue">4676</span>),
    <span class="NLM_cas:pages">850-2</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">In rats ischemia of the forebrain induced by a 30-min occlusion of the carotid artery followed by 120 min of arterial reperfusion produced ischemic lesions of selectively vulnerable pyramidal cells in both hippocampi.  Focal microinfusion into the dorsal hippocampus of 2-amino-7-phosphonoheptanoic acid  [85797-13-3], an antagonist of excitation at the N-methyl-D-aspartate-preferring receptor, before ischemia was induced protected against the development of ischemic damage.  Apparently, excitatory neurotransmission plays an important role in selective neuronal loss due to cerebral ischemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZAGwtHGrEWrVg90H21EOLACvtfcHk0lgBeZEbWq3EVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXjsl0%253D&md5=057560bcd8ee07a6a4bc35862e4b4424</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1126%2Fscience.6093256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.6093256%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DR.%2BP.%26aulast%3DSwan%26aufirst%3DJ.%2BH.%26aulast%3DGriffiths%26aufirst%3DT.%26aulast%3DMeldrum%26aufirst%3DB.%2BS.%26atitle%3DBlockade%2520of%2520N-methyl-D-aspartate%2520receptors%2520may%2520protect%2520against%2520ischemic%2520damage%2520in%2520the%2520brain%26jtitle%3DScience%26date%3D1984%26volume%3D226%26spage%3D850%26epage%3D852%26doi%3D10.1126%2Fscience.6093256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Croucher, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meldrum, B. S.</span></span> <span> </span><span class="NLM_article-title">Anticonvulsant action of excitatory amino acid antagonists</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">899</span>– <span class="NLM_lpage">901</span>, <span class="refDoi"> DOI: 10.1126/science.7079744</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1126%2Fscience.7079744" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=7079744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaL38XktFKqu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=1982&pages=899-901&author=M.+J.+Croucherauthor=J.+F.+Collinsauthor=B.+S.+Meldrum&title=Anticonvulsant+action+of+excitatory+amino+acid+antagonists&doi=10.1126%2Fscience.7079744"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Anticonvulsant action of excitatory amino acid antagonists</span></div><div class="casAuthors">Croucher, M J.; Collins, J. F.; Meldrum, B. S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">4548</span>),
    <span class="NLM_cas:pages">899-901</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">Compds. that antagonize neuronal excitation induced by dicarboxylic amino acids were tested in 2 animal models of epilepsy, namely sound-induced seizures in DBA/2 mice and threshold pentylenetetrazol seizures in Swiss mice.  Sound-induced seizures could be prevented by intracerebroventricular injection of compds. that block excitation due to N-methyl-D-aspartic acid  [6384-92-5].  The most potent compd., (-)-2-amino-7-phosphonoheptanoic acid  [81338-23-0], was anticonvulsant in both test systems when given either i.p. or intracerebroventricularly.  Specific antagonists of excitation that is caused by amino acids provide a new class of anticonvulsant agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcJYQLKxgFVrVg90H21EOLACvtfcHk0lh5YqBZSRx02A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XktFKqu74%253D&md5=19a991a8488325c2b63885b20adc8e7e</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.7079744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.7079744%26sid%3Dliteratum%253Aachs%26aulast%3DCroucher%26aufirst%3DM.%2BJ.%26aulast%3DCollins%26aufirst%3DJ.%2BF.%26aulast%3DMeldrum%26aufirst%3DB.%2BS.%26atitle%3DAnticonvulsant%2520action%2520of%2520excitatory%2520amino%2520acid%2520antagonists%26jtitle%3DScience%26date%3D1982%26volume%3D216%26spage%3D899%26epage%3D901%26doi%3D10.1126%2Fscience.7079744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Davies, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodge, D.</span></span> <span> </span><span class="NLM_article-title">Evidence for involvement of N-methylaspartate receptors in ’windup’ of class 2 neurones in the dorsal horn of the rat</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>424</i></span>,  <span class="NLM_fpage">402</span>– <span class="NLM_lpage">406</span>, <span class="refDoi"> DOI: 10.1016/0006-8993(87)91487-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2F0006-8993%2887%2991487-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=2823998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaL2sXmt12ru78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=1987&pages=402-406&author=S.+N.+Daviesauthor=D.+Lodge&title=Evidence+for+involvement+of+N-methylaspartate+receptors+in+%E2%80%99windup%E2%80%99+of+class+2+neurones+in+the+dorsal+horn+of+the+rat&doi=10.1016%2F0006-8993%2887%2991487-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Evidence for involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurons in the dorsal horn of the rat</span></div><div class="casAuthors">Davies, Stephen N.; Lodge, David</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">424</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">402-6</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">The effects of ketamine and kynurenate on the initial response and frequency dependent potentiation of response (wind-up) of class 2 neurons were examd. in the rat dorsal horn induced by repeated elec. stimulation of their receptive fields.  Iontophoretic kynurenate reduced both the initial response and the wind-up.  Iontophoretic or i.v. ketamine had no consistent effect on the initial response but consistently reduced wind-up.  N-Methylaspartate receptors therefore appear to contribute to the wind-up, but not the initial response, of class 2 neurons in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjiS775AxsxLVg90H21EOLACvtfcHk0lh5YqBZSRx02A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXmt12ru78%253D&md5=d69854b247a30a47275601027b7a9d96</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2887%2991487-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252887%252991487-9%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DS.%2BN.%26aulast%3DLodge%26aufirst%3DD.%26atitle%3DEvidence%2520for%2520involvement%2520of%2520N-methylaspartate%2520receptors%2520in%2520%25E2%2580%2599windup%25E2%2580%2599%2520of%2520class%25202%2520neurones%2520in%2520the%2520dorsal%2520horn%2520of%2520the%2520rat%26jtitle%3DBrain%2520Res.%26date%3D1987%26volume%3D424%26spage%3D402%26epage%3D406%26doi%3D10.1016%2F0006-8993%2887%2991487-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Preskorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macaluso, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehra, D. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zammit, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, R. M.</span></span> <span> </span><span class="NLM_article-title">GLYX-13 Clinical Study Group. Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent</span>. <i>J. Psychiatr. Pract.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">149</span>, <span class="refDoi"> DOI: 10.1097/01.pra.0000462606.17725.93</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1097%2F01.pra.0000462606.17725.93" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=25782764" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A280%3ADC%252BC2MnlsFajtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=140-149&author=S.+Preskornauthor=M.+Macalusoauthor=D.+V.+Mehraauthor=G.+Zammitauthor=J.+R.+Moskalauthor=R.+M.+Burch&title=GLYX-13+Clinical+Study+Group.+Randomized+proof+of+concept+trial+of+GLYX-13%2C+an+N-methyl-D-aspartate+receptor+glycine+site+partial+agonist%2C+in+major+depressive+disorder+nonresponsive+to+a+previous+antidepressant+agent&doi=10.1097%2F01.pra.0000462606.17725.93"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized proof of concept trial of GLYX-13, an N-methyl-D-aspartate receptor glycine site partial agonist, in major depressive disorder nonresponsive to a previous antidepressant agent</span></div><div class="casAuthors">Preskorn Sheldon; Macaluso Matthew; Mehra D O Vishaal; Zammit Gary; Moskal Joseph R; Burch Ronald M</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric practice</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Approximately 45% of patients with major depressive disorder (MDD) do not remit when treated with biogenic amine antidepressants.  Consequently, there is a significant need for antidepressant agents with different mechanisms of action.  Early proof of concept (POC) studies with such novel agents play a significant role in helping drug developers identify agents and mechanisms of action that merit more intensive research.  Studies have demonstrated that high affinity N-methyl-Daspartate (NMDA) receptor blockers (eg, ketamine) can produce rapid antidepressant effects in patients who have not responded to currently available agents, but treatment with these agents is accompanied by psychotomimetic effects that make their use problematic.  This column describes a POC study involving GLYX-13, an N-methyl-D-aspartate receptor glycine site functional partial agonist.  METHOD:  In this double-blind, randomized, placebo-controlled study, a single intravenous (IV) dose of GLYX-13 (1, 5, 10, or 30 mg/kg) or placebo was administered to 116 subjects with MDD who had not benefitted from a trial of at least one biogenic amine antidepressant during the current episode.  The primary outcome measure was score on the Hamilton Depression Rating Scale-17 (Ham-D17), which was used to rate overall depressive symptoms at baseline and at 24 hours and days 3, 7, 14, and, in some arms, days 21 and 28 after administration.  RESULTS:  GLYX-13, 5 or 10 mg/kg IV, reduced depressive symptoms as assessed by the Ham-D17 at days 1 through 7.  Onset of action as assessed using the Bech-6 occurred within 2 hours.  GLYX-13 did not elicit psychotomimetic or other significant side effects.  CONCLUSION:  In this early POC study, GLYX-13 reduced depressive symptoms within 2 hours and this effect was maintained for 7 days on average in subjects with MDD who had not responded to another antidepressant agent during the current depressive episode.  The findings of this study support the hypothesis that modulation of the NMDA receptor is a valid target for the development of antidepressant drugs and the need for additional studies to further evaluate the effects of GLYX-13.  POC studies such as the one described here play a pivotal role in allowing drug researchers to decide whether to move forward with larger and more expensive studies, and they enable them to focus available resources on those molecules that appear to have the most therapeutic promise.  Based on the POC study described here, a multiple dose study has been completed which showed sustained therapeutic benefit with repeated dosing of GLYX-13 for more than 6 weeks.  Phase 3 studies are now being planned.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRv64RH14l-ZEwlCcfExbvbfW6udTcc2eb-hQweUcxmobntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MnlsFajtA%253D%253D&md5=9e82a9c5facdfbf48c4bf31c24a059bc</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1097%2F01.pra.0000462606.17725.93&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.pra.0000462606.17725.93%26sid%3Dliteratum%253Aachs%26aulast%3DPreskorn%26aufirst%3DS.%26aulast%3DMacaluso%26aufirst%3DM.%26aulast%3DMehra%26aufirst%3DD.%2BV.%26aulast%3DZammit%26aufirst%3DG.%26aulast%3DMoskal%26aufirst%3DJ.%2BR.%26aulast%3DBurch%26aufirst%3DR.%2BM.%26atitle%3DGLYX-13%2520Clinical%2520Study%2520Group.%2520Randomized%2520proof%2520of%2520concept%2520trial%2520of%2520GLYX-13%252C%2520an%2520N-methyl-D-aspartate%2520receptor%2520glycine%2520site%2520partial%2520agonist%252C%2520in%2520major%2520depressive%2520disorder%2520nonresponsive%2520to%2520a%2520previous%2520antidepressant%2520agent%26jtitle%3DJ.%2520Psychiatr.%2520Pract.%26date%3D2015%26volume%3D21%26spage%3D140%26epage%3D149%26doi%3D10.1097%2F01.pra.0000462606.17725.93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moskal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colley, P. A.</span></span> <span> </span><span class="NLM_article-title">The use of antibody engineering to create novel drugs that target N-methyl-D-aspartate receptors</span>. <i>Curr. Drug Targets</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">331</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.2174/1389450013348399</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.2174%2F1389450013348399" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=11554557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntVGlu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2001&pages=331-345&author=J.+R.+Moskalauthor=H.+Yamamotoauthor=P.+A.+Colley&title=The+use+of+antibody+engineering+to+create+novel+drugs+that+target+N-methyl-D-aspartate+receptors&doi=10.2174%2F1389450013348399"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">The use of antibody engineering to create novel drugs that target N-methyl-D-aspartate receptors</span></div><div class="casAuthors">Moskal, Joseph R.; Yamamoto, Hirotaka; Colley, Patricia A.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">331-345</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  According to a recent World Health Organization survey, there are over four hundred million people worldwide suffering from mental and neurol. disorders; schizophrenia affects some forty-five million people, and unipolar major depression ranked fifth in major causes of disability and death.  Clearly it is of the utmost importance to develop new, effective, and safe neuro-pharmaceuticals with this increasing "global burden of disease".  To this end, we have developed a strategy of generating monoclonal antibodies that act as modulators of the cell-surface central nervous system receptor-ion channel complexes.  In this review we will focus on the generation and characterization of a monoclonal antibody that acts as a partial agonist to the N-methyl-D-aspartate receptor.  The creation of peptide mimetics, derived from this monoclonal antibody, that may be useful as cognitive enhancers and protect neurons hypoxic and ischemic insults caused by stroke, will also be discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrcm86hOZbC8rVg90H21EOLACvtfcHk0lgZpN2HmAejlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntVGlu74%253D&md5=49ff6126fb6a6f520f88b6a92bf34653</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2174%2F1389450013348399&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389450013348399%26sid%3Dliteratum%253Aachs%26aulast%3DMoskal%26aufirst%3DJ.%2BR.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DColley%26aufirst%3DP.%2BA.%26atitle%3DThe%2520use%2520of%2520antibody%2520engineering%2520to%2520create%2520novel%2520drugs%2520that%2520target%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2001%26volume%3D2%26spage%3D331%26epage%3D345%26doi%3D10.2174%2F1389450013348399" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moskal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, P. K.</span></span> <span> </span><span class="NLM_article-title">A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1238</span>– <span class="NLM_lpage">1250</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2008.08.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuropharm.2008.08.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=18796308" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlShurvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=1238-1250&author=X.+L.+Zhangauthor=J.+A.+Sullivanauthor=J.+R.+Moskalauthor=P.+K.+Stanton&title=A+NMDA+receptor+glycine+site+partial+agonist%2C+GLYX-13%2C+simultaneously+enhances+LTP+and+reduces+LTD+at+Schaffer+collateral-CA1+synapses+in+hippocampus&doi=10.1016%2Fj.neuropharm.2008.08.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">A NMDA receptor glycine site partial agonist, GLYX-13, simultaneously enhances LTP and reduces LTD at Schaffer collateral-CA1 synapses in hippocampus</span></div><div class="casAuthors">Zhang, Xiao-lei; Sullivan, John A.; Moskal, Joseph R.; Stanton, Patric K.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1238-1250</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate glutamate receptors (NMDARs) are a key route for Ca2+ influx into neurons important to both activity-dependent synaptic plasticity and, when uncontrolled, triggering events that cause neuronal degeneration and death.  Among regulatory binding sites on the NMDAR complex is a glycine binding site, distinct from the glutamate binding site, which must be co-activated for NMDAR channel opening.  We developed a novel glycine site partial agonist, GLYX-13, which is both nootropic and neuroprotective in vivo.  Here, we assessed the effects of GLYX-13 on long-term synaptic plasticity and NMDAR transmission at Schaffer collateral-CA1 synapses in hippocampal slices in vitro.  GLYX-13 simultaneously enhanced the magnitude of long-term potentiation (LTP) of synaptic transmission, while reducing long-term depression (LTD).  GLYX-13 reduced NMDA receptor-mediated synaptic currents in CA1 pyramidal neurons evoked by low frequency Schaffer collateral stimulation, but enhanced NMDAR currents during high frequency bursts of activity, and these actions were occluded by a satg. concn. of the glycine site agonist D-serine.  Direct two-photon imaging of Schaffer collateral burst-evoked increases in [Ca2+] in individual dendritic spines revealed that GLYX-13 selectively enhanced burst-induced NMDAR-dependent spine Ca2+ influx.  Examg. the rate of MK-801 block of synaptic vs. extrasynaptic NMDAR-gated channels revealed that GLYX-13 selectively enhanced activation of burst-driven extrasynaptic NMDARs, with an action that was blocked by the NR2B-selective NMDAR antagonist ifenprodil.  Our data suggest that GLYX-13 may have unique therapeutic potential as a learning and memory enhancer because of its ability to simultaneously enhance LTP and suppress LTD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRu93yHBUZTbVg90H21EOLACvtfcHk0ljgYF1YXKgW1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlShurvE&md5=31eaf74a8f163be613619c93cf0fb2cc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2008.08.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2008.08.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%2BL.%26aulast%3DSullivan%26aufirst%3DJ.%2BA.%26aulast%3DMoskal%26aufirst%3DJ.%2BR.%26aulast%3DStanton%26aufirst%3DP.%2BK.%26atitle%3DA%2520NMDA%2520receptor%2520glycine%2520site%2520partial%2520agonist%252C%2520GLYX-13%252C%2520simultaneously%2520enhances%2520LTP%2520and%2520reduces%2520LTD%2520at%2520Schaffer%2520collateral-CA1%2520synapses%2520in%2520hippocampus%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D1238%26epage%3D1250%26doi%3D10.1016%2Fj.neuropharm.2008.08.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moskal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuo, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wood, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelso, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disterhoft, J. F.</span></span> <span> </span><span class="NLM_article-title">GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">1077</span>– <span class="NLM_lpage">1087</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2005.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuropharm.2005.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=16051282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFehsLzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2005&pages=1077-1087&author=J.+R.+Moskalauthor=A.+G.+Kuoauthor=C.+Weissauthor=P.+L.+Woodauthor=H.+A.+O%E2%80%99Connorauthor=S.+Kelsoauthor=R.+B.+Harrisauthor=J.+F.+Disterhoft&title=GLYX-13%3A+a+monoclonal+antibody-derived+peptide+that+acts+as+an+N-methyl-D-aspartate+receptor+modulator&doi=10.1016%2Fj.neuropharm.2005.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">GLYX-13: A monoclonal antibody-derived peptide that acts as an N-methyl-aspartate receptor modulator</span></div><div class="casAuthors">Moskal, Joseph R.; Kuo, Amy G.; Weiss, Craig; Wood, Paul L.; O'Connor Hanson, Amy; Kelso, Stephen; Harris, Robert B.; Disterhoft, John F.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1077-1087</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We previously created a monoclonal antibody (MAb), B6B21, that acts as a partial agonist at the glycine site of the N-methyl-D-aspartate (NMDA) receptor [Moskal, J.R., Schaffner, A.E., 1986. Monoclonal antibodies to the dentate gyrus: immunocytochem. characterization and flow cytometric anal. of hippocampal neurons bearing a unique cell-surface antigen. J. Neurosci. 6, 2045-2053.].  The hypervariable region of the light chain of B6B21 was cloned and sequenced.  Peptides were then synthesized based on this sequence information and screened using rat hippocampal membrane prepns. to measure [3H]MK-801 binding in the presence of 7-chlorokynurenic acid, a glycine site-specific competitive inhibitor of NMDA receptor [Moskal, J.R., Yamamoto, H., Colley, P.A., 2001. The use of antibody engineering to create novel drugs that target N-methyl-D-aspartate receptors. Curr. Drug Targets 2, 331-345.].  Peptides that were able to increase [3H]MK-801 binding in a dose-dependent manner under these conditions were named Glyxins.  Here we report that GLYX-13, a tetrapeptide (TPPT-amide), was found to readily cross the blood-brain barrier and modulate the NMDA receptor in a glycine-like fashion when examd. pharmacol. and electrophysiol.  When GLYX-13 was administered to rats at 0.5-1.0 mg/kg i.v., a significant enhancement in learning was obsd. using a hippocampus-dependent trace eyeblink conditioning paradigm.  These data indicate that the Glyxins are a new class of NMDA receptor modulators that may have therapeutic potential.  Based on the broad agonist range in vitro and the potent cognitive-enhancing properties in a valid in vivo model of learning, GLYX-13 is a new drug candidate with potential for the treatment of cognitive disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6lXatf4j137Vg90H21EOLACvtfcHk0ljgYF1YXKgW1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFehsLzN&md5=ffea1f50f3b57a761fb1ce63e5706664</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2005.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2005.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DMoskal%26aufirst%3DJ.%2BR.%26aulast%3DKuo%26aufirst%3DA.%2BG.%26aulast%3DWeiss%26aufirst%3DC.%26aulast%3DWood%26aufirst%3DP.%2BL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DH.%2BA.%26aulast%3DKelso%26aufirst%3DS.%26aulast%3DHarris%26aufirst%3DR.%2BB.%26aulast%3DDisterhoft%26aufirst%3DJ.%2BF.%26atitle%3DGLYX-13%253A%2520a%2520monoclonal%2520antibody-derived%2520peptide%2520that%2520acts%2520as%2520an%2520N-methyl-D-aspartate%2520receptor%2520modulator%26jtitle%3DNeuropharmacology%26date%3D2005%26volume%3D49%26spage%3D1077%26epage%3D1087%26doi%3D10.1016%2Fj.neuropharm.2005.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moskal, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgdorf, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroes, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stanton, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Disterhoft, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leander, J. D.</span></span> <span> </span><span class="NLM_article-title">GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1517/13543784.2014.852536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1517%2F13543784.2014.852536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=24251380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvFarsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2014&pages=243-254&author=J.+R.+Moskalauthor=R.+Burchauthor=J.+S.+Burgdorfauthor=R.+A.+Kroesauthor=P.+K.+Stantonauthor=J.+F.+Disterhoftauthor=J.+D.+Leander&title=GLYX-13%2C+an+NMDA+receptor+glycine+site+functional+partial+agonist+enhances+cognition+and+produces+antidepressant+effects+without+the+psychotomimetic+side+effects+of+NMDA+receptor+antagonists&doi=10.1517%2F13543784.2014.852536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists</span></div><div class="casAuthors">Moskal, Joseph R.; Burch, Ronald; Burgdorf, Jeffrey S.; Kroes, Roger A.; Stanton, Patric K.; Disterhoft, John F.; Leander, J. David</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Investigational Drugs</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">243-254</span>CODEN:
                <span class="NLM_cas:coden">EOIDER</span>;
        ISSN:<span class="NLM_cas:issn">1354-3784</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: The N-methyl-D-aspartate receptor-ionophore complex plays a key role in learning and memory and has efficacy in animals and humans with affective disorders.  GLYX-13 is an N-methyl-d-aspartate receptor (NMDAR) glycine-site functional partial agonist and cognitive enhancer that also shows rapid antidepressant activity without psychotomimetic side effects.  Areas covered: The authors review the mechanism of action of GLYX-13 that was investigated in preclin. studies and evaluated in clin. studies.  Specifically, the authors review its pharmacol., pharmacokinetics, and drug safety that were demonstrated in clin. studies.  Expert opinion: NMDAR full antagonists can produce rapid antidepressant effects in treatment-resistant subjects; however, they are often accompanied by psychotomimetic effects that make chronic use outside of a clin. trial inpatient setting problematic.  GLYX-13 appears to exert its antidepressant effects in the frontal cortex via NMDAR-triggered synaptic plasticity.  Understanding the mechanistic underpinning of GLYX-13's antidepressant action should provide both novel insights into the role of the glutamatergic system in depression and identify new targets for therapeutic development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1qLFmRChVArVg90H21EOLACvtfcHk0lgzlvh8HdGpCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvFarsA%253D%253D&md5=438f7150450c25f13107b9ed359c5a75</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1517%2F13543784.2014.852536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543784.2014.852536%26sid%3Dliteratum%253Aachs%26aulast%3DMoskal%26aufirst%3DJ.%2BR.%26aulast%3DBurch%26aufirst%3DR.%26aulast%3DBurgdorf%26aufirst%3DJ.%2BS.%26aulast%3DKroes%26aufirst%3DR.%2BA.%26aulast%3DStanton%26aufirst%3DP.%2BK.%26aulast%3DDisterhoft%26aufirst%3DJ.%2BF.%26aulast%3DLeander%26aufirst%3DJ.%2BD.%26atitle%3DGLYX-13%252C%2520an%2520NMDA%2520receptor%2520glycine%2520site%2520functional%2520partial%2520agonist%2520enhances%2520cognition%2520and%2520produces%2520antidepressant%2520effects%2520without%2520the%2520psychotomimetic%2520side%2520effects%2520of%2520NMDA%2520receptor%2520antagonists%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2014%26volume%3D23%26spage%3D243%26epage%3D254%26doi%3D10.1517%2F13543784.2014.852536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span>Clinicaltrials.gov: NCT03560518; NCT02943577;
NCT02943564; NCT02932943;
NCT03614156; NCT03002077; NCT02951988.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Clinicaltrials.gov%3A+NCT03560518%3B+NCT02943577%3B%0ANCT02943564%3B+NCT02932943%3B%0ANCT03614156%3B+NCT03002077%3B+NCT02951988."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Allergan</span>.  <i>Data on Allergan’s Rapastinel and NRX-1074 (AGN-241660)
presented at the Society for Neuroscience (SfN) Annual Meeting</i>; <span class="NLM_publisher-name">Allergan</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=Allergan&title=Data+on+Allergan%E2%80%99s+Rapastinel+and+NRX-1074+%28AGN-241660%29%0Apresented+at+the+Society+for+Neuroscience+%28SfN%29+Annual+Meeting"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3D%26btitle%3DData%2520on%2520Allergan%25E2%2580%2599s%2520Rapastinel%2520and%2520NRX-1074%2520%2528AGN-241660%2529%250Apresented%2520at%2520the%2520Society%2520for%2520Neuroscience%2520%2528SfN%2529%2520Annual%2520Meeting%26pub%3DAllergan%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burnell, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapkota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span> <span> </span><span class="NLM_article-title">Positive and negative allosteric modulators of N-methyl-d-aspartate (NMDA) Receptors: structure activity relationships and mechanisms of action</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">23</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01640</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01640" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1cXivFCntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=3-23&author=E.+S.+Burnellauthor=M.+Irvineauthor=G.+Fangauthor=K.+Sapkotaauthor=D.+E.+Janeauthor=D.+T.+Monaghan&title=Positive+and+negative+allosteric+modulators+of+N-methyl-d-aspartate+%28NMDA%29+Receptors%3A+structure+activity+relationships+and+mechanisms+of+action&doi=10.1021%2Facs.jmedchem.7b01640"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Positive and Negative Allosteric Modulators of N-Methyl-D-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action</span></div><div class="casAuthors">Burnell, Erica S.; Irvine, Mark; Fang, Guangyu; Sapkota, Kiran; Jane, David E.; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-23</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Excitatory activity in the CNS is predominately mediated by L-glutamate through several families of L-glutamate neurotransmitter receptors.  Of these, the N-methyl-D-aspartate receptor (NMDAR) family has many crit. roles in CNS function and in various neuropathol. and psychiatric conditions.  Until recently, the types of compds. available to regulate NMDAR function have been quite limited in terms of mechanism of action, subtype selectivity, and biol. effect.  However, several new classes of NMDAR agents have now been identified that are pos. or neg. allosteric modulators (PAMs and NAMs, resp.) with various patterns of NMDAR subtype selectivity.  These new agents act at several newly recognized binding sites on the NMDAR complex and offer significantly greater pharmacol. control over NMDAR activity than previously available agents.  The purpose of this review is to summarize the structure-activity relationships for these new NMDAR modulator drug classes and to describe the current understanding of their mechanisms of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDN2OGZJwr-LVg90H21EOLACvtfcHk0lgzlvh8HdGpCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXivFCntbk%253D&md5=2b9bc7f16ea2b763895334409c6beae0</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01640&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01640%26sid%3Dliteratum%253Aachs%26aulast%3DBurnell%26aufirst%3DE.%2BS.%26aulast%3DIrvine%26aufirst%3DM.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DSapkota%26aufirst%3DK.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DPositive%2520and%2520negative%2520allosteric%2520modulators%2520of%2520N-methyl-d-aspartate%2520%2528NMDA%2529%2520Receptors%253A%2520structure%2520activity%2520relationships%2520and%2520mechanisms%2520of%2520action%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D3%26epage%3D23%26doi%3D10.1021%2Facs.jmedchem.7b01640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span> <span> </span><span class="NLM_article-title">Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators</span>. <i>Neurochem. Int.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">592</span>, <span class="refDoi"> DOI: 10.1016/j.neuint.2012.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuint.2012.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=22269804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtVOrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2012&pages=581-592&author=D.+T.+Monaghanauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=G.+Fangauthor=D.+E.+Jane&title=Pharmacological+modulation+of+NMDA+receptor+activity+and+the+advent+of+negative+and+positive+allosteric+modulators&doi=10.1016%2Fj.neuint.2012.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators</span></div><div class="casAuthors">Monaghan, Daniel T.; Irvine, Mark W.; Costa, Blaise Mathias; Fang, Guangyu; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemistry International</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">581-592</span>CODEN:
                <span class="NLM_cas:coden">NEUIDS</span>;
        ISSN:<span class="NLM_cas:issn">0197-0186</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The NMDA receptor (NMDAR) family of l-glutamate receptors are well known to have diverse roles in CNS function as well as in various neuropathol. and psychiatric conditions.  Until recently, the types of agents available to pharmacol. regulate NMDAR function have been quite limited in terms of mechanism of action and subtype selectivity.  This has changed significantly in the past two years.  The purpose of this review is to summarize the many drug classes now available for modulating NMDAR activity.  Previously, this included competitive antagonists at the l-glutamate and glycine binding sites, high and low affinity channel blockers, and GluN2B-selective N-terminal domain binding site antagonists.  More recently, we and others have identified new classes of NMDAR agents that are either pos. or neg. allosteric modulators (PAMs and NAMs, resp.).  These compds. include the pan potentiator UBP646, the GluN2A-selective potentiator/GluN2C and GluN2D inhibitor UBP512, the GluN2D-selective potentiator UBP551, the GluN2C/GluN2D-selective potentiator CIQ as well as the new NMDAR-NAMs such as the pan-inhibitor UBP618, the GluN2C/GluN2D-selective inhibitor QZN46 and the GluN2A inhibitors UBP608 and TCN201.  These new agents do not bind within the l-glutamate or glycine binding sites, the ion channel pore or the N-terminal regulatory domain.  Collectively, these new allosteric modulators appear to be acting at multiple novel sites on the NMDAR complex.  Importantly, these agents display improved subtype-selectivity and as NMDAR PAMs and NAMs, they represent a new generation of potential NMDAR therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbjX9esQoLw7Vg90H21EOLACvtfcHk0lg7T5JZV93zFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtVOrsLk%253D&md5=451c3bb058975f210b9936e67079392f</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.neuint.2012.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuint.2012.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DPharmacological%2520modulation%2520of%2520NMDA%2520receptor%2520activity%2520and%2520the%2520advent%2520of%2520negative%2520and%2520positive%2520allosteric%2520modulators%26jtitle%3DNeurochem.%2520Int.%26date%3D2012%26volume%3D61%26spage%3D581%26epage%3D592%26doi%3D10.1016%2Fj.neuint.2012.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Collingridge, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volianskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">France, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanna, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tidball, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bortolotto, Z. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molńr, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lodge, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span> <span> </span><span class="NLM_article-title">The NMDA receptor as a target for cognitive enhancement</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">26</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.051</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuropharm.2012.06.051" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=22796429" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=13-26&author=G.+L.+Collingridgeauthor=A.+Volianskisauthor=N.+Bannisterauthor=G.+Franceauthor=L.+Hannaauthor=M.+Mercierauthor=P.+Tidballauthor=G.+Fangauthor=M.+W.+Irvineauthor=B.+M.+Costaauthor=D.+T.+Monaghanauthor=Z.+A.+Bortolottoauthor=E.+Mol%C5%84rauthor=D.+Lodgeauthor=D.+E.+Jane&title=The+NMDA+receptor+as+a+target+for+cognitive+enhancement&doi=10.1016%2Fj.neuropharm.2012.06.051"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">The NMDA receptor as a target for cognitive enhancement</span></div><div class="casAuthors">Collingridge, Graham L.; Volianskis, Arturas; Bannister, Neil; France, Grace; Hanna, Lydia; Mercier, Marion; Tidball, Patrick; Fang, Guangyu; Irvine, Mark W.; Costa, Blaise M.; Monaghan, Daniel T.; Bortolotto, Zuner A.; Molnar, Elek; Lodge, David; Jane, David E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-26</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NMDA receptors (NMDARs) play an important role in neural plasticity including long-term potentiation and long-term depression, which are likely to explain their importance for learning and memory.  Cognitive decline is a major problem facing an aging human population, so much so that its reversal has become an important goal for scientific research and pharmaceutical development.  Enhancement of NMDAR function is a core strategy toward this goal.  In this review we indicate some of the major ways of potentiating NMDAR function by both direct and indirect modulation.  There is good evidence that both pos. and neg. modulation can enhance function suggesting that a subtle approach correcting imbalances in particular clin. situations will be required.  Excessive activation and the resultant deleterious effects will need to be carefully avoided.  Finally we describe some novel pos. allosteric modulators of NMDARs, with some subunit selectivity, and show initial evidence of their ability to affect NMDAR mediated events.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwosQmB8cQb7Vg90H21EOLACvtfcHk0lg7T5JZV93zFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFahsL3P&md5=4d63552250a5bb940a8d0a7a2d51fd75</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.051&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.051%26sid%3Dliteratum%253Aachs%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DVolianskis%26aufirst%3DA.%26aulast%3DBannister%26aufirst%3DN.%26aulast%3DFrance%26aufirst%3DG.%26aulast%3DHanna%26aufirst%3DL.%26aulast%3DMercier%26aufirst%3DM.%26aulast%3DTidball%26aufirst%3DP.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26aulast%3DBortolotto%26aufirst%3DZ.%2BA.%26aulast%3DMol%25C5%2584r%26aufirst%3DE.%26aulast%3DLodge%26aufirst%3DD.%26aulast%3DJane%26aufirst%3DD.%2BE.%26atitle%3DThe%2520NMDA%2520receptor%2520as%2520a%2520target%2520for%2520cognitive%2520enhancement%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D13%26epage%3D26%26doi%3D10.1016%2Fj.neuropharm.2012.06.051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Malayev, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibbs, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farb, D. H.</span></span> <span> </span><span class="NLM_article-title">Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">901</span>– <span class="NLM_lpage">909</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0704543</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1038%2Fsj.bjp.0704543" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=11861317" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD38Xit1CntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2002&pages=901-909&author=A.+Malayevauthor=T.+T.+Gibbsauthor=D.+H.+Farb&title=Inhibition+of+the+NMDA+response+by+pregnenolone+sulphate+reveals+subtype+selective+modulation+of+NMDA+receptors+by+sulphated+steroids&doi=10.1038%2Fsj.bjp.0704543"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids</span></div><div class="casAuthors">Malayev, Andrew; Gibbs, Terrell T.; Farb, David H.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">901-909</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The neurosteroid pregnenolone sulfate (PS) potentiates N-methyl-D-aspartate (NMDA) receptor mediated responses in various neuronal prepns.  The NR1 subunit can combine with NR2A, NR2B, NR2C, or NR2D subunits to form functional receptors.  Differential NR2 subunit expression in brain and during development raises the question of how the NR2 subunit influences NMDA receptor modulation by neuroactive steroids.  The authors examd. the effects of PS on the four diheteromeric NMDA receptor subtypes generated by co-expressing the NR1100 subunit with each of the four NR2 subunits in Xenopus oocytes.  Whereas PS potentiated NMDA-, glutamate-, and glycine-induced currents of NR1/NR2A and NR1/NR2B receptors, it was inhibitory at NR1/NR2C and NR1/NR2D receptors.  In contrast, pregnanolone sulfate (3α5βS), a neg. modulator of the NMDA receptor that acts at a distinct site from PS, inhibited all four subtypes, but was approx. 4-fold more potent at NR1/NR2C and NR1/NR2D than at NR1/NR2A and NR1/NR2B receptors.  These findings demonstrate that residues on the NR2 subunit are key determinants of modulation by PS and 3α5βS.  The modulatory effects of PS, but not 3α5βS, on dose-response curves for NMDA, glutamate, and glycine are consistent with a two-state model in which PS either stabilizes or destabilizes the active state of the receptor, depending upon which NR2 subunit is present.  The selectivity of sulfated steroid modulators for NMDA receptors of specific subunit compn. is consistent with a neuromodulatory role for endogenous sulfated steroids.  The results indicate that it may be possible to develop therapeutic agents that target steroid modulatory sites of specific NMDA receptor subtypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfxjDMjy0jsrVg90H21EOLACvtfcHk0lhw0K09HoSg_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xit1CntLk%253D&md5=dae9a8ea2c48ecc4fa74140772b00ccb</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704543&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704543%26sid%3Dliteratum%253Aachs%26aulast%3DMalayev%26aufirst%3DA.%26aulast%3DGibbs%26aufirst%3DT.%2BT.%26aulast%3DFarb%26aufirst%3DD.%2BH.%26atitle%3DInhibition%2520of%2520the%2520NMDA%2520response%2520by%2520pregnenolone%2520sulphate%2520reveals%2520subtype%2520selective%2520modulation%2520of%2520NMDA%2520receptors%2520by%2520sulphated%2520steroids%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D135%26spage%3D901%26epage%3D909%26doi%3D10.1038%2Fsj.bjp.0704543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vlcek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chodounska, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vyklicky, L.,  Jr.</span></span> <span> </span><span class="NLM_article-title">Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>137</i></span>,  <span class="NLM_fpage">93</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2005.08.058</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuroscience.2005.08.058" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=16257494" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsFKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=137&publication_year=2006&pages=93-102&author=M.+Horakauthor=K.+Vlcekauthor=H.+Chodounskaauthor=L.+Vyklicky&title=Subtype-dependence+of+N-methyl-D-aspartate+receptor+modulation+by+pregnenolone+sulfate&doi=10.1016%2Fj.neuroscience.2005.08.058"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Subtype-dependence of N-methyl-D-aspartate receptor modulation by pregnenolone sulfate</span></div><div class="casAuthors">Horak, M.; Vlcek, K.; Chodounska, H.; Vyklicky, L.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">137</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93-102</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate receptors play a crit. role in synaptogenesis, synaptic plasticity, and excitotoxicity.  They are heteromeric complexes of NR1 combined with NR2A-D and/or NR3A-B subunits.  The subunit compn. dets. the biophys. and pharmacol. properties of the N-methyl-D-aspartate receptor channel complex.  In this study, the authors report that responses mediated by recombinant rat N-methyl-D-aspartate receptors expressed in human embryonic kidney HEK293 cells are differentially affected by naturally occurring neurosteroid pregnenolone sulfate.  The authors show that responses induced by 1 mM glutamate in NR1-1a/NR2A and NR1-1a/NR2B receptors are potentiated five- to eight-fold more by pregnenolone sulfate than responses of NR1-1a/NR2C and NR1-1a/NR2D receptors with no differences in the concn. of pregnenolone sulfate that produced 50% potentiation.  In addn. to potentiation, pregnenolone sulfate also has an inhibitory effect at recombinant N-methyl-D-aspartate receptors, with values of the concn. of pregnenolone sulfate that produces 50% inhibition of NR1/NR2D=NR1/NR2C<NR1/NR2B<NR1/NR2A.  In addn., the authors show that the structure of the extracellular loop between the third and fourth transmembrane domains of the NR2 subunit is crit. for both the potentiating and inhibitory effects of pregnenolone sulfate.  The modulatory effects of pregnenolone sulfate are consistent with a model in which this neurosteroid acts at two distinct binding sites on the N-methyl-D-aspartate receptor.  These data provide insight into the mechanisms by which pregnenolone sulfate and related sulfated neurosteroids modulate activity of N-methyl-D-aspartate receptor channels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9RQ7MIHbT5LVg90H21EOLACvtfcHk0lhw0K09HoSg_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsFKitg%253D%253D&md5=479309e4152abd84f6f79d4e566ce7df</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2005.08.058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2005.08.058%26sid%3Dliteratum%253Aachs%26aulast%3DHorak%26aufirst%3DM.%26aulast%3DVlcek%26aufirst%3DK.%26aulast%3DChodounska%26aufirst%3DH.%26aulast%3DVyklicky%26aufirst%3DL.%26atitle%3DSubtype-dependence%2520of%2520N-methyl-D-aspartate%2520receptor%2520modulation%2520by%2520pregnenolone%2520sulfate%26jtitle%3DNeuroscience%26date%3D2006%26volume%3D137%26spage%3D93%26epage%3D102%26doi%3D10.1016%2Fj.neuroscience.2005.08.058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doherty, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robichaud, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belfort, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawford, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linsenbardt, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shu, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mennerick, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zorumski, C. F.</span></span> <span> </span><span class="NLM_article-title">The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">17290</span>– <span class="NLM_lpage">17300</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.2619-13.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1523%2FJNEUROSCI.2619-13.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=24174662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslCjtrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=17290-17300&author=S.+M.+Paulauthor=J.+J.+Dohertyauthor=A.+J.+Robichaudauthor=G.+M.+Belfortauthor=B.+Y.+Chowauthor=R.+S.+Hammondauthor=D.+C.+Crawfordauthor=A.+J.+Linsenbardtauthor=H.+J.+Shuauthor=Y.+Izumiauthor=S.+J.+Mennerickauthor=C.+F.+Zorumski&title=The+major+brain+cholesterol+metabolite+24%28S%29-hydroxycholesterol+is+a+potent+allosteric+modulator+of+N-methyl-D-aspartate+receptors&doi=10.1523%2FJNEUROSCI.2619-13.2013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">The major brain cholesterol metabolite 24(S)-hydroxycholesterol is a potent allosteric modulator of N-methyl-D-aspartate receptors</span></div><div class="casAuthors">Paul, Steven M.; Doherty, James J.; Robichaud, Albert J.; Belfort, Gabriel M.; Chow, Brian Y.; Hammond, Rebecca S.; Crawford, Devon C.; Linsenbardt, Andrew J.; Shu, Hong-Jin; Izumi, Yukitoshi; Mennerick, Steven J.; Zorumski, Charles F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">17290-17300</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate receptors (NMDARs) are glutamate-gated ion channels that are crit. to the regulation of excitatory synaptic function in the CNS.  NMDARs govern experience-dependent synaptic plasticity and have been implicated in the pathophysiol. of various neuropsychiatric disorders including the cognitive deficits of schizophrenia and certain forms of autism.  Certain neurosteroids modulate NMDARs exptl. but their low potency, poor selectivity, and very low brain concns. make them poor candidates as endogenous ligands or therapeutic agents.  Here we show that the major brain-derived cholesterol metabolite 24(S)-hydroxycholesterol (24(S)-HC) is a very potent, direct, and selective pos. allosteric modulator of NMDARs with a mechanism that does not overlap that of other allosteric modulators.  At submicromolar concns. 24(S)-HC potentiates NMDAR-mediated EPSCs in rat hippocampal neurons but fails to affect AMPAR or GABAA receptors (GABAARs)-mediated responses.  Cholesterol itself and other naturally occurring oxysterols present in brain do not modulate NMDARs at concns. ≤10 μM.  In hippocampal slices, 24(S)-HC enhances the ability of subthreshold stimuli to induce long-term potentiation (LTP).  24(S)-HC also reverses hippocampal LTP deficits induced by the NMDAR channel blocker ketamine.  Finally, we show that synthetic drug-like derivs. of 24(S)-HC, which potently enhance NMDAR-mediated EPSCs and LTP, restore behavioral and cognitive deficits in rodents treated with NMDAR channel blockers.  Thus, 24(S)-HC may function as an endogenous modulator of NMDARs acting at a novel oxysterol modulatory site that also represents a target for therapeutic drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDNdn3JBVmtLVg90H21EOLACvtfcHk0lhLgSiw4bnPHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslCjtrbI&md5=35ab8bb8030a4ac752f224f8cd942fb4</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.2619-13.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.2619-13.2013%26sid%3Dliteratum%253Aachs%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DDoherty%26aufirst%3DJ.%2BJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26aulast%3DBelfort%26aufirst%3DG.%2BM.%26aulast%3DChow%26aufirst%3DB.%2BY.%26aulast%3DHammond%26aufirst%3DR.%2BS.%26aulast%3DCrawford%26aufirst%3DD.%2BC.%26aulast%3DLinsenbardt%26aufirst%3DA.%2BJ.%26aulast%3DShu%26aufirst%3DH.%2BJ.%26aulast%3DIzumi%26aufirst%3DY.%26aulast%3DMennerick%26aufirst%3DS.%2BJ.%26aulast%3DZorumski%26aufirst%3DC.%2BF.%26atitle%3DThe%2520major%2520brain%2520cholesterol%2520metabolite%252024%2528S%2529-hydroxycholesterol%2520is%2520a%2520potent%2520allosteric%2520modulator%2520of%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D2013%26volume%3D33%26spage%3D17290%26epage%3D17300%26doi%3D10.1523%2FJNEUROSCI.2619-13.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mony, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, P.</span></span> <span> </span><span class="NLM_article-title">Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines</span>. <i>EMBO J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">3134</span>– <span class="NLM_lpage">3146</span>, <span class="refDoi"> DOI: 10.1038/emboj.2011.203</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1038%2Femboj.2011.203" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=21685875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnslSmtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2011&pages=3134-3146&author=L.+Monyauthor=S.+Zhuauthor=S.+Carvalhoauthor=P.+Paoletti&title=Molecular+basis+of+positive+allosteric+modulation+of+GluN2B+NMDA+receptors+by+polyamines&doi=10.1038%2Femboj.2011.203"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular basis of positive allosteric modulation of GluN2B NMDA receptors by polyamines</span></div><div class="casAuthors">Mony, Laetitia; Zhu, Shujia; Carvalho, Stephanie; Paoletti, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">3134-3146</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">NMDA receptors (NMDARs) form glutamate-gated ion channels that have central roles in neuronal communication and plasticity throughout the brain.  Dysfunctions of NMDARs are involved in several central nervous system disorders, including stroke, chronic pain and schizophrenia.  One hallmark of NMDARs is that their activity can be allosterically regulated by a variety of extracellular small ligands.  While much has been learned recently regarding allosteric inhibition of NMDARs, the structural determinants underlying pos. allosteric modulation of these receptors remain poorly defined.  Polyamines, naturally occurring polycations that selectively enhance NMDARs contg. the GluN2B subunit, bind at a dimer interface between GluN1 and GluN2B subunit N-terminal domains (NTDs).  Polyamines act by shielding neg. charges present on GluN1 and GluN2B NTD lower lobes, allowing their close apposition, an effect that in turn prevents NTD clamshell closure.  The authors' work reveals the mechanistic basis for pos. allosteric modulation of NMDARs.  It provides the first example of an intersubunit binding site in this class of receptors, a discovery that holds promise for future drug interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJznH0dGqqFrVg90H21EOLACvtfcHk0lhLgSiw4bnPHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnslSmtbg%253D&md5=fdefbcfe99f7538c90ea3d6d1a0c7c9b</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1038%2Femboj.2011.203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2011.203%26sid%3Dliteratum%253Aachs%26aulast%3DMony%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DCarvalho%26aufirst%3DS.%26aulast%3DPaoletti%26aufirst%3DP.%26atitle%3DMolecular%2520basis%2520of%2520positive%2520allosteric%2520modulation%2520of%2520GluN2B%2520NMDA%2520receptors%2520by%2520polyamines%26jtitle%3DEMBO%2520J.%26date%3D2011%26volume%3D30%26spage%3D3134%26epage%3D3146%26doi%3D10.1038%2Femboj.2011.203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Costa, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eaves, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayo-Martin, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skifter, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span> <span> </span><span class="NLM_article-title">A novel family of negative and positive allosteric modulators of NMDA receptors</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>335</i></span>,  <span class="NLM_fpage">614</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.174144</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1124%2Fjpet.110.174144" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=20858708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2010&pages=614-621&author=B.+M.+Costaauthor=M.+W.+Irvineauthor=G.+Fangauthor=R.+J.+Eavesauthor=M.+B.+Mayo-Martinauthor=D.+A.+Skifterauthor=D.+E.+Janeauthor=D.+T.+Monaghan&title=A+novel+family+of+negative+and+positive+allosteric+modulators+of+NMDA+receptors&doi=10.1124%2Fjpet.110.174144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A novel family of negative and positive allosteric modulators of NMDA receptors</span></div><div class="casAuthors">Costa, Blaise Mathias; Irvine, Mark W.; Fang, Guangyu; Eaves, Richard J.; Mayo-Martin, Marie Belen; Skifter, Donald A.; Jane, David E.; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">614-621</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate (NMDA) receptor family regulates various central nervous system functions, such as synaptic plasticity.  However, hypo- or hyperactivation of NMDA receptors is critically involved in many neurol. and psychiatric conditions, such as pain, stroke, epilepsy, neurodegeneration, schizophrenia, and depression.  Consequently, subtype-selective pos. and neg. modulators of NMDA receptor function have many potential therapeutic applications not addressed by currently available compds.  We have identified allosteric modulators with several novel patterns of NMDA receptor subtype selectivity that have a novel mechanism of action.  In a series of carboxylated naphthalene and phenanthrene derivs., compds. were identified that selectively potentiate responses at GluN1/GluN2A [e.g., 9-iodophenanthrene-3-carboxylic acid (UBP512)]; GluN1/GluN2A and GluN1/GluN2B [9-cyclopropylphenanthrene-3-carboxylic acid (UBP710)]; GluN1/GluN2D [3,5-dihydroxynaphthalene-2-carboxylic acid (UBP551)]; or GluN1/GluN2C and GluN1/GluN2D receptors [6-, 7-, 8-, and 9-nitro isomers of naphth[1,2-c][1,2,5]oxadiazole-5-sulfonic acid (NSC339614)] and have no effect or inhibit responses at the other NMDA receptors.  Selective inhibition was also obsd.; UBP512 inhibits only GluN1/GluN2C and GluN1/GluN2D receptors, whereas 6-bromo-2-oxo-2H-chromene-3-carboxylic acid (UBP608) inhibits GluN1/GluN2A receptors with a 23-fold selectivity compared with GluN1/GluN2D receptors.  The actions of these compds. were not competitive with the agonists L-glutamate or glycine and were not voltage-dependent.  Whereas the N-terminal regulatory domain was not necessary for activity of either potentiators or inhibitors, segment 2 of the agonist ligand-binding domain was important for potentiating activity, whereas subtype-specific inhibitory activity was dependent upon segment 1.  In terms of chem. structure, activity profile, and mechanism of action, these modulators represent a new class of pharmacol. agents for the study of NMDA receptor subtype function and provide novel lead compds. for a variety of neurol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQ9F9N6PVoh7Vg90H21EOLACvtfcHk0lguqc9NJTeGTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFOmsrnI&md5=cefc65523d06856f6dd704274ecb6f22</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.174144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.174144%26sid%3Dliteratum%253Aachs%26aulast%3DCosta%26aufirst%3DB.%2BM.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DEaves%26aufirst%3DR.%2BJ.%26aulast%3DMayo-Martin%26aufirst%3DM.%2BB.%26aulast%3DSkifter%26aufirst%3DD.%2BA.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DA%2520novel%2520family%2520of%2520negative%2520and%2520positive%2520allosteric%2520modulators%2520of%2520NMDA%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2010%26volume%3D335%26spage%3D614%26epage%3D621%26doi%3D10.1124%2Fjpet.110.174144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sapkota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Irvine, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burnell, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bannister, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volianskis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Culley, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dravid, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collingridge, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jane, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monaghan, D. T.</span></span> <span> </span><span class="NLM_article-title">Mechanism and properties of positive allosteric modulation of N-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>125</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">79</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2017.07.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuropharm.2017.07.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=28709671" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtF2htr%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2017&pages=64-79&author=K.+Sapkotaauthor=M.+W.+Irvineauthor=G.+Fangauthor=E.+S.+Burnellauthor=N.+Bannisterauthor=A.+Volianskisauthor=G.+R.+Culleyauthor=S.+M.+Dravidauthor=G.+L.+Collingridgeauthor=D.+E.+Janeauthor=D.+T.+Monaghan&title=Mechanism+and+properties+of+positive+allosteric+modulation+of+N-methyl-d-aspartate+receptors+by+6-alkyl+2-naphthoic+acid+derivatives&doi=10.1016%2Fj.neuropharm.2017.07.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism and properties of positive allosteric modulation of n-methyl-d-aspartate receptors by 6-alkyl 2-naphthoic acid derivatives</span></div><div class="casAuthors">Sapkota, Kiran; Irvine, Mark W.; Fang, Guangyu; Burnell, Erica S.; Bannister, Neil; Volianskis, Arturas; Culley, Georgia R.; Dravid, Shashank M.; Collingridge, Graham L.; Jane, David E.; Monaghan, Daniel T.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">125</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">64-79</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The theory that N-methyl-D-aspartate receptor (NMDAR) hypofunction is responsible for the symptoms of schizophrenia is well supported by many pharmacol. and genetic studies.  Accordingly, pos. allosteric modulators (PAMs) that augment NMDAR signaling may be useful for treating schizophrenia.  Previously we have identified several NMDAR PAMs contg. a carboxylic acid attached to naphthalene, phenanthrene, or coumarin ring systems.  In this study, we describe several functional and mechanistic properties of UBP684, a 2-naphthoic acid deriv., which robustly potentiates agonist responses at each of the four GluN1a/GluN2 receptors and at neuronal NMDARs.  UBP684 increases the maximal L-glutamate/glycine response while having minor subunit-specific effects on agonist potency.  PAM binding is independent of agonist binding, and PAM activity is independent of membrane voltage, redox state, and the GluN1 exon 5 N-terminal insert.  UBP684 activity is, however, markedly pH-dependent, with greater potentiation occurring at lower pHs and inhibitory activity at pH 8.4.  UBP684 increases channel open probability (Po) and slows receptor deactivation time upon removal of L-glutamate, but not glycine.  The structurally related PAM, UBP753, reproduced most of these findings, but did not prolong agonist removal deactivation time.  Studies using cysteine mutants to lock the GluN1 and GluN2 ligand-binding domains (LBDs) in the agonist-bound states indicate that PAM potentiation requires GluN2 LBD conformational flexibility.  Together, these findings suggest that UBP684 and UBP753 stabilize the GluN2 LBD in an active conformation and thereby increase Po.  Thus, UBP684 and UBP753 may serve as lead compds. for developing agents to enhance NMDAR activity in disorders assocd. with NMDAR hypofunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqtmyAYdoW9rVg90H21EOLACvtfcHk0lguqc9NJTeGTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtF2htr%252FL&md5=c5ec93c00e1d39fb12593b89f7236572</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2017.07.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2017.07.007%26sid%3Dliteratum%253Aachs%26aulast%3DSapkota%26aufirst%3DK.%26aulast%3DIrvine%26aufirst%3DM.%2BW.%26aulast%3DFang%26aufirst%3DG.%26aulast%3DBurnell%26aufirst%3DE.%2BS.%26aulast%3DBannister%26aufirst%3DN.%26aulast%3DVolianskis%26aufirst%3DA.%26aulast%3DCulley%26aufirst%3DG.%2BR.%26aulast%3DDravid%26aufirst%3DS.%2BM.%26aulast%3DCollingridge%26aufirst%3DG.%2BL.%26aulast%3DJane%26aufirst%3DD.%2BE.%26aulast%3DMonaghan%26aufirst%3DD.%2BT.%26atitle%3DMechanism%2520and%2520properties%2520of%2520positive%2520allosteric%2520modulation%2520of%2520N-methyl-d-aspartate%2520receptors%2520by%25206-alkyl%25202-naphthoic%2520acid%2520derivatives%26jtitle%3DNeuropharmacology%26date%3D2017%26volume%3D125%26spage%3D64%26epage%3D79%26doi%3D10.1016%2Fj.neuropharm.2017.07.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mullasseril, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vance, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurtkaya, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santangelo, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellano, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">90</span>, <span class="refDoi"> DOI: 10.1038/ncomms1085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1038%2Fncomms1085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=20981015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=90&author=P.+Mullasserilauthor=K.+B.+Hansenauthor=K.+M.+Vanceauthor=K.+K.+Ogdenauthor=H.+Yuanauthor=N.+L.+Kurtkayaauthor=R.+Santangeloauthor=A.+G.+Orrauthor=P.+Leauthor=K.+M.+Vellanoauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=A+subunit-selective+potentiator+of+NR2C-+and+NR2D-containing+NMDA+receptors&doi=10.1038%2Fncomms1085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors</span></div><div class="casAuthors">Mullasseril Praseeda; Hansen Kasper B; Vance Katie M; Ogden Kevin K; Yuan Hongjie; Kurtkaya Natalie L; Santangelo Rose; Orr Anna G; Le Phuong; Vellano Kimberly M; Liotta Dennis C; Traynelis Stephen F</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">NMDA receptors are tetrameric complexes of NR1 and NR2A-D subunits that mediate excitatory synaptic transmission and have a role in neurological disorders.  In this article, we identify a novel subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit, which could allow selective modification of circuit function in regions expressing NR2C/D subunits.  The substituted tetrahydroisoquinoline CIQ (3-chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone) enhances receptor responses two-fold with an EC(50) of 3 μM by increasing channel opening frequency without altering mean open time or EC(50) values for glutamate or glycine.  The actions of CIQ depend on a single residue in the M1 region (NR2D Thr592) and on the linker between the N-terminal domain and agonist binding domain.  CIQ potentiates native NR2D-containing NMDA receptor currents from subthalamic neurons.  Our identification of a subunit-selective NMDA receptor modulator reveals a new class of pharmacological tools with which to probe the role of NR2C- and NR2D-containing NMDA receptors in brain function and disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtyzdcP07UmufW6udTcc2eYO_iV1RKIy6bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtA%253D%253D&md5=8cde7c73dc6bf72ea3050c21db4f5ad4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fncomms1085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1085%26sid%3Dliteratum%253Aachs%26aulast%3DMullasseril%26aufirst%3DP.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DVance%26aufirst%3DK.%2BM.%26aulast%3DOgden%26aufirst%3DK.%2BK.%26aulast%3DYuan%26aufirst%3DH.%26aulast%3DKurtkaya%26aufirst%3DN.%2BL.%26aulast%3DSantangelo%26aufirst%3DR.%26aulast%3DOrr%26aufirst%3DA.%2BG.%26aulast%3DLe%26aufirst%3DP.%26aulast%3DVellano%26aufirst%3DK.%2BM.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DA%2520subunit-selective%2520potentiator%2520of%2520NR2C-%2520and%2520NR2D-containing%2520NMDA%2520receptors%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D90%26doi%3D10.1038%2Fncomms1085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khatri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanger, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karakas, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furukawa, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1124/mol.114.094516</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1124%2Fmol.114.094516" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=25205677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFSlur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2014&pages=548-560&author=A.+Khatriauthor=P.+B.+Burgerauthor=S.+A.+Swangerauthor=K.+B.+Hansenauthor=S.+Zimmermanauthor=E.+Karakasauthor=D.+C.+Liottaauthor=H.+Furukawaauthor=J.+P.+Snyderauthor=S.+F.+Traynelis&title=Structural+determinants+and+mechanism+of+action+of+a+GluN2C-selective+NMDA+receptor+positive+allosteric+modulator&doi=10.1124%2Fmol.114.094516"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator</span></div><div class="casAuthors">Khatri, Alpa; Burger, Pieter B.; Swanger, Sharon A.; Hansen, Kasper B.; Zimmerman, Sommer; Karakas, Erkan; Liotta, Dennis C.; Furukawa, Hiro; Snyder, James P.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">548-560, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">NMDA receptors are tetrameric complexes of GluN1, GluN2A-D, and GluN3A-B subunits and are involved in normal brain function and neurol. disorders.  We identified a novel class of stereoselective pyrrolidinone (PYD) pos. allosteric modulators for GluN2C-contg. NMDA receptors, exemplified by Me 4-(3-acetyl-4-hydroxy-1-[2-(2-methyl-1H-indol-3-yl)ethyl]-5-oxo-2,5-dihydro-1H-pyrrol-2-yl)benzoate.  Here we explore the site and mechanism of action of a prototypical analog, PYD-106, which at 30 μM does not alter responses of NMDA receptors contg. GluN2A, GluN2B, and GluN2D and has no effect on AMPA [α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid] and kainate receptors.  Coapplication of 50 μM PYD-106 with a maximally effective concn. of glutamate and glycine increases the response of GluN1/GluN2C NMDA receptors in HEK-293 cells to 221% of that obtained in the absence of PYD (taken as 100%).  Evaluation of the concn. dependence of this enhancement revealed an EC50 value for PYD of 13 μM.  PYD-106 increased opening frequency and open time of single channel currents activated by maximally effective concns. of agonist but only had modest effects on glutamate and glycine EC50.  PYD-106 selectively enhanced the responses of diheteromeric GluN1/GluN2C receptors but not triheteromeric GluN1/GluN2A/GluN2C receptors.  Inclusion of residues encoded by GluN1-exon 5 attenuated the effects of PYD.  Three GluN2C residues (Arg194, Ser470, Lys470), at which mutagenesis virtually eliminated PYD function, line a cavity at the interface of the ligand binding and the amino terminal domains in a homol. model of GluN1/GluN2C built from crystallog. data on GluN1/GluN2B.  We propose that this domain interface constitutes a new allosteric modulatory site on the NMDA receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO8Jlk1LXDrrVg90H21EOLACvtfcHk0ljUSj8bQi46WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFSlur3F&md5=ebc48a2c667046b1adab7037868278e1</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1124%2Fmol.114.094516&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.114.094516%26sid%3Dliteratum%253Aachs%26aulast%3DKhatri%26aufirst%3DA.%26aulast%3DBurger%26aufirst%3DP.%2BB.%26aulast%3DSwanger%26aufirst%3DS.%2BA.%26aulast%3DHansen%26aufirst%3DK.%2BB.%26aulast%3DZimmerman%26aufirst%3DS.%26aulast%3DKarakas%26aufirst%3DE.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DFurukawa%26aufirst%3DH.%26aulast%3DSnyder%26aufirst%3DJ.%2BP.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DStructural%2520determinants%2520and%2520mechanism%2520of%2520action%2520of%2520a%2520GluN2C-selective%2520NMDA%2520receptor%2520positive%2520allosteric%2520modulator%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D86%26spage%3D548%26epage%3D560%26doi%3D10.1124%2Fmol.114.094516" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grand, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paoletti, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span> <span> </span><span class="NLM_article-title">Positive allosteric modulators of GluN2A-containing NMDARs with distinct modes of action and impacts on circuit function</span>. <i>Neuron</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>89</i></span>,  <span class="NLM_fpage">983</span>– <span class="NLM_lpage">999</span>, <span class="refDoi"> DOI: 10.1016/j.neuron.2016.01.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.neuron.2016.01.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=26875626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC28XisFSrtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=2016&pages=983-999&author=D.+H.+Hackosauthor=P.+J.+Lupardusauthor=T.+Grandauthor=Y.+Chenauthor=T.-M.+Wangauthor=P.+Reynenauthor=A.+Gustafsonauthor=H.+J.+Wallweberauthor=M.+Volgrafauthor=B.+D.+Sellersauthor=J.+B.+Schwarzauthor=P.+Paolettiauthor=M.+Shengauthor=Q.+Zhouauthor=J.+E.+Hanson&title=Positive+allosteric+modulators+of+GluN2A-containing+NMDARs+with+distinct+modes+of+action+and+impacts+on+circuit+function&doi=10.1016%2Fj.neuron.2016.01.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function</span></div><div class="casAuthors">Hackos, David H.; Lupardus, Patrick J.; Grand, Teddy; Chen, Yelin; Wang, Tzu-Ming; Reynen, Paul; Gustafson, Amy; Wallweber, Heidi J. A.; Volgraf, Matthew; Sellers, Benjamin D.; Schwarz, Jacob B.; Paoletti, Pierre; Sheng, Morgan; Zhou, Qiang; Hanson, Jesse E.</div><div class="citationInfo"><span class="NLM_cas:title">Neuron</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">89</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">983-999</span>CODEN:
                <span class="NLM_cas:coden">NERNET</span>;
        ISSN:<span class="NLM_cas:issn">0896-6273</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">To enhance physiol. function of NMDA receptors (NMDARs), we identified pos. allosteric modulators (PAMs) of NMDARs with selectivity for GluN2A subunit-contg. receptors.  X-ray crystallog. revealed a binding site at the GluN1-GluN2A dimer interface of the extracellular ligand-binding domains (LBDs).  Despite the similarity between the LBDs of NMDARs and AMPA receptors (AMPARs), GluN2A PAMs with good selectivity against AMPARs were identified.  Potentiation was obsd. with recombinant triheteromeric GluN1/GluN2A/GluN2B NMDARs and with synaptically activated NMDARs in brain slices from wild-type (WT), but not GluN2A knockout (KO), mice.  Individual GluN2A PAMs exhibited variable degrees of glutamate (Glu) dependence, impact on NMDAR Glu EC50, and slowing of channel deactivation.  These distinct PAMs also exhibited differential impacts during synaptic plasticity induction.  The identification of a new NMDAR modulatory site and characterization of GluN2A-selective PAMs provide powerful mol. tools to dissect NMDAR function and demonstrate the feasibility of a therapeutically desirable type of NMDAR enhancement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGros48fNAsozLVg90H21EOLACvtfcHk0ljUSj8bQi46WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XisFSrtbw%253D&md5=38661a9f898df39ba616e77f0bdf34e9</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.neuron.2016.01.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuron.2016.01.016%26sid%3Dliteratum%253Aachs%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DGrand%26aufirst%3DT.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.-M.%26aulast%3DReynen%26aufirst%3DP.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DPaoletti%26aufirst%3DP.%26aulast%3DSheng%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26atitle%3DPositive%2520allosteric%2520modulators%2520of%2520GluN2A-containing%2520NMDARs%2520with%2520distinct%2520modes%2520of%2520action%2520and%2520impacts%2520on%2520circuit%2520function%26jtitle%3DNeuron%26date%3D2016%26volume%3D89%26spage%3D983%26epage%3D999%26doi%3D10.1016%2Fj.neuron.2016.01.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villemure, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrington, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirksen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietz, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ScearceLevie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of GluN2A-selective NMDA receptor positive allosteric modulators (PAMs): tuning deactivation kinetics via structure-based design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">2760</span>– <span class="NLM_lpage">2779</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b02010</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b02010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1ynt70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=2760-2779&author=M.+Volgrafauthor=B.+D.+Sellersauthor=Y.+Jiangauthor=G.+Wuauthor=C.+Q.+Lyauthor=E.+Villemureauthor=R.+M.+Pastorauthor=P.+W.+Yuenauthor=A.+Luauthor=X.+Luoauthor=M.+Liuauthor=S.+Zhangauthor=L.+Sunauthor=Y.+Fuauthor=P.+J.+Lupardusauthor=H.+J.+Wallweberauthor=B.+M.+Liedererauthor=G.+Deshmukhauthor=E.+Pliseauthor=S.+Tayauthor=P.+Reynenauthor=J.+Herringtonauthor=A.+Gustafsonauthor=Y.+Liuauthor=A.+Dirksenauthor=M.+G.+Dietzauthor=Y.+Liuauthor=T.+M.+Wangauthor=J.+E.+Hansonauthor=D.+Hackosauthor=K.+ScearceLevieauthor=J.+B.+Schwarz&title=Discovery+of+GluN2A-selective+NMDA+receptor+positive+allosteric+modulators+%28PAMs%29%3A+tuning+deactivation+kinetics+via+structure-based+design&doi=10.1021%2Facs.jmedchem.5b02010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design</span></div><div class="casAuthors">Volgraf, Matthew; Sellers, Benjamin D.; Jiang, Yu; Wu, Guosheng; Ly, Cuong Q.; Villemure, Elisia; Pastor, Richard M.; Yuen, Po-wai; Lu, Aijun; Luo, Xifeng; Liu, Mingcui; Zhang, Shun; Sun, Liang; Fu, Yuhong; Lupardus, Patrick J.; Wallweber, Heidi J. A.; Liederer, Bianca M.; Deshmukh, Gauri; Plise, Emile; Tay, Suzanne; Reynen, Paul; Herrington, James; Gustafson, Amy; Liu, Yichin; Dirksen, Akim; Dietz, Matthias G. A.; Liu, Yanzhou; Wang, Tzu-Ming; Hanson, Jesse E.; Hackos, David; Scearce-Levie, Kimberly; Schwarz, Jacob B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2760-2779</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The N-methyl-D-aspartate receptor (NMDAR) is a Na+ and Ca2+ permeable ionotropic glutamate receptor that is activated by the coagonists glycine and glutamate.  NMDARs are crit. to synaptic signaling and plasticity, and their dysfunction has been implicated in a no. of neurol. disorders, including schizophrenia, depression, and Alzheimer's disease.  Herein we describe the discovery of potent GluN2A-selective NMDAR pos. allosteric modulators (PAMs) starting from a high-throughput screening hit.  Using structure-based design, we sought to increase potency at the GluN2A subtype, while improving selectivity against related α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs).  The structure-activity relationship of channel deactivation kinetics was studied using a combination of electrophysiol. and protein crystallog.  Effective incorporation of these strategies resulted in the discovery of GNE-0723 (46), a highly potent and brain penetrant GluN2A-selective NMDAR PAM suitable for in vivo characterization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdza-qdjBnZbVg90H21EOLACvtfcHk0li3n8LvKjLV4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1ynt70%253D&md5=2d9f7199cd3d9d9ac513006612e9bb01</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b02010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b02010%26sid%3Dliteratum%253Aachs%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DVillemure%26aufirst%3DE.%26aulast%3DPastor%26aufirst%3DR.%2BM.%26aulast%3DYuen%26aufirst%3DP.%2BW.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DSun%26aufirst%3DL.%26aulast%3DFu%26aufirst%3DY.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DReynen%26aufirst%3DP.%26aulast%3DHerrington%26aufirst%3DJ.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DDirksen%26aufirst%3DA.%26aulast%3DDietz%26aufirst%3DM.%2BG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.%2BM.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26aulast%3DHackos%26aufirst%3DD.%26aulast%3DScearceLevie%26aufirst%3DK.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26atitle%3DDiscovery%2520of%2520GluN2A-selective%2520NMDA%2520receptor%2520positive%2520allosteric%2520modulators%2520%2528PAMs%2529%253A%2520tuning%2520deactivation%2520kinetics%2520via%2520structure-based%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D2760%26epage%3D2779%26doi%3D10.1021%2Facs.jmedchem.5b02010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Villemure, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volgraf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ly, C. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuen, P.-w.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lupardus, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wallweber, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liederer, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plise, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tay, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hackos, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scearce-Levie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwarz, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellers, B. D.</span></span> <span> </span><span class="NLM_article-title">GluN2A-Selective pyridopyrimidinone series of NMDAR positive allosteric modulators with an improved <i>in vivo</i> profile</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">89</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00388</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00388" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=84-89&author=E.+Villemureauthor=M.+Volgrafauthor=Y.+Jiangauthor=G.+Wuauthor=C.+Q.+Lyauthor=P.-w.+Yuenauthor=A.+Luauthor=X.+Luoauthor=M.+Liuauthor=S.+Zhangauthor=P.+J.+Lupardusauthor=H.+J.+Wallweberauthor=B.+M.+Liedererauthor=G.+Deshmukhauthor=E.+Pliseauthor=S.+Tayauthor=T.-M.+Wangauthor=J.+E.+Hansonauthor=D.+H.+Hackosauthor=K.+Scearce-Levieauthor=J.+B.+Schwarzauthor=B.+D.+Sellers&title=GluN2A-Selective+pyridopyrimidinone+series+of+NMDAR+positive+allosteric+modulators+with+an+improved+in+vivo+profile&doi=10.1021%2Facsmedchemlett.6b00388"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00388&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00388%26sid%3Dliteratum%253Aachs%26aulast%3DVillemure%26aufirst%3DE.%26aulast%3DVolgraf%26aufirst%3DM.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DG.%26aulast%3DLy%26aufirst%3DC.%2BQ.%26aulast%3DYuen%26aufirst%3DP.-w.%26aulast%3DLu%26aufirst%3DA.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%26aulast%3DLiederer%26aufirst%3DB.%2BM.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DPlise%26aufirst%3DE.%26aulast%3DTay%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DT.-M.%26aulast%3DHanson%26aufirst%3DJ.%2BE.%26aulast%3DHackos%26aufirst%3DD.%2BH.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSchwarz%26aufirst%3DJ.%2BB.%26aulast%3DSellers%26aufirst%3DB.%2BD.%26atitle%3DGluN2A-Selective%2520pyridopyrimidinone%2520series%2520of%2520NMDAR%2520positive%2520allosteric%2520modulators%2520with%2520an%2520improved%2520in%2520vivo%2520profile%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D8%26spage%3D84%26epage%3D89%26doi%3D10.1021%2Facsmedchemlett.6b00388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Perszyk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katzman, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusumoto, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kell, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epplin, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahirovic, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menaldino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liotta, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Traynelis, S. F.</span></span> <span> </span><span class="NLM_article-title">An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups</span>. <i>eLife</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e34711</span> <span class="refDoi"> DOI: 10.7554/eLife.34711</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.7554%2FeLife.34711" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=29792594" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlyqtrzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&author=R.+Perszykauthor=B.+M.+Katzmanauthor=H.+Kusumotoauthor=S.+A.+Kellauthor=M.+P.+Epplinauthor=Y.+A.+Tahirovicauthor=R.+L.+Mooreauthor=D.+Menaldinoauthor=P.+Burgerauthor=D.+C.+Liottaauthor=S.+F.+Traynelis&title=An+NMDAR+positive+and+negative+allosteric+modulator+series+share+a+binding+site+and+are+interconverted+by+methyl+groups&doi=10.7554%2FeLife.34711"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An NMDAR positive and negative allosteric modulator series share a binding site and are interconverted by methyl groups</span></div><div class="casAuthors">Perszyk, Riley; Katzman, Brooke M.; Kusumoto, Hirofumi; Kell, Steven A.; Epplin, Matthew P.; Tahirovic, Yesim A.; Moore, Rhonda L.; Menaldino, David; Burger, Pieter; Liotta, Dennis C.; Traynelis, Stephen F.</div><div class="citationInfo"><span class="NLM_cas:title">eLife</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">e34711/1-e34711/37</span>CODEN:
                <span class="NLM_cas:coden">ELIFA8</span>;
        ISSN:<span class="NLM_cas:issn">2050-084X</span>.
    
            (<span class="NLM_cas:orgname">eLife Sciences Publications Ltd.</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate receptors (NMDARs) are an important receptor in the brain and have been implicated in multiple neurol. disorders.  Many non-selective NMDAR-targeting drugs are poorly tolerated, leading to efforts to target NMDAR subtypes to improve the therapeutic index.  We describe here a series of neg. allosteric NMDAR modulators with submaximal inhibition at satg. concns.  Modest changes to the chem. structure interconvert neg. and pos. modulation.  All modulators share the ability to enhance agonist potency and are use-dependent, requiring the binding of both agonists before modulators act with high potency.  Data suggest that these modulators, including both enantiomers, bind to the same site on the receptor and share structural determinants of action.  Due to the modulator properties, submaximal neg. modulators in this series may spare NMDAR at the synapse, while augmenting the response of NMDAR in extrasynaptic spaces.  These modulators could serve as useful tools to probe the role of extrasynaptic NMDARs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKDjnf2F9Q17Vg90H21EOLACvtfcHk0lggdLoaH4m9ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlyqtrzM&md5=fc150a9e282d0a5ea34e697e1d43bcfe</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.7554%2FeLife.34711&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7554%252FeLife.34711%26sid%3Dliteratum%253Aachs%26aulast%3DPerszyk%26aufirst%3DR.%26aulast%3DKatzman%26aufirst%3DB.%2BM.%26aulast%3DKusumoto%26aufirst%3DH.%26aulast%3DKell%26aufirst%3DS.%2BA.%26aulast%3DEpplin%26aufirst%3DM.%2BP.%26aulast%3DTahirovic%26aufirst%3DY.%2BA.%26aulast%3DMoore%26aufirst%3DR.%2BL.%26aulast%3DMenaldino%26aufirst%3DD.%26aulast%3DBurger%26aufirst%3DP.%26aulast%3DLiotta%26aufirst%3DD.%2BC.%26aulast%3DTraynelis%26aufirst%3DS.%2BF.%26atitle%3DAn%2520NMDAR%2520positive%2520and%2520negative%2520allosteric%2520modulator%2520series%2520share%2520a%2520binding%2520site%2520and%2520are%2520interconverted%2520by%2520methyl%2520groups%26jtitle%3DeLife%26date%3D2018%26volume%3D7%26doi%3D10.7554%2FeLife.34711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baell, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, G. A.</span></span> <span> </span><span class="NLM_article-title">New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">2719</span>– <span class="NLM_lpage">2740</span>, <span class="refDoi"> DOI: 10.1021/jm901137j</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901137j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2719-2740&author=J.+B.+Baellauthor=G.+A.+Holloway&title=New+substructure+filters+for+removal+of+pan+assay+interference+compounds+%28PAINS%29+from+screening+libraries+and+for+their+exclusion+in+bioassays&doi=10.1021%2Fjm901137j"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays</span></div><div class="casAuthors">Baell, Jonathan B.; Holloway, Georgina A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2719-2740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This report describes a no. of substructural features which can help to identify compds. that appear as frequent hitters (promiscuous compds.) in many biochem. high throughput screens.  The compds. identified by such substructural features are not recognized by filters commonly used to identify reactive compds.  Even though these substructural features were identified using only one assay detection technol., such compds. have been reported to be active from many different assays.  In fact, these compds. are increasingly prevalent in the literature as potential starting points for further exploration, whereas they may not be.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGro_JARcceWjLVg90H21EOLACvtfcHk0lgPoIbnwHVLvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsF2qsLw%253D&md5=fbf397aa4910753c550425708c866fd2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjm901137j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901137j%26sid%3Dliteratum%253Aachs%26aulast%3DBaell%26aufirst%3DJ.%2BB.%26aulast%3DHolloway%26aufirst%3DG.%2BA.%26atitle%3DNew%2520substructure%2520filters%2520for%2520removal%2520of%2520pan%2520assay%2520interference%2520compounds%2520%2528PAINS%2529%2520from%2520screening%2520libraries%2520and%2520for%2520their%2520exclusion%2520in%2520bioassays%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2719%26epage%3D2740%26doi%3D10.1021%2Fjm901137j" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schell, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brady, R. O.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molliver, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, S. H.</span></span> <span> </span><span class="NLM_article-title">D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">1604</span>– <span class="NLM_lpage">1615</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.17-05-01604.1997</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1523%2FJNEUROSCI.17-05-01604.1997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=9030620" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADyaK2sXhtlOmsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=1604-1615&author=M.+J.+Schellauthor=R.+O.+Bradyauthor=M.+E.+Molliverauthor=S.+H.+Snyder&title=D-serine+as+a+neuromodulator%3A+regional+and+developmental+localizations+in+rat+brain+glia+resemble+NMDA+receptors&doi=10.1523%2FJNEUROSCI.17-05-01604.1997"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors</span></div><div class="casAuthors">Schell, Michael J.; Brady, Roscoe O., Jr.; Molliver, Mark E.; Snyder, Solomon H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1604-1615</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">D-Serine is localized in mammalian brain to a discrete population of glial cells near NMDA receptors, suggesting that D-serine is an endogenous agonist of the receptor-assocd. glycine site.  To explore this possibility, the authors have compared the immunohistochem. localizations of D-serine, glycine, and NMDA receptors in rat brain.  In the telencephalon, D-serine is concd. in protoplasmic astrocytes, which are abundant in neuropil in close vicinity to NMDA receptor 2A/B subunits.  Ultrastructural examn. of the CA1 region of hippocampus reveals D-serine in the cytosolic matrix of astrocytes that ensheath neurons and blood vessels, whereas, NR2A/B is concd. in dendritic spines.  By contrast, glycine immunore-activity in telencephalon is the lowest in brain.  During postnatal week 2, D-serine levels in cerebellum are comparable to those in adult cerebral cortex but fall to undetectable levels by day 26.  During week 2, the authors observe parallel ontogeny of D-serine in Bergmann glia and NR2A/B in Purkinje cells, suggesting a role for astrocytic D-serine in NMDA receptor-mediated synaptogenesis.  D-Serine in the radial processes of Bergmann glia is also well positioned to regulate NMDA receptor-dependent granule cell migration.  In the inner granule layer, D-serine is found transiently in protoplasmic astrocytes surrounding glomeruli, where it could regulate development of the mossy fiber/granule cell synapse.  D-Serine seems to be the endogenous ligand of glycine sites in the telencephalon and developing cerebellum, whereas glycine predominates in the adult cerebellum, olfactory bulb, and hindbrain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZcgf__hbuOrVg90H21EOLACvtfcHk0lgPoIbnwHVLvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhtlOmsrY%253D&md5=9c4f92beca536383322b27867f25da66</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.17-05-01604.1997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.17-05-01604.1997%26sid%3Dliteratum%253Aachs%26aulast%3DSchell%26aufirst%3DM.%2BJ.%26aulast%3DBrady%26aufirst%3DR.%2BO.%26aulast%3DMolliver%26aufirst%3DM.%2BE.%26aulast%3DSnyder%26aufirst%3DS.%2BH.%26atitle%3DD-serine%2520as%2520a%2520neuromodulator%253A%2520regional%2520and%2520developmental%2520localizations%2520in%2520rat%2520brain%2520glia%2520resemble%2520NMDA%2520receptors%26jtitle%3DJ.%2520Neurosci.%26date%3D1997%26volume%3D17%26spage%3D1604%26epage%3D1615%26doi%3D10.1523%2FJNEUROSCI.17-05-01604.1997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kartvelishvily, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shleper, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dumin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolosker, H.</span></span> <span> </span><span class="NLM_article-title">Neuron-derived D-serine release provides a novel means to activate N-methyl-D-aspartate receptors</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">14151</span>– <span class="NLM_lpage">14162</span>, <span class="refDoi"> DOI: 10.1074/jbc.M512927200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1074%2Fjbc.M512927200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=16551623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BD28XksFeisLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=14151-14162&author=E.+Kartvelishvilyauthor=M.+Shleperauthor=L.+Balanauthor=E.+Duminauthor=H.+Wolosker&title=Neuron-derived+D-serine+release+provides+a+novel+means+to+activate+N-methyl-D-aspartate+receptors&doi=10.1074%2Fjbc.M512927200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Neuron-derived D-Serine Release Provides a Novel Means to Activate N-Methyl-D-aspartate Receptors</span></div><div class="casAuthors">Kartvelishvily, Elena; Shleper, Maria; Balan, Livia; Dumin, Elena; Wolosker, Herman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">14151-14162</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">D-Serine is a coagonist of N-methyl-D-aspartate (NMDA) receptors that occurs at high levels in the brain.  Biosynthesis of D-serine is carried out by serine racemase, which converts L-to D-serine.  D-Serine has been demonstrated to occur in glial cells, leading to the proposal that astrocytes are the only source of D-serine.  The authors now report significant amts. of serine racemase and D-serine in primary neuronal cultures and neurons in vivo.  Several neuronal culture types expressed serine racemase, and D-serine synthesis was comparable with that in glial cultures.  Immunohistochem. staining of brain sections with new antibodies revealed the presence of serine racemase and D-serine in neurons.  Cortical neurons expressing serine racemase also expressed the NR2a subunit in situ.  Neuron-derived D-serine contributes to NMDA receptor activation in cortical neuronal cultures.  Degrdn. of endogenous D-serine by addn. of the recombinant enzyme D-serine deaminase diminished NMDA-elicited excitotoxicity.  Release of neuronal D-serine was mediated by ionotropic glutamate receptor agonists such as NMDA, α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid, and kainate.  Removal of either external Ca2+ or Na+ blocked D-serine release.  Release of D-serine was mostly through a cytosolic route because it was insensitive to bafilomycin A1, a potent inhibitor of vesicular neurotransmitter uptake.  D-Serine was also not transported into purified synaptic vesicles under conditions optimal for the uptake of known transmitters.  The authors' results suggest that neurons are a major source of D-serine.  Glutamate-induced neuronal D-serine release provides a novel mechanism for activating NMDA receptors by an autocrine or paracrine way.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtkYIUvWVLsLVg90H21EOLACvtfcHk0ljSoKN3spm4vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XksFeisLo%253D&md5=2cabb656cd09b55e9a150749f0adb0a5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M512927200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M512927200%26sid%3Dliteratum%253Aachs%26aulast%3DKartvelishvily%26aufirst%3DE.%26aulast%3DShleper%26aufirst%3DM.%26aulast%3DBalan%26aufirst%3DL.%26aulast%3DDumin%26aufirst%3DE.%26aulast%3DWolosker%26aufirst%3DH.%26atitle%3DNeuron-derived%2520D-serine%2520release%2520provides%2520a%2520novel%2520means%2520to%2520activate%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D14151%26epage%3D14162%26doi%3D10.1074%2Fjbc.M512927200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudolph, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cobb, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balu, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coyle, J. T.</span></span> <span> </span><span class="NLM_article-title">Astrocytes in primary cultures express serine racemase, synthesize d-serine and acquire A1 reactive astrocyte features</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>151</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">251</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2017.12.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.bcp.2017.12.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=29305854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkslKgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=2018&pages=245-251&author=S.+Liauthor=Y.+Unoauthor=U.+Rudolphauthor=J.+Cobbauthor=J.+Liuauthor=T.+Andersonauthor=D.+Levyauthor=D.+T.+Baluauthor=J.+T.+Coyle&title=Astrocytes+in+primary+cultures+express+serine+racemase%2C+synthesize+d-serine+and+acquire+A1+reactive+astrocyte+features&doi=10.1016%2Fj.bcp.2017.12.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Astrocytes in primary cultures express serine racemase, synthesize D-serine and acquire A1 reactive astrocyte features</span></div><div class="casAuthors">Li, Suyan; Uno, Yota; Rudolph, Uwe; Cobb, Johanna; Liu, Jing; Anderson, Thea; Levy, Deborah; Balu, Darrick T.; Coyle, Joseph T.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">245-251</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">D-Serine is a co-agonist at forebrain N-methyl-D-aspartate receptors (NMDAR) and is synthesized by serine racemase (SR).  Although D-serine and SR were originally reported to be localized to glia, recent studies have provided compelling evidence that under healthy physiol. conditions both are localized primarily in neurons.  However, in pathol. conditions, reactive astrocytes can also express SR and synthesize D-serine.  Since cultured astrocytes exhibit features of reactive astrocytes, we have characterized D-serine synthesis and the expression of enzymes involved in its disposition in primary glial cultures.  The levels of SR were quite low early in culture and increased markedly in all astrocytes with the duration in vitro.  The concn. of D-serine in the culture medium increased in parallel with SR expression in the astrocytes.  Microglia, identified by robust expression of Iba1, did not express SR.  While the levels of glial fibrillary acidic protein (GFAP), glycine decarboxylase (GLDC) and phosphoglycerate dehydrogenase (PHGDH), the initial enzyme in the pathway converting glycine to L-serine, remained const. in culture, the expression of lipocalin-2, a marker for pan-reactive astrocytes, increased several-fold.  The cultured astrocytes also expressed Complement-C3a, a marker for a subpopulation of reactive astrocytes (A1).  Astrocytes grown from mice with a copy no. variant assocd. with psychosis, which have four copies of the GLDC gene, showed a more rapid prodn. of D-serine and a redn. in glycine in the culture medium.  These results substantiate the conclusion that A1 reactive astrocytes express SR and release D-serine under pathol. conditions, which may contribute to their neurotoxic effects by activating extra-synaptic NMDARs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwIDj_YSoGobVg90H21EOLACvtfcHk0ljSoKN3spm4vA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkslKgsA%253D%253D&md5=9ae885e6aa789aa1a423793c7921a8f8</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2017.12.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2017.12.023%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DUno%26aufirst%3DY.%26aulast%3DRudolph%26aufirst%3DU.%26aulast%3DCobb%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DT.%26aulast%3DLevy%26aufirst%3DD.%26aulast%3DBalu%26aufirst%3DD.%2BT.%26aulast%3DCoyle%26aufirst%3DJ.%2BT.%26atitle%3DAstrocytes%2520in%2520primary%2520cultures%2520express%2520serine%2520racemase%252C%2520synthesize%2520d-serine%2520and%2520acquire%2520A1%2520reactive%2520astrocyte%2520features%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2018%26volume%3D151%26spage%3D245%26epage%3D251%26doi%3D10.1016%2Fj.bcp.2017.12.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhi, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Chromodomain Y-like protein-mediated histone crotonylation regulates stress-induced depressive behaviors</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">635</span>– <span class="NLM_lpage">649</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2018.11.025</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.biopsych.2018.11.025" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=30665597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFyrtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2019&pages=635-649&author=Y.+Liuauthor=M.+Liauthor=M.+Fanauthor=Y.+Songauthor=H.+Yuauthor=X.+Zhiauthor=K.+Xiaoauthor=S.+Laiauthor=J.+Zhangauthor=X.+Jinauthor=Y.+Shangauthor=J.+Liangauthor=Z.+Huang&title=Chromodomain+Y-like+protein-mediated+histone+crotonylation+regulates+stress-induced+depressive+behaviors&doi=10.1016%2Fj.biopsych.2018.11.025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Chromodomain Y-like Protein-Mediated Histone Crotonylation Regulates Stress-Induced Depressive Behaviors</span></div><div class="casAuthors">Liu, Yongqing; Li, Minghua; Fan, Minghua; Song, Yan; Yu, Huajing; Zhi, Xiaojie; Xiao, Kuo; Lai, Shirong; Zhang, Jingliang; Jin, Xueqin; Shang, Yongfeng; Liang, Jing; Huang, Zhuo</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">635-649</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Major depressive disorder is a prevalent and life-threatening illness in modern society.  The susceptibility to major depressive disorder is profoundly influenced by environmental factors, such as stressful lifestyle or traumatic events, which could impose maladaptive transcriptional program through epigenetic regulation.  However, the underlying mol. mechanisms remain elusive.  Here, we examd. the role of histone crotonylation, a novel type of histone modification, and chromodomain Y-like protein (CDYL), a crotonyl-CoA hydratase and histone methyllysine reader, in this process.  We used chronic social defeat stress and microdefeat stress to examine the depressive behaviors.  In addn., we combined procedures that diagnose behavioral strategy in male mice with histone extn., viral-mediated CDYL manipulations, RNA sequencing, chromatin immunopptn., Western blot, and mRNA quantification.  The results indicate that stress-susceptible rodents exhibit lower levels of histone crotonylation in the medial prefrontal cortex concurrent with selective upregulation of CDYL.  Overexpression of CDYL in the prelimbic cortex, a subregion of the medial prefrontal cortex, increases microdefeat-induced social avoidance behaviors and anhedonia in mice.  Conversely, knockdown of CDYL in the prelimbic cortex prevents chronic social defeat stress-induced depression-like behaviors.  Mechanistically, we show that CDYL inhibits structural synaptic plasticity mainly by transcriptional repression of neuropeptide VGF nerve growth factor inducible, and this activity is dependent on its dual effect on histone crotonylation and H3K27 trimethylation on the VGF promoter.  Our results demonstrate that CDYL-mediated histone crotonylation plays a crit. role in regulating stress-induced depression, providing a potential therapeutic target for major depressive disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5ON7xmtkLJrVg90H21EOLACvtfcHk0lg7vMY_XpN4fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFyrtrc%253D&md5=24fe3342df22401e6178ffde37667c13</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2018.11.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2018.11.025%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DFan%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DZhi%26aufirst%3DX.%26aulast%3DXiao%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DShang%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DJ.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DChromodomain%2520Y-like%2520protein-mediated%2520histone%2520crotonylation%2520regulates%2520stress-induced%2520depressive%2520behaviors%26jtitle%3DBiol.%2520Psychiatry%26date%3D2019%26volume%3D85%26spage%3D635%26epage%3D649%26doi%3D10.1016%2Fj.biopsych.2018.11.025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of fused tricyclic heterocycle piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">10017</span>– <span class="NLM_lpage">10039</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01096</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01096" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVyju7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=10017-10039&author=X.+Caoauthor=Y.+Zhangauthor=Y.+Chenauthor=Y.+Qiuauthor=M.+Yuauthor=X.+Xuauthor=X.+Liuauthor=B.+F.+Liuauthor=L.+Zhangauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+fused+tricyclic+heterocycle+piperazine+%28piperidine%29+derivatives+as+potential+multireceptor+atypical+antipsychotics&doi=10.1021%2Facs.jmedchem.8b01096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41aR"><div class="casContent"><span class="casTitleNuber">41a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Fused Tricyclic Heterocycle Piperazine (Piperidine) Derivatives As Potential Multireceptor Atypical Antipsychotics</span></div><div class="casAuthors">Cao, Xudong; Zhang, Yifang; Chen, Yin; Qiu, Yinli; Yu, Minquan; Xu, Xiangqing; Liu, Xin; Liu, Bi-Feng; Zhang, Liangren; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10017-10039</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, a novel series of multireceptor ligands was developed as polypharmacol. antipsychotic agents using the designed multiple ligand approach between dopamine receptors and serotonin receptors.  Among them, compd. I possessed unique pharmacol. features, exhibiting high affinities for D2, D3, 5-HT1A, 5-HT2A, and 5-HT6 receptors and low efficacy at the off-target receptors (5-HT2C, histamine H1, and adrenergic α1 receptor).  Compd. I showed dose-dependent inhibition of apomorphine- and MK-801-induced motor behavior, and the conditioned avoidance response with low cataleptic effect.  Moreover, compd. I resulted nonsignificantly serum prolactin levels and wt. gain change compared with risperidone.  Addnl., compd. I possessed a favorable pharmacokinetic profile with oral bioavailability of 58.8% in rats.  Furthermore, compd. I displayed procognition properties in a novel object recognition task in rats.  Taken together, compd. I may constitute a novel class of atypical antipsychotic drugs for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowt81tvRDharVg90H21EOLACvtfcHk0lg7vMY_XpN4fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVyju7bI&md5=a75cb3491503c106d136f8a8c71ecc1a</span></div><a href="/servlet/linkout?suffix=cit41a&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01096%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520fused%2520tricyclic%2520heterocycle%2520piperazine%2520%2528piperidine%2529%2520derivatives%2520as%2520potential%2520multireceptor%2520atypical%2520antipsychotics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D10017%26epage%3D10039%26doi%3D10.1021%2Facs.jmedchem.8b01096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit41b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4671</span>– <span class="NLM_lpage">4690</span>, <span class="refDoi"> DOI: 10.1021/jm400408r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400408r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslWmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4671-4690&author=Y.+Chenauthor=S.+Wangauthor=X.+Xuauthor=X.+Liuauthor=M.+Yuauthor=S.+Zhaoauthor=S.+Liuauthor=Y.+Qiuauthor=T.+Zhangauthor=B.+F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+investigation+of+coumarin+piperazine+%28piperidine%29+derivatives+as+potential+multireceptor+atypical+antipsychotics&doi=10.1021%2Fjm400408r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41bR"><div class="casContent"><span class="casTitleNuber">41b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Investigation of Coumarin Piperazine (Piperidine) Derivatives as Potential Multireceptor Atypical Antipsychotics</span></div><div class="casAuthors">Chen, Yin; Wang, Songlin; Xu, Xiangqing; Liu, Xin; Yu, Minquan; Zhao, Song; Liu, Shicheng; Qiu, Yinli; Zhang, Tan; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4671-4690</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The discovery and synthesis of potential and novel antipsychotic coumarin derivs., assocd. with potent dopamine D2, D3, and serotonin 5-HT1A and 5-HT2A receptor properties, are the focus of the present article.  The most-promising deriv. was 7-(4-(4-(6-fluorobenzo[d]isoxazol-3-yl)-piperidin-1-yl)butoxy)-4-methyl-8-chloro-2H-chromen-2-one (I).  This deriv. possesses unique pharmacol. features, including high affinity for dopamine D2 and D3 and serotonin 5-HT1A and 5-HT2A receptors.  Moreover, it possesses low affinity for 5-HT2C and H1 receptors (to reduce the risk of obesity assocd. with chronic treatment) and hERG channels (to reduce the incidence of torsade de pointes).  In animal models, compd. I inhibited apomorphine-induced climbing behavior, MK-801-induced hyperactivity, and the conditioned avoidance response without observable catalepsy at the highest dose tested.  Further, fewer preclin. adverse events were noted with I compared with risperidone in assays that measured prolactin secretion and wt. gain.  Acceptable pharmacokinetic properties were also noted with I.  Taken together, I may constitute a novel class of drugs for the treatment of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoByJHAgVuYCLVg90H21EOLACvtfcHk0lhAeRVx2SiJKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslWmtbw%253D&md5=5862884cd1ca8f74276d266757689334</span></div><a href="/servlet/linkout?suffix=cit41b&amp;dbid=16384&amp;doi=10.1021%2Fjm400408r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400408r%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520investigation%2520of%2520coumarin%2520piperazine%2520%2528piperidine%2529%2520derivatives%2520as%2520potential%2520multireceptor%2520atypical%2520antipsychotics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4671%26epage%3D4690%26doi%3D10.1021%2Fjm400408r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit41c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, G.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of new 6-hydroxypyridazinone benzisoxazoles: Potential multi-receptor targeting atypical antipsychotics</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">713</span>– <span class="NLM_lpage">728</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=10.1016%2Fj.ejmech.2016.09.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=27639363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFentrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=713-728&author=X.+Caoauthor=Y.+Chenauthor=Y.+Zhangauthor=Y.+Qiuauthor=M.+Yuauthor=X.+Xuauthor=X.+Liuauthor=B.+F.+Liuauthor=G.+Zhang&title=Synthesis+and+biological+evaluation+of+new+6-hydroxypyridazinone+benzisoxazoles%3A+Potential+multi-receptor+targeting+atypical+antipsychotics&doi=10.1016%2Fj.ejmech.2016.09.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41cR"><div class="casContent"><span class="casTitleNuber">41c</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of new 6-hydroxypyridazinone benzisoxazoles: Potential multi-receptor-targeting atypical antipsychotics</span></div><div class="casAuthors">Cao, Xudong; Chen, Yin; Zhang, Yifang; Qiu, Yinli; Yu, Minquan; Xu, Xiangqing; Liu, Xin; Liu, Bi-Feng; Zhang, Guisen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">713-728</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">In recent years, multi-targeting directed ligands have attracted great interest as possible new atypical antipsychotics.  Combinations of dopamine and serotonin receptor ligands within single mols. might afford new therapeutic opportunities.  Herein, we describe the synthesis of a novel series of 6-hydroxypyridazinone benzisoxazoles and their binding behaviors to different receptors in terms of atypical antipsychotic behaviors.  The most potent compd. (I) exhibited excellent affinities for certain receptors (D2, Ki = 0.5 ± 0.07 nM; 5-HT1A, Ki = 5.9 ± 0.8 nM; 5-HT2A, Ki = 0.3 ± 0.01 nM; 5-HT6, Ki = 0.5 ± 0.04 nM) and combined with low affinities for the H1, 5-HT2C, and adrenergic α1 receptors.  In contrast to risperidone, compd. I exhibited a high cataleptic threshold; this may be useful in the development of a novel class of drugs treating schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPYNduByBs3rVg90H21EOLACvtfcHk0lhAeRVx2SiJKA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFentrbO&md5=304d05e5fc29593b59031b813b57fc03</span></div><a href="/servlet/linkout?suffix=cit41c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.008%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DB.%2BF.%26aulast%3DZhang%26aufirst%3DG.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520new%25206-hydroxypyridazinone%2520benzisoxazoles%253A%2520Potential%2520multi-receptor%2520targeting%2520atypical%2520antipsychotics%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D713%26epage%3D728%26doi%3D10.1016%2Fj.ejmech.2016.09.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KDT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5KDT','PDB','5KDT'); return false;">PDB: 5KDT</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i139"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02018">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_84532"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02018?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02018</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Figure S1. Effects of FS2921 on NMDA or glycine alone; Figure S2. Whole cell voltage clamp recordings on HEK-293 cells expressing GluN1/GluN2A, GluN1/GluN2B, GluN1/GluN2C or GluN1/GluN2D of FS2921; Figure S3. Effect of FS2921 at native AMPA and GABA receptors; Figure S4. Effects of compounds <b>32c</b>/<b>32o</b> in the FST; Figure S5. Effects of selected compounds administered for hyperactivity in mice; Figure S6. Effects of selected compounds on apomorphine (APO)-induced climbing in mice; Figure S7. Plasma concentration–time profiles for compound <b>20h</b> and compound <b>32h</b>; Figure S8. Concentration–time profiles of compound <b>32h</b> in plasma and cerebrospinal fluid; Figure S9. Effects of compounds <b>20h</b> and <b>32h</b> administered p.o. at 30 mg/kg of the weight of the mice; Table S1. Selected crystal complexes of NMDAR LBD; Table S2. G score and inhibition rate at 10 μM of hit compounds; Table S3. Binding affinities of compound <b>32h</b> for inhibiting radioligand binding to anti-depressant drug targets; Table S4. PK and brain penetration properties of compounds <b>32c</b>/<b>32o</b> in ICR mice (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf">PDF</a>)</p></li><li><p class="inline">PDB ID of the co-crystal structure of GNE0723 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_003.pdb">PDB</a>)</p></li><li><p class="inline">SMILES representation of compounds with key data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_004.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_001.pdf">jm0c02018_si_001.pdf (2.43 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_003.pdb">jm0c02018_si_003.pdb (713.99 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02018/suppl_file/jm0c02018_si_004.csv">jm0c02018_si_004.csv (5.32 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c02018&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-9%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c02018" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c02018" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67994173ad2123c8","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
